Malaysian National Cancer Registry Report 2007-2011

MOH/P/IKN/01.16 (AR)

MOH/P/IKN/01.16 (AR)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT 2007-2011

Azizah Ab M *, Nor Saleha I.T**, Noor Hashimah A***, Asmah Z.A****, Mastulu W***** *Penang State Health Department, ** Disease Control Division, MOH, ***Kelantan State Health Department, ****Perak State Health Department, *****Sarawak State Health Department

Non Communicable Disease Sector Disease Control Division Ministry Of Health MALAYSIA

National Cancer Institute Ministry Of Health Putrajaya MALAYSIA

Published by the National Cancer Institute, Ministry of Health, No 4, Jalan P7, Presint 7, 62250 Putrajaya, MALAYSIA Tel: (603) 88925555 Fax: (603) 88925625 © National Cancer Registry, June 2015 http://nci.moh.gov.my Year of Publication: 2016 Copyright © Ministry of Health Malaysia All rights reserved. This report may not be reproduced, in whole or in part, in any form or means, electronic or mechanical, including photocopying, without written permission from publisher

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

EDITORIAL BOARD: CHIEF EDITOR:

Dr. Azizah Ab Manan, MBBS, MPH

Public Health Physician & State Epidemiologist (NCDC), Penang State Health Department

EDITORS:

Dr. Nor Saleha Ibrahim Tamin, MD, MPH

Public Health Physician & Senior Principal Assistant Director (Head of Cancer Unit) Non-Communicable Disease Sector, Ministry Of Health

Dr. Noor Hashimah Abdullah, MD, MPH

Public Health Physician & State Epidemiologist (NCDC), Kelantan State Health Department

Dr. Asmah Zainal Abidin, MD, MPH

Public Health Physician & State Epidemiologist (NCDC), Perak State Health Department

Mastulu Wahab

Medical Record Assistant, Sarawak State Health Department

SUPPORTING EDITORS: Dr. Misliza Ahmad, MBBS, MPH

Public Health Physician & State Epidemiologist (NCDC) Wilayah Persekutuan Kuala Lumpur & Putrajaya State Health Department

Dr. Renuga K. Raman

Medical Officer & Coordinator of Cancer Registry Unit, National Cancer Institute, Putrajaya

Dr. Nabihah Ali

Medical Officer, Cancer Registry Unit, National Cancer Institute, Putrajaya

Dr. Puteri Nureylia Amir

Medical Officer, Cancer Registry Unit, National Cancer Institute, Putrajaya

Wan Roslida Othman

Statistician, Health Informatic Centre, Ministry Of Health, Putrajaya

SUPPORTING STAFF: Dr. Ruzawati Zahri

Medical Officer (NCDC), Pahang State Health Department

Salina Asha’ari

Staff Nurse, Cancer Registry Unit, National Cancer Institute, Putrajaya

Nik Zanariah Nik Man

Administrator Assistant, Kelantan State Health Department

Muhammad Izzat Mat Isa

Assistant Medical Officer, Kuala Lumpur & Putrajaya State Health Department

Mohd Hafiz Ishak

Assistant Environmental Health Officer, Selangor State Health Department

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

PREFACE FOREWORD MESSAGE ACKNOWLEDGEMENT SECRETARIAT LIST OF TABLES LIST OF FIGURES LIST OF APPENDICES

CONTENTS

ii iii v vi x xi xiii xv

1.0

OVERVIEW

1

2.0

INTRODUCTION

2

3.0

BACKGROUND

4.0

METHODS

5.0

RESULTS

Overall cancer incidence Cancer trends Incidence of ten most common cancers Age variations Age groups and cancers Ethnic variations Staging Data Quality

13 15 16 18 21 23 28 29

6.0

INCIDENCE SUMMARY TABLES: All Sites, 2007-2011

31

7.0

COMMENTARY ON 15 SELECTED CANCER SITES

3.1.

3.2.

3.3.

3.4.

4.1.

4.2.

4.3.

4.4.

4.5.

5.1.

5.2.

5.3.

5.4.

5.5.

5.6.

5.7.

5.8.

Geography Population Health status, socioeconomic and health facilities Cancer Death Certification Sources of data Data collection Registration procedure Quality control Description of statistical methods

7.1.

Female Breast C50 7.2.

Colorectal C18-C21 7.3.

Trachea, Bronchus, Lung C33-C34 7.4.

Lymphoma C81-C85, C96 7.5.

Nasopharynx C11 7.6.

Leukaemia C91-C95 7.7.

Cervix Uteri C53 7.8.

Liver C22 7.9.

Ovary C56 7.10.

Stomach C16 7.11.

Prostate C61 7.12.

Other skin C44 7.13.

Thyroid C73 7.14.

Brain, nervous system C70-C72 7.15.

Corpus Uteri C54

REFERENCES APPENDICES

2 3 5 7 8 8 8 11 11

33 36 39 42 44 47 50 53 56 59 62 65 67 69 71 73 74

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

PREFACE This is the first 5-year report of the Malaysian National Cancer Registry (MNCR) since it was established in all states in 2007 under the Public Health Division, Ministry of Health. The report is based on new cancers diagnosed for the period of 1st January 2007 through to 31st December 2011 and registered by state registries. The data reported in this report were as they stood on 1st June 2015.

The cancer registry database is dynamic, and the data are continually updated in the light of the most recent available information. Accordingly, the numbers in this report for the earlier years may vary slightly from those in previous publications.

The value of cancer registries will be enhanced when they are linked with other well established international databases as these will help to profile the different types of cancers and how such cancers are linked with the specific environmental, socio-cultural, ethnic and other related characteristic inherent in a specific population or defined geographical area. In this report we made the international comparisons with Singapore (Singapore Cancer Registry, Interim Report: Trends in Cancer Incidence in Singapore 2009 – 2013) and with other countries (Cancer Incidence in Five Continents Volume X, 2014).

The registry collects and disseminates reliable population-based cancer data to assist in the planning of services and in the prevention and treatment of cancer. In addition, timely, accurate, reliable and validated information on cancers occurring in the country is crucial in the planning of effective preventive and management strategies for cancer. There will also be research opportunities for those who are keen to study more about the aetiology of common cancers in our population or to look for more innovative ways of diagnosing or treat patients with specific cancers.

Much time and effort has been put into accuracy, completeness and data quality, in the process of collecting the data and in preparing this report. We sincerely hope that the data in this report would be used as a reference material.

We wish to record our thanks to all participating hospitals, clinics, institutions, and laboratories for their corporation and regular notifications to the respective state cancer registries. We also wish to extend our appreciation to Health Informatics Centre (HIC), Ministry of Health for their assistance in active searching of cancer data. Lastly, our deep appreciation to National Cancer Institute staff especially Dr Gerard Lim Chin Chye and Cancer Registry Unit for giving us the full support during the preparation of this report.

ii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

FOREWORD In 2002, the National Cancer Registry (NCR) was operating under the Clinical Research Centre (CRC). In 2007, the NCR and the Regional Cancer Registries were merged and managed by the Non-Communicable Disease Sector, Disease Control Division of the Ministry of Health.

This will be the first Report of the National Cancer Registry that is published after the National Cancer Institute took over as the secretariat on 1st January 2015. The National Cancer Registry will be reporting on Cancer Incidence of Malaysia. Much work has already been carried out by the Disease Control Division of the Ministry of Health, together with the State Epidemiology officers and staff of the State Health Departments.

Staff from both central and state agencies have worked hard, in ensuring the validity of the data which has been gathered. Appreciation is mentioned particularly to Dr. Azizah Abd Manan, Dr. Nor Saleha, Dr. Noor Hashimah, and Dr. Asmah Zainal Abidin and other state epidemiology officers and staff, staff of Cancer Registry Unit of National Cancer Institute (NCI), Health Informatic Centre (PIK) and all who have been contributing in one way or another towards the production of this report. Special mention is made to Dr. Noor Hashimah for allowing the use of her template in the analysis of the data.

Much time and effort has been put into the process of collecting data and ensuring its accuracy, completeness and quality by the National Cancer Registry. It is hoped that this report can provide an insight on cancer incidence in Malaysia which can be used by the health authorities, service providers and researchers. Cancer Registries are crucial in any Cancer Control Programme as the data in the Cancer Registries are needed in developing strategies in primary, secondary and tertiary prevention, as well as health care planning and planning for patient care and research.

The following actions can be taken to improve the future reports: establishing closer rapport with all the Source Data Providers (SDP’s), providing feedback regularly to respective SDP’s including their performance, regular road shows and strengthening human resource. To strengthen and sustain population based cancer registries according to international standards requires meticulous planning, cooperation of medical institutions, dedicated and committed personnel, and adequate resources.

We look forward to further developments of the National Cancer Registry.

Thank you.

DR. GERARD LIM CHIN CHYE Head of Department, Department of Radiotherapy and Oncology National Cancer Institute, Putrajaya

iii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

FOREWORD This 5-year Malaysian National Cancer Registry (MNCR) report, which covers the years 2007 to 2011, is another milestone in the development of healthcare services in this country, whereby it will enable us to appreciate the overall cancer incidence and burden in Malaysia.

The report from this registry will facilitates the planning and institutionalisation of appropriate measures and the distribution of cancer care. The overall benefits derived from this result will be reflected in our ability to provide effective healthcare services which is in line with the 11th Malaysia Plan (RMK-11). Cancer trends represent a subtle interplay between incidence, mortality and survival. These patterns are altering due to many interacting causes such as early detection, screening programmes, changing exposure to risk factors and advances in cancer care.

The Government will intensify its efforts to increase quality of health care by targeting the areas that has lack of access to health services by uplifting the capacity of healthcare facilities, and trained health personnel.

Regional Cancer Registries such as Penang, Johor, Kelantan, Pahang, Melaka, Sabah and Sarawak have each published a 5-year report. The Penang Cancer Registry has published its third 5-year report since it was established in 1994; its report has also been included in the Cancer Incidence in Five Continents Volume IX, 2007 and Volume X, 2014.

We thank all the physicians, epidemiologists, pathologists, statisticians and data managers in hospitals, State Cancer Registries and Ministry of Health who have effortlessly collaborated and cooperated in supporting the Malaysia Cancer Registry. Our special thanks for this publication go to all our data managers who have worked so meticulously to compile the present information. We are also grateful to all of our close collaborators and look forward to continue this effort.

I would also like to acknowledge and place on record the excellent teamwork by members of the Cancer Unit of Disease Control Division, Health Informatics Centre (Pusat Informatik Kesihatan), the State Epidemiology Officers (NCDC) and staff, and Cancer Registry Unit of National Cancer Institute who have been involved in producing, gathering and processing the data for the Malaysia Cancer Registry. The close rapport between the source data providers, experts and staff of the NCR is one of the main reasons for the success of the NCR. We look forward to continuation of these efforts in providing reliable national data on cancer.

Thank you.

iv

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

MESSAGE Cancer constitutes an enormous burden on societies globally. The occurrence of cancer is increasing because of growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity and changing reproductive patterns associated with urbanization and economic development. According to WHO, cancer is among the leading causes of morbidity and mortality worldwide with approximately 14 million new cases and 8.2 million cancer related deaths in 2012. More than 60% of the world’s total new annual cases occur in Africa, Asia and Central and South America.

These regions account of 70% of the world’s cancer deaths. It is expected that annual cancer cases will escalate from 14 million in 2012 to 22 million within the next 2 decades.

In 2013, World Health Organization (WHO) had launched the global action plan for the prevention and control of non-communicable disease 2013-2020 that aims to reduce premature mortality from cancer and other NCDCs by 25%. The World Health Organization Members State agreed that among the indicators of progress in the fight against NCDCs is the need to record “cancer incidence, by type of cancer, per 100,000 populations”, thus placing an onus on countries to establish population- based cancer registries and to report on the progress.

The National Cancer Registry provides important epidemiological data of cancers, cancer burdens, trending and high risk group identification. The National Cancer Registry is one of the key priorities in the National Cancer Control Blueprint 2008-2015. Previously the National Cancer Registry was run by the Disease Control Division at the Ministry of Health until 2014. Since January 2015, the NCR is now within the jurisdiction of the National Cancer Institute, Putrajaya. Data for the year 2015 and onwards will be handled and managed by the NCI, Cancer Registry Unit.

Cancer registration should never be a goal in itself. The global objective is to improve the quality of life for cancer survivors and outcome of cancer treatments. Registration takes into account prognostic variables and allows individual feedback to all cancer centres on process and outcome indicators. Joint venture researches and the use of cancer registry data by researchers show that the effort invested by all authorities involved in public health has been successful. Let us continue this path to be at par with international examples on population- based cancer researches.

Thank you.

DATUK SERI DR. S. SUBRAMANIAM Minister of Health, MALAYSIA

v

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

ACKNOWLEDGEMENT We would like to express gratitude to all individuals and organisations that have directly or indirectly contributed to the Malaysian National Cancer Registry Report, 2007-2011.

We would like to thank especially the following: 1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

The Honourable Minister of Health Malaysia, Y.B. Datuk Seri Dr. S. Subramaniam.

Director General of Health Malaysia, YBhg. Datuk Dr. Noor Hisham Bin Abdullah.

Deputy Director General of Health Malaysia (Public Health), YBhg. Datuk Dr. Lokman Hakim b. Sulaiman.

Deputy Director General of Health Malaysia (Medical), YBhg. Datuk Dr. Jeyaindran Tan Sri Sinnadurai.

Deputy Director General of Health Malaysia (Research & Technical Support), YBhg. Datuk Dr. Shahnaz Bt. Murad.

Head of Department, Department of Radiotherapy and Oncology, National Cancer Institute, Putrajaya, Dr. Gerard Lim Chin Chye.

Deputy Director Health Informatics Centre, Planning Division, Ministry of Health, Malaysia, Dr. Md. Khadzir b Sheikh Haji Ahmad State Health Directors.

Deputy State Directors.

Oncologists, pathologists, other disciplines specialists, palliative care professionals, and all other members of the medical profession from various government, universities, non-government and private centres.

Director of National Registration Department.

Medical record departments of all hospitals.

All hospitals, institutions, public and private clinics.

We also would like to express our gratitude to all states Epidemiology Officers (NCDCC), Medical Officers, Statisticians, Paramedics, Assistant Record Officers and Clerical Staff at all State Cancer Registries, for continuously collecting and contributing data to the National Cancer Registry.

Epidemiologist and Medical Officer of State Cancer Registries: 1.

Dr. Zulhizzam Hj. Abdullah Public Health Physician & State Epidemiologist (NCDC), Perlis State Health Department Dr. Husna Hakimah Tajau Rahim Medical Officer (NCDC), Perlis State Health Department

2.

Dr. Shahrul Bariyah Ahmad Public Health Physician & State Epidemiologist (NCDC), Kedah State Health Department Dr. Muhamad Fadhil Mohamad Marzuki Medical Officer (NCDC), Kedah State Health Department

3.

Dr. Azizah Ab Manan Public Health Physician & State Epidemiologist (NCDC), Penang State Health Department Dr. Muhammad Ihsan Suhaidi Medical Officer (NCDC), Penang State Health Department

vi

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

4.

Dr. Asmah Zainal Abidin Public Health Physician & State Epidemiologist (NCDC), Perak State Health Department

5.

Dr. Norli Abd Jabbar Public Health Physician & State Epidemiologist (NCDC), Selangor State Health Department Dr. Ozrinalifah Omar Medical Officer (NCDC), Selangor State Health Department

6.

Dr. Misliza Ahmad Public Health Physician & State Epidemiologist (NCDC), WP. Kuala Lumpur (WPKL) & Putrajaya State Health Department

7.

Dr. Khalijah Mohd Yusof Public Health Physician & State Epidemiologist (NCDC), Negeri Sembilan State Health Department Dr. Murni Hayati Baharom Medical Officer (NCDC), Negeri Sembilan State Health Department

8.

Dr. Suhaila Osman Public Health Physician & State Epidemiologist (NCDC), Melaka State Health Department

9.

Dr. Yusmah Muhamad Public Health Physician & State Epidemiologist (NCDC), Johor State Health Department Dr. Rahayu Othman Medical Officer (NCDC), Johor State Health Department

10. Dr. Fatimah A. Majid Public Health Physician & State Epidemiologist (NCDC), Pahang State Health Department Dr. Ruzawati Zahri Medical Officer (NCDC), Pahang State Health Department 11. Dr. Fatimah Muda Public Health Physician & State Epidemiologist (NCDC), Terengganu State Health Department 12. Dr. Noor Hashimah Abdullah Public Health Physician & State Epidemiologist (NCDC), Kelantan State Health Department 13. Dr. Hashimah Basri Public Health Physician & State Epidemiologist (NCDC), Sarawak State Health Department 14. Dr. Nirmal Kaur A/P Sadhu Singh Public Health Physician & State Epidemiologist (NCDC), Sabah State Health Department Dr. Nafisah Ahmad Medical Officer (NCDC), Sabah State Health Department 15. Dr. Wan Mohd Harith Wan Mustapa Medical Officer (NCDC), W.P. Labuan State Health Department

vii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Special gratitude to all stakeholders for their support and valuable comments on the report: 1.

Dato’ Dr. Abd Jamil Abdullah National Advisor for Surgery, Sultanah Nur Zahirah Hospital

2.

Dr. Arni Talib National Advisor for Pathology, Kuala Lumpur Hospital

3.

Dr. Azura Daniel Head of Department, Department of Radiotherapy & Oncology, Kuala Lumpur Hospital

4.

Dato’ Dr. Chang Kian Meng National Advisor for Hematology, Ampang Hospital

5.

Prof. Dr. Cheong Soon Keng Dean of Medical & Health Science Faculty, Tunku Abdul Rahman University

6.

Dato’ Dr. Fitjerald Henry National Advisor for Colorectal Surgery, Selayang Hospital

7.

Assc. Prof. Dato’ Dr. Fuad Ismail Head of Department, Department of Radiotherapy & Oncology, Universiti Kebangsaan Malaysia Medical Centre

8.

Dato’ Dr. Ghazali Ismail National Advisor for Gynaecology Oncology, Sultan Ismail Hospital

9.

Dr. Goh Pik Pin Director of National Clinical Research Centre

10.

Dr. Hishamshah Mohd Ibrahim National Advisor for Paediatric Oncology, Kuala Lumpur Hospital

11.

Dr. Jamaiyah Haniff Head of Unit, Malaysia Health Care Performance

12.

Dr. Jamalul Azizi Abdul Rahaman National Advisor for Respiratory Medicine, Serdang Hospital

13.

Dr. Krishnan Raman National Advisor for Hepatobiliary Surgery, Selayang Hospital

14.

Dr. Lim Teck Onn Senior Consultant, ClinResearch Sdn. Bhd.

15.

Dr. Matin Mellor Abdullah President of Malaysian Oncology Society, Subang Jaya Medical Centre

16.

Dr. Mohd Roslan Haron National Advisor for Radiotherapy & Oncology, Sultan Ismail Hospital

viii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

17. Dato’ Dr. Muhammad Radzi Abu Hassan National Advisor for Gastroenterology, Sultanah Bahiyah Hospital 18. Dato’ Sri Dr. N. Premchandran National Advisor for Orthopaedic Surgery, Tengku Ampuan Hafzan Hospital 19. Dr. Nor Aina Emran National Advisor for Breast and Endocrine Surgery, Kuala Lumpur Hospital 20. Prof. Dr. Nur Aishah Mohd Taib Breast Surgeon, Department of Surgery, University Malaya Medical Centre 21. Dr. Richard Lim Boon Leong National Advisor for Palliative Medicine, Selayang Hospital 22. Dato’ Dr. Rohan Malek Dato’ Dr. Johan Thambu National Advisor for Urology, Selayang Hospital 23. Dr. Saunthari Somasundram President of National Cancer Society of Malaysia 24. Datin Dr. Siti Sabzah Mohd Hashim National Advisor for Otolaryngology, Sultanah Bahiyah Hospital 25. Prof. Dr. Teo Soo Hwang Cancer Research Initiatives Foundation (CARIF), Subang Jaya Medical Centre Gratitude also to the international reviewers: 1.

Mr. Les Mery (International Agency for Research on Cancer, Lyon, France) Global Programme Manager, Global Initiative for Cancer Registry Development.

2.

Dr. Suleeporn Sangrajrang (NCI Bangkok, Thailand) Medical Scientist, Expert Level Deputy Director, Health System Development, National Cancer Institute, Thailand.

To all others who had contributed directly and indirectly towards this report.

ix

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

SECRETARIAT The National Cancer Registry (NCR) previously was under the Non-Communicable Disease Sector, Disease Control Division, at the Ministry of Health. Since January 2015, its secretariat had been transferred to the National Cancer Institute in Putrajaya.

Secretariat of the National Cancer Registry (2007 - 2014) 1.

Dr. Chong Chee Kheong Director of Non-Communicable Disease Sector, Disease Control Division, Ministry of Health

2.

Dr. Zainal Ariffin Omar Deputy Director of Non-Communicable Disease Sector, Disease Control Division, Ministry of Health

3.

Dr. Nor Saleha Ibrahim Tamin Head of Cancer Unit, Non-Communicable Disease Sector, Disease Control Division, Ministry of Health

4.

Dr. Renuga K. Raman (2013-2014) Senior Assistant Director

5.

Puan Raja Rohanira Raja Taib Administrative Assistant

6.

Puan Dayang Pujiah Awang Shamsudin Administrative Assistant

Secretariat of the National Cancer Registry (Starting from 1st January 2015 until present) .

1.

Dr. Asmayani Khalib Director of National Cancer Institute

2.

Dr. Gerard Lim Chin Chye Head of Radiotherapy and Oncology Department, National Cancer Institute

3.

Dr. Renuga K. Raman Medical Officer & Coordinator of Cancer Registry Unit, National Cancer Institute

4.

Dr. Nabihah Ali Medical Officer of Cancer Registry Unit, National Cancer Institute

5.

Dr. Puteri Nureylia Amir Medical Officer of Cancer Registry Unit, National Cancer Institute

6.

Salina Asha’ari Staff Nurse of Cancer Registry Unit, National Cancer Institute

x

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

LIST OF TABLES Table 1 Table 2 Table 3 Table 4 Table 5 Table 6 Table 7 Table 8 Table 9 Table 10 Table 11 Table 12 Table 13 Table 14 Table 15 Table 16 Table 17 Table 18 Table 19 Table 20 Table 21 Table 22 Table 23 Table 24 Table 25 Table 26 Table 27 Table 28 Table 29 Table 30 Table 31 Table 32 Table 33 Table 34 Table 35 Table 36 Table 37 Table 38 Table 39 Table 40

xi

Malaysian population, 2011 Malaysian citizens by sex, 2011 Malaysian citizens by ethnic groups, 2011 Malaysian population by state and area of land coverage, 2011 Gross domestic product (GDP) per capita, Malaysia, 2007-2011 Health facilities and number of Doctors in Malaysia, 2007-2011 Number of new cancer cases, Crude Rate (CR), Age-standardised rate (ASR), Cumulative Risk (CumR) and Lifetime Risk by sex, Malaysia, 2007-2011 Incidence summary by major ethnic groups and sex, Malaysia, 2007-2011 Incidence summary by state and sex, Malaysia, 2007-2011 ASR by sex comparing Malaysia, Penang, Sarawak Cancer Registry 2007-2011 and Globocan 2012 Ten most common cancers, all residents, Malaysia, 2007-2011 Ten most common cancers in Malaysia by sex, all residents, 2007-2011 Age-standardised rates for ten most common cancer in males by ethnicity, Malaysia, 2007-2011 Age-standardised rates for ten most common cancer in females by ethnicity, Malaysia, 2007-2011 Ten most common cancers in Malaysia, Malay residents by sex, 2007-2011 Ten most common cancers in Malaysia, Chinese residents by sex, 2007-2011 Ten most common cancers in Malaysia, Indian residents by sex, 2007-2011 Ten most common cancers in Malaysia, other ethnic groups by sex, 2007-2011 Staging for all cancer types, Malaysia, 2007-2011 Quality Indicator Summary of all cancer sites 2007-2011 by sex, year and ethnic Summary of all cancer sites 2007-2011 by states Female Breast: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Female Breast: Incidence summary by ethnicity, Malaysia, 2007-2011 Female Breast: Incidence summary by year, Malaysia, 2007-2011 Colorectal: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Colorectal: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Colorectal: Incidence summary by year and sex, Malaysia, 2007-2011 Trachea, Bronchus, Lung: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Trachea, Bronchus, Lung: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Trachea, Bronchus, Lung: Incidence summary by year and sex, Malaysia, 2007-2011 Lymphoma: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Lymphoma: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Lymphoma: Incidence summary by year and sex, Malaysia, 2007-2011 Nasopharynx: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Nasopharynx: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Nasopharynx: Incidence summary by year and sex, Malaysia, 2007-2011 Leukaemia: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Leukaemia: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Leukaemia: Incidence summary by year and sex, Malaysia, 2007-2011

Page 4 4 4 4 5 6 13 13 13 14 16 17 23 23 24 25 26 27 28 30 31 31 33 33 33 36 36 36 39 39 39 42 42 42 44 44 44 47 47 47

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Table 41 Cervix Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Table 42 Cervix Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011 Table 43 Cervix Uteri: Incidence summary by year, Malaysia, 2007-2011 Table 44 Liver: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Table 45 Liver: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Table 46 Liver: Incidence summary by year and sex, Malaysia, 2007-2011 Table 47 Ovary: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Table 48 Ovary: Incidence summary by ethnicity, Malaysia, 2007-2011 Table 49 Ovary: Incidence summary by year, Malaysia, 2007-2011 Table 50 Stomach: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Table 51 Stomach: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Table 52 Stomach: Incidence summary by year and sex, Malaysia, 2007-2011 Table 53 Prostate: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Table 54 Prostate: Incidence summary by ethnicity, Malaysia, 2007-2011 Table 55 Prostate: Incidence summary by year, Malaysia, 2007-2011 Table 56 Other skin: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Table 57 Other skin: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Table 58 Other skin: Incidence summary by year and sex, Malaysia, 2007-2011 Table 59 Thyroid: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Table 60 Thyroid: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Table 61 Thyroid: Incidence summary by year and sex, Malaysia, 2007-2011 Table 62 Brain, Nervous system: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Table 63 Brain, Nervous system: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Table 64 Brain, Nervous system: Incidence summary by year and sex, Malaysia, 2007-2011 Table 65 Corpus Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Table 66 Corpus Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011 Table 67 Corpus Uteri: Incidence summary by year, Malaysia, 2007-2011

Page 50 50 50 53 53 53 56 56 56 59 59 59 62 62 62 65 65 65 67 67 67 69 69 69 71 71 71

xii

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

LIST OF FIGURES Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 Figure 9 Figure 10 Figure 11 Figure 12 Figure 13 Figure 14 Figure 15 Figure 16 Figure 17 Figure 18 Figure 19 Figure 20 Figure 21 Figure 22 Figure 23 Figure 24 Figure 25 Figure 26 Figure 27 Figure 28 Figure 29 Figure 30 Figure 31 Figure 32 Figure 33 Figure 34 Figure 35 Figure 36 Figure 37 Figure 38 Figure 39 Figure 40 Figure 41 Figure 42 Figure 43 Figure 44 Figure 45 Figure 46 Figure 47 Figure 48

xiii

Map of Malaysia Population pyramid, Malaysia, all residents, 2011 Perinatal, Neonatal, Infant and Maternal mortality rates in MOH Hospitals, Malaysia, 2007-2011 Number of medically certified and non-medically certified cancer death, Malaysia, 2007-2011 Certified and uncertified cancer death, Malaysia, 2007-2011 Outline of registration procedures Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Annual Age-standardised rate (ASR) by sex, Malaysia, 2007-2011 Percentage of ten most common cancers, all residents, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancer by sex, Malaysia, 2007-2011 Age-specific incidence rate by sex, all sites, Malaysia, 2007-2011 Age-specific incidence rate for ten common sites, males, Malaysia 2007-2011 Age-specific incidence rate for ten common sites, females, Malaysia, 2007-2011 Common cancers among 0-14 years age group by sex, Malaysia, 2007-2011 Common cancers among 15-24 years age group by sex, Malaysia, 2007-2011 Common cancers among 25-59 years age group by sex, Malaysia, 2007-2011 Common cancers among 60-74 years age group by sex, Malaysia, 2007-2011 Common cancers in 75 years and above age group by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in Malays by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in Chinese by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in Indians by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in other ethnic groups by sex, Malaysia, 2007-2011 All sites: International comparisons- Age standardised rates Female Breast: Age-specific incidence rate, Malaysia, 2007-2011 Female Breast: Stage Female Breast: Age-standardised rate (ASR) by state, Malaysia, 2007-2011 Female Breast: International comparisons- Age standardised rates Colorectal: Age-specific incidence rate by sex, Malaysia, 2007-2011 Colorectal: Stage by sex Colorectal: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Colorectal: International comparisons- Age standardised rates Trachea, Bronchus, Lung: Age -specific incidence rate by sex, Malaysia, 2007-2011 Trachea, Bronchus ,Lung: Stage by sex Trachea, Bronchus, Lung: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Trachea, Bronchus, Lung: International comparisons- Age standardised rates Lymphoma: Age-specific incidence rate by sex, Malaysia, 2007-2011 Lymphoma: Stage by sex Lymphoma: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Nasopharynx: Age-specific incidence rate by sex, Malaysia, 2007-2011 Nasopharynx: Stage by sex Nasopharynx: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Nasopharynx: International comparisons- Age-standardised rates Leukaemia: Age-specific incidence rate by sex, Malaysia, 2007-2011 Leukaemia types: Age-specific incidence rate, males, Malaysia, 2007-2011 Leukaemia types: Age-specific incidence rate, females, Malaysia, 2007-2011 Leukaemia: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Leukaemia: International comparisons- Age-standardised rates Cervix Uteri: Age-specific incidence rate ,Malaysia, 2007-2011

Page 3 3 5 7 7 10 14 15 16 18 18 19 20 21 21 21 22 22 24 25 26 27 32 34 34 34 35 37 37 37 38 40 40 40 41 43 43 43 45 45 45 46 47 48 48 48 49 51

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 49 Figure 50 Figure 51 Figure 52 Figure 53 Figure 54 Figure 55 Figure 56 Figure 57 Figure 58 Figure 59 Figure 60 Figure 61 Figure 62 Figure 63 Figure 64 Figure 65 Figure 66 Figure 67 Figure 68 Figure 69 Figure 70 Figure 71 Figure 72 Figure 73 Figure 74 Figure 75 Figure 76 Figure 77 Figure 78 Figure 79

Cervix Uteri: Stage Cervix Uteri: Age-standardised rate (ASR) by state, Malaysia 2007-2011 Cervix Uteri: International comparisons- Age-standardised rates Liver: Age-specific incidence rate by sex, Malaysia, 2007-2011 Liver: Stage by sex Liver: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Liver: International comparisons- Age-standardised rates Ovary: Age-specific incidence rate, Malaysia, 2007-2011 Ovary: Stage Ovary: Age-standardised rate (ASR) by state, Malaysia, 2007-2011 Ovary: International comparisons- Age-standardised rates Stomach: Age-specific incidence rate by sex, Malaysia, 2007-2011 Stomach: Stage by sex Stomach: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Stomach: International comparisons- Age-standardised rates Prostate: Age-specific incidence rate, Malaysia, 2007-2011 Prostate: Stage Prostate: Age-standardised rate (ASR) by state, Malaysia, 2007-2011 Prostate: International comparisons- Age-standardised rates Other Skin: Age-specific incidence rate by sex, Malaysia, 2007-2011 Other Skin: Stage by sex Other Skin Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Thyroid: Age-specific incidence rate by sex, Malaysia, 2007-2011 Thyroid: Stage by sex Thyroid: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Brain, Nervous system: Age-specific incidence rate by sex, Malaysia, 2007-2011 Brain, Nervous system: Stage by sex Brain, Nervous system: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011 Corpus Uteri: Age-specific incidence rate, Malaysia, 2007-2011 Corpus Uteri: Stage Corpus Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

Page 51 51 52 54 54 54 55 57 57 57 58 60 60 60 61 63 63 63 64 66 66 66 68 68 68 70 70 70 72 72 72

xiv

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

LIST OF APPENDICES Appendix 1 Appendix 2 Appendix 3 Appendix 4 Appendix 5 Appendix 6 Appendix 7 Appendix 8 Appendix 9 Appendix 10 Appendix 11 Appendix 12 Appendix 13 Appendix 14 Appendix 15 Appendix 16 Appendix 17 Appendix 18 Appendix 19 Appendix 20 Appendix 21 Appendix 22 Appendix 23 Appendix 24 Appendix 25 Appendix 26 Appendix 27 Appendix 28 Appendix 29 Appendix 30 Appendix 31 Appendix 32 Appendix 33 Appendix 34 Appendix 35 Appendix 36 Appendix 37 Appendix 38 Appendix 39 Appendix 40 Appendix 41 Appendix 42 Appendix 43 Appendix 44 Appendix 45 Appendix 46 Appendix 47

xv

Person-years at risk by sex, ethnic and age group, Malaysian residents, 2007-2011 Person-years at risk by sex, state and age group, Malaysian residents, 2007-2011 Person-years at risk, all Malaysian, 2007-2011 Person-years at risk, Malay residents, Malaysia, 2007-2011 Person-years at risk, Chinese residents, Malaysia, 2007-2011 Person-years at risk, Indian residents, Malaysia, 2007-2011 Person-years at risk, Others residents, Malaysia, 2007-2011 Incidence summary table, all residents, males, Malaysia, 2007-2011 Incidence summary table, all residents, females, Malaysia, 2007-2011 Incidence summary table, Malay males, Malaysia, 2007-2011 Incidence summary table, Malay females, Malaysia, 2007-2011 Incidence summary table, Chinese males, Malaysia, 2007-2011 Incidence summary table, Chinese females, Malaysia, 2007-2011 Incidence summary table, Indian males, Malaysia, 2007-2011 Incidence summary table, Indian females, Malaysia, 2007-2011 Incidence summary table, Others males, Malaysia, 2007-2011 Incidence summary table, Others females, Malaysia, 2007-2011 Incidence summary table of 15 selected cancer sites by state and sex, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, all residents, males, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, all residents, females, Malaysia, 2007-2011 Cancer incidence by sites and age group, all residents, males, Malaysia, 2007-2011 Cancer incidence by sites and age group, all residents, females, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Malay males, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Malay females, Malaysia, 2007-2011 Cancer incidence by sites and age group, Malay males, Malaysia, 2007-2011 Cancer incidence by sites and age group, Malay females, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Chinese males, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Chinese females, Malaysia, 2007-2011 Cancer incidence by sites and age group, Chinese males, Malaysia, 2007-2011 Cancer incidence by sites and age group, Chinese females, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Indian males, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Indian females, Malaysia, 2007-2011 Cancer incidence by sites and age group, Indian males, Malaysia, 2007-2011 Cancer incidence by sites and age group, Indian females, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Others males, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Others females, Malaysia, 2007-2011 Cancer incidence by sites and age group, Others males, Malaysia, 2007-2011 Cancer incidence by sites and age group, Other females, Malaysia, 2007-2011 Number of new cancer cases by sites and age group, Selangor, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Selangor, all residents, females, 2007-2011 Cancer incidence by sites and age group, Selangor, all residents, males, 2007-2011 Cancer incidence by sites and age group, Selangor, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Johor, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Johor, all residents, females, 2007-2011 Cancer incidence by sites and age group, Johor, all residents, males, 2007-2011 Cancer incidence by sites and age group, Johor, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Sabah, all residents, males, 2007-2011

Page 74 75 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Appendix 48 Appendix 49 Appendix 50 Appendix 51 Appendix 52 Appendix 53 Appendix 54 Appendix 55 Appendix 56 Appendix 57 Appendix 58 Appendix 59 Appendix 60 Appendix 61 Appendix 62 Appendix 63 Appendix 64 Appendix 65 Appendix 66 Appendix 67 Appendix 68 Appendix 69 Appendix 70 Appendix 71 Appendix 72 Appendix 73 Appendix 74 Appendix 75 Appendix 76 Appendix 77 Appendix 78 Appendix 79 Appendix 80 Appendix 81 Appendix 82 Appendix 83 Appendix 84 Appendix 85 Appendix 86 Appendix 87 Appendix 88 Appendix 89 Appendix 90 Appendix 91 Appendix 92 Appendix 93

Number of new cancer cases by sites and age group, Sabah, all residents, females, 2007-2011 Cancer incidence by sites and age group, Sabah, all residents, males, 2007-2011 Cancer incidence by sites and age group, Sabah, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Sarawak, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Sarawak, all residents, females, 2007-2011 Cancer incidence by sites and age group, Sarawak, all residents, males, 2007-2011 Cancer incidence by sites and age group, Sarawak, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Perak, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Perak, all residents, females, 2007-2011 Cancer incidence by sites and age group, Perak, all residents, males, 2007-2011 Cancer incidence by sites and age group, Perak, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Kedah, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Kedah, all residents, females, 2007-2011 Cancer incidence by sites and age group, Kedah, all residents, males, 2007-2011 Cancer incidence by sites and age group, Kedah, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, WPKL & Putrajaya, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, WPKL & Putrajaya, all residents, females, 2007-2011 Cancer incidence by sites and age group, WPKL & Putrajaya, all residents, males, 2007-2011 Cancer incidence by sites and age group, WPKL & Putrajaya, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Kelantan, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Kelantan, all residents, females, 2007-2011 Cancer incidence by sites and age group, Kelantan, all residents, males, 2007-2011 Cancer incidence by sites and age group, Kelantan, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Penang, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Penang, all residents, females, 2007-2011 Cancer incidence by sites and age group, Penang, all residents, males, 2007-2011 Cancer incidence by sites and age group, Penang, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Pahang, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Pahang, all residents, females, 2007-2011 Cancer incidence by sites and age group, Pahang, all residents, males, 2007-2011 Cancer incidence by sites and age group, Pahang, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Terengganu, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Terengganu, all residents, females, 2007-2011 Cancer incidence by sites and age group, Terengganu, all residents, males, 2007-2011 Cancer incidence by sites and age group, Terengganu, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Negeri Sembilan, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Negeri Sembilan, all residents, females, 2007-2011 Cancer incidence by sites and age group, Negeri Sembilan, all residents, males, 2007-2011 Cancer incidence by sites and age group, Negeri Sembilan, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Melaka, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Melaka, all residents, females, 2007-2011 Cancer incidence by sites and age group, Melaka, all residents, males, 2007-2011 Cancer incidence by sites and age group, Melaka, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, Perlis, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, Perlis, all residents, females, 2007-2011 Cancer incidence by sites and age group, Perlis, all residents, males, 2007-2011

Page 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172

xvi

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Appendix 94 Appendix 95 Appendix 96 Appendix 97 Appendix 98 Appendix 99 Appendix 100 Appendix 101

xvi

Cancer incidence by sites and age group, Perlis, all residents, females, 2007-2011 Number of new cancer cases by sites and age group, W.P. Labuan, all residents, males, 2007-2011 Number of new cancer cases by sites and age group, W.P. Labuan, all residents, females, 2007-2011 Cancer incidence by sites and age group, W.P. Labuan, all residents, males, 2007-2011 Cancer incidence by sites and age group, W.P. Labuan, all residents, females, 2007-2011 Morphologically verified cases by histology types, all sites, Malaysia, 2007-2011 Cancer Notification Form Explanatory notes for completing Cancer Notification Form

Page 173 174 175 176 177 178 201 202

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

1.0 OVERVIEW The first five year report of the Malaysian National Cancer Registry attempts to provide information on cancer incidence from 2007 to 2011 on cases which were reported and recorded in thirteen states and two federal territories. This report will serve as a baseline by which future reports will be compared with. It is recommended that in this report, caution is advised in the interpretation of the incidence of cancer rather than focusing on the absolute numbers and rates of the burden of cancer. The profile of cancer should be looked at in terms of distribution by age, ethnicity, sex and geography. The incidence varies between states partialy due to the difference of population structure, for example the incidence rates in Penang are among the highest and this could be due to higher proportion of Chinese in Penang compared to other states.

1.1 Cancer Incidence A total number of 103,507 new cancer cases were diagnosed in Malaysia during the period of 2007 to 2011. Of these 46,794 (45.2%) were reported in males and 56,713 (54.8%) in females. The age standardised incidence rates (ASR) for males and females were 86.9 and 89.0 per 100,000 population in males and females respectively.

The ASR in Chinese males were 112.9 per 100,000 population while in females were 126.2 per 100,000 population, Malay males were 70.7 per 100,000 population and females were 81.9 per 100,000 population, Indian males were 70.4 per 100,000 population and females were 110.1 per 100,000 population. The five most common cancers among males were cancers of the colorectal, lung, nasopharynx, lymphoma and prostate. Among females, the five most common were cancers of the breast, colorectal, cervix uteri, ovary and lung.

Further analysis was done based on six regional registries which were established before 2007 (Penang, Kelantan, Pahang, Johor, Sabah, Sarawak). The ASR were higher compared to the incidence based on all state registries which were 100.0 per 100,000 population in males and 109.0 per 100,000 population in females. As the period of coverage of the report begins in 2007, and since registries generally require several years of operation before they attain adequate levels of data quality (defined as completeness of case ascertainment, accuracy and timeliness of reporting), the main concern is underreporting in the nine new registries, for this more time would be required for other registries to mature.

1.2 Staging The stage of cancer at the time of diagnosis was reported based on information provided by the notifying clinician.

The staging system was based on the TNM Classification System for most tumour sites. In total 51.0% of recorded cases had reports on staging, of those cases whose staging was recorded, 17.1% in stage I, 23.6% in stage II, 23.0% in stage III and 35.8% in stage IV.

1

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

2.0 INTRODUCTION Ministry of Health has started its population-based cancer registry in 1993. It was started with regional population-based cancer registries to ensure long term sustainability. Penang was chosen as a pilot location in 1994 to cover northern region. Following this, other regional registries were established in Sarawak, Kelantan, Pahang, Johor and Sabah. Since 2007 all states in Malaysia had set up their own population-based registries which were headed by National Cancer Registry in the Ministry of Heatlh under the Non-Communicable Disease Sector, Disease Control Division. The secretariat for the NCR has been transferred to the National Cancer Institute (NCI) since 1st January 2015.

Cancer is one of the leading causes of death in Malaysia today. This report aims to provide an epidemiological profile of cancer, which is important in the National Cancer Control Programme. Cancer represents a tremendous burden on patients, families and the society they live in. Besides financial cost, cancer has an important psychosocial effect on patients and their families.

Specification of cancer incidence with varying degrees of confidence is fundamental for cancer control. These data do not only establish the burden of disease as it may impinge upon public health and clinical services planning, they also indicate in many instances, causative relationships, the impact of socioeconomic differences and priorities that maybe accorded to particular cancer control options.

This is the first five year national report which covers the period of 2007-2011. This MNCR report follows reports for 2003-2005, 2006, 2007 and 2008. The initial reports only covered cancer incidence among all residents in Peninsular Malaysia. Meanwhile the subsequent reports in 2007 and 2008 covered residents in all states in Malaysia. This 2007-2011 report applied to Malaysian citizens living in Malaysia at the time of diagnosis. The population denominator used was the 2009 intercensal population. The Segi World Standard Population (1960) was applied as a reference in calculating the ASR.

3.0 BACKGROUND 3.1 Geography Malaysia covers an area of about 330,289 sq. km, consisting of Peninsular Malaysia and East Malaysia (Sabah, Sarawak and Federal Territory of Labuan). It is separated by the South China Sea and has its frontier with Thailand, Singapore, Indonesia and Brunei.

Peninsular Malaysia is located south of Thailand, north of Singapore and east of the Indonesian Island of Sumatera. East Malaysia comprises most of the northern part of Borneo and shares borders with Brunei and Indonesia. Located near the equator, Malaysia’s climate is categorised as equatorial, being hot and humid throughout the year.

Malaysia is divided into thirteen states and three Federal Territories. Eleven states and two Federal Territories are found in Peninsular Malaysia meanwhile, two states and one Federal Territory are found in East Malaysia.

The Peninsular Malaysia consists of the following states (from north to south): Perlis, Kedah, Pulau Pinang (Penang), Perak, Selangor, Federal Territory of Kuala Lumpur and Putrajaya (WPKL & Putrajaya), Negeri Sembilan, Melaka, Johor, Pahang, Terengganu and Kelantan. The East Malaysia consists of Sabah, Sarawak and Federal Territory Labuan (W.P. Labuan).

2

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Petunjuk: Eastern Region Northern Region Central Region Southern Region East Malaysia

SOUTH CHINA SEA

SARAWAK

BORNEO

Figure 1: Map of Malaysia

3.2 Population The estimated Malaysian population in 2011 was 29.1 million including the non-citizens. The population pyramid and its distribution of ethnic, sex and age group is shown in Figure 2, Table 2 and Table 3 respectively. Overall, there were 50.7% males and 49.3% females (Table 2). The ethnic distribution was as follows: Malay 54.7%, Chinese 24.3%, Indian 7.3%, other Bumiputera 12.8% and others 0.9%. In addition, there were almost 2.5 million non-citizens (8.4%) in Malaysia (Table 1). Intercensal Population Estimates are data that will be reviewed every ten years after Population and Housing Census is conducted using the final data on births and deaths. The projection is calculated yearly and used the cohort-component method which contained births, deaths, internal and international migration of the reference year. These estimates provide an overview of the growth and potential changes in population in terms of structure and compositions.

Source: Dept. of Statistics Malaysia

Figure 2: Population pyramid, Malaysia, all residents, 2011

3

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Table 1: Malaysian population, 2011 Citizenship Citizen Non-citizen Total

Numbers 26,617,100 2,445,000 29,062,100

% 91.6 8.4 100.0

Numbers 13,489,100 13,127,800 26,616,100

% 50.7 49.3 100.0

Numbers 14,551,300 6,471,100 1,939,700 3,654,800 26,616,900

% 54.7 24.3 7.3 13.7 100.0

Source: Dept. of Statistics Malaysia

Table 2: Malaysian citizens by sex, 2011 Sex Male Female Total Source: Dept. of Statistics Malaysia

Table 3: Malaysian citizens by ethnic groups, 2011 Ethnic Malay Chinese Indian *Others Total * Other Bumiputera and Others Source: Dept. of Statistics Malaysia

Table 4: Malaysian population by state and area of land coverage, 2011 Ethnics State

Total

Malay Numbers

Chinese %

%

Numbers

Other Bumiputera

Others

%

Numbers

%

Numbers

%

Area (Km²)

Selangor

5,126,200

2,869,200 56.0

1,460,900 28.5

685,900 13.4

73,800

1.4

36,400

0.7

7,930

Johor

3,131,700

1,792,300 57.2

1,049,900 33.5

220,200

7.0

54,900

1.8

14,400

0.5

18,987

Sabah

2,446,700

232,300

9.5

298,300 12.2

10,400

0.4

1,801,500 73.6

104,300

4.3

73,620

Sarawak

2,399,000

578,400 24.1

589,300 24.6

7,200

0.3

1,217,100 50.7

7,000

0.3 124,450

Perak

2,326,800

1,264,500 54.3

701,500 30.1

285,700 12.3

66,300

2.8

8,800

0.4

21,005

Kedah

1,898,700

1,481,200 78.0

256,900 13.5

137,300

7.2

4,700

0.2

18,700

1.0

9,425

Kelantan

1,578,200

1,492,400 94.6

52,800

4,600

0.3

17,700

1.1

10,600

0.7

15,105

W.P. Kuala Lumpur

1,544,800

692,300 44.8

659,800 42.7

159,200 10.3

18,700

1.2

14,600

0.9

243

Penang

1,493,700

648,700 43.4

674,900 45.2

159,000 10.6

6,400

0.4

4,600

0.3

1,031

Pahang

1,446,300

1,067,800 73.8

232,900 16.1

64,000

4.4

75,300

5.2

6,300

0.4

35,965

Terengganu

1,055,100

1,019,500 96.6

26,900

2,800

0.3

3,800

0.4

2,100

0.2

12,955

Negeri Sembilan

985,300

584,500 59.3

226,900 23.0

151,000 15.3

19,500

2.0

3,600

0.4

6,657

Melaka

797,600

521,300 65.4

210,700 26.4

47,700

6.0

13,600

1.7

4,200

0.5

1652

Perlis

230,300

202,700 88.0

18,900

8.2

3,100

1.3

1,100

0.5

4,600

2.0

795

W.P. Labuan

81,200

31,100 38.3

10,100 12.4

700

0.9

37,700 46.4

1,600

2.0

92

W.P. Putrajaya

75,500

73,000 96.7

900

1.2

1,000

0

0.0

49

TOTAL

26,616,900

14,551,300

Note: The added total may differ due to rounding Source: Dept. of Statistics Malaysia

4

Numbers

Indian

500 6,471,100

3.3

2.5

0.7

1,939,700

3,413,100

1.3

3,413,100

329,961

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

3.3 Health Status, Socioeconomic and Health Facilities.

The health status of Malaysia has also been enhanced by improvement in health infrastructure and health services.

Since Independence in 1957, changes in disease pattern in relation to lifestyle related conditions are occurring. Life expectancy in Malaysia at birth for both sexes has increased over the years, rising from 56 years for males and 58 for females in 1957 to 72.2 years for males and 76.8 years for females in 2011. Over the same period, the crude death rate fell from 12.4 per 1,000 population to 4.7. The average crude birth rate from 2007 to 2011 was 17.66 per 1,000 population and the crude of natural increase in average from 2007 to 2011 was 13.04 per 1,000 population (Department of Statistics Malaysia, Time Series Data). A decrease in perinatal, infant and maternal mortality rates from 2007 to 2011 are viewed in Figure 3. The gross domestic product (GDP) per capita 2007-2011 in Malaysia is depicted in Table 5.

* Health Facts source Health Informatics Centre, MOH

Figure 3: Perinatal, Neonatal, Infant and Maternal mortality rates in MOH Hospitals, Malaysia, 2007-2011

Table 5: Gross domestic product (GDP) per capita, Malaysia, 2007-2011 Year GDP per capita, Malaysia (USD

2007 7,241

2008 8,487

2009 7,312

2010 9,069

2011 10,427

* World Development Indicators, World Bank

5

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

The following table provides an overview of the health delivery system in Malaysia. An overall number of health facilities and doctors treating all types of diseases are seen in Table 6. From 2007 to 2011 the number of doctors to the population ratio had increased from 1:791 to 1:1,145. Gradual increases in a total number of hospitals were from 371 in 2007 to 409 in 2011. Whereas, there was also increase in hospital beds (Government MOH, Government Non-MOH, and Private) from 51,923 in 2007 to 55,789 in 2011. Other public health facilities include 1Malaysia Clinics, Government (MOH) and Private (GP), form a total of 5,822 in 2007 and have increased to 9,547 by the year 2011.

Table 6: Health facilities and number of Doctors in Malaysia, 2007-2011 No. of Medical Officer Government (MOH) Government (non-MOH) Private Total Doctor: Population ratio Hospitals Government (MOH) Government (non-MOH) Private Total Hospitals Beds Government (MOH) Government (non-MOH) Private Total Health Clinics 1Malaysia Clinics Government (MOH) Private (GP) Total

2007

2008

2009

2010

2011

12,273 2,025 9,440 23,738 1:1,145

13,096 2,000 10,006 25,102 1:1,105

17,302 2,890 10,344 30,536 1:927

19,429 3,000 10,550 32,979 1:859

22,437 3,408 10,762 36,607 1:791

136 6 229 371

136 7 246 389

136 8 245 389

137 8 254 399

138 8 263 409

37,293 2,908 11,722 51,923

37,934 3,245 12,165 53,344

38,057 3,523 12,619 54,199

37,793 3,690 13,576 55,059

38,394 3,322 14,073 55,789

NA 2,830 2,992 5,822

NA 2,824 6,371 9,195

NA 2,818 6,307 9,125

53 2,833 6,442 9,328

109 2,849 6,589 9,547

Private Hospitals: Private Hospitals, Private Maternity Home, Private Nursing Home And Hospice Government (MOH) Health Clinics: Health Clinic, Community Clinic, Maternal and Child Health Clinic Government (non-MOH) Hospitals: Army Hospitals, University Hospitals 1Malaysia Clinic: initiated in 2010 Source: Health Indicators Ministry of Health Malaysia, Health Facts Ministry of Health Malaysia

6

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

3.4

Cancer Death Certification

A total of 64,275 medically certified and non-medically certified cancer deaths were reported by the National Registration Department of the period 2007 to 2011. Over the years, the numbers of medically certified cancer deaths have gradually increased. However, the number of non-medically certified cancer death remained relatively unchanged (Figure 4). Medically Certified Death was certified by medical practitioners with Malaysian Medical Council, which involves medical officers, district health officers and coroners. Non-medically Certified Death certified by persons such as policemen, medical assistants and other informants. The proportion of medically certified cancer death is 64.3% and non-medically certified cancer death is 35.7% (Figure 5).

Source: Department of Statistic, Malaysia

Figure 4: Number of medically certified and non-medically certified cancer death, Malaysia, 2007-2011

Source: Department of Statistic, Malaysia

Figure 5: Certified and uncertified cancer death, Malaysia, 2007-2011

7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

4.0 METHODS 4.1 Sources of data The registry sought to obtain basic epidemiological and clinical data on all cases of cancer diagnosed in Malaysia since 1st January 2007, regardless of citizenship, place of stay and basis of diagnosis. The registry received notifications from all data source providers in government and private health facilities (hospitals, clinics, laboratories, Hospice, National Registration Department and Health Informatics, MOH) in Malaysia. The National Cancer Registry team consolidated information from all state registries.

4.2. Data Collection Case registration is based primarily on voluntary notifications. All identified data providers were asked to provide information concerning cancer on the standardised forms as attached in Appendix 100 and were sent to the respective registries. Patient confidentiality was maintained at all times. Both passive and active case finding methods were used by the registries.

Passive notification – registry relies on other healthcare workers to complete notification forms and forward them to the registry.

Active search – collecting at source, whereby registry staff would visit the sources of data to extract the required information and record it onto forms, or to obtain copies of the relevant information.

To ensure completeness of the data, active case finding and routine checks were done using government and private hospital discharge records, as well as pathology records from the public and private laboratories. These were supplemented by case detection from death records supplied by the National Registration Department. Any cancer case detected from pathology and death records were then checked with previously registered cases. If they were not yet notified, reminders were sent to the person in-charge for more information. Additional missing data for these cases were also sought by registry staff by searching the relevant hospital records.

4.3. Registration Procedure Every item relating to the patient were collated and updated. The registry registered all new cases of cancer diagnosed in Malaysia. Multiple sources of data had assisted in optimising completeness of collection; however, this could create problem of multiple notification of a patient. This issue was addressed by cross checking names, age, date of birth and National Registration Identity Card numbers (NRIC) using CanReg4 software prior to the case registration. Identification card number is a unique number given to each Malaysian citizen and permanent resident.

Children below 12 years of age are registered under their mother’s identification card number. In this report, the population is divided into 5 ethnic groups which are ‘Malay’, ‘Chinese’, ‘Indian’, ‘Other Bumiputera’ and ‘Others’.

‘Other Bumiputera’ refers to indigenous peoples, natives of Sarawak and Sabah meanwhile, ‘Others’ refers to ethnic groups which are not mentioned in other ethnic groups. The CanReg program accommodates comparison of essential variables across cases. 80% conformity is the standard used to trigger a further check of duplication.

If the patient has been registered before, a check will be done along with the previous notifications to ascertain if it was a new primary. If the cancer is a new primary, the case is registered with a new registration number and if it is not, the records are updated.

Data from hospital discharges and reports from laboratories and death list from National Registration Department (NRD) were also sent to the registry and the same procedures were followed as described above.

8

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Every effort was made to ensure that all the variables were completed. In the event if there was incomplete information, the notification forms with incomplete information were sent back to the respective data providers for further clarification and returned back to the registry upon completion. If there were no clarification, or incomplete forms returned, registries staff would visit the source providers to obtain the required information and to decide whether the case can be registered or not. For most cases the staging used was TNM Classification System.

However, for cases with other staging classifications the registry staff assisted in converting it to TNM Classification System too.

Death certificate list were obtained from the National Registration Department, government and private hospitals in the same procedures as explained earlier. Those with mention of cancer on death certificate were identified, and transcripts of associated reports or certificates were used by the registry. If no information was available, then the case would be registered as Death Certificate Only (DCO). All updated information collected on hardcopies, either passively or actively, were entered into the computer database. Electronic data maintained in the cancer registry databases were subjected to on-going quality control.

9

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

NRIC: National Ragistration Identification Card, RN: Registration Number, ICD-O: International Classification of Disease for Oncology

Figure 6: Outline of registration procedure

10

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

4.4

Quality control

In order to achieve a high validity and accuracy of data the Malaysian National Cancer Registry (MNCR) has used the same five common indices as indicated in the Cancer Incidence in Five Continents (CI5), Vol X, which are (a) Internal consistency; (b) Histological verification; (c) Death certificate only (DCO); (d) Other and unspecified cases (ill-defined cases ) and (e) Age unknown.

All data supplied for this report were coded to ICD-O-3 and then were converted to ICD-10 for analysis and report writing. To ensure data comparability, all cases notified to the registry must follow the IARC rules.

4.5

Description of statistical methods 4.5.1

Crude incidence rate (CR)

The number of new cancer cases (incidence cases) observed in the population during a defined period, divided by the number of population at risk in the same period. It is usually expressed per 100,000.

4.5.2

CR = N / P x 100,000 N – Total number of new cancer cases P – Person-years at risk

Age-specific rate (AR)

Incidence rate in a specified five-year age group; calculated by dividing the number of cancer cases in the five-year age group by the Malaysian population in the particular age group and multiply by 100,000.

4.5.3

AR = N i / Pi x 100,000 Ni - Number of new cancer occurring in the ith age group Pi – Person-years at risk in the i th age group

Age-standardised rate (ASR)

Since the incidence of cancer depends heavily on the age structure of the population, there is a need for age adjustment for comparative analysis. The age-standardised incidence rate is a summary measure, indicating the rate that a population would have if it had a standard age structure.

It is calculated by summing the age-specific rates weighting to the world standard population; the calculated incidence rate is then called the World Standardised incidence rate. It is also expressed per 100,000.

ASR = ∑ (AR i x Pi.std ) / total world standard population

ARi - Age specific rate in the ith age class

Pi.std - The number in the ith age class of world standard population

4.5.4

Standard error (SE)

As with any measurement of a population, incidence rates have a certain amount of chance variation. The index measure of this variability is known as the standard error and is computed as follows:

SE = √ ∑i di (wi /yi) 2 di - Number of cases of the cancer of interest in the age class i w i - Standard world population for age class i yi - Person-years at risk for age class i

11

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

4.5.5

95% Confidence Limit of ASR (95% CL)

ASRs are subject to random variation around the true underlying rate. 95% confidence limits are endpoints of a range in which the true rate would be expected to fall 95% of the time. 95%CLs are computed from the standard error (SE) of the ASR using the following formula:

4.5.6

95% CL = ASR ± (1.96 x SE)

Cumulative rate (CR74)

Cumulative rate is the weighted sum of age-specific incidence rates until completion of 74 years of age.

The weighting used in this calculation is based simply on the widths of the age groups, i.e. multiplying the five-year age-sex specific rates per person by 5 and summing over age groups from 0-4 to 70-74. CR74 is necessary in order to ascertain the cumulative risk and is expressed in percentages.

4.5.7

CR74 = 5 x ∑i (d i /y i ) x 100 i - 5-year age groups d i – Number of cases in age class i y i – Person-years at risk of age class i

Cumulative risk (CumR)

Cumulative risk is defined as a probability that an individual would develop cancer during a certain age period, in the absence of any competing cause of death. The age period over which the risk is accumulated in this report is 0-74 years. The precise mathematical relationship between the cumulative rate and the cumulative risk is:

4.5.8

CumR = 100 x [1 – exp (- CR74/100)] exp - exponential

Lifetime risk

Lifetime risk is defined as the likelihood that a person who is free of a certain type of cancer will develop or die from that type of cancer during his or her lifetime. Lifetime risk estimates are usually expressed as the odds of developing cancer (‘1 in x’) or as a percentage.

12

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

5.0 RESULTS 5.1 Overall cancer incidence A total of 103,507 new cancer cases were diagnosed in Malaysia for the period of 2007- 2011.

The age-standardised rates (ASR) were 86.9 per 100,000 males and 99.3 per 100,000 females. The cumulative risk (CumR) was 9.8 for males and 10.6 for females, representing the risks of males and females in Malaysia developing cancer before the age of 75, in the absence of other causes of death. The lifetime risk for males was 1 in 10 and 1 in 9 for females (Table 7). The incidence was highest among Chinese for both sexes (ASR: 112.9 per 100,000 population in male and 126.2 per 100,000 populations in female).

Table 7: Number of new cancer cases, Crude Rate (CR), Age-standardised rate (ASR), Cumulative Risk (CumR) and Lifetime Risk by sex, Malaysia, 2007-2011 Sex Males Females Both

Number 46,794 56,713 103,507

% 45.2 54.8 100.0

CR 71.4 89.0

ASR 86.9 99.3

CR74 10.3 11.2

CumR 9.8 10.6

Lifetime Risk 10 9

Table 8: Incidence summary by major ethnic groups and sex, Malaysia, 2007-2011 Ethnicity Malay Chinese Indian Others*

Male

Number

CR

18,757 20,424 2,679 4,934

53.1 124.4 56.0 55.0

ASR

CumR

70.7 112.9 70.4 80.5

8.0 12.5 8.1 9.2

Number 24,188 22,114 4,798 5,613

Female CR ASR 69.5 81.9 143.2 126.2 101.2 110.1 64.4 89.6

CumR 8.7 13.2 12.2 9.7

* Other Bumiputera and Others: ‘Other Bumiputera’ includes indigenous peoples, natives of Sarawak and natives of Sabah while ‘Others’ other than mentioned before not including missing ethnicity.

A comparison of age-standardised rates in Table 9 ranging from 51 to 151 per 100,000 in males and 42 to 158 per 100,000 in females are due to the difference in population structure and size. The small population in Labuan could also contribute to the limitation of the report and the rates could fluctuate in such instances.

Table 9: Incidence summary by state and sex, Malaysia, 2007-2011 State Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan

Number

Male CR

ASR

6,261 7,202 3,522 4,549 4,465 2,774 2,277 2,105 5,245 2,193 1,668 1,917 1,811 405 53

49.3 91.8 58.9 76.4 77.9 59.6 59.5 54.8 144.1 60.9 63.7 79.0 94.2 46.2 26.5

71.3 109.0 93.6 85.7 74.7 66.5 73.1 68.0 150.5 75.1 83.1 89.1 104.7 72.8 50.9

Number

Male CR

ASR

8,484 8,110 4,045 5,185 5,504 3,565 3,307 2,281 6,085 2,499 1,977 2,528 2,214 495 51

69.2 109.4 69.8 90.3 96.6 76.7 88.3 59.6 166.6 73.6 79.1 106.9 110.2 86.4 26.8

89.7 118.7 105.3 100.2 88.4 77.0 101.2 65.8 157.8 82.6 93.8 108.9 108.1 84.9 41.7

13

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

The cancer incidence reported in this publication is different from the estimates of WHO publication in Globocan 2012. The incidence rate reported by Globocan was higher compared to MNCR. The WHO Globocan data was an estimate with the purpose of comparing the distribution of cancer cases in the world. This comparison was done among countries using best available data for the respective countries. The estimation of ASR for Malaysia was based on Penang and Sarawak Registries where the ethnic distributions were not similar to the national distribution.

Table 10: ASR by sex comparing Malaysia, Penang, Sarawak Cancer Registry 2007-2011 and Globocan 2012 ASR

State

Male 86.9 144.9 150.5 85.7

Malaysian National Cancer Registry (total of 15 states) Globocan 2012 Penang Cancer Registry Sarawak Cancer Registry

Female 99.3 143.4 157.8 100.2

*Globocan 2012: Simple mean of the incidence rates recorded in Peninsular Malaysia, Penang (2006), Penang (2004-2008) and Sarawak (1998-2002)

200

Males

180

Females

Incidence per 100,000

160 140 120 100 80 60 40 20 0

r

go

an

l Se

Jo

r

ho

Sa

h

ba

r Sa

ak

aw

Pe

ra

k

Ke

h

ya

da

W

L PK

&

P

ja ra ut

ng na

n

a nt

la Ke

State

Pe

ng ha

Pa

n u la an bi gg m n e re iS Te er eg N

a ak

el M

Figure 7: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

14

s rli Pe W

n ua ab L . .P

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

5.2 Cancer trends The annual cancer incidence in Malaysia varied over the 5 years (2007-2011) in males between 80.9 and 90.2, and in females between 93.8 and 102.6.

200 180

Male

Female

Incidence per 100,000

160 140 120

102.6

102.3

98.4

98.8

89.7

90.2

87.9

85.4

80.9

2007

2008

2009

2010

2011

100 80 60

93.8

40 20 0

Year

Figure 8: Annual age-standardised rate (ASR) by sex, Malaysia, 2007-2011

15

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

5.3 Incidence of ten most common cancers The three most common cancers among Malaysian residents were breast followed by colorectal and lung (Table 11 and Figure 9). The most common cancer among male and female residents was colorectal and breast respectively (Table 12 and Figure 10).

Table 11: Ten most common cancers, all residents, Malaysia, 2007-2011 ICD-10 C50 C18-C21 C33-C34 C81-C85,C96 C11 C91-C95 C53 C22 C56 C16

Sites Breast Colorectal Trachea, Bronchus, Lung Lymphoma Nasopharynx Leukaemia Cervix Uteri Liver Ovary Stomach Others Total

Number 18,343 13,693 10,608 5,374 5,090 4,573 4,352 4,128 3,472 3,461 30,413 103,507

Figure 9: Percentage of ten most common cancers, all residents, Malaysia, 2007-2011

16

% 17.7 13.2 10.2 5.2 4.9 4.4 4.2 4.0 3.4 3.3 29.4 100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Table 12: Ten most common cancers in Malaysia by sex, all residents, 2007-2011 ICD-10

Sites

Number

%

CR

ASR

Male C18-C21

Colorectal

7,646

16.3

11.7

14.6

C33-C34

Trachea, Bronchus, Lung

7,415

15.8

11.3

14.4

C11

Nasopharynx

3,785

8.1

5.8

6.4

C81-C85,C96

Lymphoma

3,171

6.8

4.8

5.5

C61

Prostate

3,132

6.7

4.8

6.6

C22

Liver

3,054

6.5

4.7

5.6

C91-C95

Leukaemia

2,549

5.4

3.9

4.2

C16

Stomach

2,014

4.3

3.1

3.9

C67

Bladder

1,477

3.2

2.3

2.9

C44

Other Skin

1,384

3.0

2.1

2.7

Others

11,167

23.9

Total

46,794

100.0

71.4

86.9

C50

Breast

18,206

32.1

28.6

31.1

C18-C21

Colorectal

6,047

10.7

9.5

11.1

C53

Cervix Uteri

4,352

7.7

6.8

7.6

C56

Ovary

3,472

6.1

5.4

5.9

C33-C34

Trachea, Bronchus, Lung

3,193

5.6

5.0

6.0

C81-C85,C96

Lymphoma

2,203

3.9

3.5

3.8

C54

Corpus Uteri

2,181

3.8

3.4

3.8

C91-C95

Leukaemia

2,024

3.6

3.2

3.4

C73

Thyroid

1,723

3.0

2.7

2.9

C16

Stomach

1,447

2.6

2.3

2.6

Others

11,865

20.9

Total

56,713

100.0

89.0

99.3

Female

17

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Male

Female 14.6

Trachea,Bronchus,Lung

14.4

Sites

Colorectal

Prostate

6.6

Nasopharynx

6.4

Liver

5.6

Lymphoma

5.5

Leukaemia

4.2

Stomach

3.9

Bladder

2.9

Other Skin

2.7

0

5

10

.0

15

20

Incidence per 100,000

Figure 10: Age-standardised rate (ASR) for ten common cancers by sex, Malaysia 2007-2011

5.4 Age variations The incidence of cancer increased for both males and females after the age of 30 years (Figure 11). The incidence rate in males exceeded the incidence rate in females after the age of 60 years.

Figure 11: Age-specific incidence rate by sex, all sites, Malaysia, 2007-2011

18

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 12: Age-specific incidence rate for ten common sites, males, Malaysia, 2007-2011

19

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 13: Age-specific incidence rate for ten common sites, females, Malaysia, 2007-2011

20

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

5.5 Age groups and cancers The five most common cancers by sex in each of the five broad age groups are shown in Figures 14-18.

In children below age of 14 years, main cancers in both sexes were leukaemia (47.1% in males, 45.5% in females) followed by brain, nervous system (13.8% in males, 16.0% in females) and lymphoma (11.3% in males, 8.4% in females). Childhood cancer age 0 to 18 years old comprised of 3,829 cases, 2,131 (55.7%) cases were males and 1,698 (44.3%) cases were females.

Male

Female

Figure 14: Common cancers among 0-14 years age group by sex, Malaysia, 2007-2011 In the 15-24 year age group, the most common cancers in males were leukaemia (23.0%) followed by lymphoma (20.9%) and bone cancer (9.4%). While in females, the most common cancers were lymphoma (17.7%) was followed by leukaemia (15.3%) and ovarian cancer (14.5%).

Male

Female

Figure 15: Common cancers among 15-24 years age group by sex, Malaysia, 2007-2011 In the group aged 25-59 years, colorectal cancer was the most common cancer in males (16.0%), followed by nasopharyngeal cancer (13.7%), and lung cancer (13.4%). The most common cancers seen in females were breast (40.7%), cervix uteri (8.9%) and colorectal cancers (7.6%).

Male

Female

Figure 16: Common cancers among 25-59 years age group by sex, Malaysia, 2007-2011

21

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

In the 60-74 year age group, the most common cancers in males were lung (19.8%), colorectal (18.3%) and prostate cancers (10.4%). In females the most common cancers were breast (24.4%), colorectal (15.4%) and lung cancers (8.8%).

Male

Female

Figure 17: Common cancers among 60-74 years age group by sex, Malaysia, 2007-2011 In the group aged 75 years and above, cancer of the lung remained the most common cancer among males (19.1%) followed by colorectal (19.1%) and prostate cancers (14.5%). In females, colorectal cancer (21.3%) was followed by cancer of the breast (14.5%) and lung (10.3%).

Male

Female

Other skin

Figure 18: Common cancers in 75 years and above age group by sex, Malaysia, 2007-2011

22

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

5.6 Ethnic variations The incidences of cancer among the ethnic groups for ten common cancers are shown in Table 13 and Table 14. In males, the incidence of colorectal, lung, nasopharynx, prostate, and liver cancers were more common in Chinese whereas leukaemia and bladder cancers were more common in Malays. In females, the incidence of breast, colorectal, ovarian and lung cancers were more common in Chinese whereas leukaemia and thyroid cancer were more common in Malays.

Table 13: Age-standardised rates for ten most common cancers in males by ethnicity, Malaysia, 2007-2011 Sites

Ethnic Groups Malay

Chinese

Indian

Others*

Colorectal

11.3

21.1

10.3

9.4

Trachea, Bronchus, Lung

12.6

18.8

7.6

11.9

Nasopharynx

3.3

11.0

1.1

9.9

Lymphoma

5.6

5.0

4.2

6.7

Prostate

5.3

9.0

6.1

3.8

Liver

4.5

7.7

3.1

5.8

Leukaemia

4.4

4.0

3.8

3.8

Stomach

1.7

5.6

5.2

7.1

Bladder

3.3

2.8

2.5

1.8

Other Skin

2.0

3.8

1.3

2.6

* Other Bumiputera and Others

Table 14: Age-standardised rates for ten most common cancers in females by ethnicity, Malaysia, 2007-2011 Sites

Ethnic Groups Malay

Chinese

Indian

Others*

Breast

27.2

41.5

37.1

14.3

Colorectal

8.1

17.1

8.7

7.4

Cervix Uteri

5.1

9.8

7.6

12.0

Ovary

5.8

6.3

6.1

4.9

Trachea, Bronchus, Lung

4.4

8.5

3.1

7.4

Lymphoma

3.7

3.7

3.0

4.5

Corpus Uteri

3.3

4.9

4.8

2.5

Leukaemia

3.5

3.4

3.0

3.2

Thyroid

3.3

2.1

2.5

3.2

Stomach

1.1

4.1

3.2

4.9

* Other Bumiputera and Others

23

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Among Malay males, the most common cancers were lung, colorectal, lymphoma, prostate and liver cancers, whereas among Malay females, breast, colorectal, ovarian, cervix uteri and lung cancers were the most common.

Table 15: Ten most common cancers in Malaysia, Malay residents by sex, 2007-2011 ICD-10 Male C33-C34 C18-C21 C81-C85,C96 C91-C95 C22 C61 C11 C67 C70-C72 C44

Female C50 C18-C21 C56 C53 C33-C34 C81-C85,C96 C91-C95 C73 C54 C70-C72

Sites

Number

%

CR

ASR

Trachea, Bronchus, Lung Colorectal Lymphoma Leukaemia Liver Prostate Nasopharynx Bladder Brain, Nervous system Other Skin Others Total

3,094 2,872 1,639 1,419 1,195 1,163 959 781 612 504 4,519 18,757

16.5 15.3 8.7 7.6 6.4 6.2 5.1 4.2 3.3 2.7 24.1 100.0

8.8 8.1 4.6 4.0 3.4 3.3 2.7 2.2 1.7 1.4

12.6 11.3 5.6 4.4 4.5 5.3 3.3 3.3 1.9 2.0

53.1

70.7

Breast Colorectal Ovary Cervix Uteri Trachea, Bronchus, Lung Lymphoma Leukaemia Thyroid Corpus Uteri Brain, Nervous system Others Total

8,225 2,231 1,754 1,502 1,187 1,142 1,119 1,023 964 566 4,475 24,188

34.0 9.2 7.3 6.2 4.9 4.7 4.6 4.2 4.0 2.3 18.5 100.0

23.6 6.4 5.0 4.3 3.4 3.3 3.2 2.9 2.8 1.6

27.2 8.1 5.8 5.1 4.4 3.7 3.5 3.3 3.3 1.8

69.5

81.9

Male

Female

Figure 19: Age-standardised rate (ASR) for ten common cancers in Malays by sex, Malaysia, 2007-2011

24

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Among Chinese males, the most common cancers were colorectal, lung, nasopharynx, prostate and liver cancers, whereas among Chinese females, breast, colorectal, cervix uteri, lung and ovarian cancers were the most common.

Table 16: Ten most common cancers in Malaysia, Chinese residents by sex, 2007-2011 ICD-10 Male C18-C21 C33-C34 C11 C61 C22 C16 C81-C85,C96 C44 C91-C95 C25

Female C50 C18-C21 C53 C33-C34 C56 C54 C16 C81-C85,C96 C11 C91-C95

Sites

Number

%

CR

ASR

Colorectal Trachea, Bronchus, Lung Nasopharynx Prostate Liver Stomach Lymphoma Other Skin Leukaemia Pancreas Others Total

3,825 3,390 2,104 1,589 1,416 1,001 908 687 657 516 4,331 20,424

18.7 16.6 10.3 7.8 6.9 4.9 4.4 3.4 3.2 2.5 21.2 100.0

23.3 20.6 12.8 9.7 8.6 6.1 5.5 4.2 4.0 3.1

21.1 18.8 11.0 9.0 7.7 5.6 5.0 3.8 4.0 2.8

124.4

112.9

Breast Colorectal Cervix Uteri Trachea, Bronchus, Lung Ovary Corpus Uteri Stomach Lymphoma Nasopharynx Leukaemia Others Total

7,333 3,023 1,732 1,486 1,107 853 725 639 611 527 4,078 22,114

33.2 13.7 7.8 6.7 5.0 3.9 3.3 2.9 2.8 2.4 18.4 100.0

47.5 19.6 11.2 9.6 7.2 5.5 4.7 4.1 4.0 3.4

41.5 17.1 9.8 8.5 6.3 4.9 4.1 3.7 3.5 3.4

143.2

126.2

Male

Female

Figure 20: Age-standardised rate (ASR) for ten common cancers in Chinese by sex, Malaysia, 2007-2011

25

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Among Indian males, the most common cancers were colorectal, lung, prostate, stomach and lymphoma, whereas among Indian females, breast, colorectal, cervix uteri, mouth and ovarian cancers were the most common.

Table 17: Ten most common cancers in Malaysia, Indian residents by sex, 2007-2011 ICD-10 Male C18-C21 C33-C34 C61 C16 C81-C85,C96 C91-C95 C22 C03-C06 C15 C32

Female C50 C18-C21 C53 C03-C06 C56 C54 C15 C16 C91-C95 C81-C85,C96

Number

%

CR

ASR

Colorectal Trachea, Bronchus, Lung Prostate Stomach Lymphoma Leukaemia Liver Mouth Oesophagus Larynx Others Total

389 270 188 187 187 171 114 107 98 90 878 2,679

14.5 10.1 7.0 7.0 7.0 6.4 4.3 4.0 3.7 3.4 32.8 100.0

8.1 5.6 3.9 3.9 3.9 3.6 2.4 2.2 2.0 1.9

10.3 7.6 6.1 5.2 4.2 3.8 3.1 2.9 2.7 2.3

56.0

70.4

Breast Colorectal Cervix Uteri Mouth Ovary Corpus Uteri Oesophagus Stomach Leukaemia Lymphoma Others Total

1,705 364 327 287 277 204 145 137 137 130 1,085 4,798

35.5 7.6 6.8 6.0 5.8 4.3 3.0 2.9 2.9 2.7 22.6 100.0

36.0 7.7 6.9 6.1 5.8 4.3 3.1 2.9 2.9 2.7

37.1 8.7 7.6 7.5 6.1 4.8 3.6 3.2 3.0 3.0

101.2

110.1

Sites

Male

Female

Figure 21: Age-standardised rate (ASR) for ten common cancers in Indians by sex, Malaysia, 2007-2011

26

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

In other ethnic groups, the most common cancers among males were nasopharynx, lung, colorectal, lymphoma and stomach, whereas among females, breast, cervix uteri, colorectal, lung and ovarian cancers were the most common.

Table 18: Ten most common cancers in Malaysia, other ethnic groups by sex, 2007-2011 ICD-10 Male C11 C33-C34 C18-C21 C81-C85,C96 C16 C22 C91-C95 C61 C44 C70-C72

Female C50 C53 C18-C21 C33-C34 C56 C81-C85,C96 C16 C11 C91-C95 C73

Number

%

CR

ASR

Nasopharynx Trachea, Bronchus, Lung Colorectal Lymphoma Stomach Liver Leukaemia Prostate Other Skin Brain, Nervous system Others Total

678 661 560 437 397 329 302 192 148 113 1,117 4,934

13.7 13.4 11.3 8.9 8.0 6.7 6.1 3.9 3.0 2.3 22.6 100.0

7.6 7.4 6.2 4.9 4.4 3.7 3.4 2.1 1.6 1.3

9.9 11.9 9.4 6.7 7.1 5.8 3.8 3.8 2.6 1.5

55.0

80.5

Breast Cervix Uteri Colorectal Trachea, Bronchus, Lung Ovary Lymphoma Stomach Nasopharynx Leukaemia Thyroid Others Total

943 791 429 393 334 292 273 268 241 210 1,439 5,613

16.8 14.1 7.6 7.0 6.0 5.2 4.9 4.8 4.3 3.7 25.6 100.0

10.8 9.1 4.9 4.5 3.8 3.3 3.1 3.1 2.8 2.4

14.3 12.0 7.4 7.4 4.9 4.5 4.9 4.0 3.2 3.2

64.4

89.6

Sites

Male

Female

Figure 22: Age-standardised rate (ASR) for ten common cancers in other ethnic groups by sex, Malaysia, 2007-2011

27

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

5.7 Staging Table 19: Staging for all cancer types, Malaysia, 2007-2011 ICD-10

SITES

SEX

TOTAL

30 M 55 F 461 M 401 F 391 M C03-C06 MOUTH 525 F 273 M C07-C08 SALIVARY GLAND 226 F 127 M C09 TONSIL 68 F 81 M C10 OTHER OROPHARYNX 30 F 3,785 M C11 NASOPHARYNX 1,305 F 172 M C12-C13 HYPOPHARYNX 86 F 37 M C14 PHARYNX UNSPEC 20 F 737 M C15 OESOPHAGUS 429 F 2,013 M C16 STOMACH 1,447 F C17 SMALL INTESTINE 154 M 89 F C18-C21 COLORECTAL 7,646 M 6,047 F C22 LIVER 3,054 M 1,074 F C23-C24 GALLBLADDER 413 M 409 F C25 PANCREAS 1,041 M 788 F C30-C31 NOSE,SINUSES ETC. 270 M 138 F C32 LARYNX 825 M 113 F C33-C34 TRACHEA,BRONCHUS,LUNG 7,415 M 3,193 F C37-C38 OTHER THORACIC ORGANS 167 M 123 F C40-C41 BONE 493 M 365 F C43 MELANOMA OF SKIN 167 M 155 F C44 OTHER SKIN 1,384 M 1,045 F C45 MESOTHELIOMA 22 M 19 F C46 KAPOSI SARCOMA 17 M 2 F C47;C49 CONNECTIVE TISSUE 434 M 378 F C50 BREAST 137 M 18,206 F C51 VULVA 123 F C52 VAGINA 124 F C53 CERVIX UTERI 4,352 F C54 CORPUS UTERI 2,181 F C55 UTERUS UNSPEC 580 F C56 OVARY 3,472 F C57 OTHER FEMALE GENITAL 42 F C58 PLACENTA 65 F C60 PENIS 115 M C61 PROSTATE 3,132 M C62 TESTIS 496 M C63 OTHER MALE GENITAL 31 M C64 KIDNEY 901 M 434 F C65 RENAL PELVIS 13 M 8 F C66 URETER 19 M 11 F C67 BLADDER 1,477 M 400 F C68 OTHER URINARY ORGANS 17 M 10 F C69 EYE 104 M 67 F C70-C72 BRAIN,NERVOUS SYSTEM 1,176 M 1,060 F C73 THYROID 549 M 1,723 F C74 ADRENAL GLAND 47 M 45 F C75 OTHER ENDOCRINE 109 M 51 F C81-C85;C96 LYMPHOMA 3,171 M 2,203 F C90 MULTIPLE MYELOMA 396 M 348 F C91-C95 LEUKAEMIA 2,549 M 2,024 F OTHER & UNSPEC 746 M 654 F Grand Total 103,507 C00

C01-C02

28

LIP

TONGUE

NUMBER WITH RECORDED STAGE

%

15 34 272 221 210 304 117 94 74 33 55 14 2,072 652 86 46 18 10 365 203 823 649 65 37 4,263 3,372 1,221 412 147 193 535 407 132 65 509 62 4,189 1,769 62 38 184 137 60 58 436 319 13 8 2 0 136 89 73 11,938 64 61 2,794 1,442 272 2,358 25 14 40 1,592 235 14 504 242 8 7 12 7 688 175 5 6 24 14 433 361 213 671 16 17 27 12 1,323 931 56 38 168 132 253 242 52,794

50.0 61.8 59.0 55.1 53.7 57.9 42.9 41.6 58.3 48.5 67.9 46.7 54.7 50.0 50.0 53.5 48.6 50.0 49.5 47.3 40.9 44.9 42.2 41.6 55.8 55.8 40.0 38.4 35.6 47.2 51.4 51.6 48.9 47.1 61.7 54.9 56.5 55.4 37.1 30.9 37.3 37.5 35.9 37.4 31.5 30.5 59.1 42.1 11.8 0.0 31.3 23.5 53.3 65.6 52.0 49.2 64.2 66.1 46.9 67.9 59.5 21.5 34.8 50.8 47.4 45.2 55.9 55.8 61.5 87.5 63.2 63.6 46.6 43.8 29.4 60.0 23.1 20.9 36.8 34.1 38.8 38.9 34.0 37.8 24.8 23.5 41.7 42.3 14.1 10.9 6.6 6.5 33.9 37.0 51.0

STAGE I

%

II

%

III

%

IV

%

7 10 39 36 26 47 24 21 11 3 8 2 243 70 10 3 1 2 22 14 73 59 4 8 448 328 124 37 15 22 35 29 23 19 124 16 149 55 7 5 24 26 9 7 219 170 1 0 0 0 40 21 16 2,373 9 11 668 664 116 729 8 5 10 249 105 6 78 48 4 4 3 4 205 48 0 0 8 4 93 111 47 245 1 3 10 6 219 152 9 11 32 19 9,029

46.7 29.4 14.3 16.3 12.4 15.5 20.5 22.3 14.9 9.1 14.5 14.3 11.7 10.7 11.6 6.5 5.6 20.0 6.0 6.9 8.9 9.1 6.2 21.6 10.5 9.7 10.2 9.0 10.2 11.4 6.5 7.1 17.4 29.2 24.4 25.8 3.6 3.1 11.3 13.2 13.0 19.0 15.0 12.1 50.2 53.3 7.7 0.0 0.0 0.0 29.4 23.6 21.9 19.9 14.1 18.0 23.9 46.0 42.6 30.9 32.0 35.7 25.0 15.6 44.7 42.9 15.5 19.8 50.0 57.1 25.0 57.1 29.8 27.4 0.0 0.0 33.3 28.6 21.5 30.7 22.1 36.5 6.3 17.6 37.0 50.0 16.6 16.3 16.1 28.9 12.6 7.9 17.1

2 7 62 57 44 53 28 28 13 4 7 4 513 193 26 10 4 2 65 52 130 107 11 6 1,006 845 134 39 20 28 65 43 34 10 99 16 290 125 10 8 41 14 7 5 90 64 2 1 0 0 24 19 25 4,413 15 15 1,000 286 47 309 4 0 6 388 46 2 98 59 2 0 3 1 182 37 3 2 4 1 78 74 55 155 0 1 8 0 328 250 11 8 26 36 12,445

13.3 20.6 22.8 25.8 21.0 17.4 23.9 29.8 17.6 12.1 12.7 28.6 24.8 29.6 30.2 21.7 22.2 20.0 17.8 25.6 15.8 16.5 16.9 16.2 23.6 25.1 11.0 9.5 13.6 14.5 12.1 10.6 25.8 15.4 19.4 25.8 6.9 7.1 16.1 21.1 22.3 10.2 11.7 8.6 20.6 20.1 15.4 12.5 0.0 0.0 17.6 21.3 34.2 37.0 23.4 24.6 35.8 19.8 17.3 13.1 16.0 0.0 15.0 24.4 19.6 14.3 19.4 24.4 25.0 0.0 25.0 14.3 26.5 21.1 60.0 33.3 16.7 7.1 18.0 20.5 25.8 23.1 0.0 5.9 29.6 0.0 24.8 26.9 19.6 21.1 10.3 14.9 23.6

2 8 64 52 49 53 30 17 15 16 11 5 602 195 22 13 6 3 99 55 211 149 14 11 1,294 1,075 169 69 29 26 68 70 20 10 117 15 967 344 16 8 18 22 13 13 41 37 2 3 0 0 22 9 20 2,753 21 12 612 288 51 760 6 1 4 297 24 3 65 26 0 2 3 2 121 32 0 0 1 1 63 75 33 76 1 2 4 3 314 199 12 5 34 30 12,135

13.3 23.5 23.5 23.5 23.3 17.4 25.6 18.1 20.3 48.5 20.0 35.7 29.1 29.9 25.6 28.3 33.3 30.0 27.1 27.1 25.6 23.0 21.5 29.7 30.4 31.9 13.8 16.7 19.7 13.5 12.7 17.2 15.2 15.4 23.0 24.2 23.1 19.4 25.8 21.1 9.8 16.1 21.7 22.4 9.4 11.6 15.4 37.5 0.0 0.0 16.2 10.1 27.4 23.1 32.8 19.7 21.9 20.0 18.8 32.2 24.0 7.1 10.0 18.7 10.2 21.4 12.9 10.7 0.0 28.6 25.0 28.6 17.6 18.3 0.0 0.0 4.2 7.1 14.5 20.8 15.5 11.3 6.3 11.8 14.8 25.0 23.7 21.4 21.4 13.2 13.4 12.4 22.9

4 9 107 76 91 151 35 28 35 10 29 3 714 194 28 20 7 3 179 82 409 334 36 12 1,515 1,124 794 267 83 117 367 265 55 26 169 15 2,783 1,245 29 17 101 75 31 33 86 48 8 4 2 0 50 40 12 2,399 19 23 514 204 58 560 7 8 20 658 60 3 263 109 2 1 3 0 180 58 2 4 11 8 199 101 78 195 14 11 5 3 462 330 24 14 161 157 18,885

26.7 26.5 39.3 34.4 43.3 49.7 29.9 29.8 47.3 30.3 52.7 21.4 34.5 29.8 32.6 43.5 38.9 30.0 49.0 40.4 49.7 51.5 55.4 32.4 35.5 33.3 65.0 64.8 56.5 60.6 68.6 65.1 41.7 40.0 33.2 24.2 66.4 70.4 46.8 44.7 54.9 54.7 51.7 56.9 19.7 15.0 61.5 50.0 100.0 0.0 36.8 44.9 16.4 20.1 29.7 37.7 18.4 14.1 21.3 23.7 28.0 57.1 50.0 41.3 25.5 21.4 52.2 45.0 25.0 14.3 25.0 0.0 26.2 33.1 40.0 66.7 45.8 57.1 46.0 28.0 36.6 29.1 87.5 64.7 18.5 25.0 34.9 35.4 42.9 36.8 63.6 64.9 35.8

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Summary table for all cancer sites is shown in Table 19. A total of 103,507 new cancer cases were reported, of whom 52,794 (51.0%) had reports on staging. Of the patients whose stages were reported, 9,029 (17.1%) were in stage I, 12,445 (23.6%) in stage II, 12,135 (23.0%) in stage III and 18,885 (35.8%) in stage IV. Thus at the time of diagnosis, 31,020 (58.8%) had advanced cancers (classified as either stage III or IV).

5.8 Data Quality The Data Quality in this report were measured through data completeness, comparability and validity. Validity can be defined as the proportion of cases in a data-set which truly have the reported attribute. The Malaysian National Cancer Registry (MNCR) has used the same five common indices as indicated in the Cancer Incidence in Five Continents (CI5), Vol X, which are (a) internal consistency; (b) histological verification; (c) death certificate only (DCO); (d) other and unspecified cases (ill-defined cases ) and (e) age unknown. (a) Internal consistency: The MNCR uses the IARC/IACR CHECK program to perform consistency checks on the cancer notifications. All cases queried are checked by the registry staff, using the software program, before incorporating relevant items into the database. (b) Histological verification: The accuracy of the stated diagnosis is likely to be higher if there is histological confirmation by a pathologist or cytology/haematology confirmation. As the MNCR does not distinguish between histology and cytology/haematology verification, morphologically verified (MV) is used rather than histological verification. For cancers with specified sites, the morphologically verified proportion was 96.6% of all cases for both sexes. (c) Death Certificate Only (DCO): All the death notified by the public, private health facilities to the registry was traced and checked with the National Registry Departments. For cancer with specified sites, the DCO percentage was 0.3% of total cases for both sexes. (d) Other and unspecified cases (ill-defined cases): For this category, the percentage was 2.7% (1.6% for males and 1.1% for females) A low proportion of cases that are assigned to this category generally imply a better diagnostic precision in determining the site of primary cancer. (e) Age unknown: If there are a large number of cases with age unknown, several of the figures and graphs from the data-set would not be accurate. In this report, all the ages were known.

29

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Table 20: Quality indicator

30

ICD-10

SITE

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18-C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81-C85,C96 C88 C90 C91-C95

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colorectal Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Lymphoma Immunoproliferative dis.

Multiple Myeloma Leukaemia Other & unspecified All Sites Total

TOTAL 85 862 916 499 195 111 5,090 258 57 1,166 3,461 242 13,693 4,128 822 1,829 408 938 10,608 290 858 322 2,429 41 19 812 18,343 123 124 4,352 2,181 580 3,472 42 65 115 3,132 496 31 1,335 21 30 1,877 27 171 2,236 2,272 92 160 5,374 12 744 4,573 1,388 103,507

MV 85 854 913 487 192 110 5,024 252 54 1,146 3,377 240 13,490 3,260 779 1,573 400 924 9,826 284 802 320 2,423 41 18 781 18,258 123 123 4,324 2,171 575 3,408 39 62 114 3,089 488 31 1,302 20 29 1,842 26 155 1,925 2,249 87 153 5,348 11 725 4,570 1,082 99,984

QUALITY INDICATOR DCO %

%

100.0 99.1 99.7 97.6 98.5 99.1 98.7 97.7 94.7 98.3 97.6 99.2 98.5 79.0 94.8 86.0 98.0 98.5 92.6 97.9 93.5 99.4 99.8 100.0 94.7 96.2 99.5 100.0 99.2 99.4 99.5 99.1 98.2 92.9 95.4 99.1 98.6 98.4 100.0 97.5 95.2 96.7 98.1 96.3 90.6 86.1 99.0 94.6 95.6 99.5 91.7 97.4 99.9 78.0 96.6

0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.4 1.8 0.1 0.2 0.0 0.3 0.9 0.1 0.2 0.2 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.3

0 1 0 0 1 0 0 1 1 1 8 0 35 37 1 4 1 0 31 0 6 0 0 0 0 0 17 0 0 2 1 0 0 0 0 0 2 0 0 2 0 0 1 0 0 10 1 0 0 1 0 0 1 116 282

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

6.0 INCIDENCE SUMMARY TABLES : All sites, 2007-2011 The table below explains the incidence by year, sex, ethnic group and states.

Table 21: Summary of all cancer sites 2007-2011 by sex, year and ethnic Male No. Year 2007 8,969 2008 9,383 2009 9,495 2010 9,571 2011 9,376 Ethnic All Residents 46,794 Malay 18,757 Chinese 20,424 Indian 2,679 Other 4,934

Female

CR

ASR

(ASR 95% CL)

CumR

No.

CR

ASR

(ASR 95% CL)

CumR

70.8 72.5 72.5 71.9 68.6

89.7 90.2 87.9 85.4 80.9

(87.8 , 91.6) (88.3 , 92.0) (86.1 , 89.7) (83.7 , 87.2) (79.2 , 82.5)

10.1 10.1 9.9 9.7 9.3

11,035 11,344 11,216 11,672 11,446

89.5 89.7 88.0 90.1 87.2

102.6 102.3 98.4 98.8 93.8

(100.6 , 104.5) (100.4 , 104.2) (96.5 , 100.2) (97.0 , 100.6) (92.0 , 95.5)

10.8 10.9 10.6 10.6 10.0

71.4 53.1 124.4 56.0 55.0

86.9 70.7 112.9 70.4 80.5

(86.1 , 87.7) (69.7 , 71.8) (111.4 , 114.5) (67.6 , 73.2) (78.2 , 82.8)

9.8 8.0 12.5 8.1 9.2

56,713 24,188 22,114 4,798 5,613

89.0 69.5 143.2 101.2 64.4

99.3 81.9 126.2 110.1 89.6

(98.4 , 100.1) (80.8 , 82.9) (124.5 , 127.9) (106.9 , 113.3) (87.2 , 92.0)

10.6 8.7 13.2 12.2 9.7

Table 22: Summary of all cancer sites 2007-2011 by states Male Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu N.Sembilan Melaka Perlis W.P. Labuan

Female

No.

CR

ASR

(ASR 95% CL)

CumR

No.

CR

ASR

(ASR 95% CL)

CumR

6,261 7,202 3,522 4,549 4,465 2,774 2,277 2,105 5,245 2,193 1,668 1,917 1,811 405 53

49.3 91.8 58.9 76.4 77.9 59.6 59.5 54.8 144.1 60.9 63.7 79.0 94.2 46.2 26.5

71.3 109.0 93.6 85.7 74.7 66.5 73.1 68.0 150.5 75.1 83.1 89.1 104.7 72.8 50.9

(69.4 , 73.2) (106.5 , 111.6) (90.3 , 96.8) (83.2 , 88.3) (72.5 , 76.9) (64.0 , 69.1) (70.0 , 76.2) (65.0 , 70.9) (146.4 , 154.6) (71.9 , 78.2) (79.0 , 87.2) (85.1 , 93.2) (99.8 , 109.6) (65.7 , 80.0) (36.0 , 65.8)

8.5 12.2 10.8 9.5 8.3 7.4 8.6 7.5 15.9 8.6 9.5 9.9 11.3 8.4 6.1

8,484 8,110 4,045 5,185 5,504 3,565 3,307 2,281 6,085 2,499 1,977 2,528 2,214 495 51

69.2 109.4 69.8 90.3 96.6 76.7 88.3 59.6 166.6 73.6 79.1 106.9 110.2 86.4 26.8

89.7 118.7 105.3 100.2 88.4 77.0 101.2 65.8 157.8 82.6 93.8 108.9 108.1 84.9 41.7

(87.7 , 91.7) (116.1 , 121.3) (101.9 , 108.8) (97.5 , 103.0) (86.1 , 90.8) (74.4 , 79.5) (97.6 , 104.7) (63.1 , 68.6) (153.8 , 161.8) (79.4 , 85.9) (89.6 , 98.0) (104.6 , 113.2) (103.6 , 112.7) (77.4 , 92.5) (28.7 , 54.7)

10.0 12.4 11.3 10.5 9.2 8.2 11.1 7.1 16.1 8.7 9.8 11.6 11.3 8.7 4.9

31

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

**The highest incidence from CI5 Volume X *The lowest incidence from CI5 Volume X NB: Singapore (2009-2013 report) Note: International comparisons of age standardised rates of selected countries according to ethnicities and sex.

Figure 23: All Sites: International comparisons – Age standardised rates

32

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.0 COMMENTARY ON 15 SELECTED CANCER SITES In this section, cancers are reviewed focussing on ethnic variations, staging, Age-specific incidence rate as well as annual and state distributions. International comparisons were made with Singapore (Singapore Cancer Registry, Interim Report: Trends in Cancer Incidence in Singapore 2009-2013) and other countries (Cancer Incidence in Five Continents Volume X, 2014). Fifteen most common cancers (male and female combined) were selected.

7.1 Female Breast (ICD-10: C50) Female breast cancer was accounted for 32.1% of all cancer among females in Malaysia. The incidence of breast cancer was highest among Chinese followed by Indian and Malay.

The cumulative risk (CumR) was highest among Chinese and lowest among Malay. The lifetime risk was 1 in 30, while for Chinese was 1 in 22, Indian 1 in 24 and Malay 1 in 35. The percentage of breast cancer detected at stage I and II was 56.9%.

Table 23: Female Breast: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Sex Female

No. 18,206

CR 28.6

CR74 3.4

ASR 31.1

(ASR 95%CL) (30.7, 31.6)

CumR 3.4

Table 24: Female Breast: Incidence summary by ethnicity, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 8,225 7,333 1,705

CR 23.6 47.5 36.0

CR74 2.9 4.6 4.2

ASR 27.2 41.5 37.1

CumR 2.9 4.5 4.2

ASR 32.3 32.0 29.9 30.8 30.4

CumR 3.4 3.5 3.3 3.3 3.3

Table 25: Female Breast: Incidence summary by year, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 3,579 3,643 3,501 3,717 3,766

CR 29.0 28.8 27.5 28.7 28.7

CR74 3.5 3.5 3.3 3.4 3.4

33

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 24: Female Breast: Age-specific incidence rate, Malaysia, 2007-2011

Figure 25: Female Breast: Stage

Figure 26: Female Breast: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

34

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

*The lowest incidence from CI5, Volume X

NB: Singapore (2009-2013 report)

Figure 27: Female Breast: International comparisons – Age-standardised rates

35

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.2 Colorectal (ICD10: C18-C21) Colorectal cancer was the most common cancer in male and second in female. The incidence of colorectal cancer increases with age and highest among Chinese for males and females. The lifetime risk for males was 1 in 56.

It was 1 in 39 for Chinese, 1 in 72 for Malay and 1 in 82 for Indian. The lifetime risk for females was 1 in 74; for Chinese 1 in 49, Indian 1 in 91 and Malay 1 in 100. The male to female ASR ratio was 1.3:1.

The percentage of colorectal cancer detected at stage I and II was only 34.1% and 34.8% respectively for both male and female.

Table 26: Colorectal: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 7,646 6,047 13,693

% 55.8 44.2 100.0

CR 11.7 9.5

CR74 1.8 1.4

ASR 14.6 11.1

(ASR 95%CL) (14.2, 14.9) (10.8, 11.4)

CumR 1.8 1.3

CR 6.4 19.6 7.7

Female CR74 1.0 2.1 1.1

ASR 8.1 17.1 8.7

CumR 1.0 2.0 1.1

CR 9.1 9.4 9.8 9.7 9.3

Female CR74 1.4 1.4 1.4 1.3 1.3

ASR 11.1 11.3 11.6 11.0 10.4

CumR 1.3 1.3 1.4 1.3 1.3

Table 27: Colorectal: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 2,872 3,825 389

CR 8.1 23.3 8.1

Male CR74 1.4 2.6 1.2

ASR 11.3 21.1 10.3

CumR 1.4 2.5 1.2

No. 2,231 3,023 364

Table 28: Colorectal: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

36

No. 1,371 1,483 1,566 1,633 1,593

CR 10.8 11.5 12.0 12.3 11.7

Male CR74 1.7 1.8 1.9 1.9 1.7

ASR 14.1 14.6 15.0 14.9 14.0

CumR 1.7 1.8 1.8 1.9 1.7

No. 1,124 1,194 1,253 1,251 1,225

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 28: Colorectal: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 29: Colorectal: Stage by sex

Figure 30: Colorectal: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

37

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

*The lowest incidence from CI5, Volume X

NB: Singapore (2009-2013 report)

Figure 31: Colorectal: International comparisons by sex – Age-standardised rates

38

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.3 Trachea, Bronchus, Lung (ICD-10: C33-C34) Lung cancer is the second most common cancer among males and fifth among females in Malaysia. The incidence increased with age and the peak of age-specific incidence rate was at the age of 70 and above.

The lifetime risk for males was 1 in 55. For Indian, Malay and Chinese, it was 1 in 103, 1 in 62 and 1 in 43, respectively. The lifetime risk for females was 1 in 135. For Indian it was 1 in 255, 1 in 185 for Malay and 1 in 97 for Chinese. The male to female ASR ratio was 2.4:1.

Most of lung cancer cases were detected at late stage (stage III and stage IV) for both sexes.

Table 29: Trachea, Bronchus, Lung: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 7,415 3,193 10,608

% 69.9 30.1 100.0

CR 11.3 5.0

CR74 1.8 0.7

ASR 14.4 6.0

(ASR 95%CL) (14.1, 14.8) (5.8, 6.2)

CumR 1.8 0.7

Table 30: Trachea, Bronchus, Lung: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 3,094 3,390 270

CR 8.8 20.6 5.6

Male CR74 1.6 2.4 1.0

ASR 12.6 18.8 7.6

CumR 1.6 2.3 1.0

No. 1,187 1,486 127

CR 3.4 9.6 2.7

Female CR74 0.5 1.0 0.4

ASR 4.4 8.5 3.1

CumR 0.5 1.0 0.4

ASR 6.1 6.3 6.0 6.0 5.4

CumR 0.8 0.8 0.8 0.8 0.6

Table 31: Trachea, Bronchus, Lung: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 1,474 1,504 1,499 1,493 1,445

CR 11.6 11.6 11.4 11.2 10.6

Male CR74 2.0 2.0 1.9 1.8 1.7

ASR 15.5 15.4 14.5 13.9 13.0

CumR 2.0 2.0 1.8 1.7 1.7

No. 596 658 649 658 632

CR 4.8 5.2 5.1 5.1 4.8

Female CR74 0.8 0.8 0.8 0.8 0.6

39

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 32: Trachea, Bronchus, Lung: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 33: Trachea, Bronchus, Lung: Stage by sex

40

Figure 34: Trachea, Bronchus, Lung: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

*The lowest incidence from CI5, Volume X

NB: Singapore (2009-2013 report)

Figure 35: Trachea, Bronchus, Lung: International comparisons – Age-standardised rates

41

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.4 Lymphoma (ICD10: C81-C85; C96) Lymphoma ranked fourth in males and sixth in females. Malay males had the higher rate compared to Chinese and Indian.

The lifetime risk for males was 1 in 167; 1 in 229 for Indian, 1 in 177 for Chinese and 1 in 165 for Malay. The lifetime risk for females was 1 in 247; 1 in 285 for Indian, 1 in 253 for Malay and 1 in 248 for Chinese.

Table 32: Lymphoma: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 3,171 2,203 5,374

% 59.0 41.0 100.0

CR 4.8 3.5

CR74 0.6 0.4

ASR 5.5 3.8

(ASR 95%CL) (5.3, 5.7) (3.6, 3.9)

CumR 0.6 0.4

CR 3.3 4.1 2.7

Female CR74 0.4 0.4 0.4

ASR 3.7 3.7 3.0

CumR 0.4 0.4 0.4

CR 2.9 3.8 3.4 3.7 3.5

Female CR74 0.3 0.5 0.4 0.4 0.4

ASR 3.3 4.2 3.7 3.9 3.6

CumR 0.3 0.5 0.4 0.4 0.4

Table 33: Lymphoma: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 1,639 908 187

CR 4.6 5.5 3.9

Male CR74 0.6 0.6 0.4

ASR 5.6 5.0 4.2

CumR 0.6 0.6 0.4

No. 1,142 639 130

Table 34: Lymphoma: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

42

No. 532 659 664 641 675

CR 4.2 5.1 5.1 4.8 4.9

Male CR74 0.5 0.7 0.6 0.6 0.6

ASR 4.9 5.9 5.7 5.3 5.5

CumR 0.5 0.7 0.6 0.6 0.6

No. 358 480 431 477 457

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 36: Lymphoma: Age-specific incidence rate by sex, Malaysia, 2007-2011 Male (n = 1,323) Stage 4 35%

Stage 3 24%

Female (n = 931) Stage 1 16%

Stage 2 25%

Stage 4 35%

Stage 3 22%

Stage 1 16%

Stage 2 27%

Figure 37: Lymphoma: Stage by sex

Figure 38: Lymphoma: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

43

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.5 Nasopharynx (ICD10:C11) Nasopharynx was the fifth most common cancer in Malaysian population and third most common in males. The lifetime risk for males was 1 in 143 and for females was 1 in 417. The incidence in males increased at the age of 25 years old and peaked at the age of 65 years old.

Most of nasopharynx cancer cases in males were detected at stage III and IV (63.6%).

Table 35: Nasopharynx: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 3,785 1,305 5,090

% 74.4 25.6 100.0

CR 5.8 2.0

CR74 0.7 0.2

ASR 6.4 2.2

(ASR 95%CL) (6.1, 6.6) (2.1, 2.3)

CumR 0.7 0.2

Table 36: Nasopharynx: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 959 2,104 44

CR 2.7 12.8 0.9

Male CR74 0.4 1.2 0.1

ASR 3.3 11.0 1.1

CumR 0.4 1.2 0.1

No. 401 611 25

CR 1.2 4.0 0.5

Female CR74 0.1 0.4 0.1

ASR 1.3 3.5 0.6

CumR 0.1 0.4 0.1

Female CR74 0.3 0.3 0.2 0.2 0.2

ASR 2.5 2.3 2.0 2.2 2.0

CumR 0.3 0.3 0.2 0.2 0.2

Table 37: Nasopharynx: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

44

No. 762 857 791 689 686

CR 6.0 6.6 6.0 5.2 5.0

Male CR74 0.8 0.8 0.7 0.6 0.6

ASR 6.9 7.4 6.6 5.6 5.4

CumR 0.8 0.8 0.7 0.6 0.6

No. 281 264 244 268 248

CR 2.3 2.1 1.9 2.1 1.9

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Incidence per 100,000

25

Male

Female

20

15

10

5

0

0-

5-

10-

15-

20-

25-

30-

35-

40-

45-

50-

55-

60-

65-

70-

75+

Age group (years)

Figure 39: Nasopharynx: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 40: Nasopharynx: Stage by sex

Figure 41: Nasopharynx: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

45

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

* The lowest incidence from CI5, Volume X

Figure 42: Nasopharynx: International comparisons – Age-standardised rates

46

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.6 Leukaemia (ICD-10: C91-C95) Leukaemia is the sixth most common cancer in Malaysian population and seventh most common in males and eighth most common in females. It is the most common cancer among 0-14 years old. Malay had the highest rate followed by Chinese and Indian in both sexes. The lifetime risk for males was 1 in 275 and for females was 1 in 348.

Table 38: Leukaemia: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 2,549 2,024 4,573

% 55.7 44.3 100.0

CR 3.9 3.2

CR74 0.4 0.3

ASR 4.2 3.4

(ASR 95%CL) (4.0, 4.4) (3.2, 3.5)

CumR 0.4 0.3

CR 3.2 3.4 2.9

Female CR74 0.3 0.3 0.3

ASR 3.5 3.4 3.0

CumR 0.3 0.3 0.3

CR 3.0 3.3 3.4 3.3 2.8

Female CR74 0.3 0.3 0.3 0.3 0.3

ASR 3.2 3.6 3.6 3.5 3.0

CumR 0.3 0.3 0.3 0.3 0.3

Table 39: Leukaemia: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 1,419 657 171

CR 4.0 4.0 3.6

Male CR74 0.4 0.4 0.3

ASR 4.4 4.0 3.8

CumR 0.4 0.3 0.3

No. 1,119 527 137

Table 40: Leukaemia: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 484 525 554 517 469

CR 3.8 4.1 4.2 3.9 3.4

Male CR74 0.4 0.4 0.4 0.4 0.3

ASR 4.1 4.4 4.5 4.2 3.7

CumR 0.4 0.4 0.4 0.4 0.3

No. 374 421 431 428 370

Figure 43: Leukaemia: Age-specific incidence rate by sex, Malaysia, 2007-2011

47

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 44: Leukaemia types: Age-specific incidence rate, males, Malaysia, 2007-2011

Figure 45: Leukaemia types: Age-specific incidence rate, females, Malaysia, 2007-2011

Figure 46: Leukaemia: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

48

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

* The lowest incidence from CI5, Volume X

Figure 47: Leukaemia: International comparisons – Age-standardised rates

49

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.7 Cervix Uteri (ICD-10:C53) Cancer of the cervix uteri was the third most common cancer in females. The lifetime risk was 1 in 116. Chinese had higher incidence rate followed by Indian and Malay. The cumulative risk (CumR) for Chinese was 1.2, Indian 0.9 and Malay 0.6. The incidence rate over the five years was found to have decreased from 8.4 to 6.5.

Almost 60% of cervix uteri cancer cases were detected at stage I and II. Table 41: Cervix Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Sex

No.

CR

CR74

ASR

(ASR 95%CL)

CumR

Female

4,352

6.8

0.9

7.6

(7.3, 7.8)

0.9

Table 42: Cervix Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 1,502 1,732 327

CR 4.3 11.2 6.9

CR74 0.6 1.2 0.9

ASR 5.1 9.8 7.6

CumR 0.6 1.2 0.9

ASR 8.3 8.4 7.6 7.1 6.5

CumR 0.9 0.9 0.9 0.8 0.7

Table 43: Cervix Uteri: Incidence summary by year, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

50

No. 895 937 884 841 795

CR 7.3 7.4 6.9 6.5 6.1

CR74 0.9 1.0 0.9 0.8 0.7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 48: Cervix Uteri: Age-specific incidence rate, Malaysia, 2007-2011

Figure 49: Cervix Uteri: Stage

Figure 50: Cervix Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

51

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

*The lowest incidence from CI5, Volume X

NB: Singapore (2009-2013 report)

Figure 51: Cervix Uteri: International comparisons – Age-standardised rates

52

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.8 Liver (ICD-10:C22) Liver cancer is the eighth most common cancer among Malaysian population and sixth most common cancer among males. The incidence of liver cancer increased with age and higher in males compared to females. Chinese were found to have higher incidence rate compared to Malay and Indian. The lifetime risk was 1 in 144 for males and 1 in 418 for females.

Most of liver cancer cases were detected at late stage (stage III and stage IV) for both sexes.

Table 44: Liver: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 3,054 1,074 4,128

% 74.0 26.0 100.0

CR 4.7 1.7

CR74 0.7 0.2

ASR 5.6 2.0

(ASR 95%CL) (5.4, 5.8) (1.9, 2.1)

CumR 0.7 0.2

CR 1.4 2.7 1.2

Female CR74 0.2 0.3 0.2

ASR 1.7 2.3 1.5

CumR 0.2 0.3 0.2

CR 1.6 1.7 1.7 1.6 1.7

Female CR74 0.2 0.3 0.3 0.2 0.2

ASR 2.0 2.1 2.1 1.8 2.0

CumR 0.2 0.3 0.3 0.2 0.2

Table 45: Liver: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 1,195 1,416 114

CR 3.4 8.6 2.4

Male CR74 0.5 0.9 0.4

ASR 4.5 7.7 3.1

CumR 0.5 0.9 0.4

No. 477 411 58

Table 46: Liver: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 544 570 658 692 590

CR 4.3 4.4 5.0 5.2 4.3

Male CR74 0.7 0.7 0.7 0.7 0.6

ASR 5.5 5.5 6.1 6.1 5.1

CumR 0.7 0.7 0.7 0.7 0.6

No. 201 218 219 207 229

53

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 52: Liver: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 53: Liver: Stage by sex

Figure 54: Liver: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

54

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

* The lowest incidence from CI5, Volume X

Figure 55: Liver: International comparisons – Age-standardised rates

55

7.9 Ovary (ICD10: C56) Ovary cancer was ninth most common cancer in all residents and fourth in female. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 158. For Chinese 1 in 147, Indian 1 in 153 and Malay 1 in 159. Forty four per cent of ovary cancer cases were detected at stage I and II. Table 47: Ovary: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Sex

No.

CR

CR74

ASR

(ASR 95%CL)

CumR

Female

3,472

5.4

0.6

5.9

(5.7, 6.1)

0.6

Table 48: Ovary: Incidence summary by ethnicity, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 1,754 1,107 277

CR 5.0 7.2 5.8

CR74 0.6 0.7 0.7

ASR 5.8 6.3 6.1

CumR 0.6 0.7 0.7

CR74 0.7 0.6 0.7 0.6 0.6

ASR 6.4 5.4 6.3 5.7 5.7

CumR 0.7 0.6 0.7 0.6 0.6

Table 49: Ovary: Incidence summary by year, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

56

No. 709 615 739 695 714

CR 5.7 4.9 5.8 5.4 5.4

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 56: Ovary: Age-specific incidence rate, Malaysia, 2007-2011

Figure 57: Ovary: Stage 10

Incidence per 100,000

8.6

8.1

8 6.4 6

4

7.8 7.1

5.1

6.1

6.1

5.9

5.3

5.0

5.0

3.5

3.9

1.7

2

0

State

Figure 58: Ovary: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

57

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

*The lowest incidence from CI5, Volume

NB: Singapore (2009-2013 report)

Figure 59: Ovary: International comparisons – Age-standardised rates

58

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.10 Stomach (ICD10: C16) Cancer of the stomach was eighth most common cancer in males and tenth in females. The incidence of stomach cancer increased with age. The incidence was highest among Chinese followed by Indian and Malay for both sexes.

The lifetime risk for males was 1 in 215 and for females was 1 in 326. For males, it was 1 in 156 for Chinese and Indian, and 1 in 489 for Malay. For females, it was 1 in 223 for Chinese, 1 in 268 for Indian and 1 in 733 for Malay.

Most of stomach cancer cases were detected at late stage (stage III and stage IV) for both sexes.

Table 50: Stomach: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 2,014 1,447 3,461

% 58.2 41.8 100.0

CR 3.1 2.3

CR74 0.5 0.3

ASR 3.9 2.6

(ASR 95%CL) (3.7, 4.1) (2.5, 2.8)

CumR 0.5 0.3

CR 0.9 4.7 2.9

Female CR74 0.1 0.4 0.4

ASR 1.1 4.1 3.2

CumR 0.1 0.4 0.4

CR 2.5 2.3 2.2 2.5 1.9

Female CR74 0.4 0.3 0.3 0.3 0.2

ASR 3.0 2.7 2.5 2.8 2.1

CumR 0.4 0.3 0.3 0.3 0.2

Table 51: Stomach: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 429 1,001 187

CR 1.2 6.1 3.9

Male CR74 0.2 0.6 0.6

ASR 1.7 5.6 5.2

CumR 0.2 0.6 0.6

No. 312 725 137

Table 52: Stomach: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 373 388 418 411 424

CR 2.9 3.0 3.2 3.1 3.1

Male CR74 0.5 0.5 0.5 0.5 0.4

ASR 3.9 3.9 4.0 3.8 3.7

CumR 0.5 0.5 0.5 0.5 0.4

No. 306 291 278 319 253

59

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 60: Stomach: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 61: Stomach: Stage by sex

Figure 62: Stomach: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

60

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

* The lowest incidence from CI5, Volume X

Figure 63: Stomach: International comparisons – Age-standardised rates

61

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.11 Prostate (ICD10: C61) Prostate cancer was fifth in male and eleventh most common cancer in all residents. The incidence of prostate cancer increased with age. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 117. It was 1 in 86 for Chinese, 1 in 124 for Indian and 1 in 146 for Malay. The percentage of prostate cancer detected at stage I and II was 40%.

Table 53: Prostate: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Sex

No.

CR

CR74

ASR

(ASR 95%CL)

CumR

Male

3,132

4.8

0.9

6.6

(6.3, 6.8)

0.9

Table 54: Prostate: Incidence summary by ethnicity, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 1,163 1,589 188

CR 3.3 9.7 3.9

CR74 0.7 1.2 0.8

ASR 5.3 9.0 6.1

CumR 0.7 1.2 0.8

ASR 6.6 6.8 6.4 6.5 6.5

CumR 0.9 0.8 0.8 0.9 0.9

Table 55: Prostate: Incidence summary by year, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

62

No. 575 621 608 651 677

CR 4.5 4.8 4.6 4.9 5.0

CR74 0.9 0.8 0.8 0.9 0.9

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 64: Prostate: Age-specific incidence rate, Malaysia, 2007-2011

Figure 65: Prostate: Stage

Figure 66: Prostate: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

63

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

** The highest incidence from CI5, Volume X

*The lowest incidence from CI5, Volume X

NB: Singapore (2009-2013 report)

Figure 67: Prostate: International comparisons – Age-standardised rates

64

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.12 Other Skin (ICD10: C44) Skin cancer other than melanoma ranked twelve among all residents, ten most common cancer in males and fourteenth in females. The cumulative risk (CumR) for males was 0.3 and females 0.2. The incidence rate was highest among Chinese in both sexes.

The lifetime risk for males was 1 in 317. Among Chinese male, it was 1 in 237, Malay 1 in 402 and Indian 1 in 642.

The lifetime risk for females was 1 in 466. For Chinese female, it was 1 in 388, Indian 1 in 627 and Malay was 1 in 633.

Staging was reported for 436 cases in males and 319 cases in females. Of these 71% were diagnosed at stage I and II in males and 73% in females.

Table 56: Other skin: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 1,384 1,045 2,429

% 57.0 43.0 100.0

CR 2.1 1.6

CR74 0.3 0.2

ASR 2.7 1.9

(ASR 95%CL) (2.5, 2.8) (1.8, 2.0)

CumR 0.3 0.2

CR 1.0 2.9 1.2

Female CR74 0.2 0.3 0.2

ASR 1.3 2.5 1.5

CumR 0.2 0.3 0.2

CR 1.5 1.6 1.4 2.0 1.7

Female CR74 0.2 0.2 0.2 0.2 0.2

ASR 1.8 1.9 1.6 2.2 1.9

CumR 0.2 0.2 0.2 0.2 0.2

Table 57: Other skin: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 504 687 45

CR 1.4 4.2 0.9

Male CR74 0.2 0.4 0.2

ASR 2.0 3.8 1.3

CumR 0.2 0.4 0.2

No. 363 446 59

Table 58: Other skin: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 288 259 276 283 278

CR 2.3 2.0 2.1 2.1 2.0

Male CR74 0.4 0.3 0.3 0.3 0.3

ASR 3.0 2.6 2.7 2.6 2.5

CumR 0.4 0.3 0.3 0.3 0.3

No. 189 200 178 255 223

65

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 68: Other skin: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 69: Other Skin: Stage by sex

Figure 70: Other Skin: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

66

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.13 Thyroid (ICD10: C73) Thyroid cancer was ranked seventeenth among males and ninth among females. The incidence rate was the highest among Malays in both sexes.

The lifetime risk was 1 in 884 for males and 1 in 336 for females, whereas among Malay males 1 in 734 and females 1 in 284.

Staging was reported for 213 cases in males and 671 cases in females, 48% were diagnosed at stage I and II in males and 60% in females.

Table 59: Thyroid: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 549 1,723 2,272

% 24.2 75.8 100.0

CR 0.8 2.7

CR74 0.1 0.3

ASR 1.0 2.9

(ASR 95%CL) (0.9, 1.0) (2.7, 3.0)

CumR 0.1 0.3

CR 2.9 2.4 2.5

Female CR74 0.4 0.2 0.3

ASR 3.3 2.1 2.5

CumR 0.4 0.2 0.3

CR 2.8 2.8 2.6 2.7 2.6

Female CR74 0.3 0.3 0.3 0.3 0.3

ASR 3.0 3.0 2.7 2.8 2.7

CumR 0.3 0.3 0.3 0.3 0.3

Table 60: Thyroid: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 312 142 30

CR 0.9 0.9 0.6

Male CR74 0.1 0.1 0.1

ASR 1.1 0.8 0.7

CumR 0.1 0.1 0.1

No. 1,023 371 119

Table 61: Thyroid: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 137 108 100 108 96

CR 1.1 0.8 0.8 0.8 0.7

Male CR74 0.1 0.1 0.1 0.1 0.1

ASR 1.3 1.0 0.9 0.9 0.8

CumR 0.1 0.1 0.1 0.1 0.1

No. 345 352 327 352 347

67

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 71: Thyroid: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 72: Thyroid: Stage by sex

Figure 73: Thyroid: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

68

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.14 Brain, Nervous system (ICD10: C70-C72) Cancer of the brain and nervous system were ranked as eleventh most common cancer in males and thirteenth in females. Chinese have the highest incidence rate followed by Malay and Indian in both sexes.

The lifetime risk for males was 1 in 533, of these Chinese was 1 in 480, 1 in 550 in Malay and 1 in 587 in Indian.

Whereas, for females was 1 in 563, Chinese 1 in 530, Malay 1 in 560 and Indian 1 in 636. 39% was detected at stage I and II in males and 51% in females.

Table 62: Brain, Nervous system: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011 Sex Male Female Both

No. 1,176 1,060 2,236

% 52.6 47.4 100.0

CR 1.8 1.7

CR74 0.2 0.2

ASR 1.9 1.8

(ASR 95%CL) (1.8, 2.1) (1.7, 1.9)

CumR 0.2 0.2

Table 63: Brain, Nervous system: Incidence summary by ethnicity and sex, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 612 368 83

CR 1.7 2.2 1.7

Male CR74 0.2 0.2 0.2

ASR 1.9 2.1 1.8

CumR 0.2 0.2 0.2

No. 566 305 78

CR 1.6 2.0 1.6

Female CR74 0.2 0.2 0.2

ASR 1.8 1.9 1.7

CumR 0.2 0.2 0.2

ASR 2.0 2.0 1.4 1.7 1.9

CumR 0.2 0.2 0.1 0.2 0.2

Table 64: Brain, Nervous system: Incidence summary by year and sex, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 271 248 214 223 220

CR 2.1 1.9 1.6 1.7 1.6

Male CR74 0.2 0.2 0.2 0.2 0.2

ASR 2.4 2.1 1.8 1.7 1.7

CumR 0.2 0.2 0.2 0.2 0.2

No. 227 226 169 202 236

CR 1.8 1.8 1.3 1.6 1.8

Female CR74 0.2 0.2 0.1 0.2 0.2

69

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 74: Brain, Nervous system: Age-specific incidence rate by sex, Malaysia, 2007-2011

Figure 75: Brain, Nervous system: Stage by sex

Figure 76: Brain, Nervous system: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011

70

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

7.15 Corpus Uteri (ICD10: C54) Corpus uteri cancer was the seventh most common cancer in females. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 224, 1 in 170 for Indian, 1 in 175 for Chinese and 1 in 263 for Malay.

Staging was reported for 1,442 cases, of which 66% were diagnosed at stage I and II Table 65: Corpus Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011 Sex

No.

CR

CR74

ASR

(ASR 95%CL)

CumR

Female

2,181

3.4

0.4

3.8

(3.7, 4.0)

0.4

Table 66: Corpus Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011 Ethnic Malay Chinese Indian

No. 964 853 204

CR 2.8 5.5 4.3

CR74 0.4 0.6 0.6

ASR 3.3 4.9 4.8

CumR 0.4 0.6 0.6

ASR 4.1 3.6 3.7 4.0 3.8

CumR 0.5 0.4 0.5 0.5 0.4

Table 67: Corpus Uteri: Incidence summary by year, Malaysia, 2007-2011 Year 2007 2008 2009 2010 2011

No. 446 393 414 466 462

CR 3.6 3.1 3.2 3.6 3.5

CR74 0.5 0.4 0.5 0.5 0.4

71

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

Figure 77: Corpus Uteri: Age-specific incidence rate, Malaysia, 2007-2011

Figure 78: Corpus Uteri: Stage

Figure 79: Corpus Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011

72

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

References 1.

Ahmad Zudfadli et al, Pahang Cancer Registry Report, 1999-2003, Pahang State Health Department, Malaysia.

2.

Azizah Ab M, Devaraj T, Bina Rai S, Norbaiyah Y, Nooraihan M, Noorshila S (2010, August), Penang Cancer Registry Report 2004-2008, Penang State Health Department, Malaysia.

3.

Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M. and Boyle P., eds (2007), Cancer Incidence in Five Continents, Vol. X, IARC Scientific Publications No 160, Lyon, France.

4.

D. Forman, F. Bray, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Pineros, E. Steliarova-Foucher, R. Swaminathan and J. Ferlay (2014), Cancer Incidence in Five Continents, Vol. X, IARC Scientific Publications No.164, Lyon, France.

5.

Department of Statistics, Malaysia (2007-2011), Population Distribution and Basic Demographic Characteristics, Population and Housing Census of Malaysia 2010, Malaysia.

6.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F, GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: Population Fact Sheets, Malaysia [Internet].

7.

Fritz A., et al., 2000, International Classification of Diseases for Oncology, 3rd Edition, World Health Organization.

8.

Health Facts 2009-2013, Health Informatics Center, Planning and Development Division, Ministry of Health Malaysia.

9.

National Cancer Institute (NIH), www.cancer.gov/publication/dictionaries/cancer-terms.

10.

Noor Hashimah A., Fauziah M.N., Norazmi A., Rohaida I., Anees A.H and Wan Mansor H (2011), Kelantan Cancer Registry Report 2004-2008, Kelantan State Health Department, Malaysia.

11.

O.M. Jensen, D.M. Parkin, R. MacLennan, C.S. Muir and R.G. Skeet (1991), Cancer Registration: Principles and Methods, IARC Scientific Publications No. 95, Lyon, France.

12.

Parkin, D.M., Chen, V.W., Ferlay, J., Galceran, J., Storm, H.H. & Whelan, S.L. (1994), Comparability and Quality Control in Cancer Registration, IARC Technical Report No. 19, Lyon, France.

13.

Percy, C., Van Holten, V., Muir, C. (1990), International Classification of Diseases for Oncology, 2nd Edition, World Health Organization.

14.

Segi, M. (1960), Cancer Mortality for Selected Sites in 24 Countries (1950-1957), Sendai, Japan, Tohoku University School of Medicine, Department of Public Health.

15.

Singapore Cancer Registry, Annual Registry Report; Trends in Cancer Incidence in Singapore 2009-2013, National Registry of Disease Office, Singapore.

16.

Sobin LH, Gospodarowicz MK & Wittekind C (eds.). (2009). TNM Classification of Malignant Tumours. (7th Edition). Wiley Blackwell.

17.

Zainal Ariffin Omar, Nor Saleha Ibrahim Tamin (2011, Feb), National Cancer Registry Report 2007, Ministry of Health, Putrajaya, Malaysia.

73

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 1: PERSON-YEARS AT RISK BY SEX, ETHNIC AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011 AGE GROUP

74

MALAY

ETHNIC GROUPS INDIAN CHINESE

OTHERS

TOTAL

Male 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

3,727,400 3,897,400 3,878,000 3,770,000 3,459,000 3,026,900 2,403,200 2,160,400 2,021,700 1,872,900 1,572,400 1,231,200 889,200 577,900 415,100 458,000 35,361,000

1,137,200 1,295,400 1,359,600 1,396,300 1,348,600 1,325,200 1,244,300 1,202,700 1,173,700 1,148,800 1,023,800 855,200 690,100 490,800 357,700 352,800 16,401,800

387,900 437,900 450,200 459,400 466,700 434,900 374,200 335,500 320,000 314,300 266,100 199,100 136,400 77,300 55,500 60,700 4,776,600

1,039,000 1,045,600 1,020,500 980,200 857,800 752,300 585,000 543,300 506,900 450,900 362,900 255,200 179,400 135,700 91,400 116,200 8,922,800

6,291,300 6,676,300 6,708,300 6,606,000 6,131,700 5,539,500 4,606,700 4,241,700 4,022,500 3,786,800 3,225,200 2,540,900 1,895,200 1,281,500 919,700 989,000 65,462,200

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

3,536,100 3,698,800 3,691,000 3,667,100 3,420,500 2,966,900 2,347,400 2,187,200 2,069,100 1,850,500 1,581,400 1,232,300 905,000 617,800 476,000 590,400 34,837,700

1,065,200 1,222,300 1,284,400 1,322,800 1,319,400 1,270,800 1,145,000 1,131,200 1,125,400 1,025,300 920,100 776,600 627,600 442,900 338,400 423,400 15,440,400

372,300 421,000 438,700 443,900 446,800 423,000 359,500 337,300 331,800 310,400 270,200 205,000 146,800 86,800 67,600 78,500 4,740,100

989,700 997,100 988,600 973,800 880,900 750,700 582,900 541,900 488,800 414,400 318,500 224,700 173,500 132,800 93,500 123,500 8,674,900

5,963,500 6,339,300 6,402,500 6,407,400 6,067,800 5,411,300 4,434,900 4,197,500 4,015,000 3,600,400 3,090,300 2,438,700 1,852,900 1,280,300 975,700 1,215,700 63,693,100

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

7,263,500 7,596,100 7,569,100 7,437,000 6,879,500 5,993,800 4,750,800 4,347,700 4,090,700 3,723,400 3,154,000 2,463,500 1,794,300 1,195,600 891,000 1,048,900 70,198,600

2,202,400 2,517,700 2,643,900 2,719,100 2,667,900 2,596,000 2,389,300 2,333,800 2,299,100 2,174,100 1,943,800 1,631,800 1,317,500 933,900 696,300 776,000 31,842,400

760,100 858,800 888,800 903,300 913,600 857,800 733,900 672,500 651,800 624,800 536,300 404,200 283,300 164,200 123,000 140,200 9,516,700

2,028,800 2,042,700 2,009,300 1,954,100 1,738,500 1,503,200 1,167,700 1,085,200 995,800 865,000 681,600 480,100 353,000 268,200 184,900 239,700 17,597,600

12,254,900 13,015,700 13,111,100 13,013,400 12,199,500 10,950,800 9,041,600 8,439,100 8,037,600 7,387,400 6,315,400 4,979,500 3,748,000 2,561,900 1,895,200 2,204,900 129,155,300

Source: Dept. of Statistics Malaysia, 2007-2011 Note: The added total may differ due to rounding

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011 AGE GROUP

SELANGOR

JOHOR

STATE SABAH

Male 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

1,186,600 1,170,100 1,102,600 1,128,800 1,348,200 1,330,600 1,098,300 962,000 830,000 723,200 577,700 428,200 301,600 183,600 124,800 128,900 12,624,400

728,400 786,400 783,600 734,700 720,100 680,800 581,200 538,600 500,800 463,000 387,500 307,900 232,000 158,700 115,600 124,700 7,844,200

690,600 702,500 692,900 673,000 581,900 524,700 387,400 350,100 332,900 306,100 250,100 169,500 109,200 83,900 56,800 65,200 5,976,300

574,400 631,400 619,400 593,600 499,200 436,900 384,500 397,200 391,200 359,600 303,400 237,900 177,300 127,500 82,900 107,200 5,924,100

482,500 573,200 597,800 587,500 500,800 376,100 333,200 330,100 349,300 353,000 330,700 281,500 224,800 160,000 122,000 129,000 5,730,600

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

1,126,600 1,114,700 1,057,400 1,127,300 1,389,800 1,311,900 1,026,200 894,400 769,200 648,900 520,900 400,300 304,600 177,500 130,100 160,800 12,160,900

682,100 739,300 732,000 687,800 678,400 641,200 533,700 509,500 479,600 423,100 370,200 291,500 215,900 149,500 116,000 147,000 7,396,500

654,500 667,700 669,200 664,300 600,500 536,000 394,900 354,900 319,200 274,100 214,900 144,200 100,100 77,800 56,700 63,500 5,790,700

559,100 613,000 601,800 580,700 516,300 433,000 380,300 386,400 361,000 321,200 266,700 215,700 164,200 122,600 85,400 125,600 5,732,400

465,000 562,500 593,100 579,400 472,300 357,500 325,300 332,000 360,700 349,800 324,800 282,400 229,300 162,800 138,200 160,600 5,695,400

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

2,313,200 2,284,500 2,159,900 2,256,300 2,738,000 2,642,600 2,124,400 1,856,400 1,599,000 1,371,900 1,098,400 828,500 606,200 361,000 255,000 290,100 24,785,500

1,410,400 1,525,400 1,515,400 1,422,300 1,398,400 1,322,000 1,114,900 1,047,900 980,400 886,400 757,600 599,600 448,100 308,200 231,900 271,500 15,240,600

1,345,300 1,370,100 1,362,000 1,337,400 1,182,000 1,060,700 782,400 704,900 652,100 580,200 465,100 313,600 209,400 161,900 113,600 128,700 11,769,100

1,133,500 1,244,500 1,221,300 1,174,300 1,015,500 870,100 764,800 783,500 752,300 680,700 569,900 453,500 341,400 250,200 168,300 232,900 11,660,600

947,500 1,135,600 1,190,900 1,166,700 973,000 733,900 658,300 662,000 710,000 702,700 655,500 563,900 454,100 322,700 260,100 288,900 11,426,100

Source: Dept. of Statistics Malaysia, 2007-2011 Note: The added total may differ due to rounding

SARAWAK

PERAK

75

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011 (CONTINUE)

76

AGE GROUP

KEDAH

WPKL & P

STATE KELANTAN

PENANG

PAHANG

Male 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

440,200 493,500 539,000 480,300 390,000 326,600 285,700 283,200 286,200 275,300 241,600 198,000 146,200 100,300 80,400 83,400 4,650,300

327,200 333,600 303,100 348,500 392,100 407,500 352,500 284,200 247,300 250,000 202,400 156,000 112,500 71,800 51,800 49,400 3,889,300

435,400 472,000 503,600 469,500 317,600 252,200 198,700 185,400 197,100 194,600 171,700 140,600 114,200 73,600 52,000 64,000 3,841,200

289,900 312,400 324,600 328,400 302,700 309,600 285,800 271,300 252,900 234,000 203,200 168,500 133,800 88,800 64,800 65,800 3,636,200

373,500 386,500 402,600 402,300 345,200 307,300 227,600 202,000 199,100 194,400 173,200 142,300 113,500 75,000 52,200 48,500 3,644,700

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

419,400 467,600 504,200 462,200 381,900 324,000 291,000 298,900 299,700 280,100 252,400 203,300 149,400 109,300 92,500 111,400 4,647,200

307,600 315,300 294,600 346,100 413,200 421,200 328,900 279,000 278,500 223,100 187,700 144,100 105,000 70,800 47,300 55,900 3,818,200

409,700 446,400 471,700 438,300 292,300 229,500 203,000 215,900 225,100 216,200 189,100 146,700 116,000 84,900 60,200 85,800 3,830,200

277,100 302,600 315,400 319,200 314,200 314,300 283,500 272,900 257,100 229,800 204,900 170,900 134,800 94,700 70,500 90,000 3,652,300

342,900 350,500 370,800 360,800 303,900 281,300 204,800 201,400 197,900 194,800 171,200 134,700 104,600 66,400 51,600 56,100 3,393,000

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

859,600 961,300 1,043,100 942,400 772,100 650,700 576,300 582,300 585,400 555,100 493,900 401,200 295,500 209,500 173,200 195,300 9,297,200

634,800 649,200 597,600 694,500 805,100 828,600 681,200 563,400 525,600 473,200 390,200 300,100 217,400 142,500 99,000 105,200 7,707,500

845,200 918,200 975,500 907,700 609,600 481,900 401,900 401,300 422,000 410,900 360,900 287,100 230,000 158,100 112,100 148,600 7,671,500

567,200 615,000 640,100 647,900 616,800 623,900 569,400 544,000 510,100 463,600 408,200 339,700 268,400 183,700 135,200 155,200 7,288,700

716,200 736,900 773,400 763,000 649,000 588,500 432,200 403,200 397,000 389,100 344,300 277,000 218,100 141,400 103,600 104,600 7,037,900

Source: Dept. of Statistics Malaysia, 2007-2011 Note: The added total may differ due to rounding

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011 (CONTINUE) TERENGGANU

N. SEMBILAN

STATE MELAKA

PERLIS

W. P. LABUAN

Male 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

290,300 302,800 307,000 304,900 253,400 192,100 150,200 137,800 137,200 133,700 115,300 89,100 66,900 45,800 31,600 35,200 2,593,700

225,200 249,100 249,900 253,400 228,000 184,200 157,900 144,200 140,800 141,200 132,500 110,000 77,300 51,900 39,300 40,400 2,426,300

173,900 189,200 203,500 211,300 176,600 147,500 120,700 114,800 114,200 115,600 98,200 80,400 62,700 44,500 32,600 34,700 1,920,900

50,100 52,700 59,800 70,800 54,600 38,400 28,200 27,800 31,900 32,200 29,500 25,400 20,400 15,100 11,100 12,300 560,100

22,800 21,000 18,700 18,600 22,000 24,900 15,300 12,600 11,700 11,200 8,200 5,300 3,000 2,100 1,300 1,700 200,000

Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Total

273,500 285,200 292,600 289,800 236,500 173,000 145,400 143,700 144,200 135,600 113,400 84,300 63,300 48,900 35,400 44,800 2,509,700

208,500 226,200 231,700 241,600 218,100 176,400 154,200 147,000 149,200 147,400 136,200 106,600 75,500 53,100 43,400 50,700 2,366,400

168,600 178,100 190,000 214,700 177,900 151,700 121,000 119,900 128,900 113,500 100,300 82,800 67,300 45,600 35,200 44,900 1,940,100

48,100 50,700 59,100 76,000 51,500 37,300 29,400 29,700 33,900 33,800 31,400 26,400 20,400 15,200 12,400 17,100 571,300

20,500 19,800 19,300 19,500 21,100 22,500 14,000 12,600 11,000 8,800 6,500 4,200 2,600 2,000 1,100 2,000 186,700

Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

563,900 588,200 599,400 595,000 490,000 365,200 295,500 281,600 281,500 269,500 228,800 173,500 130,000 94,600 67,500 79,600 5,103,300

433,800 475,400 481,800 494,900 446,100 360,900 311,900 291,200 290,100 288,600 268,900 216,700 152,900 105,000 82,900 91,400 4,792,500

342,700 367,500 393,500 426,200 354,700 299,200 241,500 234,700 243,100 229,100 198,500 163,300 130,200 89,800 67,800 80,300 3,861,200

98,600 103,200 119,100 146,800 106,100 75,700 57,500 57,400 65,700 66,000 60,900 52,000 40,400 30,100 23,400 29,300 1,131,500

43,400 40,800 37,800 38,300 43,100 47,200 29,000 25,100 22,700 19,800 14,600 9,600 5,800 3,600 2,400 3,100 386,800

AGE GROUP

Source: Dept. of Statistics Malaysia, 2007-2011 Note: The added total may differ due to rounding

77

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 3: PERSON-YEARS AT RISK, ALL MALAYSIAN, 2007-2011

AGE GROUP 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

78

MALAYSIA POPULATION MALE

FEMALE

WORLD STANDARD POPULATION

6,291,300 6,676,300 6,708,300 6,606,000 6,131,700 5,539,500 4,606,700 4,241,700 4,022,500 3,786,800 3,225,200 2,540,900 1,895,200 1,281,500 919,700 989,000 65,462,200

5,963,500 6,339,300 6,402,500 6,407,400 6,067,800 5,411,300 4,434,900 4,197,500 4,015,000 3,600,400 3,090,300 2,438,700 1,852,900 1,280,300 975,700 1,215,700 63,693,100

12,000 10,000 9,000 9,000 8,000 8,000 6,000 6,000 6,000 6,000 5,000 4,000 4,000 3,000 2,000 2,000 100,000

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 4: PERSON-YEARS AT RISK, MALAY RESIDENTS, MALAYSIA, 2007-2011

AGE GROUP

MALE

FEMALE

0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

3,727,400 3,897,400 3,878,000 3,770,000 3,459,000 3,026,900 2,403,200 2,160,400 2,021,700 1,872,900 1,572,400 1,231,200 889,200 577,900 415,100 458,000 35,361,000

3,536,100 3,698,800 3,691,000 3,667,100 3,420,500 2,966,900 2,347,400 2,187,200 2,069,100 1,850,500 1,581,400 1,232,300 905,000 617,800 476,000 590,400 34,837,700

79

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 5: PERSON-YEARS AT RISK, CHINESE RESIDENTS, MALAYSIA, 2007-2011

80

AGE GROUP

MALE

FEMALE

0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

1,137,200 1,295,400 1,359,600 1,396,300 1,348,600 1,325,200 1,244,300 1,202,700 1,173,700 1,148,800 1,023,800 855,200 690,100 490,800 357,700 352,800 16,401,800

1,065,200 1,222,300 1,284,400 1,322,800 1,319,400 1,270,800 1,145,000 1,131,200 1,125,400 1,025,300 920,100 776,600 627,600 442,900 338,400 423,400 15,440,400

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 6: PERSON-YEARS AT RISK, INDIAN RESIDENTS, MALAYSIA, 2007-2011

AGE GROUP

MALE

FEMALE

0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

387,900 437,900 450,200 459,400 466,700 434,900 374,200 335,500 320,000 314,300 266,100 199,100 136,400 77,300 55,500 60,700 4,776,600

372,300 421,000 438,700 443,900 446,800 423,000 359,500 337,300 331,800 310,400 270,200 205,000 146,800 86,800 67,600 78,500 4,740,100

81

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 7: PERSON-YEARS AT RISK, OTHER RESIDENTS, MALAYSIA, 2007-2011

82

AGE GROUP

MALE

FEMALE

0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ TOTAL

1,039,000 1,045,600 1,020,500 980,200 857,800 752,300 585,000 543,300 506,900 450,900 362,900 255,200 179,400 135,700 91,400 116,200 8,922,800

989,700 997,100 988,600 973,800 880,900 750,700 582,900 541,900 488,800 414,400 318,500 224,700 173,500 132,800 93,500 123,500 8,674,900

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 8: INCIDENCE SUMMARY TABLE, ALL RESIDENTS, MALES, MALAYSIA, 2007-2011 ICD 10

SITE

C18-C21 C33-C34 C11 C81-C85,C96 C61 C22 C91-C95 C16 C67 C44 C70-C72 C25 C64 C32 Other C15 C73 C62 C40-C41 C01-C02 C47;C49 C23-C24 C90 C03-C06 C07-C08 C30-C31 C12-C13 C43 C37-C38 C17 C50 C09 C60 C75 C69 C10 C74 C14 C63 C00 C45 C66 C46 C68 C65 C88 All

Colorectal Trachea,Bronchus,Lung Nasopharynx Lymphoma Prostate Liver Leukaemia Stomach Bladder Other Skin Brain, Nervous system Pancreas Kidney Larynx Other & unspecified Oesophagus Thyroid Testis Bone Tongue Connective,Soft tissue Gallbladder etc.

Multiple Myeloma Mouth Salivary glands Nose, sinuses etc.

Hypopharynx Melanoma of Skin Other Thoracic organs Small intestine Breast Tonsil Penis Other Endocrine Eye Other Oropharynx Adrenal gland Pharynx unspec.

Other male genital Lip Mesothelioma Ureter Kaposi sarcoma Other Urinary organs Renal Pelvis Immunoproliferative dis.

All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

7,646 7,415 3,785 3,171 3,132 3,054 2,549 2,014 1,477 1,384 1,176 1,041 901 825 741 737 549 496 493 461 434 413 396 391 273 270 172 167 167 153 137 127 115 109 104 81 47 37 31 30 22 19 17 17 13 5 46,794

16.4 15.8 8.1 6.8 6.7 6.5 5.4 4.3 3.2 3.0 2.5 2.2 1.9 1.8 1.6 1.6 1.2 1.1 1.1 1.0 0.9 0.9 0.8 0.8 0.6 0.6 0.4 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 100.0

11.7 11.3 5.8 4.8 4.8 4.7 3.9 3.1 2.3 2.1 1.8 1.6 1.4 1.3 1.1 1.1 0.8 0.8 0.8 0.7 0.7 0.6 0.6 0.6 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 71.4

1.8 1.8 0.7 0.6 0.9 0.7 0.4 0.5 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3

14.6 14.4 6.4 5.5 6.6 5.6 4.2 3.9 2.9 2.7 1.9 2.0 1.7 1.6 1.4 1.4 1.0 0.7 0.8 0.8 0.7 0.8 0.7 0.7 0.5 0.5 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 86.9

(14.2 , 14.9) (14.1 , 14.8) (6.1 , 6.6) (5.3 , 5.7) (6.3 , 6.8) (5.4 , 5.8) (4.0 , 4.4) (3.7 , 4.1) (2.8 , 3.1) (2.5 , 2.8) (1.8 , 2.1) (1.9 , 2.1) (1.6 , 1.8) (1.5 , 1.7) (1.3 , 1.5) (1.3 , 1.5) (0.9 , 1.0) (0.7 , 0.8) (0.7 , 0.8) (0.8 , 0.9) (0.7 , 0.8) (0.7 , 0.9) (0.7 , 0.8) (0.7 , 0.8) (0.4 , 0.5) (0.4 , 0.5) (0.3 , 0.4) (0.3 , 0.4) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.2) (0.1 , 0.2) (0.2 , 0.2) (0.1 , 0.2) (0.1 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (86.1 , 87.7)

1.8 1.8 0.7 0.6 0.9 0.7 0.4 0.5 0.4 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8

83

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 9: INCIDENCE SUMMARY TABLE, ALL RESIDENTS, FEMALES, MALAYSIA, 2007-2011

84

ICD 10

SITE

C50 C18-C21 C53 C56 C33-C34 C81-C85,C96 C54 C91-C95 C73 C16 C11 C22 C70-C72 C44 C25 Other C55 C03-C06 C64 C15 C23-C24 C01-C02 C67 C47;C49 C40-C41 C90 C07-C08 C43 C30-C31 C52 C37-C38 C51 C32 C17 C12-C13 C09 C69 C58 C00 C75 C74 C57 C10 C14 C45 C66 C68 C65 C88 C46 All

Breast Colorectal Cervix Uteri Ovary Trachea,Bronchus,Lung Lymphoma Corpus Uteri Leukaemia Thyroid Stomach Nasopharynx Liver Brain, Nervous system Other Skin Pancreas Other & unspecified Uterus unspec.

Mouth Kidney Oesophagus Gallbladder etc.

Tongue Bladder Connective,Soft tissue Bone Multiple Myeloma Salivary glands Melanoma of Skin Nose, sinuses etc.

Vagina Other Thoracic organs Vulva Larynx Small intestine Hypopharynx Tonsil Eye Placenta Lip Other Endocrine Adrenal gland Other Female Genital Other Oropharynx Pharynx unspec.

Mesothelioma Ureter Other Urinary organs Renal Pelvis Immunoproliferative dis.

Kaposi sarcoma All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

18,206 6,047 4,352 3,472 3,193 2,203 2,181 2,024 1,723 1,447 1,305 1,074 1,060 1,045 788 647 580 525 434 429 409 401 400 378 365 348 226 155 138 124 123 123 113 89 86 68 67 65 55 51 45 42 30 20 19 11 10 8 7 2 56,713

32.1 10.7 7.7 6.1 5.6 3.9 3.8 3.5 3.0 2.6 2.3 1.9 1.9 1.8 1.4 1.1 1.0 0.9 0.8 0.8 0.7 0.7 0.7 0.7 0.6 0.6 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0

28.6 9.5 6.8 5.4 5.0 3.5 3.4 3.2 2.7 2.3 2.0 1.7 1.7 1.6 1.2 1.0 0.9 0.8 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.5 0.4 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 89.0

3.4 1.4 0.9 0.6 0.7 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2

31.1 11.1 7.6 5.9 6.0 3.8 3.8 3.4 2.9 2.6 2.2 2.0 1.8 1.9 1.5 1.1 1.0 1.0 0.8 0.8 0.8 0.7 0.7 0.6 0.6 0.7 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.3

(30.7 , 31.6) (10.8 , 11.4) (7.3 , 7.8) (5.7 , 6.1) (5.8 , 6.2) (3.6 , 3.9) (3.7 , 4.0) (3.2 , 3.5) (2.7 , 3.0) (2.5 , 2.8) (2.1 , 2.3) (1.9 , 2.1) (1.7 , 1.9) (1.8 , 2.0) (1.4 , 1.6) (1.1 , 1.2) (0.9 , 1.1) (0.9 , 1.1) (0.7 , 0.9) (0.7 , 0.9) (0.7 , 0.8) (0.6 , 0.8) (0.7 , 0.8) (0.6 , 0.7) (0.5 , 0.7) (0.6 , 0.7) (0.3 , 0.4) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.3) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.1) (0.1 , 0.1) (0.1 , 0.1) (0.1 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (98.4 , 100.1)

3.4 1.3 0.9 0.6 0.7 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 10: INCIDENCE SUMMARY TABLE, MALAY MALES, MALAYSIA, 2007-2011 ICD 10

SITE

C33-C34 C18-C21 C81-C85,C96 C91-C95 C22 C61 C11 C67 C70-C72 C44 C16 C25 C64 C73 C40-C41 C62 Other C15 C32 C47;C49 C90 C01-C02 C23-C24 C03-C06 C30-C31 C07-C08 C17 C43 C69 C37-C38 C75 C50 C09 C12-C13 C60 C74 C10 C63 C14 C45 C00 C46 C66 C65 C68 C88 All

Trachea,Bronchus,Lung Colorectal Lymphoma Leukaemia Liver Prostate Nasopharynx Bladder Brain, Nervous system Other Skin Stomach Pancreas Kidney Thyroid Bone Testis Other & unspecified Oesophagus Larynx Connective,Soft tissue Multiple Myeloma Tongue Gallbladder etc.

Mouth Nose, sinuses etc.

Salivary glands Small intestine Melanoma of Skin Eye Other Thoracic organs Other Endocrine Breast Tonsil Hypopharynx Penis Adrenal gland Other Oropharynx Other male genital Pharynx unspec.

Mesothelioma Lip Kaposi sarcoma Ureter Renal Pelvis Other Urinary organs Immunoproliferative dis.

All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

3,094 2,872 1,639 1,419 1,195 1,163 959 781 612 504 429 379 316 312 282 273 273 258 252 240 220 165 165 130 128 122 69 62 61 61 61 50 42 35 26 22 22 14 14 11 8 4 4 3 3 3 18,757

16.5 15.3 8.7 7.6 6.4 6.2 5.1 4.2 3.3 2.7 2.3 2.0 1.7 1.7 1.5 1.5 1.5 1.4 1.3 1.3 1.2 0.9 0.9 0.7 0.7 0.7 0.4 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 100.0

8.8 8.1 4.6 4.0 3.4 3.3 2.7 2.2 1.7 1.4 1.2 1.1 0.9 0.9 0.8 0.8 0.8 0.7 0.7 0.7 0.6 0.5 0.5 0.4 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.1

1.6 1.4 0.6 0.4 0.5 0.7 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3

12.6 11.3 5.6 4.4 4.5 5.3 3.3 3.3 1.9 2.0 1.7 1.5 1.2 1.1 0.9 0.8 1.0 1.1 1.0 0.8 0.8 0.6 0.7 0.5 0.5 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.7

(12.1 , 13.0) (10.8 , 11.7) (5.3 , 5.9) (4.2 , 4.7) (4.2 , 4.7) (5.0 , 5.6) (3.1 , 3.5) (3.1 , 3.6) (1.8 , 2.1) (1.8 , 2.2) (1.5 , 1.8) (1.3 , 1.7) (1.1 , 1.3) (1.0 , 1.3) (0.7 , 1.0) (0.7 , 0.8) (0.9 , 1.1) (0.9 , 1.2) (0.9 , 1.2) (0.7 , 0.9) (0.7 , 1.0) (0.5 , 0.7) (0.6 , 0.8) (0.4 , 0.6) (0.4 , 0.5) (0.3 , 0.5) (0.2 , 0.3) (0.2 , 0.3) (0.2 , 0.3) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (69.7 , 71.8)

1.6 1.4 0.6 0.4 0.5 0.7 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0

85

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 11: INCIDENCE SUMMARY TABLE, MALAY FEMALES, MALAYSIA, 2007-2011

86

ICD 10

SITE

C50 C18-C21 C56 C53 C33-C34 C81-C85,C96 C91-C95 C73 C54 C70-C72 C22 C11 C44 C16 C25 C55 Other C47;C49 C40-C41 C90 C64 C01-C02 C23-C24 C67 C15 C03-C06 C07-C08 C43 C30-C31 C51 C58 C37-C38 C32 C52 C17 C69 C12-C13 C09 C75 C57 C74 C00 C14 C10 C45 C88 C65 C66 C68 C46 All

Breast Colorectal Ovary Cervix Uteri Trachea,Bronchus,Lung Lymphoma Leukaemia Thyroid Corpus Uteri Brain, Nervous system Liver Nasopharynx Other Skin Stomach Pancreas Uterus unspec.

Other & unspecified Connective,Soft tissue Bone Multiple Myeloma Kidney Tongue Gallbladder etc.

Bladder Oesophagus Mouth Salivary glands Melanoma of Skin Nose, sinuses etc.

Vulva Placenta Other Thoracic organs Larynx Vagina Small intestine Eye Hypopharynx Tonsil Other Endocrine Other Female Genital Adrenal gland Lip Pharynx unspec.

Other Oropharynx Mesothelioma Immunoproliferative dis.

Renal Pelvis Ureter Other Urinary organs Kaposi sarcoma All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

8,225 2,231 1,754 1,502 1,187 1,142 1,119 1,023 964 566 477 401 363 312 273 264 236 207 190 178 167 163 155 151 149 112 101 69 64 46 42 40 38 38 37 31 28 24 24 21 21 17 10 8 6 5 2 2 2 1 24,188

34.0 9.3 7.3 6.2 4.9 4.7 4.7 4.2 4.0 2.3 2.0 1.7 1.5 1.3 1.1 1.1 1.0 0.9 0.8 0.7 0.7 0.7 0.6 0.6 0.6 0.5 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0

23.6 6.4 5.0 4.3 3.4 3.3 3.2 2.9 2.8 1.6 1.4 1.2 1.0 0.9 0.8 0.8 0.7 0.6 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.5

2.9 1.0 0.6 0.6 0.5 0.4 0.3 0.4 0.4 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1

27.2 8.1 5.8 5.1 4.4 3.7 3.5 3.3 3.3 1.8 1.7 1.3 1.3 1.1 1.0 0.9 0.8 0.6 0.5 0.7 0.6 0.6 0.6 0.6 0.6 0.4 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9

(26.6 , 27.8) (7.8 , 8.4) (5.5 , 6.1) (4.8 , 5.4) (4.1 , 4.6) (3.5 , 4.0) (3.3 , 3.7) (3.1 , 3.5) (3.1 , 3.5) (1.7 , 2.0) (1.6 , 1.9) (1.2 , 1.4) (1.2 , 1.5) (1.0 , 1.3) (0.9 , 1.1) (0.8 , 1.0) (0.7 , 0.9) (0.6 , 0.7) (0.5 , 0.6) (0.6 , 0.8) (0.5 , 0.7) (0.5 , 0.6) (0.5 , 0.7) (0.5 , 0.6) (0.5 , 0.7) (0.3 , 0.5) (0.3 , 0.4) (0.2 , 0.3) (0.2 , 0.3) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.1) (0.1 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (80.8 , 82.9)

2.9 1.0 0.6 0.6 0.5 0.4 0.3 0.4 0.4 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 12: INCIDENCE SUMMARY TABLE,CHINESE MALES, MALAYSIA, 2007-2011 ICD 10

SITE

C18-C21 C33-C34 C11 C61 C22 C16 C81-C85,C96 C44 C91-C95 C25 C67 C64 C32 C70-C72 Other C15 C23-C24 C01-C02 C73 C40-C41 C62 C47;C49 C30-C31 C03-C06 C90 C07-C08 C12-C13 C37-C38 C50 C17 C43 C09 C60 C75 C10 C69 C63 C66 C68 C74 C14 C00 C65 C45 C46 C88 All

Colorectal Trachea,Bronchus,Lung Nasopharynx Prostate Liver Stomach Lymphoma Other Skin Leukaemia Pancreas Bladder Kidney Larynx Brain, Nervous system Other & unspecified Oesophagus Gallbladder etc.

Tongue Thyroid Bone Testis Connective,Soft tissue Nose, sinuses etc.

Mouth Multiple Myeloma Salivary glands Hypopharynx Other Thoracic organs Breast Small intestine Melanoma of Skin Tonsil Penis Other Endocrine Other Oropharynx Eye Other male genital Ureter Other Urinary organs Adrenal gland Pharynx unspec.

Lip Renal Pelvis Mesothelioma Kaposi sarcoma Immunoproliferative dis.

All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

3,825 3,390 2,104 1,589 1,416 1,001 908 687 657 516 510 498 431 368 327 305 177 171 142 128 126 126 116 110 102 98 74 73 64 62 53 46 39 31 30 23 15 14 14 12 11 10 10 7 6 2 20,424

18.7 16.6 10.3 7.8 6.9 4.9 4.5 3.4 3.2 2.5 2.5 2.4 2.1 1.8 1.6 1.5 0.9 0.8 0.7 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 100.0

23.3 20.6 12.8 9.7 8.6 6.1 5.5 4.2 4.0 3.1 3.1 3.0 2.6 2.2 2.0 1.9 1.1 1.0 0.9 0.8 0.8 0.8 0.7 0.7 0.6 0.6 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 124.4

2.6 2.4 1.2 1.2 0.9 0.6 0.6 0.4 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4

21.1 18.8 11.0 9.0 7.7 5.6 5.0 3.8 4.0 2.8 2.8 2.7 2.4 2.1 1.8 1.7 1.0 0.9 0.8 0.7 0.7 0.7 0.6 0.6 0.6 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 112.9

(20.4 , 21.7) (18.2 , 19.4) (10.5 , 11.5) (8.6 , 9.5) (7.3 , 8.1) (5.2 , 5.9) (4.7 , 5.3) (3.5 , 4.1) (3.7 , 4.4) (2.6 , 3.1) (2.6 , 3.1) (2.5 , 3.0) (2.2 , 2.6) (1.9 , 2.3) (1.6 , 2.0) (1.5 , 1.9) (0.8 , 1.1) (0.8 , 1.1) (0.6 , 0.9) (0.6 , 0.9) (0.6 , 0.9) (0.6 , 0.8) (0.5 , 0.7) (0.5 , 0.7) (0.4 , 0.7) (0.4 , 0.6) (0.3 , 0.5) (0.3 , 0.5) (0.3 , 0.4) (0.3 , 0.4) (0.2 , 0.4) (0.2 , 0.3) (0.1 , 0.3) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.0) (111.4 , 114.5)

2.5 2.3 1.2 1.2 0.9 0.6 0.6 0.4 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5

87

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 13: INCIDENCE SUMMARY TABLE,CHINESE FEMALES, MALAYSIA, 2007-2011

88

ICD 10

SITE

C50 C18-C21 C53 C33-C34 C56 C54 C16 C81-C85,C96 C11 C91-C95 C44 C22 C25 C73 C70-C72 Other C64 C55 C67 C23-C24 C40-C41 C47;C49 C01-C02 C90 C15 C07-C08 C03-C06 C43 C30-C31 C51 C52 C37-C38 C32 C17 C09 C75 C69 C74 C57 C12-C13 C66 C10 C45 C00 C58 C65 C68 C14 C46 C88 All

Breast Colorectal Cervix Uteri Trachea,Bronchus,Lung Ovary Corpus Uteri Stomach Lymphoma Nasopharynx Leukaemia Other Skin Liver Pancreas Thyroid Brain, Nervous system Other & unspecified Kidney Uterus unspec.

Bladder Gallbladder etc.

Bone Connective,Soft tissue Tongue Multiple Myeloma Oesophagus Salivary glands Mouth Melanoma of Skin Nose, sinuses etc.

Vulva Vagina Other Thoracic organs Larynx Small intestine Tonsil Other Endocrine Eye Adrenal gland Other Female Genital Hypopharynx Ureter Other Oropharynx Mesothelioma Lip Placenta Renal Pelvis Other Urinary organs Pharynx unspec.

Kaposi sarcoma Immunoproliferative dis.

All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

7,333 3,023 1,732 1,486 1,107 853 725 639 611 527 446 411 400 371 305 273 214 199 185 171 105 104 99 98 82 71 66 55 52 52 52 49 41 32 24 18 16 14 12 10 9 8 8 7 5 5 4 3 1 1 22,114

33.2 13.7 7.8 6.7 5.0 3.9 3.3 2.9 2.8 2.4 2.0 1.9 1.8 1.7 1.4 1.2 1.0 0.9 0.8 0.8 0.5 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 100.0

47.5 19.6 11.2 9.6 7.2 5.5 4.7 4.1 4.0 3.4 2.9 2.7 2.6 2.4 2.0 1.8 1.4 1.3 1.2 1.1 0.7 0.7 0.6 0.6 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.2

4.6 2.1 1.2 1.0 0.7 0.6 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2

41.5 17.1 9.8 8.5 6.3 4.9 4.1 3.7 3.5 3.4 2.5 2.3 2.3 2.1 1.9 1.5 1.2 1.1 1.0 1.0 0.6 0.6 0.6 0.6 0.5 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 126.2

(40.6 , 42.5) (16.5 , 17.7) (9.4 , 10.3) (8.1 , 8.9) (6.0 , 6.7) (4.5 , 5.2) (3.8 , 4.4) (3.4 , 4.0) (3.2 , 3.7) (3.1 , 3.7) (2.2 , 2.7) (2.1 , 2.6) (2.1 , 2.5) (1.9 , 2.3) (1.7 , 2.2) (1.4 , 1.7) (1.1 , 1.4) (1.0 , 1.3) (0.9 , 1.2) (0.8 , 1.1) (0.5 , 0.7) (0.5 , 0.7) (0.4 , 0.7) (0.4 , 0.7) (0.4 , 0.6) (0.3 , 0.5) (0.3 , 0.5) (0.2 , 0.4) (0.2 , 0.4) (0.2 , 0.4) (0.2 , 0.4) (0.2 , 0.4) (0.2 , 0.3) (0.1 , 0.2) (0.1 , 0.2) (0.1 , 0.2) (0.0 , 0.1) (0.0 , 0.2) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (0.0 , 0.0) (124.5 , 127.9)

4.5 2.0 1.2 1.0 0.7 0.6 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 14: INCIDENCE SUMMARY TABLE, INDIAN MALES, MALAYSIA, 2007-2011 ICD 10

SITE

C18-C21 C33-C34 C61 C16 C81-C85,C96 C91-C95 C22 C03-C06 C15 C32 C67 C70-C72 C01-C02 C25 Other C64 C44 C11 C62 C12-C13 C73 C09 C40-C41 C23-C24 C10 C90 C07-C08 C60 C47;C49 C50 C75 C00 C17 C14 C43 C30-C31 C37-C38 C69 C74 C45 C46 C63 C66 All

Colorectal Trachea,Bronchus,Lung Prostate Stomach Lymphoma Leukaemia Liver Mouth Oesophagus Larynx Bladder Brain, Nervous system Tongue Pancreas Other & unspecified Kidney Other Skin Nasopharynx Testis Hypopharynx Thyroid Tonsil Bone Gallbladder etc.

Other Oropharynx Multiple Myeloma Salivary glands Penis Connective,Soft tissue Breast Other Endocrine Lip Small intestine Pharynx unspec.

Melanoma of Skin Nose, sinuses etc.

Other Thoracic organs Eye Adrenal gland Mesothelioma Kaposi sarcoma Other male genital Ureter All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

389 270 188 187 187 171 114 107 98 90 86 83 74 70 55 47 45 44 43 38 30 29 28 27 26 25 24 16 14 10 10 9 9 8 8 6 4 4 2 1 1 1 1 2,679

14.5 10.1 7.0 7.0 7.0 6.4 4.3 4.0 3.7 3.4 3.2 3.1 2.8 2.6 2.1 1.8 1.7 1.6 1.6 1.4 1.1 1.1 1.0 1.0 1.0 0.9 0.9 0.6 0.5 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 100.0

8.1 5.6 3.9 3.9 3.9 3.6 2.4 2.2 2.0 1.9 1.8 1.7 1.5 1.5 1.2 1.0 0.9 0.9 0.9 0.8 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 56.0

1.2 1.0 0.8 0.6 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4

10.3 7.6 6.1 5.2 4.2 3.8 3.1 2.9 2.7 2.3 2.5 1.8 1.9 1.8 1.4 1.3 1.3 1.1 0.8 1.0 0.7 0.7 0.6 0.7 0.7 0.8 0.6 0.4 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 70.4

(9.2 , 11.4) (6.6 , 8.5) (5.2 , 7.0) (4.4 , 5.9) (3.6 , 4.8) (3.2 , 4.3) (2.5 , 3.7) (2.3 , 3.4) (2.1 , 3.2) (1.8 , 2.8) (2.0 , 3.1) (1.4 , 2.2) (1.4 , 2.3) (1.3 , 2.2) (1.0 , 1.8) (0.9 , 1.6) (0.9 , 1.6) (0.8 , 1.4) (0.6 , 1.1) (0.7 , 1.4) (0.4 , 1.0) (0.5 , 1.0) (0.4 , 0.8) (0.4 , 1.0) (0.4 , 1.0) (0.5 , 1.1) (0.4 , 0.9) (0.2 , 0.6) (0.1 , 0.5) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.3) (0.0 , 0.3) (0.0 , 0.1) (0.0 , 0.2) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (67.6 , 73.2)

1.2 1.0 0.8 0.6 0.4 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1

89

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 15: INCIDENCE SUMMARY TABLE, INDIAN FEMALES, MALAYSIA, 2007-2011

90

ICD 10

SITE

C50 C18-C21 C53 C03-C06 C56 C54 C15 C16 C91-C95 C81-C85,C96 C33-C34 C73 C01-C02 C70-C72 C55 C44 C22 Other C25 C23-C24 C12-C13 C64 C40-C41 C11 C67 C90 C32 C07-C08 C47;C49 C00 C52 C10 C09 C30-C31 C37-C38 C51 C75 C17 C14 C43 C57 C69 C45 C58 C65 C74 C88 All

Breast Colorectal Cervix Uteri Mouth Ovary Corpus Uteri Oesophagus Stomach Leukaemia Lymphoma Trachea,Bronchus,Lung Thyroid Tongue Brain, Nervous system Uterus unspec.

Other Skin Liver Other & unspecified Pancreas Gallbladder etc.

Hypopharynx Kidney Bone Nasopharynx Bladder Multiple Myeloma Larynx Salivary glands Connective,Soft tissue Lip Vagina Other Oropharynx Tonsil Nose, sinuses etc.

Other Thoracic organs Vulva Other Endocrine Small intestine Pharynx unspec.

Melanoma of Skin Other Female Genital Eye Mesothelioma Placenta Renal Pelvis Adrenal gland Immunoproliferative dis.

All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

1,705 364 327 287 277 204 145 137 137 130 127 119 100 78 60 59 58 58 57 37 35 27 26 25 24 24 20 18 16 15 14 11 10 10 10 10 8 6 5 5 4 3 2 1 1 1 1 4,798

35.5 7.6 6.8 6.0 5.8 4.3 3.0 2.9 2.9 2.7 2.6 2.5 2.1 1.6 1.3 1.2 1.2 1.2 1.2 0.8 0.7 0.6 0.5 0.5 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 100.0

36.0 7.7 6.9 6.1 5.8 4.3 3.1 2.9 2.9 2.7 2.7 2.5 2.1 1.6 1.3 1.2 1.2 1.2 1.2 0.8 0.7 0.6 0.5 0.5 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 101.2

4.2 1.1 0.9 1.0 0.7 0.6 0.5 0.4 0.3 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0

37.1 8.7 7.6 7.5 6.1 4.8 3.6 3.2 3.0 3.0 3.1 2.5 2.5 1.7 1.4 1.5 1.5 1.4 1.3 0.9 0.9 0.6 0.6 0.6 0.6 0.6 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 110.1

(35.3 , 38.9) (7.8 , 9.7) (6.7 , 8.4) (6.6 , 8.4) (5.3 , 6.8) (4.1 , 5.4) (3.0 , 4.2) (2.7 , 3.8) (2.5 , 3.5) (2.5 , 3.5) (2.5 , 3.7) (2.0 , 3.0) (2.0 , 2.9) (1.3 , 2.1) (1.1 , 1.8) (1.1 , 1.8) (1.1 , 1.9) (1.1 , 1.8) (1.0 , 1.7) (0.6 , 1.3) (0.6 , 1.1) (0.4 , 0.8) (0.4 , 0.9) (0.3 , 0.8) (0.4 , 0.9) (0.4 , 0.9) (0.3 , 0.7) (0.2 , 0.5) (0.2 , 0.6) (0.2 , 0.5) (0.1 , 0.5) (0.1 , 0.5) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.3) (0.1 , 0.4) (0.0 , 0.3) (0.0 , 0.2) (0.0 , 0.2) (0.0 , 0.2) (0.0 , 0.2) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (106.9 , 113.3)

4.2 1.1 0.9 1.0 0.7 0.6 0.5 0.4 0.3 0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 16: INCIDENCE SUMMARY TABLE, OTHERS MALES, MALAYSIA, 2007-2011 ICD 10

SITE

C11 C33-C34 C18-C21 C81-C85,C96 C16 C22 C91-C95 C61 C44 C70-C72 C67 Other C25 C15 C73 C40-C41 C62 C47;C49 C32 C01-C02 C90 C23-C24 C43 C03-C06 C64 C60 C07-C08 C37-C38 C12-C13 C30-C31 C69 C17 C50 C74 C09 C75 C46 C14 C00 C10 C45 C63 All

Nasopharynx Trachea,Bronchus,Lung Colorectal Lymphoma Stomach Liver Leukaemia Prostate Other Skin Brain, Nervous system Bladder Other & unspecified Pancreas Oesophagus Thyroid Bone Testis Connective,Soft tissue Larynx Tongue Multiple Myeloma Gallbladder etc.

Melanoma of Skin Mouth Kidney Penis Salivary glands Other Thoracic organs Hypopharynx Nose, sinuses etc.

Eye Small intestine Breast Adrenal gland Tonsil Other Endocrine Kaposi sarcoma Pharynx unspec.

Lip Other Oropharynx Mesothelioma Other male genital All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

678 661 560 437 397 329 302 192 148 113 100 86 76 76 65 55 54 54 52 51 49 44 44 44 40 34 29 29 25 20 16 13 13 11 10 7 6 4 3 3 3 1 4,934

13.7 13.4 11.3 8.9 8.0 6.7 6.1 3.9 3.0 2.3 2.0 1.7 1.5 1.5 1.3 1.1 1.1 1.1 1.1 1.0 1.0 0.9 0.9 0.9 0.8 0.7 0.6 0.6 0.5 0.4 0.3 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 100.0

7.6 7.4 6.2 4.9 4.4 3.7 3.4 2.1 1.6 1.3 1.1 1.0 0.8 0.8 0.7 0.6 0.6 0.6 0.6 0.6 0.5 0.5 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 55.0

1.1 1.5 1.1 0.8 0.9 0.7 0.3 0.5 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7

9.9 11.9 9.4 6.7 7.1 5.8 3.8 3.8 2.6 1.5 1.8 1.5 1.4 1.4 1.1 0.6 0.6 0.7 1.0 0.9 0.8 0.8 0.8 0.8 0.6 0.5 0.4 0.5 0.5 0.3 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 80.5

(9.1 , 10.6) (11.0 , 12.8) (8.6 , 10.2) (6.0 , 7.3) (6.4 , 7.8) (5.1 , 6.4) (3.3 , 4.2) (3.2 , 4.3) (2.2 , 3.1) (1.2 , 1.7) (1.4 , 2.2) (1.1 , 1.8) (1.0 , 1.7) (1.1 , 1.7) (0.8 , 1.3) (0.4 , 0.8) (0.4 , 0.8) (0.5 , 1.0) (0.7 , 1.3) (0.6 , 1.1) (0.6 , 1.1) (0.6 , 1.0) (0.5 , 1.0) (0.5 , 1.0) (0.4 , 0.9) (0.3 , 0.7) (0.2 , 0.6) (0.3 , 0.7) (0.3 , 0.7) (0.2 , 0.4) (0.1 , 0.3) (0.1 , 0.3) (0.1 , 0.3) (0.1 , 0.3) (0.1 , 0.3) (0.0 , 0.1) (0.0 , 0.2) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.0) (78.2 , 82.8)

1.1 1.5 1.1 0.8 0.9 0.7 0.3 0.5 0.3 0.1 0.3 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2

91

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 17: INCIDENCE SUMMARY TABLE, OTHERS FEMALES, MALAYSIA, 2007-2011

92

ICD 10

SITE

C50 C53 C18-C21 C33-C34 C56 C81-C85,C96 C16 C11 C91-C95 C73 C44 C54 C22 C70-C72 Other C03-C06 C25 C55 C15 C47;C49 C90 C23-C24 C40-C41 C67 C01-C02 C07-C08 C43 C64 C37-C38 C52 C58 C69 C00 C51 C17 C32 C12-C13 C30-C31 C09 C74 C57 C68 C10 C45 C14 C75 All

Breast Cervix Uteri Colorectal Trachea,Bronchus,Lung Ovary Lymphoma Stomach Nasopharynx Leukaemia Thyroid Other Skin Corpus Uteri Liver Brain, Nervous system Other & unspecified Mouth Pancreas Uterus unspec.

Oesophagus Connective,Soft tissue Multiple Myeloma Gallbladder etc.

Bone Bladder Tongue Salivary glands Melanoma of Skin Kidney Other Thoracic organs Vagina Placenta Eye Lip Vulva Small intestine Larynx Hypopharynx Nose, sinuses etc.

Tonsil Adrenal gland Other Female Genital Other Urinary organs Other Oropharynx Mesothelioma Pharynx unspec.

Other Endocrine All sites Total

NO.

%

CR

CR74

ASR

(ASR 95%CL)

CumR

943 791 429 393 334 292 273 268 241 210 177 160 128 111 80 60 58 57 53 51 48 46 44 40 39 36 26 26 24 20 17 17 16 15 14 14 13 12 10 9 5 4 3 3 2 1 5,613

16.8 14.1 7.6 7.0 6.0 5.2 4.9 4.8 4.3 3.7 3.2 2.9 2.3 2.0 1.4 1.1 1.0 1.0 0.9 0.9 0.9 0.8 0.8 0.7 0.7 0.6 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 100.0

10.8 9.1 4.9 4.5 3.8 3.3 3.1 3.1 2.8 2.4 2.0 1.8 1.5 1.3 0.9 0.7 0.7 0.7 0.6 0.6 0.6 0.5 0.5 0.5 0.4 0.4 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 64.4

1.5 1.3 0.9 1.0 0.5 0.5 0.6 0.4 0.3 0.4 0.4 0.3 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2

14.3 12.0 7.4 7.4 4.9 4.5 4.9 4.0 3.2 3.2 3.2 2.5 2.3 1.5 1.3 1.1 1.0 0.9 1.0 0.7 0.9 0.9 0.5 0.7 0.6 0.5 0.5 0.4 0.4 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 89.6

(13.3 , 15.2) (11.2 , 12.9) (6.6 , 8.1) (6.7 , 8.2) (4.3 , 5.4) (4.0 , 5.1) (4.3 , 5.5) (3.5 , 4.5) (2.8 , 3.6) (2.7 , 3.6) (2.7 , 3.7) (2.1 , 2.9) (1.9 , 2.7) (1.2 , 1.8) (1.0 , 1.6) (0.8 , 1.4) (0.7 , 1.3) (0.6 , 1.1) (0.7 , 1.3) (0.5 , 0.9) (0.6 , 1.1) (0.6 , 1.1) (0.4 , 0.7) (0.5 , 1.0) (0.4 , 0.8) (0.3 , 0.7) (0.3 , 0.6) (0.2 , 0.5) (0.2 , 0.6) (0.2 , 0.5) (0.1 , 0.3) (0.1 , 0.3) (0.2 , 0.5) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.4) (0.1 , 0.3) (0.1 , 0.3) (0.0 , 0.2) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (0.0 , 0.1) (87.2 , 92.0)

1.5 1.3 0.9 1.0 0.5 0.5 0.6 0.4 0.3 0.4 0.4 0.3 0.3 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 18: INCIDENCE SUMMARY TABLE OF 15 SELECTED CANCER SITES BY STATE AND SEX, MALAYSIA, 2007-2011 MALE FEMALE STATE ASR CumR ASR CumR CR CR74 CR CR74 NO. NO. 1. Female Breast 3.5 31.7 3.6 25.8 Selangor 3,159 4.2 39.8 4.3 37.7 Johor 2,792 2.1 19.7 2.2 13.9 Sabah 805 2.4 22.7 2.5 20.9 Sarawak 1,198 3.1 29.3 3.2 31.8 Perak 1,809 2.7 25.9 2.7 26.2 Kedah 1,220 4.7 42.2 4.8 38.8 WPKL & Putrajaya 1,453 1.8 17.0 1.8 15.5 Kelantan 594 5.4 50.0 5.5 53.6 Penang 1,958 2.7 25.7 2.8 23.3 Pahang 790 2.6 24.8 2.6 21.4 Terengganu 534 3.9 37.0 4.0 37.4 Negeri Sembilan 883 3.9 35.7 4.0 36.4 Melaka 731 2.9 26.4 2.9 26.4 Perlis 151 1.5 12.6 1.5 8.9 W.P. Labuan 17 2. Colorectal 1.4 10.6 1.4 7.3 889 Selangor 1.8 13.5 8.7 1.8 1,108 1.7 14.1 1.7 12.4 920 Johor 2.2 18.2 15.0 2.3 1,173 1.3 10.6 1.3 6.3 367 Sabah 1.7 14.3 8.7 1.7 519 1.2 10.2 1.2 8.9 509 Sarawak 1.5 12.3 10.7 1.5 638 1.0 8.3 1.0 9.3 532 Perak 1.3 10.9 11.5 1.3 657 1.2 9.3 1.2 9.1 422 Kedah 1.6 13.2 11.7 1.6 545 1.5 11.8 1.5 9.3 348 WPKL & Putrajaya 1.9 14.5 11.2 1.9 428 1.0 7.8 1.0 7.0 266 Kelantan 1.4 11.9 9.3 1.4 357 2.1 18.7 2.2 19.7 720 Penang 2.6 23.3 22.3 2.7 810 1.0 8.1 1.0 7.0 239 Pahang 1.5 12.3 9.9 1.5 355 1.1 8.9 1.1 7.0 175 Terengganu 1.6 12.0 8.7 1.6 227 1.7 14.4 1.7 13.6 322 Negeri Sembilan 2.4 19.2 16.5 2.5 400 1.5 12.2 1.5 12.5 251 Melaka 2.1 17.4 15.5 2.1 298 0.9 7.7 0.9 8.2 47 Perlis 1.5 12.4 7.9 1.5 69 0.3 2.8 0.3 1.6 3 W.P. Labuan 1.3 11.4 5.0 1.3 10 3. Trachea, Bronchus, Lung 0.5 4.3 0.5 2.9 353 Selangor 1.2 9.4 6.0 1.2 759 0.9 7.6 0.9 6.6 487 Johor 2.6 20.3 16.4 2.7 1,289 1.2 9.2 1.2 5.1 294 Sabah 1.8 14.0 8.1 1.8 482 1.0 7.3 1.0 6.0 347 Sarawak 1.5 12.2 10.4 1.6 619 0.6 4.7 0.6 5.2 299 Perak 1.6 13.1 13.7 1.6 788 0.5 4.2 0.5 4.2 193 Kedah 1.2 9.8 8.6 1.2 400 0.7 6.0 0.7 4.7 175 WPKL & Putrajaya 1.6 12.9 10.0 1.6 383 0.5 4.2 0.5 3.7 141 Kelantan 1.4 11.2 8.7 1.4 333 1.0 8.9 1.0 9.3 341 Penang 3.1 25.1 23.7 3.2 861 0.7 5.9 0.7 4.8 164 Pahang 2.0 15.9 12.3 2.0 444 0.7 5.7 0.7 4.5 113 Terengganu 2.2 16.7 11.9 2.2 313 0.7 5.4 0.7 5.2 122 Negeri Sembilan 1.6 12.9 11.1 1.6 270 0.6 4.5 0.6 4.6 92 Melaka 2.5 20.4 17.8 2.5 343 0.5 4.5 0.5 4.7 27 Perlis 1.6 12.4 7.9 1.6 69 0.2 1.5 0.3 0.5 1 W.P. Labuan 0.7 6.3 2.5 0.7 5

93

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

STATE 4. Lymphoma Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 5. Nasopharynx Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 6. Leukaemia Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan

94

MALE ASR CR74

CumR

NO.

CR

FEMALE ASR CR74

CumR

NO.

CR

24 456 261 359 219 153 135 132 272 160 107 139 145 24 5

2.7 5.8 4.4 6.0 3.8 3.3 3.5 3.4 7.5 4.4 4.1 5.7 7.5 2.7 2.5

0.6 0.7 0.7 0.7 0.4 0.4 0.5 0.4 0.8 0.6 0.6 0.6 0.9 0.6 0.5

4.3 6.4 6.3 6.6 3.7 3.5 3.9 3.9 7.6 5.3 4.9 6.0 7.9 4.3 4.0

0.6 0.7 0.7 0.7 0.4 0.4 0.5 0.4 0.8 0.6 0.6 0.6 0.9 0.6 0.5

13 320 195 255 173 85 106 82 191 106 60 91 97 13 6

2.3 4.3 3.4 4.4 3.0 1.8 2.8 2.1 5.2 3.1 2.4 3.8 4.8 2.3 3.1

0.2 0.5 0.5 0.5 0.3 0.2 0.4 0.2 0.6 0.4 0.3 0.4 0.5 0.2 0.3

2.1 4.6 4.8 4.9 2.8 1.8 3.2 2.4 5.0 3.5 2.8 4.0 4.6 2.1 3.5

0.2 0.5 0.5 0.5 0.3 0.2 0.4 0.2 0.6 0.4 0.3 0.4 0.5 0.2 0.3

382 524 369 665 459 182 210 77 394 135 70 143 112 23 9

3.0 6.7 6.2 11.2 8.0 3.9 5.5 2.0 10.8 3.7 2.7 5.9 5.8 2.6 4.5

0.4 0.8 1.0 1.3 0.9 0.5 0.6 0.3 1.1 0.5 0.3 0.7 0.6 0.5 1.0

3.5 7.2 8.5 11.6 7.7 4.1 5.9 2.4 10.2 4.4 3.1 6.2 6.1 4.0 8.1

0.4 0.8 1.0 1.2 0.9 0.5 0.6 0.3 1.1 0.5 0.3 0.7 0.6 0.5 1.0

130 172 152 258 141 48 71 28 127 40 35 38 53 3 1

1.1 2.3 2.6 4.5 2.5 1.0 1.9 0.7 3.5 1.2 1.4 1.6 2.6 0.5 0.5

0.1 0.2 0.4 0.5 0.2 0.1 0.2 0.1 0.4 0.2 0.2 0.1 0.3 0.1 0.1

1.2 2.4 3.7 4.8 2.3 1.0 2.0 0.8 3.3 1.3 1.7 1.5 2.6 0.6 0.7

0.1 0.2 0.4 0.5 0.2 0.1 0.2 0.1 0.4 0.2 0.2 0.1 0.3 0.1 0.1

439 392 212 248 147 152 91 145 217 116 131 86 118 32 0

3.5 5.0 3.5 4.2 2.6 3.3 2.4 3.8 6.0 3.2 5.0 3.5 6.1 3.7 0.0

0.4 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.6 0.3 0.4 0.4 0.5 0.5 0.0

4.0 5.3 3.9 4.5 2.7 3.4 2.6 4.0 6.4 3.5 5.2 3.8 6.6 6.0 0.0

0.4 0.4 0.3 0.4 0.2 0.3 0.3 0.3 0.6 0.3 0.4 0.4 0.5 0.5 0.0

350 288 153 196 151 128 75 116 183 96 96 76 83 11 4

2.9 3.9 2.6 3.4 2.7 2.8 2.0 3.0 5.0 2.8 3.8 3.2 4.1 1.9 2.1

0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.3 0.4 0.3 0.4 0.3 0.4 0.1 0.4

3.2 4.1 3.0 3.7 2.6 2.9 2.1 3.2 5.3 3.0 4.2 3.3 4.4 2.1 3.1

0.3 0.3 0.2 0.3 0.2 0.2 0.2 0.3 0.4 0.3 0.4 0.3 0.4 0.1 0.4

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

STATE 7. Cervix Uteri Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 8. Liver Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 9. Ovary Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan

NO.

550 413 236 289 226 128 79 166 361 150 157 127 126 20 2

CR

4.3 5.3 3.9 4.9 3.9 2.7 2.1 4.3 9.9 4.2 6.0 5.2 6.6 2.3 1.0

MALE ASR CR74

0.8 0.7 0.8 0.7 0.5 0.4 0.3 0.6 1.2 0.6 0.9 0.7 0.9 0.4 0.0

6.4 6.1 6.6 5.5 3.7 3.1 2.5 5.4 10.2 5.0 7.6 5.8 7.2 3.6 1.9

CumR

0.8 0.7 0.8 0.7 0.5 0.4 0.3 0.6 1.2 0.6 0.9 0.7 0.9 0.4 0.0

FEMALE ASR CR74

CumR

NO.

CR

537 518 471 640 380 295 222 132 399 193 120 190 162 55 7

4.4 7.0 8.1 11.2 6.7 6.3 5.9 3.5 10.9 5.7 4.8 8.0 8.1 9.6 3.7

0.7 0.9 1.3 1.3 0.7 0.7 0.8 0.4 1.2 0.7 0.7 1.0 0.9 1.0 0.6

5.7 7.6 11.5 12.1 6.1 6.3 6.8 3.8 10.1 6.3 5.8 8.2 7.9 9.6 6.3

0.7 0.9 1.3 1.3 0.7 0.7 0.8 0.4 1.2 0.7 0.7 1.0 0.9 1.0 0.6

185 144 84 88 73 66 24 69 135 57 49 49 35 11 0

1.5 1.9 1.4 1.5 1.3 1.4 0.6 1.8 3.7 1.7 2.0 2.1 1.7 1.9 0.0

0.3 0.3 0.4 0.2 0.1 0.2 0.1 0.2 0.4 0.2 0.3 0.3 0.2 0.2 0.0

2.2 2.2 2.7 1.8 1.1 1.4 0.7 2.0 3.6 1.9 2.5 2.3 1.7 1.8 0.0

0.3 0.3 0.4 0.2 0.1 0.2 0.1 0.2 0.4 0.2 0.3 0.3 0.2 0.2 0.0

508 446 259 325 359 233 118 184 332 158 173 168 161 23 2

4.1 6.0 4.5 5.7 6.3 5.0 3.1 4.8 9.1 4.7 6.9 7.1 8.0 4.0 1.0

0.6 0.7 0.6 0.6 0.6 0.5 0.4 0.6 0.9 0.5 0.9 0.8 0.8 0.4 0.2

5.1 6.4 6.1 6.1 5.9 5.0 3.5 5.3 8.6 5.0 8.1 7.1 7.8 3.9 1.7

0.2 0.4 0.6 0.5 0.2 0.2 0.3 0.1 0.5 0.2 0.2 0.4 0.3 0.2 0.1

95

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

STATE 10. Stomach Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 11. Prostate Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 12. Other Skin Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan

96

MALE ASR CR74

CumR

NO.

CR

162 208 183 195 121 77 65 23 184 45 33 75 58 6 2

1.3 2.8 3.2 3.4 2.1 1.7 1.7 0.6 5.0 1.3 1.3 3.2 2.9 1.0 1.0

77 157 148 90 163 48 33 54 125 40 35 34 33 4 0

0.6 2.1 2.6 1.6 2.9 1.0 0.9 1.4 3.4 1.2 1.4 1.4 1.6 0.7 0.0

NO.

CR

237 310 253 337 155 80 80 35 238 65 35 98 65 12 3

1.9 4.0 4.2 5.7 2.7 1.7 2.1 0.9 6.5 1.8 1.3 4.0 3.4 1.4 1.5

0.4 0.6 1.0 0.8 0.3 0.2 0.3 0.1 0.8 0.3 0.3 0.6 0.5 0.2 0.6

2.8 4.9 7.4 6.6 2.6 1.9 2.7 1.1 6.9 2.3 1.9 4.7 3.8 2.1 3.5

0.4 0.6 0.9 0.8 0.3 0.2 0.3 0.1 0.8 0.3 0.3 0.6 0.4 0.2 0.6

383 548 199 206 325 216 187 170 447 106 96 100 101 24 2

3.0 7.0 3.3 3.5 5.7 4.6 4.9 4.4 12.3 2.9 3.7 4.1 5.3 2.7 1.0

0.8 1.2 0.8 0.5 0.7 0.7 1.0 0.8 1.7 0.5 0.8 0.7 0.7 0.6 0.6

5.5 9.3 6.4 4.3 5.4 5.5 7.1 5.9 13.8 4.0 5.6 5.1 6.4 4.2 2.8

0.8 1.2 0.8 0.5 0.7 0.7 1.0 0.8 1.7 0.5 0.8 0.7 0.7 0.6 0.6

120 206 125 110 208 88 42 64 184 60 58 52 52 5 1

0.9 2.6 2.1 1.8 3.6 1.9 1.1 1.7 5.1 1.7 2.2 2.1 2.7 0.6 0.5

0.1 0.4 0.5 0.2 0.4 0.3 0.2 0.3 0.6 0.3 0.3 0.2 0.3 0.1 0.3

1.5 3.2 3.7 2.1 3.5 2.1 1.6 2.1 5.4 2.2 2.9 2.4 3.1 0.9 1.3

0.1 0.4 0.5 0.2 0.4 0.3 0.2 0.3 0.6 0.3 0.3 0.2 0.3 0.1 0.3

FEMALE ASR CR74

CumR

0.2 0.4 0.6 0.5 0.2 0.2 0.3 0.1 0.5 0.2 0.2 0.4 0.3 0.2 0.1

1.9 3.2 5.4 4.0 1.9 1.7 2.2 0.6 4.7 1.6 1.6 3.4 2.8 0.9 0.9

0.2 0.4 0.6 0.5 0.2 0.2 0.3 0.1 0.5 0.2 0.2 0.4 0.3 0.2 0.1

0.1 0.3 0.5 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0

0.9 2.4 4.6 1.8 2.5 1.0 1.2 1.6 3.3 1.5 1.7 1.5 1.6 0.5 0.0

0.1 0.3 0.5 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

STATE 13. Thyroid Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 14. Brain Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan 15. Corpus Uteri Selangor Johor Sabah Sarawak Perak Kedah WPKL & Putrajaya Kelantan Penang Pahang Terengganu Negeri Sembilan Melaka Perlis W.P. Labuan

MALE ASR CR74

CumR

NO.

CR

FEMALE ASR CR74

CumR

NO.

CR

53 79 55 41 42 38 23 46 50 41 26 19 25 7 0

0.4 1.0 0.9 0.7 0.7 0.8 0.6 1.2 1.4 1.1 1.0 0.8 1.3 0.8 0.0

0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0

0.6 1.1 1.4 0.8 0.7 0.9 0.7 1.5 1.4 1.4 1.2 0.8 1.4 1.3 0.0

0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0

210 265 135 161 149 101 70 170 124 96 111 43 62 20 0

1.7 3.6 2.3 2.8 2.6 2.2 1.9 4.4 3.4 2.8 4.4 1.8 3.1 3.5 0.0

0.2 0.4 0.3 0.3 0.3 0.2 0.2 0.5 0.3 0.3 0.5 0.2 0.3 0.4 0.0

1.9 3.6 3.2 3.0 2.5 2.2 2.0 4.9 3.1 3.0 5.2 1.8 3.0 3.7 0.0

0.2 0.4 0.3 0.3 0.3 0.2 0.2 0.5 0.3 0.3 0.5 0.2 0.3 0.4 0.0

168 172 80 96 192 59 74 56 90 51 39 47 34 9 3

1.3 2.2 1.3 1.6 3.3 1.3 1.9 1.5 2.5 1.4 1.5 1.9 1.8 1.0 1.5

0.2 0.2 0.2 0.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.2

1.6 2.4 1.7 1.6 3.2 1.3 2.0 1.5 2.5 1.6 1.6 2.0 1.9 1.6 1.8

0.2 0.2 0.2 0.1 0.3 0.1 0.2 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.2

131 124 68 89 204 74 51 49 83 63 41 33 27 14 1

1.1 1.7 1.2 1.6 3.6 1.6 1.4 1.3 2.3 1.9 1.6 1.4 1.3 2.4 0.5

0.1 0.2 0.2 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.1

1.3 1.8 1.6 1.6 3.4 1.6 1.6 1.4 2.3 1.9 1.9 1.5 1.4 2.5 0.7

0.1 0.2 0.2 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.1

336 326 119 190 190 127 112 88 273 78 97 96 109 20 2

2.7 4.4 2.1 3.3 3.3 2.7 3.0 2.3 7.5 2.3 3.9 4.1 5.4 3.5 1.0

0.4 0.6 0.3 0.4 0.4 0.3 0.4 0.3 0.8 0.3 0.5 0.5 0.6 0.4 0.5

3.7 4.8 3.1 3.7 3.1 2.8 3.5 2.5 7.0 2.5 4.6 4.1 5.2 3.4 2.5

0.4 0.6 0.3 0.4 0.4 0.3 0.4 0.3 0.8 0.3 0.5 0.5 0.6 0.4 0.5

97

98

30 461 391 273 127 81 3785 172 37 737 2014 153 3826 3731 89 3054 413 1041 270 825 7415 167 493 167 1384 22 17 434 137 115 3132 496 31 901 13 19 1477 17 104 1176 549 47 109 379 2792 5 396 779 1328 442 741 ----46794

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 20 0 0 1 0 0 0 6 1 1 0 0 17 0 2 0 40 1 26 1 0 2 0 52 87 0 14 4 3 32 0 0 199 74 90 6 ----682

0-9

0 0 0 2 0 0 4 0 1 0 0 0 1 0 0 3 0 0 2 2 0 0 16 0 4 0 0 8 0 1 0 7 0 4 0 0 1 0 5 61 2 3 1 9 60 0 0 121 42 58 6 ----424

50 0 3 0 0 0 28 0 0 0 1 0 4 0 0 8 0 0 4 2 0 3 62 0 5 0 0 11 0 0 0 13 0 3 0 0 0 0 1 72 6 2 10 16 61 0 0 74 57 37 6 ----489

10-14 0 2 3 3 1 1 57 1 0 0 2 0 5 2 0 3 0 0 3 0 3 6 82 4 12 0 0 25 0 0 3 38 3 2 0 0 3 0 0 65 10 1 11 47 90 0 0 54 78 35 10 ----665

15-19 0 6 3 13 1 1 58 1 0 3 4 3 20 13 1 11 1 1 4 1 30 16 54 5 10 0 2 18 0 2 3 80 0 3 0 0 2 0 0 46 15 0 5 52 113 0 1 44 98 23 10 ----777

20-24 0 10 11 12 2 1 91 0 0 3 21 3 44 24 0 24 3 6 2 1 38 13 34 3 15 0 1 23 1 0 2 93 2 5 0 0 5 0 0 42 29 2 3 40 95 0 4 39 83 24 13 ----867

25-29 1 17 4 16 1 0 182 1 0 5 29 6 62 61 2 52 1 13 3 7 67 7 18 3 27 0 1 20 4 4 2 60 1 13 0 0 9 0 4 68 15 0 3 25 110 0 3 26 67 9 9 ----1038

30-34 0 18 14 21 4 0 313 0 1 7 56 2 109 89 3 82 10 19 17 8 135 14 19 6 27 0 2 23 5 7 1 55 0 22 0 1 21 0 3 72 30 1 8 24 135 0 8 21 85 17 25 ----1540

35-39 4 32 18 19 7 2 440 3 0 27 79 9 191 150 9 168 17 44 26 16 253 12 29 10 49 1 4 34 11 11 14 25 1 55 0 0 46 1 1 82 46 2 10 27 191 0 19 26 97 13 39 ----2370

40-44 2 57 34 30 15 8 574 8 2 54 132 20 281 282 5 255 30 92 32 45 483 11 21 10 85 2 1 41 13 9 26 23 2 90 3 0 74 1 4 94 58 1 14 22 229 0 43 20 103 11 56 ----3508

45-49 5 53 42 25 13 8 585 17 6 71 188 14 400 384 10 438 46 116 43 94 754 18 23 22 92 4 1 42 18 10 100 20 3 116 0 1 116 0 7 117 58 3 12 31 304 1 48 29 115 29 75 ----4727

50-54 3 64 48 31 16 6 502 18 6 104 219 27 526 499 10 511 69 148 25 114 911 16 29 26 148 2 1 47 18 17 231 9 4 130 2 0 153 3 3 112 74 4 11 25 325 0 75 41 117 18 101 ----5599

55-59 2 60 59 34 27 15 376 24 8 121 271 22 535 619 15 506 65 186 44 166 1219 15 34 19 181 2 0 37 21 17 474 10 4 143 0 4 215 5 2 86 62 4 7 12 335 0 71 25 93 19 99 ----6370

60-64 4 49 46 23 11 8 298 31 4 111 310 21 522 620 11 368 60 169 23 148 1267 18 28 28 214 5 2 43 16 16 671 8 4 124 3 8 251 3 4 69 63 4 7 15 314 1 55 24 89 19 99 ----6309

65-69 4 47 39 25 15 14 170 38 2 103 301 21 515 476 13 322 60 123 16 107 1120 8 16 14 210 3 0 18 13 8 745 7 3 103 2 3 257 1 7 56 46 4 1 17 201 0 34 21 67 18 80 ----5494

70-74 % of Total

5 0.10% 46 1.00% 67 0.80% 19 0.60% 14 0.30% 16 0.20% 106 8.10% 29 0.40% 7 0.10% 128 1.60% 401 4.30% 5 0.30% 611 8.20% 512 8.00% 10 0.20% 283 6.50% 51 0.90% 124 2.20% 25 0.60% 114 1.80% 1135 15.80% 10 0.40% 22 1.10% 16 0.40% 304 3.00% 3 0.00% 2 0.00% 27 0.90% 17 0.30% 11 0.20% 860 6.70% 8 1.10% 3 0.10% 62 1.90% 2 0.00% 2 0.00% 322 3.20% 3 0.00% 11 0.20% 47 2.50% 35 1.20% 2 0.10% 2 0.20% 14 0.80% 197 6.00% 3 0.00% 35 0.80% 15 1.70% 63 2.80% 22 0.90% 107 1.60% --------5935 100.00%

75+

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 19: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, ALL RESIDENTS, MALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

99

55 401 525 226 68 30 1305 86 20 429 1447 89 3350 2611 86 1074 409 788 138 113 3193 123 365 155 1045 19 2 378 18206 123 124 4352 2181 580 3472 42 65 434 8 11 400 10 67 1060 1723 45 51 279 1924 7 348 524 1149 351 647 ----56713

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 2 0 1 0 0 0 0 0 0 16 0 1 3 1 1 0 7 1 2 0 0 17 0 0 1 0 0 0 11 0 0 21 0 0 1 0 28 60 0 11 0 0 23 0 0 148 67 75 10 ----508

0-9

0 0 1 2 0 0 2 0 0 0 0 0 0 1 0 1 0 0 0 0 0 2 14 0 4 0 0 12 0 0 0 0 0 0 11 0 0 3 0 0 0 0 3 74 2 4 0 1 22 0 0 83 32 33 6 ----313

51 2 3 6 0 1 4 0 1 0 1 0 3 1 0 1 0 0 3 0 0 3 49 0 3 0 0 14 2 0 1 0 0 0 43 0 0 5 0 0 1 0 2 64 15 0 1 4 54 0 0 56 39 28 2 ----413

10-14 0 1 4 9 1 0 24 0 0 0 10 0 7 0 0 6 0 0 2 0 1 1 49 1 12 0 0 30 3 0 0 0 0 0 94 0 2 6 0 0 1 0 3 40 55 1 3 40 63 0 0 38 59 22 7 ----595

15-19 0 3 2 10 0 1 48 2 0 0 10 3 30 13 1 5 1 6 3 0 10 5 21 4 8 0 0 15 71 0 0 16 2 4 117 0 9 7 1 0 3 0 0 46 101 1 2 59 96 1 0 22 71 12 23 ----865

20-24 0 12 5 15 0 1 42 2 0 0 23 1 47 24 1 11 1 8 3 0 27 3 16 4 14 0 0 24 251 0 2 64 30 10 127 1 10 6 1 0 1 0 3 44 132 1 1 49 88 0 1 16 62 13 13 ----1210

25-29 1 17 3 7 2 1 59 1 2 0 29 7 64 46 0 22 10 14 3 3 36 6 21 5 21 0 0 19 714 3 0 136 59 19 133 2 11 10 0 0 6 0 1 41 123 1 1 29 72 0 0 13 71 8 18 ----1870

30-34 1 13 10 16 1 1 101 0 0 5 41 2 97 72 1 35 9 20 13 4 79 5 12 10 20 1 0 27 1329 3 7 337 105 33 196 4 16 20 0 0 7 0 1 62 166 4 5 10 92 0 9 20 93 18 28 ----3161

35-39 1 39 19 23 4 0 154 4 1 19 71 5 146 128 6 47 8 38 10 3 147 7 30 16 44 0 0 28 2365 6 7 491 190 60 330 5 6 16 1 0 12 0 2 82 175 4 5 14 108 0 22 18 82 15 37 ----5051

40-44 2 35 18 24 6 2 193 9 1 22 109 6 248 196 4 73 22 44 5 8 261 8 21 9 53 0 1 43 3286 11 13 683 278 96 527 12 8 45 0 0 26 0 4 108 194 2 6 18 166 0 22 17 108 19 55 ----7127

45-49 7 59 49 22 8 1 192 7 3 48 145 17 329 285 11 99 30 83 14 10 335 11 18 12 68 2 0 26 3030 16 11 676 383 98 557 6 1 55 1 2 32 3 4 112 194 5 11 15 217 1 46 25 112 21 61 ----7586

50-54 5 40 56 20 13 3 169 13 4 60 172 12 464 363 12 144 70 116 23 14 411 17 24 15 89 5 0 28 2647 18 24 588 410 92 449 3 1 50 0 1 50 1 3 89 157 2 8 10 224 1 62 19 116 19 83 ----7489

55-59 3 52 78 24 7 5 126 13 3 62 180 6 445 339 12 148 54 130 8 17 455 14 24 17 95 3 0 22 1790 12 9 455 309 67 319 1 1 60 1 0 51 4 4 76 125 3 4 10 209 2 66 13 87 16 77 ----6113

60-64 4 28 79 15 6 4 80 9 1 57 190 9 392 347 10 139 59 99 13 18 500 14 19 23 145 2 0 29 1174 12 15 330 186 36 256 5 0 39 1 5 56 0 3 82 143 2 3 5 178 0 47 14 44 17 56 ----5000

65-69 11 51 95 21 8 4 66 16 1 63 174 7 455 376 8 144 64 103 14 15 416 13 18 15 160 4 1 20 820 17 16 320 119 42 159 1 0 40 1 1 58 0 2 48 70 2 1 6 156 0 46 8 53 13 72 ----4414

70-74 % of Total

19 0.10% 49 0.70% 103 0.90% 12 0.40% 12 0.10% 6 0.10% 43 2.30% 10 0.20% 2 0.00% 93 0.80% 292 2.60% 14 0.20% 623 5.90% 420 4.60% 20 0.20% 183 1.90% 81 0.70% 126 1.40% 21 0.20% 20 0.20% 514 5.60% 14 0.20% 22 0.60% 23 0.30% 307 1.80% 2 0.00% 0 0.00% 24 0.70% 724 32.10% 25 0.20% 18 0.20% 256 7.70% 110 3.80% 23 1.00% 143 6.10% 2 0.10% 0 0.10% 51 0.80% 1 0.00% 2 0.00% 95 0.70% 2 0.00% 4 0.10% 32 1.90% 71 3.00% 2 0.10% 0 0.10% 9 0.50% 156 3.40% 2 0.00% 27 0.60% 14 0.90% 53 2.00% 22 0.60% 99 1.10% --------4998 100.00%

75+

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 20: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, ALL RESIDENTS, FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

100

30 461 391 273 127 81 3785 172 37 737 2014 153 3826 3731 89 3054 413 1041 270 825 7415 167 493 167 1384 22 17 434 137 115 3132 496 31 901 13 19 1477 17 104 1176 549 47 109 379 2792 5 396 779 1328 442 741 ----46794

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0.6 0 0.4 0 0 0 0 0.8 1.4 0 0.2 0.1 0 0.5 0 0 3.2 1.2 1.4 0.1 ----11

0-9

0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 0 0.1 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.9 0 0 0 0.1 0.9 0 0 1.8 0.6 0.9 0.1 ----6

50 0 0 0 0 0 0.4 0 0 0 0 0 0.1 0 0 0.1 0 0 0.1 0 0 0 0.9 0 0.1 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 0 1.1 0.1 0 0.1 0.2 0.9 0 0 1.1 0.8 0.6 0.1 ----7

10-14 0 0 0 0 0 0 0.9 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 1.2 0.1 0.2 0 0 0.4 0 0 0 0.6 0 0 0 0 0 0 0 1 0.2 0 0.2 0.7 1.4 0 0 0.8 1.2 0.5 0.2 ----10

15-19 0 0.1 0 0.2 0 0 0.9 0 0 0 0.1 0 0.3 0.2 0 0.2 0 0 0.1 0 0.5 0.3 0.9 0.1 0.2 0 0 0.3 0 0 0 1.3 0 0 0 0 0 0 0 0.8 0.2 0 0.1 0.8 1.8 0 0 0.7 1.6 0.4 0.2 ----13

20-24 0 0.2 0.2 0.2 0 0 1.6 0 0 0.1 0.4 0.1 0.8 0.4 0 0.4 0.1 0.1 0 0 0.7 0.2 0.6 0.1 0.3 0 0 0.4 0 0 0 1.7 0 0.1 0 0 0.1 0 0 0.8 0.5 0 0.1 0.7 1.7 0 0.1 0.7 1.5 0.4 0.2 ----16

25-29 0 0.4 0.1 0.3 0 0 4 0 0 0.1 0.6 0.1 1.4 1.3 0 1.1 0 0.3 0.1 0.2 1.5 0.2 0.4 0.1 0.6 0 0 0.4 0.1 0.1 0 1.3 0 0.3 0 0 0.2 0 0.1 1.5 0.3 0 0.1 0.5 2.4 0 0.1 0.6 1.5 0.2 0.2 ----23

30-34 0 0.4 0.3 0.5 0.1 0 7.4 0 0 0.2 1.3 0 2.6 2.1 0.1 1.9 0.2 0.4 0.4 0.2 3.2 0.3 0.4 0.1 0.6 0 0 0.5 0.1 0.2 0 1.3 0 0.5 0 0 0.5 0 0.1 1.7 0.7 0 0.2 0.6 3.2 0 0.2 0.5 2 0.4 0.6 ----36

35-39 0.1 0.8 0.4 0.5 0.2 0 10.9 0.1 0 0.7 2 0.2 4.7 3.7 0.2 4.2 0.4 1.1 0.6 0.4 6.3 0.3 0.7 0.2 1.2 0 0.1 0.8 0.3 0.3 0.3 0.6 0 1.4 0 0 1.1 0 0 2 1.1 0 0.2 0.7 4.7 0 0.5 0.6 2.4 0.3 1 ----59

40-44 0.1 1.5 0.9 0.8 0.4 0.2 15.1 0.2 0.1 1.4 3.5 0.5 7.4 7.4 0.1 6.7 0.8 2.4 0.8 1.2 12.7 0.3 0.6 0.3 2.2 0.1 0 1.1 0.3 0.2 0.7 0.6 0.1 2.4 0.1 0 1.9 0 0.1 2.5 1.5 0 0.4 0.6 6 0 1.1 0.5 2.7 0.3 1.5 ----92

45-49 0.2 1.6 1.3 0.8 0.4 0.2 18.2 0.5 0.2 2.2 5.8 0.4 12.4 11.9 0.3 13.6 1.4 3.6 1.3 2.9 23.4 0.6 0.7 0.7 2.9 0.1 0 1.3 0.6 0.3 3.1 0.6 0.1 3.6 0 0 3.6 0 0.2 3.6 1.8 0.1 0.4 1 9.4 0 1.5 0.9 3.6 0.9 2.3 ----147

50-54 0.1 2.5 1.9 1.2 0.6 0.2 19.8 0.7 0.2 4.1 8.6 1.1 20.7 19.7 0.4 20.1 2.7 5.8 1 4.5 35.9 0.6 1.1 1 5.8 0.1 0 1.9 0.7 0.7 9.1 0.4 0.2 5.1 0.1 0 6 0.1 0.1 4.4 2.9 0.2 0.4 1 12.8 0 3 1.6 4.6 0.7 4 ----221

55-59 0.1 3.2 3.1 1.8 1.4 0.8 19.8 1.3 0.4 6.4 14.3 1.2 28.1 32.6 0.8 26.6 3.4 9.8 2.3 8.7 64.1 0.8 1.8 1 9.5 0.1 0 1.9 1.1 0.9 24.9 0.5 0.2 7.5 0 0.2 11.3 0.3 0.1 4.5 3.3 0.2 0.4 0.6 17.6 0 3.7 1.3 4.9 1 5.2 ----335

60-64 0.3 3.9 3.6 1.8 0.9 0.6 23.6 2.5 0.3 8.8 24.6 1.7 41.4 49.1 0.9 29.2 4.8 13.4 1.8 11.7 100.4 1.4 2.2 2.2 17 0.4 0.2 3.4 1.3 1.3 53.2 0.6 0.3 9.8 0.2 0.6 19.9 0.2 0.3 5.5 5 0.3 0.6 1.2 24.9 0.1 4.4 1.9 7.1 1.5 7.8 ----500

65-69 0.4 5 4.2 2.7 1.6 1.5 18.2 4.1 0.2 11 32.2 2.2 55.2 51 1.4 34.5 6.4 13.2 1.7 11.5 120 0.9 1.7 1.5 22.5 0.3 0 1.9 1.4 0.9 79.8 0.7 0.3 11 0.2 0.3 27.5 0.1 0.7 6 4.9 0.4 0.1 1.8 21.5 0 3.6 2.2 7.2 1.9 8.6 ----589

70-74 0.5 4.7 6.9 2 1.4 1.6 10.9 3 0.7 13.2 41.2 0.5 62.8 52.7 1 29.1 5.2 12.8 2.6 11.7 116.7 1 2.3 1.6 31.3 0.3 0.2 2.8 1.7 1.1 88.4 0.8 0.3 6.4 0.2 0.2 33.1 0.3 1.1 4.8 3.6 0.2 0.2 1.4 20.3 0.3 3.6 1.5 6.5 2.3 11 ----610

75+

APPENDIX 21: CANCER INCIDENCE BY SITES AND AGE GROUP, ALL RESIDENTS, MALES, MALAYSIA, 2007-2011

0 0.7 0.6 0.4 0.2 0.1 5.8 0.3 0.1 1.1 3.1 0.2 5.8 5.7 0.1 4.7 0.6 1.6 0.4 1.3 11.3 0.3 0.8 0.3 2.1 0 0 0.7 0.2 0.2 4.8 0.8 0 1.4 0 0 2.3 0 0.2 1.8 0.8 0.1 0.2 0.6 4.3 0 0.6 1.2 2 0.7 1.1 ----71.4

Crude Rate 0.1 0.8 0.7 0.5 0.2 0.2 6.4 0.3 0.1 1.4 3.9 0.3 7.2 7.2 0.2 5.6 0.8 2 0.5 1.6 14.4 0.3 0.8 0.3 2.7 0 0 0.7 0.3 0.2 6.6 0.7 0.1 1.7 0 0 2.9 0 0.2 1.9 1 0.1 0.2 0.6 4.9 0 0.7 1.3 2.2 0.7 1.4 ----86.9

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

101

55 401 525 226 68 30 1305 86 20 429 1447 89 3350 2611 86 1074 409 788 138 113 3193 123 365 155 1045 19 2 378 18206 123 124 4352 2181 580 3472 42 65 434 8 11 400 10 67 1060 1723 45 51 279 1924 7 348 524 1149 351 647 ----56713

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0 0 0 0.2 0 0 0.4 0 0 0 0 0.5 1 0 0.2 0 0 0.4 0 0 2.5 1.1 1.3 0.2 ----8

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 1.2 0 0.1 0 0 0.3 0 0 1.3 0.5 0.5 0.1 ----5

50 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.2 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0 1 0.2 0 0 0.1 0.8 0 0 0.9 0.6 0.4 0 ----6

10-14 0 0 0.1 0.1 0 0 0.4 0 0 0 0.2 0 0.1 0 0 0.1 0 0 0 0 0 0 0.8 0 0.2 0 0 0.5 0 0 0 0 0 0 1.5 0 0 0.1 0 0 0 0 0 0.6 0.9 0 0 0.6 1 0 0 0.6 0.9 0.3 0.1 ----9

15-19 0 0 0 0.2 0 0 0.8 0 0 0 0.2 0 0.5 0.2 0 0.1 0 0.1 0 0 0.2 0.1 0.3 0.1 0.1 0 0 0.2 1.2 0 0 0.3 0 0.1 1.9 0 0.1 0.1 0 0 0 0 0 0.8 1.7 0 0 1 1.6 0 0 0.4 1.2 0.2 0.4 ----14

20-24 0 0.2 0.1 0.3 0 0 0.8 0 0 0 0.4 0 0.9 0.4 0 0.2 0 0.1 0.1 0 0.5 0.1 0.3 0.1 0.3 0 0 0.4 4.6 0 0 1.2 0.6 0.2 2.3 0 0.2 0.1 0 0 0 0 0.1 0.8 2.4 0 0 0.9 1.6 0 0 0.3 1.1 0.2 0.2 ----22

25-29 0 0.4 0.1 0.2 0 0 1.3 0 0 0 0.7 0.2 1.5 1 0 0.5 0.2 0.3 0.1 0.1 0.8 0.1 0.5 0.1 0.5 0 0 0.4 16.3 0.1 0 3.1 1.3 0.4 3 0 0.3 0.2 0 0 0.1 0 0 0.9 2.8 0 0 0.7 1.6 0 0 0.3 1.6 0.2 0.4 ----43

30-34 0 0.3 0.2 0.4 0 0 2.4 0 0 0.1 1 0 2.3 1.7 0 0.8 0.2 0.5 0.3 0.1 1.9 0.1 0.3 0.2 0.5 0 0 0.6 31.7 0.1 0.2 8 2.5 0.8 4.7 0.1 0.4 0.5 0 0 0.2 0 0 1.5 4 0.1 0.1 0.2 2.2 0 0.2 0.5 2.2 0.4 0.7 ----75

35-39 0 1 0.5 0.6 0.1 0 3.8 0.1 0 0.5 1.8 0.1 3.6 3.2 0.1 1.2 0.2 0.9 0.2 0.1 3.6 0.2 0.7 0.4 1.1 0 0 0.7 58.7 0.1 0.2 12.2 4.7 1.5 8.2 0.1 0.1 0.4 0 0 0.3 0 0 2 4.3 0.1 0.1 0.3 2.7 0 0.5 0.4 2 0.4 0.9 ----125

40-44 0.1 1 0.5 0.7 0.2 0.1 5.4 0.3 0 0.6 3 0.2 6.9 5.4 0.1 2 0.6 1.2 0.1 0.2 7.3 0.2 0.6 0.3 1.5 0 0 1.2 91.3 0.3 0.4 19 7.7 2.7 14.6 0.3 0.2 1.3 0 0 0.7 0 0.1 3 5.4 0.1 0.2 0.5 4.6 0 0.6 0.5 3 0.5 1.5 ----198

45-49 0.2 1.9 1.6 0.7 0.3 0 6.2 0.2 0.1 1.6 4.7 0.5 10.6 9.2 0.4 3.2 1 2.7 0.5 0.3 10.8 0.4 0.6 0.4 2.2 0.1 0 0.8 97.9 0.5 0.4 21.8 12.4 3.2 18 0.2 0 1.8 0 0.1 1 0.1 0.1 3.6 6.3 0.2 0.4 0.5 7 0 1.5 0.8 3.6 0.7 2 ----245

50-54 0.2 1.6 2.3 0.8 0.5 0.1 6.9 0.5 0.2 2.5 7.1 0.5 19.1 14.9 0.5 5.9 2.9 4.8 0.9 0.6 16.9 0.7 1 0.6 3.7 0.2 0 1.2 108.7 0.7 1 24.2 16.8 3.8 18.4 0.1 0 2.1 0 0 2.1 0 0.1 3.7 6.4 0.1 0.3 0.4 9.2 0 2.5 0.8 4.8 0.8 3.4 ----308

55-59 0.2 2.8 4.2 1.3 0.4 0.3 6.8 0.7 0.2 3.3 9.7 0.3 23.9 18.2 0.6 8 2.9 7 0.4 0.9 24.4 0.8 1.3 0.9 5.1 0.2 0 1.2 96.2 0.6 0.5 24.4 16.6 3.6 17.1 0.1 0.1 3.2 0.1 0 2.7 0.2 0.2 4.1 6.7 0.2 0.2 0.5 11.2 0.1 3.5 0.7 4.7 0.9 4.1 ----328

60-64 0.3 2.2 6.3 1.2 0.5 0.3 6.4 0.7 0.1 4.5 15.2 0.7 31.3 27.7 0.8 11.1 4.7 7.9 1 1.4 39.9 1.1 1.5 1.8 11.6 0.2 0 2.3 93.6 1 1.2 26.3 14.8 2.9 20.4 0.4 0 3.1 0.1 0.4 4.5 0 0.2 6.5 11.4 0.2 0.2 0.4 14.2 0 3.7 1.1 3.5 1.4 4.5 ----399

65-69 1.1 5.2 9.6 2.1 0.8 0.4 6.7 1.6 0.1 6.4 17.6 0.7 46.1 38.1 0.8 14.6 6.5 10.4 1.4 1.5 42.2 1.3 1.8 1.5 16.2 0.4 0.1 2 83.1 1.7 1.6 32.4 12.1 4.3 16.1 0.1 0 4.1 0.1 0.1 5.9 0 0.2 4.9 7.1 0.2 0.1 0.6 15.8 0 4.7 0.8 5.4 1.3 7.3 ----447

70-74 1.6 4.1 8.6 1 1 0.5 3.6 0.8 0.2 7.8 24.4 1.2 52 35 1.7 15.3 6.8 10.5 1.8 1.7 42.9 1.2 1.8 1.9 25.6 0.2 0 2 60.4 2.1 1.5 21.4 9.2 1.9 11.9 0.2 0 4.3 0.1 0.2 7.9 0.2 0.3 2.7 5.9 0.2 0 0.8 13 0.2 2.3 1.2 4.4 1.8 8.3 ----417

75+ 0.1 0.6 0.8 0.4 0.1 0 2 0.1 0 0.7 2.3 0.1 5.3 4.1 0.1 1.7 0.6 1.2 0.2 0.2 5 0.2 0.6 0.2 1.6 0 0 0.6 28.6 0.2 0.2 6.8 3.4 0.9 5.4 0.1 0.1 0.7 0 0 0.6 0 0.1 1.7 2.7 0.1 0.1 0.4 3 0 0.5 0.8 1.8 0.6 1 ----89

Crude Rate

APPENDIX 22: CANCER INCIDENCE BY SITES AND AGE GROUP, ALL RESIDENTS, FEMALES, MALAYSIA, 2007-2011

0.1 0.7 1 0.4 0.1 0.1 2.2 0.2 0 0.8 2.6 0.2 6.1 4.8 0.2 2 0.8 1.5 0.2 0.2 6 0.2 0.6 0.3 1.9 0 0 0.6 31.1 0.2 0.2 7.6 3.9 1 5.9 0.1 0.1 0.8 0 0 0.7 0 0.1 1.8 2.9 0.1 0.1 0.4 3.3 0 0.7 0.9 1.9 0.6 1.1 ----99.3

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

102

8 165 130 122 42 22 959 35 14 258 429 69 1291 1536 45 1195 165 379 128 252 3094 61 282 62 504 11 4 240 50 26 1163 273 14 316 3 4 781 3 61 612 312 22 61 226 1413 3 220 381 704 334 273 ----18757

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 10 0 0 1 0 0 0 5 1 1 0 0 12 0 1 0 19 1 14 1 0 2 0 33 62 0 7 1 2 18 0 0 107 55 69 2 ----425

0-9

0 0 0 1 0 0 2 0 1 0 0 0 1 0 0 0 0 0 1 1 0 0 12 0 3 0 0 5 0 1 0 4 0 3 0 0 0 0 5 33 1 1 1 4 31 0 0 59 25 53 3 ----251

50 0 3 0 0 0 18 0 0 0 1 0 2 0 0 4 0 0 1 1 0 3 32 0 4 0 0 6 0 0 0 11 0 3 0 0 0 0 0 40 2 1 6 14 40 0 0 41 29 30 4 ----296

10-14 0 1 0 1 0 1 25 0 0 0 2 0 5 0 0 2 0 0 2 0 1 4 56 2 9 0 0 16 0 0 2 23 2 2 0 0 1 0 0 34 9 0 8 30 44 0 0 26 48 25 7 ----388

15-19 0 2 3 6 1 1 28 0 0 1 1 2 10 6 1 8 0 0 3 0 20 11 25 5 7 0 0 11 0 1 3 52 0 2 0 0 1 0 0 31 10 0 3 37 73 0 1 24 52 18 5 ----465

20-24 0 6 5 8 1 1 43 0 0 2 5 1 20 14 0 14 1 5 1 0 21 7 27 1 10 0 0 18 1 0 2 62 1 3 0 0 3 0 0 18 21 1 2 24 55 0 1 20 46 18 8 ----497

25-29 1 7 2 11 1 0 38 0 0 0 9 4 31 43 0 30 0 7 2 2 37 4 11 1 12 0 1 12 3 1 1 28 1 5 0 0 4 0 3 42 10 0 2 18 57 0 1 8 32 8 5 ----495

30-34 0 4 8 14 1 0 66 0 1 4 21 0 49 51 2 43 5 6 8 2 76 6 12 3 13 0 1 7 1 1 1 25 0 9 0 1 8 0 1 36 17 0 6 19 70 0 7 9 42 12 9 ----677

35-39 1 18 10 5 4 1 92 0 0 13 24 3 86 75 7 80 9 28 13 3 137 4 10 5 24 0 1 17 6 2 4 9 1 15 0 0 25 1 1 40 23 1 7 17 109 0 14 13 53 10 20 ----1041

40-44 1 25 10 12 4 5 136 3 0 21 48 9 114 128 3 115 11 43 17 19 239 3 11 4 43 1 0 28 4 0 10 13 1 34 1 0 49 0 1 50 32 1 8 13 129 0 29 10 55 7 35 ----1535

45-49 1 23 15 10 3 2 148 1 3 24 54 7 171 176 6 228 27 45 18 30 361 5 13 8 36 1 0 23 5 1 44 6 3 48 0 0 65 0 4 65 29 1 7 20 167 1 32 12 68 22 32 ----2071

50-54 1 18 13 12 4 0 115 6 2 33 48 15 206 205 3 198 27 51 13 45 397 1 13 10 56 2 0 27 10 5 80 5 1 51 0 0 77 2 2 60 43 2 3 8 163 0 43 13 54 13 32 ----2188

55-59 0 18 17 15 8 2 96 1 2 54 50 10 181 267 9 168 24 73 22 39 517 5 22 2 70 1 0 18 6 6 171 6 0 42 0 1 124 0 1 36 36 1 5 4 151 0 37 12 46 14 35 ----2425

60-64 1 12 16 6 2 2 71 6 2 31 64 7 135 230 5 118 22 53 9 35 460 3 14 9 75 1 1 17 3 3 229 5 1 40 0 1 131 0 2 29 31 3 2 6 139 1 27 12 39 10 18 ----2139

65-69 0 16 11 11 5 1 47 6 0 37 48 8 132 184 5 93 24 35 7 31 435 3 9 6 69 3 0 8 5 1 287 2 1 30 1 0 127 0 3 18 30 2 0 5 85 0 15 10 29 12 26 ----1923

70-74 % of Total

2 0.00% 15 0.90% 17 0.70% 10 0.70% 8 0.20% 5 0.10% 34 5.10% 12 0.20% 3 0.10% 38 1.40% 54 2.30% 3 0.40% 148 6.90% 157 8.20% 4 0.20% 84 6.40% 15 0.90% 33 2.00% 10 0.70% 44 1.30% 393 16.50% 2 0.30% 10 1.50% 5 0.30% 72 2.70% 2 0.10% 0 0.00% 15 1.30% 6 0.30% 3 0.10% 329 6.20% 3 1.50% 1 0.10% 15 1.70% 0 0.00% 1 0.00% 164 4.20% 0 0.00% 5 0.30% 18 3.30% 18 1.70% 1 0.10% 0 0.30% 5 1.20% 82 7.50% 1 0.00% 13 1.20% 5 2.00% 31 3.80% 13 1.80% 32 1.50% --------1941 100.00%

75+

APPENDIX 23: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, MALAY MALES, MALAYSIA, 2007-2011

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

103

17 163 112 101 24 8 401 28 10 149 312 37 1101 1104 26 477 155 273 64 38 1187 40 190 69 363 6 1 207 8225 46 38 1502 964 264 1754 21 42 167 2 2 151 2 31 566 1023 21 24 164 978 5 178 259 626 234 236 ----24188

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 9 0 1 3 0 1 0 7 0 2 0 0 11 0 0 0 0 0 0 5 0 0 17 0 0 1 0 14 30 0 5 0 0 17 0 0 83 46 58 4 ----316

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 11 0 2 0 0 9 0 0 0 0 0 0 8 0 0 0 0 0 0 0 3 46 0 3 0 0 10 0 0 33 18 24 4 ----174

51 1 2 1 0 1 2 0 1 0 1 0 2 1 0 1 0 0 2 0 0 2 29 0 2 0 0 8 1 0 1 0 0 0 28 0 0 3 0 0 0 0 2 39 7 0 1 3 28 0 0 29 24 20 1 ----244

10-14 0 0 3 6 1 0 12 0 0 0 4 0 5 0 0 6 0 0 1 0 0 1 31 0 9 0 0 20 3 0 0 0 0 0 61 0 1 4 0 0 1 0 1 22 34 1 2 24 29 0 0 24 38 12 2 ----358

15-19 0 3 0 4 0 1 19 1 0 0 1 1 17 6 0 3 1 4 2 0 7 2 12 2 4 0 0 9 46 0 0 5 2 0 63 0 5 3 1 0 2 0 0 28 71 1 2 42 68 1 0 18 49 10 14 ----530

20-24 0 4 3 6 0 1 18 0 0 0 9 1 26 10 0 7 0 2 2 0 12 3 12 2 10 0 0 16 146 0 1 23 18 8 80 0 5 3 1 0 1 0 3 27 82 1 1 24 57 0 1 5 29 11 7 ----678

25-29 1 10 2 2 2 1 20 1 2 0 8 4 33 29 0 12 6 8 1 1 18 1 11 2 9 0 0 11 415 2 0 45 38 10 74 2 9 3 0 0 1 0 0 19 67 0 1 20 39 0 0 4 44 4 6 ----998

30-34 0 5 2 7 0 0 30 0 0 1 10 0 38 37 1 16 7 13 7 1 44 1 7 3 5 1 0 14 723 1 3 108 52 21 111 2 9 11 0 0 3 0 0 36 108 2 3 4 38 0 2 9 48 13 16 ----1573

35-39 0 20 6 7 0 0 34 3 0 6 23 4 65 73 3 24 1 17 2 2 62 2 18 8 23 0 0 23 1178 4 3 201 103 22 163 4 4 8 0 0 8 0 0 41 104 2 4 8 54 0 13 10 42 9 13 ----2424

40-44 0 22 5 11 2 0 61 2 0 6 29 2 114 99 2 40 11 17 1 2 115 2 11 6 25 0 0 18 1596 4 4 258 130 45 256 6 7 19 0 0 10 0 1 64 112 0 3 14 102 0 11 6 60 14 27 ----3352

45-49 2 21 10 11 2 1 54 1 1 21 41 7 141 134 2 59 14 26 3 3 153 3 8 5 23 1 0 16 1385 8 7 256 174 46 286 1 1 25 0 0 10 0 2 55 107 2 3 9 110 0 30 12 50 11 20 ----3373

50-54 2 18 7 7 4 0 59 4 1 20 36 5 156 164 3 72 31 48 14 4 161 4 11 7 30 3 0 15 1123 7 6 233 176 49 226 3 0 18 0 1 27 1 1 47 82 1 4 7 103 1 35 7 66 14 30 ----3154

55-59 0 13 17 13 1 1 41 5 1 18 41 1 148 142 5 65 23 45 4 6 159 7 6 8 37 0 0 10 708 3 1 163 127 27 135 0 1 22 0 0 17 1 1 40 79 2 0 2 113 2 28 6 43 10 29 ----2377

60-64 1 11 14 7 0 0 17 3 0 20 38 4 104 139 3 58 17 27 7 7 162 5 3 11 48 0 0 11 411 4 5 87 76 20 124 2 0 16 0 1 20 0 1 36 90 0 0 1 73 0 27 3 27 7 13 ----1761

65-69 5 13 19 11 5 0 24 4 1 26 34 4 130 148 0 54 18 38 6 6 138 3 8 5 57 0 1 7 285 8 3 72 37 13 84 0 0 10 0 0 20 0 1 23 42 0 0 2 71 0 22 5 19 6 26 ----1514

70-74 5 22 22 8 7 2 9 4 2 31 37 4 122 122 7 50 26 27 9 6 155 2 5 10 77 1 0 9 205 5 4 51 31 3 50 1 0 5 0 0 30 0 1 13 38 1 0 4 66 1 9 5 23 11 24 ----1362

75+ 0.10% 0.70% 0.50% 0.40% 0.10% 0.00% 1.70% 0.10% 0.00% 0.60% 1.30% 0.20% 4.60% 4.60% 0.10% 2.00% 0.60% 1.10% 0.30% 0.20% 4.90% 0.20% 0.80% 0.30% 1.50% 0.00% 0.00% 0.90% 34.00% 0.20% 0.20% 6.20% 4.00% 1.10% 7.30% 0.10% 0.20% 0.70% 0.00% 0.00% 0.60% 0.00% 0.10% 2.30% 4.20% 0.10% 0.10% 0.70% 4.00% 0.00% 0.70% 1.10% 2.60% 1.00% 1.00% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 24: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, MALAY FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

104

8 165 130 122 42 22 959 35 14 258 429 69 1291 1536 45 1195 165 379 128 252 3094 61 282 62 504 11 4 240 50 26 1163 273 14 316 3 4 781 3 61 612 312 22 61 226 1413 3 220 381 704 334 273 ----18757

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0.5 0 0.4 0 0 0.1 0 0.9 1.7 0 0.2 0 0.1 0.5 0 0 2.9 1.5 1.9 0.1 ----11

0-9

0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 0 0.1 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.8 0 0 0 0.1 0.8 0 0 1.5 0.6 1.4 0.1 ----6

50 0 0.1 0 0 0 0.5 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0.1 0.8 0 0.1 0 0 0.2 0 0 0 0.3 0 0.1 0 0 0 0 0 1 0.1 0 0.2 0.4 1 0 0 1.1 0.7 0.8 0.1 ----8

10-14 0 0 0 0 0 0 0.7 0 0 0 0.1 0 0.1 0 0 0.1 0 0 0.1 0 0 0.1 1.5 0.1 0.2 0 0 0.4 0 0 0.1 0.6 0.1 0.1 0 0 0 0 0 0.9 0.2 0 0.2 0.8 1.2 0 0 0.7 1.3 0.7 0.2 ----10

15-19 0 0.1 0.1 0.2 0 0 0.8 0 0 0 0 0.1 0.3 0.2 0 0.2 0 0 0.1 0 0.6 0.3 0.7 0.1 0.2 0 0 0.3 0 0 0.1 1.5 0 0.1 0 0 0 0 0 0.9 0.3 0 0.1 1.1 2.1 0 0 0.7 1.5 0.5 0.1 ----13

20-24 0 0.2 0.2 0.3 0 0 1.4 0 0 0.1 0.2 0 0.7 0.5 0 0.5 0 0.2 0 0 0.7 0.2 0.9 0 0.3 0 0 0.6 0 0 0.1 2 0 0.1 0 0 0.1 0 0 0.6 0.7 0 0.1 0.8 1.8 0 0 0.7 1.5 0.6 0.3 ----16

25-29 0 0.3 0.1 0.5 0 0 1.6 0 0 0 0.4 0.2 1.3 1.8 0 1.3 0 0.3 0.1 0.1 1.6 0.2 0.5 0 0.5 0 0 0.5 0.1 0 0 1.2 0 0.2 0 0 0.2 0 0.1 1.8 0.4 0 0.1 0.8 2.4 0 0 0.3 1.3 0.3 0.2 ----21

30-34 0 0.2 0.4 0.6 0 0 3.1 0 0 0.2 1 0 2.3 2.4 0.1 2 0.2 0.3 0.4 0.1 3.5 0.3 0.6 0.1 0.6 0 0 0.3 0 0 0 1.2 0 0.4 0 0 0.4 0 0 1.7 0.8 0 0.3 0.9 3.2 0 0.3 0.4 1.9 0.6 0.4 ----31

35-39 0 0.9 0.5 0.2 0.2 0 4.5 0 0 0.6 1.2 0.1 4.3 3.7 0.3 4 0.4 1.4 0.6 0.1 6.8 0.2 0.5 0.2 1.2 0 0 0.8 0.3 0.1 0.2 0.4 0 0.7 0 0 1.2 0 0 2 1.1 0 0.3 0.8 5.4 0 0.7 0.6 2.6 0.5 1 ----51

40-44 0.1 1.3 0.5 0.6 0.2 0.3 7.2 0.2 0 1.1 2.6 0.5 6.1 6.8 0.2 6.1 0.6 2.3 0.9 1 12.7 0.2 0.6 0.2 2.3 0.1 0 1.5 0.2 0 0.5 0.7 0.1 1.8 0.1 0 2.6 0 0.1 2.7 1.7 0.1 0.4 0.7 6.9 0 1.5 0.5 2.9 0.4 1.9 ----82

45-49 0.1 1.5 1 0.6 0.2 0.1 9.4 0.1 0.2 1.5 3.4 0.4 10.9 11.2 0.4 14.5 1.7 2.9 1.1 1.9 23 0.3 0.8 0.5 2.3 0.1 0 1.5 0.3 0.1 2.8 0.4 0.2 3.1 0 0 4.1 0 0.3 4.1 1.8 0.1 0.4 1.3 10.6 0.1 2 0.8 4.3 1.4 2 ----132

50-54 0.1 1.5 1.1 1 0.3 0 9.3 0.5 0.2 2.7 3.9 1.2 16.7 16.6 0.2 16.1 2.2 4.1 1.1 3.7 32.2 0.1 1.1 0.8 4.5 0.2 0 2.2 0.8 0.4 6.5 0.4 0.1 4.1 0 0 6.2 0.2 0.2 4.9 3.5 0.2 0.2 0.6 13.2 0 3.5 1.1 4.4 1.1 2.6 ----178

55-59 0 2 1.9 1.7 0.9 0.2 10.8 0.1 0.2 6.1 5.6 1.1 20.3 30 1 18.9 2.7 8.2 2.5 4.4 58 0.6 2.5 0.2 7.9 0.1 0 2 0.7 0.7 19.2 0.7 0 4.7 0 0.1 13.9 0 0.1 4 4 0.1 0.6 0.4 16.9 0 4.2 1.3 5.2 1.6 3.9 ----272

60-64 0.2 2.1 2.8 1.1 0.4 0.4 12.5 1.1 0.4 5.5 11.3 1.2 23.8 40.6 0.9 20.8 3.9 9.3 1.6 6.2 81.1 0.5 2.5 1.6 13.2 0.2 0.2 3 0.5 0.5 40.4 0.9 0.2 7.1 0 0.2 23.1 0 0.4 5.1 5.5 0.5 0.4 1.1 24.5 0.2 4.8 2.1 6.9 1.8 3.2 ----377

65-69

APPENDIX 25: CANCER INCIDENCE BY SITES AND AGE GROUP, MALAY MALES, MALAYSIA, 2007-2011

0 3.8 2.6 2.6 1.2 0.2 11.1 1.4 0 8.7 11.3 1.9 31.2 43.5 1.2 22 5.7 8.3 1.7 7.3 102.7 0.7 2.1 1.4 16.3 0.7 0 1.9 1.2 0.2 67.8 0.5 0.2 7.1 0.2 0 30 0 0.7 4.3 7.1 0.5 0 1.2 20.1 0 3.5 2.4 6.8 2.8 6.1 ----454

70-74 0.4 3.3 3.8 2.2 1.8 1.1 7.6 2.7 0.7 8.5 12 0.7 33 35 0.9 18.7 3.3 7.4 2.2 9.8 87.5 0.4 2.2 1.1 16 0.4 0 3.3 1.3 0.7 73.3 0.7 0.2 3.3 0 0.2 36.5 0 1.1 4 4 0.2 0 1.1 18.3 0.2 2.9 1.1 6.9 2.9 7.1 ----432

75+ 0 0.5 0.4 0.3 0.1 0.1 2.7 0.1 0 0.7 1.2 0.2 3.7 4.3 0.1 3.4 0.5 1.1 0.4 0.7 8.8 0.2 0.8 0.2 1.4 0 0 0.7 0.1 0.1 3.3 0.8 0 0.9 0 0 2.2 0 0.2 1.7 0.9 0.1 0.2 0.6 4 0 0.6 1.1 2 0.9 0.8 ----53.1

Crude Rate 0 0.6 0.5 0.4 0.2 0.1 3.3 0.2 0.1 1.1 1.7 0.3 5 6.1 0.2 4.5 0.7 1.5 0.5 1 12.6 0.2 0.9 0.2 2 0 0 0.8 0.2 0.1 5.3 0.8 0 1.2 0 0 3.3 0 0.2 1.9 1.1 0.1 0.2 0.6 5 0 0.8 1.1 2.3 1 1 ----70.8

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

105

17 163 112 101 24 8 401 28 10 149 312 37 1101 1104 26 477 155 273 64 38 1187 40 190 69 363 6 1 207 8225 46 38 1502 964 264 1754 21 42 167 2 2 151 2 31 566 1023 21 24 164 978 5 178 259 626 234 236 ----24188

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0.2 0 0.1 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0.5 0 0 0 0 0.4 0.9 0 0.1 0 0 0.5 0 0 2.4 1.3 1.6 0.1 ----9

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.3 0 0.1 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0.1 1.2 0 0.1 0 0 0.3 0 0 0.9 0.5 0.6 0.1 ----5

50 0 0.1 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0.1 0.8 0 0.1 0 0 0.2 0 0 0 0 0 0 0.8 0 0 0.1 0 0 0 0 0.1 1.1 0.2 0 0 0.1 0.8 0 0 0.8 0.7 0.5 0 ----7

10-14 0 0 0.1 0.2 0 0 0.3 0 0 0 0.1 0 0.1 0 0 0.2 0 0 0 0 0 0 0.8 0 0.2 0 0 0.5 0.1 0 0 0 0 0 1.7 0 0 0.1 0 0 0 0 0 0.6 0.9 0 0.1 0.7 0.8 0 0 0.7 1 0.3 0.1 ----10

15-19 0 0.1 0 0.1 0 0 0.6 0 0 0 0 0 0.5 0.2 0 0.1 0 0.1 0.1 0 0.2 0.1 0.4 0.1 0.1 0 0 0.3 1.3 0 0 0.1 0.1 0 1.8 0 0.1 0.1 0 0 0.1 0 0 0.8 2.1 0 0.1 1.2 2 0 0 0.5 1.4 0.3 0.4 ----16

20-24 0 0.1 0.1 0.2 0 0 0.6 0 0 0 0.3 0 0.9 0.3 0 0.2 0 0.1 0.1 0 0.4 0.1 0.4 0.1 0.3 0 0 0.5 4.9 0 0 0.8 0.6 0.3 2.7 0 0.2 0.1 0 0 0 0 0.1 0.9 2.7 0 0 0.8 1.9 0 0 0.2 1 0.4 0.2 ----23

25-29 0 0.4 0.1 0.1 0.1 0 0.9 0 0.1 0 0.3 0.2 1.4 1.3 0 0.5 0.3 0.3 0 0 0.8 0 0.5 0.1 0.4 0 0 0.5 17.9 0.1 0 1.9 1.6 0.4 3.2 0.1 0.4 0.1 0 0 0 0 0 0.8 2.9 0 0 0.9 1.7 0 0 0.2 1.9 0.2 0.3 ----43

30-34 0 0.2 0.1 0.3 0 0 1.4 0 0 0 0.5 0 1.7 1.7 0 0.7 0.3 0.6 0.3 0 2 0 0.3 0.1 0.2 0 0 0.6 33.1 0 0.1 4.9 2.4 1 5.1 0.1 0.4 0.5 0 0 0.1 0 0 1.6 4.9 0.1 0.1 0.2 1.7 0 0.1 0.4 2.2 0.6 0.7 ----72

35-39 0 1 0.3 0.3 0 0 1.6 0.1 0 0.3 1.1 0.2 3.1 3.5 0.1 1.2 0 0.8 0.1 0.1 3 0.1 0.9 0.4 1.1 0 0 1.1 56.8 0.2 0.1 9.7 5 1.1 7.9 0.2 0.2 0.4 0 0 0.4 0 0 2 5 0.1 0.2 0.4 2.6 0 0.6 0.5 2 0.4 0.6 ----117

40-44 0 1.2 0.3 0.6 0.1 0 3.3 0.1 0 0.3 1.6 0.1 6.2 5.3 0.1 2.2 0.6 0.9 0.1 0.1 6.2 0.1 0.6 0.3 1.4 0 0 1 86.2 0.2 0.2 13.9 7 2.4 13.8 0.3 0.4 1 0 0 0.5 0 0.1 3.5 6.1 0 0.2 0.8 5.5 0 0.6 0.3 3.2 0.8 1.5 ----181

45-49 0.1 1.3 0.6 0.7 0.1 0.1 3.4 0.1 0.1 1.3 2.6 0.4 8.9 8.5 0.1 3.7 0.9 1.6 0.2 0.2 9.7 0.2 0.5 0.3 1.5 0.1 0 1 87.4 0.5 0.4 16.1 11 2.9 18 0.1 0.1 1.6 0 0 0.6 0 0.1 3.5 6.7 0.1 0.2 0.6 6.9 0 1.9 0.8 3.2 0.7 1.3 ----213

50-54 0.2 1.5 0.6 0.6 0.3 0 4.8 0.3 0.1 1.6 2.9 0.4 12.7 13.3 0.2 5.8 2.5 3.9 1.1 0.3 13.1 0.3 0.9 0.6 2.4 0.2 0 1.2 91.1 0.6 0.5 18.9 14.3 4 18.3 0.2 0 1.5 0 0.1 2.2 0.1 0.1 3.8 6.7 0.1 0.3 0.6 8.4 0.1 2.8 0.6 5.4 1.1 2.4 ----256

55-59 0 1.4 1.9 1.4 0.1 0.1 4.5 0.6 0.1 2 4.5 0.1 16.3 15.6 0.6 7.2 2.5 5 0.4 0.7 17.5 0.8 0.7 0.9 4.1 0 0 1.1 78 0.3 0.1 18 14 3 14.9 0 0.1 2.4 0 0 1.9 0.1 0.1 4.4 8.7 0.2 0 0.2 12.5 0.2 3.1 0.7 4.7 1.1 3.2 ----262

60-64 0.2 1.8 2.3 1.2 0 0 2.8 0.5 0 3.3 6.3 0.7 17.2 23 0.5 9.6 2.8 4.5 1.2 1.2 26.8 0.8 0.5 1.8 7.9 0 0 1.8 68.1 0.7 0.8 14.4 12.6 3.3 20.5 0.3 0 2.6 0 0.2 3.3 0 0.2 6 14.9 0 0 0.2 12.1 0 4.5 0.5 4.5 1.2 2.2 ----292

65-69 1 2.7 3.9 2.3 1 0 5 0.8 0.2 5.4 7 0.8 26.9 30.6 0 11.2 3.7 7.9 1.2 1.2 28.5 0.6 1.7 1 11.8 0 0.2 1.4 58.9 1.7 0.6 14.9 7.6 2.7 17.4 0 0 2.1 0 0 4.1 0 0.2 4.8 8.7 0 0 0.4 14.7 0 4.5 1 3.9 1.2 5.4 ----313

70-74

APPENDIX 26: CANCER INCIDENCE BY SITES AND AGE GROUP, MALAY FEMALES, MALAYSIA, 2007-2011

0.9 3.8 3.8 1.4 1.2 0.3 1.5 0.7 0.3 5.3 6.4 0.7 21 21 1.2 8.6 4.5 4.6 1.5 1 26.7 0.3 0.9 1.7 13.2 0.2 0 1.5 35.3 0.9 0.7 8.8 5.3 0.5 8.6 0.2 0 0.9 0 0 5.2 0 0.2 2.2 6.5 0.2 0 0.7 11.4 0.2 1.5 0.9 4 1.9 4.1 ----234

75+ 0 0.5 0.3 0.3 0.1 0 1.2 0.1 0 0.4 0.9 0.1 3.2 3.2 0.1 1.4 0.4 0.8 0.2 0.1 3.4 0.1 0.5 0.2 1 0 0 0.6 23.6 0.1 0.1 4.3 2.8 0.8 5 0.1 0.1 0.5 0 0 0.4 0 0.1 1.6 2.9 0.1 0.1 0.5 2.8 0 0.5 0.7 1.8 0.7 0.7 ----69.5

Crude Rate 0.1 0.6 0.4 0.3 0.1 0 1.3 0.1 0 0.6 1.1 0.1 4 4.1 0.1 1.7 0.6 1 0.2 0.1 4.4 0.1 0.5 0.2 1.3 0 0 0.6 27.2 0.2 0.1 5.1 3.3 0.9 5.8 0.1 0.1 0.6 0 0 0.6 0 0.1 1.8 3.3 0.1 0.1 0.4 3.3 0 0.7 0.8 2 0.7 0.8 ----81.9

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

106

10 171 110 98 46 30 2104 74 11 305 1001 62 2033 1764 28 1416 177 516 116 431 3390 73 128 53 687 7 6 126 64 39 1589 126 15 498 10 14 510 14 23 368 142 12 31 78 830 2 102 204 383 70 327 ----20424

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 8 0 6 0 0 0 0 8 12 0 2 0 0 4 0 0 42 8 15 1 ----116

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 1 0 0 2 0 1 0 0 2 0 0 0 3 0 1 0 0 0 0 0 12 1 1 0 1 2 0 0 20 8 4 1 ----64

50 0 0 0 0 0 1 0 0 0 0 0 1 0 0 3 0 0 2 0 0 0 17 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 18 0 0 0 0 9 0 0 19 13 4 1 ----90

10-14 0 0 1 0 1 0 13 0 0 0 0 0 0 1 0 1 0 0 0 0 1 2 13 1 1 0 0 4 0 0 0 8 1 0 0 0 2 0 0 18 0 1 1 8 13 0 0 13 15 5 3 ----127

15-19 0 2 0 7 0 0 9 0 0 2 0 0 6 2 0 2 0 0 1 1 6 4 11 0 2 0 1 2 0 1 0 11 0 0 0 0 1 0 0 9 5 0 2 8 24 0 0 11 25 2 3 ----160

20-24 0 2 1 1 1 0 25 0 0 0 10 2 6 5 0 3 1 0 0 1 11 5 5 0 5 0 1 3 0 0 0 14 1 2 0 0 1 0 0 14 4 0 0 8 17 0 3 11 22 3 4 ----192

25-29 0 7 1 2 0 0 111 0 0 3 9 1 13 12 1 13 1 2 0 2 22 2 4 0 9 0 0 5 1 0 0 18 0 8 0 0 5 0 0 19 3 0 1 3 23 0 0 11 20 1 2 ----335

30-34 0 8 3 4 3 0 185 0 0 1 15 1 44 20 0 25 3 11 6 4 33 2 7 0 7 0 1 10 2 3 0 21 0 12 0 0 8 0 2 22 9 0 1 3 44 0 1 4 25 1 14 ----565

35-39 1 10 5 7 3 0 264 2 0 7 27 2 68 48 1 67 5 12 10 10 81 5 11 3 19 1 2 12 3 1 8 11 0 33 0 0 15 0 0 21 13 0 2 5 46 0 2 8 32 3 10 ----896

40-44 1 16 8 12 3 2 325 2 1 20 43 9 112 112 1 109 11 33 12 21 161 6 5 4 29 0 1 9 6 0 11 7 0 46 2 0 12 1 0 25 19 0 3 6 65 0 8 6 28 2 14 ----1329

45-49 1 18 11 10 4 2 339 6 1 22 73 4 175 158 2 156 14 51 23 42 280 8 7 6 38 2 0 12 9 3 38 11 0 51 0 0 28 0 1 33 15 2 5 6 67 0 5 8 28 3 25 ----1803

50-54 1 29 12 11 7 1 299 8 2 43 98 11 260 241 5 238 29 75 10 47 403 14 12 10 70 0 0 14 3 6 118 2 3 69 2 0 50 1 1 37 18 2 8 8 108 0 21 19 40 2 42 ----2510

55-59 0 23 20 12 8 5 215 15 4 45 141 9 293 300 5 259 30 92 20 92 537 7 8 9 95 1 0 14 13 7 240 3 3 89 0 3 73 5 0 41 15 1 1 3 121 0 20 11 30 3 46 ----2987

60-64 2 20 15 13 4 3 176 15 0 51 153 11 327 330 4 195 29 99 8 97 645 9 9 13 113 2 0 17 10 7 368 3 3 75 3 7 84 3 2 32 19 1 4 6 130 0 14 9 39 9 65 ----3253

65-69 2 19 11 12 9 9 95 17 1 44 178 10 334 248 5 177 25 68 8 57 583 3 6 2 107 0 0 10 7 4 376 1 2 65 1 3 99 1 4 29 9 1 1 9 76 0 15 7 26 5 40 ----2821

70-74 2 17 22 7 3 8 46 9 2 67 254 2 394 287 4 159 29 73 15 56 627 6 10 5 191 1 0 9 10 7 430 4 2 41 2 1 132 3 5 26 12 1 2 4 81 2 13 5 24 8 56 ----3176

75+ 0.00% 0.80% 0.50% 0.50% 0.20% 0.10% 10.30% 0.40% 0.10% 1.50% 4.90% 0.30% 10.00% 8.60% 0.10% 6.90% 0.90% 2.50% 0.60% 2.10% 16.60% 0.40% 0.60% 0.30% 3.40% 0.00% 0.00% 0.60% 0.30% 0.20% 7.80% 0.60% 0.10% 2.40% 0.00% 0.10% 2.50% 0.10% 0.10% 1.80% 0.70% 0.10% 0.20% 0.40% 4.10% 0.00% 0.50% 1.00% 1.90% 0.30% 1.60% ----100.00%

% of Total

APPENDIX 27: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, CHINESE MALES, MALAYSIA, 2007-2011

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

107

7 99 66 71 24 8 611 10 3 82 725 32 1837 1151 35 411 171 400 52 41 1486 49 105 55 446 8 1 104 7333 52 52 1732 853 199 1107 12 5 214 5 9 185 4 16 305 371 14 18 70 569 1 98 133 314 80 273 ----22114

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 4 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 0 2 0 0 0 0 1 21 0 3 0 0 3 0 0 25 9 10 2 ----85

0-9

0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 14 1 1 0 1 6 0 0 23 4 5 1 ----63

50 0 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 8 0 1 0 0 3 0 0 0 0 0 0 5 0 0 1 0 0 1 0 0 11 5 0 0 1 11 0 0 12 11 7 0 ----82

10-14 0 0 1 3 0 0 5 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 5 1 1 0 0 6 0 0 0 0 0 0 17 0 0 0 0 0 0 0 0 10 12 0 1 11 19 0 0 8 12 6 1 ----122

15-19 0 0 1 2 0 0 14 0 0 0 4 0 6 3 0 1 0 1 0 0 1 2 4 2 2 0 0 6 13 0 0 5 0 2 23 0 1 2 0 0 0 0 0 10 12 0 0 7 15 0 0 4 9 1 4 ----157

20-24 0 4 0 5 0 0 13 0 0 0 6 0 10 6 0 3 1 4 1 0 8 0 1 1 1 0 0 4 61 0 0 18 7 0 28 0 1 0 0 0 0 0 0 5 29 0 0 13 20 0 0 3 25 2 3 ----283

25-29 0 5 0 2 0 0 21 0 0 0 12 2 17 9 0 2 2 4 2 1 11 3 7 3 9 0 0 4 200 0 0 45 9 7 37 0 0 3 0 0 2 0 0 12 30 0 0 7 18 0 0 6 14 2 8 ----516

30-34 0 6 2 5 1 1 42 0 0 0 16 0 47 19 0 11 1 5 4 3 23 2 3 6 10 0 0 8 425 0 0 111 27 9 52 0 2 7 0 0 4 0 1 19 26 0 2 3 37 0 3 5 30 3 4 ----985

35-39 0 7 2 10 3 0 87 0 0 1 29 1 57 33 2 14 4 13 5 0 62 1 7 5 12 0 0 2 826 2 1 135 53 17 99 0 1 7 0 0 2 0 2 25 40 2 0 4 32 0 6 6 20 3 13 ----1653

40-44 1 5 2 7 2 1 90 0 0 5 47 2 93 68 0 19 8 16 4 3 103 5 6 2 12 0 1 16 1224 3 5 243 100 33 170 5 0 17 0 0 11 0 2 27 42 0 2 3 31 0 4 8 34 3 16 ----2501

45-49 1 15 5 4 3 0 92 2 2 2 52 7 137 104 5 26 11 38 9 3 127 4 7 4 25 1 0 8 1183 7 2 238 147 42 171 2 0 23 1 2 13 2 2 31 46 3 4 4 58 1 6 6 36 6 27 ----2757

50-54 0 10 5 9 4 1 88 0 0 8 80 5 253 142 2 47 27 48 5 4 177 5 10 4 34 0 0 9 1138 6 8 234 176 25 162 0 0 26 0 0 17 0 0 26 42 1 2 2 76 0 17 8 23 3 35 ----3004

55-59 0 15 11 4 3 1 63 1 1 9 93 3 242 154 5 55 20 70 4 6 215 6 15 5 40 2 0 8 842 6 7 195 129 23 128 0 0 33 1 0 26 2 3 24 25 0 3 4 48 0 19 6 27 6 34 ----2642

60-64 0 8 10 5 3 0 42 0 0 14 97 2 247 172 5 59 22 63 5 8 245 7 11 7 61 2 0 12 608 5 7 169 84 11 88 3 0 19 1 4 26 0 2 37 24 2 3 3 68 0 9 6 11 8 27 ----2332

65-69 1 9 10 8 2 2 26 2 0 9 90 1 274 188 6 63 36 52 2 4 206 5 7 7 67 2 0 8 405 7 11 188 61 18 59 1 0 29 1 1 29 0 1 18 13 1 1 3 62 0 21 2 26 6 32 ----2083

70-74 4 15 15 4 3 2 27 5 0 34 197 9 454 252 10 107 39 86 10 8 308 8 13 8 169 1 0 10 408 16 10 151 60 12 65 1 0 44 1 2 54 0 2 15 24 1 0 4 65 0 13 5 23 9 66 ----2849

75+ 0.00% 0.40% 0.30% 0.30% 0.10% 0.00% 2.80% 0.00% 0.00% 0.40% 3.30% 0.10% 8.30% 5.20% 0.20% 1.90% 0.80% 1.80% 0.20% 0.20% 6.70% 0.20% 0.50% 0.20% 2.00% 0.00% 0.00% 0.50% 33.20% 0.20% 0.20% 7.80% 3.90% 0.90% 5.00% 0.10% 0.00% 1.00% 0.00% 0.00% 0.80% 0.00% 0.10% 1.40% 1.70% 0.10% 0.10% 0.30% 2.60% 0.00% 0.40% 0.60% 1.40% 0.40% 1.20% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 28: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, CHINESE FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

108

10 171 110 98 46 30 2104 74 11 305 1001 62 2033 1764 28 1416 177 516 116 431 3390 73 128 53 687 7 6 126 64 39 1589 126 15 498 10 14 510 14 23 368 142 12 31 78 830 2 102 204 383 70 327 ----20424

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0.1 0 0 0 0 0.2 0 0 0 0.7 0 0.5 0 0 0 0 0.7 1.1 0 0.2 0 0 0.4 0 0 3.7 0.7 1.3 0.1 ----10

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.1 0.1 0 0 0.2 0 0.1 0 0 0.2 0 0 0 0.2 0 0.1 0 0 0 0 0 0.9 0.1 0.1 0 0.1 0.2 0 0 1.5 0.6 0.3 0.1 ----5

50 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0.2 0 0 0.1 0 0 0 1.2 0 0 0 0 0.1 0 0 0 0.1 0 0 0 0 0 0 0 1.3 0 0 0 0 0.7 0 0 1.4 1 0.3 0.1 ----7

10-14 0 0 0.1 0 0.1 0 0.9 0 0 0 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.1 0.9 0.1 0.1 0 0 0.3 0 0 0 0.6 0.1 0 0 0 0.1 0 0 1.3 0 0.1 0.1 0.6 0.9 0 0 0.9 1.1 0.4 0.2 ----9

15-19 0 0.1 0 0.5 0 0 0.7 0 0 0.1 0 0 0.4 0.1 0 0.1 0 0 0.1 0.1 0.4 0.3 0.8 0 0.1 0 0.1 0.1 0 0.1 0 0.8 0 0 0 0 0.1 0 0 0.7 0.4 0 0.1 0.6 1.8 0 0 0.8 1.9 0.1 0.2 ----12

20-24 0 0.2 0.1 0.1 0.1 0 1.9 0 0 0 0.8 0.2 0.5 0.4 0 0.2 0.1 0 0 0.1 0.8 0.4 0.4 0 0.4 0 0.1 0.2 0 0 0 1.1 0.1 0.2 0 0 0.1 0 0 1.1 0.3 0 0 0.6 1.3 0 0.2 0.8 1.7 0.2 0.3 ----14

25-29 0 0.6 0.1 0.2 0 0 8.9 0 0 0.2 0.7 0.1 1 1 0.1 1 0.1 0.2 0 0.2 1.8 0.2 0.3 0 0.7 0 0 0.4 0.1 0 0 1.4 0 0.6 0 0 0.4 0 0 1.5 0.2 0 0.1 0.2 1.9 0 0 0.9 1.6 0.1 0.2 ----27

30-34 0 0.7 0.2 0.3 0.2 0 15.4 0 0 0.1 1.2 0.1 3.7 1.7 0 2.1 0.2 0.9 0.5 0.3 2.7 0.2 0.6 0 0.6 0 0.1 0.8 0.2 0.2 0 1.7 0 1 0 0 0.7 0 0.2 1.8 0.7 0 0.1 0.2 3.7 0 0.1 0.3 2.1 0.1 1.2 ----47

35-39 0.1 0.9 0.4 0.6 0.3 0 22.5 0.2 0 0.6 2.3 0.2 5.8 4.1 0.1 5.7 0.4 1 0.9 0.9 6.9 0.4 0.9 0.3 1.6 0.1 0.2 1 0.3 0.1 0.7 0.9 0 2.8 0 0 1.3 0 0 1.8 1.1 0 0.2 0.4 3.9 0 0.2 0.7 2.7 0.3 0.9 ----76

40-44 0.1 1.4 0.7 1 0.3 0.2 28.2 0.2 0.1 1.7 3.7 0.8 9.7 9.7 0.1 9.5 1 2.9 1 1.8 14 0.5 0.4 0.3 2.5 0 0.1 0.8 0.5 0 1 0.6 0 4 0.2 0 1 0.1 0 2.2 1.6 0 0.3 0.5 5.6 0 0.7 0.5 2.4 0.2 1.2 ----115

45-49 0.1 1.8 1.1 1 0.4 0.2 33.1 0.6 0.1 2.2 7.1 0.4 17.1 15.4 0.2 15.3 1.4 5 2.2 4.1 27.4 0.8 0.7 0.6 3.7 0.2 0 1.2 0.9 0.3 3.7 1.1 0 5 0 0 2.7 0 0.1 3.2 1.5 0.2 0.5 0.6 6.6 0 0.5 0.8 2.7 0.3 2.4 ----176

50-54 0.1 3.4 1.4 1.3 0.8 0.1 35 0.9 0.2 5 11.5 1.3 30.4 28.2 0.6 27.9 3.4 8.8 1.2 5.5 47.2 1.6 1.4 1.2 8.2 0 0 1.6 0.4 0.7 13.8 0.2 0.4 8.1 0.2 0 5.9 0.1 0.1 4.3 2.1 0.2 0.9 0.9 12.6 0 2.5 2.2 4.7 0.2 4.9 ----294

55-59 0 3.3 2.9 1.7 1.2 0.7 31 2.2 0.6 6.5 20.3 1.3 42.2 43.2 0.7 37.3 4.3 13.3 2.9 13.3 77.4 1 1.2 1.3 13.7 0.1 0 2 1.9 1 34.6 0.4 0.4 12.8 0 0.4 10.5 0.7 0 5.9 2.2 0.1 0.1 0.4 17.4 0 2.9 1.6 4.3 0.4 6.6 ----430

60-64 0.4 4.1 3.1 2.7 0.8 0.6 36.3 3.1 0 10.5 31.6 2.3 67.5 68.1 0.8 40.3 6 20.4 1.7 20 133.1 1.9 1.9 2.7 23.3 0.4 0 3.5 2.1 1.4 76 0.6 0.6 15.5 0.6 1.4 17.3 0.6 0.4 6.6 3.9 0.2 0.8 1.2 26.8 0 2.9 1.9 8.1 1.9 13.4 ----672

65-69 0.6 5.2 3 3.3 2.5 2.5 26.2 4.7 0.3 12.1 49 2.8 92 68.3 1.4 48.8 6.9 18.7 2.2 15.7 160.6 0.8 1.7 0.6 29.5 0 0 2.8 1.9 1.1 103.6 0.3 0.6 17.9 0.3 0.8 27.3 0.3 1.1 8 2.5 0.3 0.3 2.5 20.9 0 4.1 1.9 7.2 1.4 11 ----777

70-74

APPENDIX 29: CANCER INCIDENCE BY SITES AND AGE GROUP, CHINESE MALES, MALAYSIA, 2007-2011

0.6 4.9 6.3 2 0.9 2.3 13.3 2.6 0.6 19.3 73.2 0.6 113.6 82.7 1.2 45.8 8.4 21 4.3 16.1 180.7 1.7 2.9 1.4 55.1 0.3 0 2.6 2.9 2 123.9 1.2 0.6 11.8 0.6 0.3 38 0.9 1.4 7.5 3.5 0.3 0.6 1.2 23.3 0.6 3.7 1.4 6.9 2.3 16.1 ----915

75+ 0.1 1 0.7 0.6 0.3 0.2 12.8 0.5 0.1 1.9 6.1 0.4 12.4 10.7 0.2 8.6 1.1 3.1 0.7 2.6 20.7 0.4 0.8 0.3 4.2 0 0 0.8 0.4 0.2 9.7 0.8 0.1 3 0.1 0.1 3.1 0.1 0.1 2.2 0.9 0.1 0.2 0.5 5.1 0 0.6 1.2 2.3 0.4 2 ----124.4

Crude Rate 0.1 0.9 0.6 0.5 0.2 0.2 11 0.4 0.1 1.7 5.6 0.3 11.2 9.7 0.2 7.7 1 2.8 0.6 2.4 18.8 0.4 0.7 0.3 3.8 0 0 0.7 0.4 0.2 9 0.7 0.1 2.7 0.1 0.1 2.8 0.1 0.2 2.1 0.8 0.1 0.2 0.4 4.6 0 0.6 1.4 2.2 0.5 1.8 ----113

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

109

7 99 66 71 24 8 611 10 3 82 725 32 1837 1151 35 411 171 400 52 41 1486 49 105 55 446 8 1 104 7333 52 52 1732 853 199 1107 12 5 214 5 9 185 4 16 305 371 14 18 70 569 1 98 133 314 80 273 ----22114

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

All sites Total

All Ages

Site 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.4 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0.2 0 0 0 0 0.1 2 0 0.3 0 0 0.3 0 0 2.3 0.8 0.9 0.2 ----8

0-9

0 0 0.1 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0.2 0 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0 0 1.1 0.1 0.1 0 0.1 0.5 0 0 1.9 0.3 0.4 0.1 ----5

50 0 0.1 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.6 0 0.1 0 0 0.2 0 0 0 0 0 0 0.4 0 0 0.1 0 0 0.1 0 0 0.9 0.4 0 0 0.1 0.9 0 0 0.9 0.9 0.5 0 ----6

10-14 0 0 0.1 0.2 0 0 0.4 0 0 0 0.2 0 0 0 0 0 0 0 0.1 0 0 0 0.4 0.1 0.1 0 0 0.5 0 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0.8 0.9 0 0.1 0.8 1.4 0 0 0.6 0.9 0.5 0.1 ----9

15-19 0 0 0.1 0.2 0 0 1.1 0 0 0 0.3 0 0.5 0.2 0 0.1 0 0.1 0 0 0.1 0.2 0.3 0.2 0.2 0 0 0.5 1 0 0 0.4 0 0.2 1.7 0 0.1 0.2 0 0 0 0 0 0.8 0.9 0 0 0.5 1.1 0 0 0.3 0.7 0.1 0.3 ----12

20-24 0 0.3 0 0.4 0 0 1 0 0 0 0.5 0 0.8 0.5 0 0.2 0.1 0.3 0.1 0 0.6 0 0.1 0.1 0.1 0 0 0.3 4.8 0 0 1.4 0.5 0 2.2 0 0.1 0 0 0 0 0 0 0.4 2.3 0 0 1 1.6 0 0 0.2 2 0.2 0.2 ----22

25-29 0 0.4 0 0.2 0 0 1.8 0 0 0 1.1 0.2 1.5 0.8 0 0.2 0.2 0.4 0.2 0.1 1 0.3 0.6 0.3 0.8 0 0 0.4 17.6 0 0 4 0.8 0.6 3.3 0 0 0.3 0 0 0.2 0 0 1.1 2.6 0 0 0.6 1.6 0 0 0.5 1.2 0.2 0.7 ----45

30-34 0 0.5 0.2 0.4 0.1 0.1 3.7 0 0 0 1.4 0 4.2 1.7 0 1 0.1 0.4 0.4 0.3 2 0.2 0.3 0.5 0.9 0 0 0.7 37.6 0 0 9.8 2.4 0.8 4.6 0 0.2 0.6 0 0 0.4 0 0.1 1.7 2.3 0 0.2 0.3 3.3 0 0.3 0.4 2.7 0.3 0.4 ----87

35-39 0 0.6 0.2 0.9 0.3 0 7.7 0 0 0.1 2.6 0.1 5 2.9 0.2 1.2 0.4 1.2 0.4 0 5.5 0.1 0.6 0.4 1.1 0 0 0.2 73.1 0.2 0.1 11.9 4.7 1.5 8.8 0 0.1 0.6 0 0 0.2 0 0.2 2.2 3.5 0.2 0 0.4 2.8 0 0.5 0.5 1.8 0.3 1.2 ----146

40-44 0.1 0.5 0.2 0.7 0.2 0.1 8.8 0 0 0.5 4.6 0.2 9.1 6.7 0 1.9 0.8 1.6 0.4 0.3 10.1 0.5 0.6 0.2 1.2 0 0.1 1.6 120 0.3 0.5 23.8 9.8 3.2 16.7 0.5 0 1.7 0 0 1.1 0 0.2 2.6 4.1 0 0.2 0.3 3 0 0.4 0.8 3.3 0.3 1.6 ----245

45-49 0.1 1.6 0.5 0.4 0.3 0 10 0.2 0.2 0.2 5.7 0.8 14.9 11.3 0.5 2.8 1.2 4.1 1 0.3 13.8 0.4 0.8 0.4 2.7 0.1 0 0.9 128.6 0.8 0.2 25.9 16 4.6 18.6 0.2 0 2.5 0.1 0.2 1.4 0.2 0.2 3.4 5 0.3 0.4 0.4 6.3 0.1 0.7 0.7 3.9 0.7 2.9 ----300

50-54 0 1.3 0.6 1.2 0.5 0.1 11.3 0 0 1 10.3 0.6 32.6 18.3 0.3 6.1 3.5 6.2 0.6 0.5 22.8 0.6 1.3 0.5 4.4 0 0 1.2 146.7 0.8 1 30.2 22.7 3.2 20.9 0 0 3.4 0 0 2.2 0 0 3.4 5.4 0.1 0.3 0.3 9.8 0 2.2 1 3 0.4 4.5 ----387

55-59 0 2.4 1.7 0.6 0.5 0.2 10 0.2 0.2 1.4 14.7 0.5 38.3 24.4 0.8 8.7 3.2 11.1 0.6 1 34.1 1 2.4 0.8 6.3 0.3 0 1.3 133.4 1 1.1 30.9 20.4 3.6 20.3 0 0 5.2 0.2 0 4.1 0.3 0.5 3.8 4 0 0.5 0.6 7.6 0 3 1 4.3 1 5.4 ----418

60-64 0 1.8 2.3 1.2 0.7 0 9.7 0 0 3.2 22.4 0.5 56.9 39.6 1.2 13.6 5.1 14.5 1.2 1.8 56.5 1.6 2.5 1.6 14.1 0.5 0 2.8 140.1 1.2 1.6 38.9 19.4 2.5 20.3 0.7 0 4.4 0.2 0.9 6 0 0.5 8.5 5.5 0.5 0.7 0.7 15.7 0 2.1 1.4 2.5 1.8 6.2 ----537

65-69 0.3 2.6 2.9 2.3 0.6 0.6 7.6 0.6 0 2.6 26.4 0.3 80.2 55.1 1.8 18.5 10.5 15.2 0.6 1.2 60.3 1.5 2.1 2.1 19.6 0.6 0 2.3 118.6 2.1 3.2 55.1 17.9 5.3 17.3 0.3 0 8.5 0.3 0.3 8.5 0 0.3 5.3 3.8 0.3 0.3 0.9 18.2 0 6.2 0.6 7.6 1.8 9.4 ----610

70-74

APPENDIX 30: CANCER INCIDENCE BY SITES AND AGE GROUP, CHINESE FEMALES, MALAYSIA, 2007-2011

1 3.6 3.6 1 0.7 0.5 6.5 1.2 0 8.1 47.2 2.2 108.8 60.4 2.4 25.6 9.3 20.6 2.4 1.9 73.8 1.9 3.1 1.9 40.5 0.2 0 2.4 97.7 3.8 2.4 36.2 14.4 2.9 15.6 0.2 0 10.5 0.2 0.5 12.9 0 0.5 3.6 5.7 0.2 0 1 15.6 0 3.1 1.2 5.5 2.2 15.8 ----682

75+ 0 0.6 0.4 0.5 0.2 0.1 4 0.1 0 0.5 4.7 0.2 11.9 7.5 0.2 2.7 1.1 2.6 0.3 0.3 9.6 0.3 0.7 0.4 2.9 0.1 0 0.7 47.5 0.3 0.3 11.2 5.5 1.3 7.2 0.1 0 1.4 0 0.1 1.2 0 0.1 2 2.4 0.1 0.1 0.5 3.7 0 0.6 0.9 2 0.5 1.8 ----143.2

Crude Rate 0 0.6 0.4 0.4 0.1 0 3.5 0.1 0 0.5 4.1 0.2 10.4 6.6 0.2 2.3 1 2.3 0.3 0.2 8.5 0.3 0.6 0.3 2.5 0 0 0.6 41.5 0.3 0.3 9.8 4.9 1.1 6.3 0.1 0 1.2 0 0.1 1 0 0.1 1.9 2.1 0.1 0.1 0.4 3.3 0 0.6 1 1.9 0.5 1.5 ----126.2

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

110

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

9 74 107 24 29 26 44 38 8 98 187 9 197 183 9 114 27 70 6 90 270 4 28 8 45 1 1 14 10 16 188 43 1 47 0 1 86 0 4 83 30 2 10 31 156 0 25 67 89 15 55 ----2679

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 2 3 0 1 0 0 0 0 0 10 1 3 0 ----24

0-9

0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 9 0 0 14 1 0 0 ----30

50 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 1 1 1 1 4 0 0 3 7 2 0 ----31

10-14 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 2 0 0 1 0 0 0 3 0 0 0 0 0 0 0 5 0 0 1 6 12 0 0 6 5 3 0 ----50

15-19 0 1 0 0 0 0 1 1 0 0 2 1 1 1 0 1 0 0 0 0 2 0 8 0 0 0 0 2 0 0 0 9 0 1 0 0 0 0 0 2 0 0 0 3 7 0 0 6 3 1 0 ----53

20-24 0 0 2 0 0 0 1 0 0 1 3 0 3 2 0 3 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 10 0 0 0 0 1 0 0 3 3 0 1 5 7 0 0 3 8 1 0 ----60

25-29 0 2 0 0 0 0 3 1 0 0 8 0 5 1 0 1 0 2 0 3 1 1 0 1 1 0 0 0 0 0 1 7 0 0 0 0 0 0 0 3 2 0 0 0 11 0 0 5 7 0 1 ----67

30-34 0 3 0 1 0 0 3 0 0 2 4 1 6 5 1 0 0 1 1 1 4 0 0 1 0 0 0 0 1 1 0 4 0 0 0 0 2 0 0 9 0 0 1 1 5 0 0 3 4 0 0 ----65

35-39 0 0 2 4 0 1 2 0 0 4 7 1 10 8 1 2 2 4 1 2 9 1 4 0 2 0 0 1 1 0 2 3 0 5 0 0 2 0 0 7 3 0 1 2 13 0 1 4 4 0 4 ----120

40-44 0 12 14 2 6 1 2 2 0 7 11 1 27 20 0 12 4 7 0 4 26 0 2 0 3 0 0 3 0 3 4 2 0 5 0 0 5 0 0 10 3 0 3 0 6 0 1 3 11 2 2 ----226

45-49 3 8 13 1 4 4 6 10 2 19 22 0 20 29 1 13 2 14 0 17 37 1 2 1 5 0 0 0 3 3 8 1 0 8 0 1 11 0 0 10 5 0 0 3 25 0 2 3 10 1 9 ----337

50-54 1 13 18 5 4 5 6 3 1 16 28 0 27 27 2 19 5 10 2 15 30 0 2 1 6 0 0 2 2 3 14 1 0 5 0 0 12 0 0 8 5 0 0 5 19 0 1 4 10 0 13 ----350

55-59 2 17 15 5 9 7 8 5 1 11 22 1 28 23 1 17 6 14 0 23 50 0 2 1 1 0 0 1 1 1 30 1 1 6 0 0 9 0 1 5 2 0 1 1 14 0 9 0 7 2 7 ----368

60-64 1 5 10 3 2 3 5 3 2 19 31 1 22 24 1 11 1 4 1 5 40 0 2 0 4 1 0 2 1 3 40 0 0 8 0 0 20 0 0 1 3 0 1 1 10 0 6 1 4 0 6 ----308

65-69 2 5 11 1 1 3 2 9 1 10 22 3 21 18 1 19 3 10 1 10 36 0 0 2 10 0 0 0 0 1 42 1 0 4 0 0 11 0 0 4 2 0 0 2 7 0 1 0 4 0 4 ----284

70-74 0 8 20 1 3 2 4 3 1 9 27 0 27 25 1 14 4 3 0 9 35 0 2 0 10 0 1 1 1 1 47 1 0 3 0 0 13 0 1 2 1 0 0 1 7 0 4 2 3 0 9 ----306

75+ 0.30% 2.80% 4.00% 0.90% 1.10% 1.00% 1.60% 1.40% 0.30% 3.70% 7.00% 0.30% 7.40% 6.80% 0.30% 4.30% 1.00% 2.60% 0.20% 3.40% 10.10% 0.10% 1.00% 0.30% 1.70% 0.00% 0.00% 0.50% 0.40% 0.60% 7.00% 1.60% 0.00% 1.80% 0.00% 0.00% 3.20% 0.00% 0.10% 3.10% 1.10% 0.10% 0.40% 1.20% 5.80% 0.00% 0.90% 2.50% 3.30% 0.60% 2.10% ----100.00%

% of Total

APPENDIX 31: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, INDIAN MALES, MALAYSIA, 2007-2011

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

111

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

15 100 287 18 10 11 25 35 5 145 137 6 182 170 12 58 37 57 10 20 127 10 26 5 59 2 0 16 1705 10 14 327 204 60 277 4 1 27 1 0 24 0 3 78 119 1 8 25 105 1 24 45 72 20 58 ----4798

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 7 1 6 1 ----20

0-9

0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 5 0 0 0 0 0 0 0 9 2 3 0 ----25

50 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 4 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 4 1 0 0 0 5 0 0 4 1 0 0 ----24

10-14 0 0 0 0 0 0 1 0 0 0 2 0 1 0 0 0 0 0 0 0 0 0 3 0 1 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 2 2 0 0 2 3 0 0 1 2 2 1 ----28

15-19 0 0 0 0 0 0 1 0 0 0 2 0 2 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 0 0 3 0 0 9 0 0 0 0 0 0 0 0 2 9 0 0 4 3 0 0 0 0 0 1 ----42

20-24 0 1 0 2 0 0 0 2 0 0 4 0 3 0 1 0 0 1 0 0 0 0 1 0 0 0 0 1 20 0 0 4 1 0 4 0 0 1 0 0 0 0 0 7 9 0 0 8 2 0 0 6 4 0 1 ----83

25-29 0 1 0 0 0 0 0 0 0 0 3 1 5 5 0 2 0 1 0 1 2 1 1 0 1 0 0 1 57 0 0 6 3 1 4 0 0 2 0 0 0 0 0 4 8 0 0 1 3 0 0 3 6 1 3 ----127

30-34 1 1 3 1 0 0 0 0 0 3 6 0 3 8 0 1 1 2 2 0 2 1 0 0 2 0 0 1 87 1 2 15 12 0 11 1 0 0 0 0 0 0 0 3 15 0 0 2 5 0 0 4 6 2 2 ----206

35-39 0 7 7 3 1 0 2 1 0 9 8 0 12 11 0 4 2 1 0 1 8 2 2 0 4 0 0 1 192 0 0 21 14 7 29 0 0 1 1 0 1 0 0 7 9 0 1 2 4 0 0 0 4 2 6 ----387

40-44 1 6 10 3 1 0 1 6 1 8 13 2 12 9 1 3 1 4 0 1 11 0 1 1 2 0 0 2 264 1 2 40 22 5 49 1 0 5 0 0 1 0 0 6 14 1 1 0 7 0 3 1 7 1 1 ----532

45-49 2 16 31 4 2 0 5 3 0 21 19 2 18 26 0 4 2 13 0 3 18 0 2 0 5 0 0 0 314 1 2 58 32 4 52 1 0 6 0 0 3 0 0 13 17 0 4 2 12 0 2 4 13 2 5 ----743

50-54 1 9 37 1 2 2 6 7 2 21 19 0 25 25 4 7 9 10 2 5 21 4 2 1 9 1 0 0 281 3 4 45 33 11 33 0 1 3 0 0 2 0 2 8 10 0 1 1 14 0 5 4 10 0 8 ----711

55-59 0 22 46 3 2 1 2 5 1 26 15 0 31 24 2 8 5 8 0 2 16 0 0 1 6 0 0 2 176 1 0 44 38 14 33 1 0 3 0 0 3 0 0 7 10 0 1 3 16 0 6 1 8 0 6 ----599

60-64 0 6 41 0 2 4 2 5 1 17 14 1 16 13 1 9 6 4 1 0 17 0 4 1 7 0 0 3 115 1 2 30 21 4 25 0 0 2 0 0 1 0 0 4 8 0 0 0 15 0 5 1 1 0 10 ----420

65-69 2 22 55 0 0 2 3 5 0 20 14 0 30 25 1 8 5 6 3 5 16 1 3 0 7 1 0 2 102 1 0 31 16 7 7 0 0 0 0 0 6 0 0 1 6 0 0 0 9 0 0 0 5 0 9 ----436

70-74 8 9 57 0 0 2 1 1 0 20 18 0 23 22 2 12 6 7 0 2 16 1 2 1 15 0 0 2 93 1 2 30 12 7 14 0 0 2 0 0 7 0 1 1 1 0 0 0 6 1 3 0 2 1 4 ----415

75+ 0.30% 2.10% 6.00% 0.40% 0.20% 0.20% 0.50% 0.70% 0.10% 3.00% 2.90% 0.10% 3.80% 3.50% 0.30% 1.20% 0.80% 1.20% 0.20% 0.40% 2.60% 0.20% 0.50% 0.10% 1.20% 0.00% 0.00% 0.30% 35.50% 0.20% 0.30% 6.80% 4.30% 1.30% 5.80% 0.10% 0.00% 0.60% 0.00% 0.00% 0.50% 0.00% 0.10% 1.60% 2.50% 0.00% 0.20% 0.50% 2.20% 0.00% 0.50% 0.90% 1.50% 0.40% 1.20% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 32: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, INDIAN FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

112

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

9 74 107 24 29 26 44 38 8 98 187 9 197 183 9 114 27 70 6 90 270 4 28 8 45 1 1 14 10 16 188 43 1 47 0 1 86 0 4 83 30 2 10 31 156 0 25 67 89 15 55 ----2679

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0.5 0.8 0 0.3 0 0 0 0 0 2.6 0.3 0.8 0 ----6

0-9

0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 2.1 0 0 3.2 0.2 0 0 ----7

50 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.2 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 1.3 0.2 0.2 0.2 0.2 0.9 0 0 0.7 1.6 0.4 0 ----7

10-14 0 0 0.4 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0.4 0 0 0.2 0 0 0 0.7 0 0 0 0 0 0 0 1.1 0 0 0.2 1.3 2.6 0 0 1.3 1.1 0.7 0 ----11

15-19 0 0.2 0 0 0 0 0.2 0.2 0 0 0.4 0.2 0.2 0.2 0 0.2 0 0 0 0 0.4 0 1.7 0 0 0 0 0.4 0 0 0 1.9 0 0.2 0 0 0 0 0 0.4 0 0 0 0.6 1.5 0 0 1.3 0.6 0.2 0 ----11

20-24 0 0 0.5 0 0 0 0.2 0 0 0.2 0.7 0 0.7 0.5 0 0.7 0 0.2 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 2.3 0 0 0 0 0.2 0 0 0.7 0.7 0 0.2 1.1 1.6 0 0 0.7 1.8 0.2 0 ----14

25-29 0 0.5 0 0 0 0 0.8 0.3 0 0 2.2 0 1.3 0.3 0 0.3 0 0.5 0 0.8 0.3 0.3 0 0.3 0.3 0 0 0 0 0 0.3 1.9 0 0 0 0 0 0 0 0.8 0.5 0 0 0 3 0 0 1.3 1.9 0 0.3 ----18

30-34 0 0.9 0 0.3 0 0 0.9 0 0 0.6 1.2 0.3 1.8 1.5 0.3 0 0 0.3 0.3 0.3 1.2 0 0 0.3 0 0 0 0 0.3 0.3 0 1.2 0 0 0 0 0.6 0 0 2.7 0 0 0.3 0.3 1.5 0 0 0.9 1.2 0 0 ----19

35-39 0 0 0.6 1.3 0 0.3 0.6 0 0 1.3 2.2 0.3 3.1 2.5 0.3 0.6 0.6 1.3 0.3 0.6 2.8 0.3 1.3 0 0.6 0 0 0.3 0.3 0 0.6 0.9 0 1.6 0 0 0.6 0 0 2.2 0.9 0 0.3 0.6 4.1 0 0.3 1.3 1.3 0 1.3 ----38

40-44 0 3.8 4.4 0.6 1.9 0.3 0.6 0.6 0 2.2 3.5 0.3 8.5 6.3 0 3.8 1.3 2.2 0 1.3 8.2 0 0.6 0 0.9 0 0 0.9 0 0.9 1.3 0.6 0 1.6 0 0 1.6 0 0 3.2 0.9 0 0.9 0 1.9 0 0.3 0.9 3.5 0.6 0.6 ----71

45-49 1.1 3 4.9 0.4 1.5 1.5 2.3 3.8 0.8 7.1 8.3 0 7.5 10.9 0.4 4.9 0.8 5.3 0 6.4 13.9 0.4 0.8 0.4 1.9 0 0 0 1.1 1.1 3 0.4 0 3 0 0.4 4.1 0 0 3.8 1.9 0 0 1.1 9.4 0 0.8 1.1 3.8 0.4 3.4 ----127

50-54 0.5 6.5 9 2.5 2 2.5 3 1.5 0.5 8 14.1 0 13.6 13.6 1 9.5 2.5 5 1 7.5 15.1 0 1 0.5 3 0 0 1 1 1.5 7 0.5 0 2.5 0 0 6 0 0 4 2.5 0 0 2.5 9.5 0 0.5 2 5 0 6.5 ----176

55-59 1.5 12.4 10.9 3.6 6.5 5.1 5.8 3.6 0.7 8 16 0.7 20.4 16.7 0.7 12.4 4.4 10.2 0 16.7 36.4 0 1.5 0.7 0.7 0 0 0.7 0.7 0.7 21.8 0.7 0.7 4.4 0 0 6.5 0 0.7 3.6 1.5 0 0.7 0.7 10.2 0 6.5 0 5.1 1.5 5.1 ----268

60-64 1.3 6.7 13.4 4 2.7 4 6.7 4 2.7 25.5 41.6 1.3 29.5 32.2 1.3 14.8 1.3 5.4 1.3 6.7 53.7 0 2.7 0 5.4 1.3 0 2.7 1.3 4 53.7 0 0 10.7 0 0 26.8 0 0 1.3 4 0 1.3 1.3 13.4 0 8.1 1.3 5.4 0 8.1 ----413

65-69 3.5 8.9 19.5 1.8 1.8 5.3 3.5 15.9 1.8 17.7 38.9 5.3 37.2 31.9 1.8 33.6 5.3 17.7 1.8 17.7 63.7 0 0 3.5 17.7 0 0 0 0 1.8 74.3 1.8 0 7.1 0 0 19.5 0 0 7.1 3.5 0 0 3.5 12.4 0 1.8 0 7.1 0 7.1 ----503

70-74

APPENDIX 33: CANCER INCIDENCE BY SITES AND AGE GROUP, INDIAN MALES, MALAYSIA, 2007-2011

0 13.1 32.8 1.6 4.9 3.3 6.6 4.9 1.6 14.8 44.3 0 44.3 41 1.6 23 6.6 4.9 0 14.8 57.4 0 3.3 0 16.4 0 1.6 1.6 1.6 1.6 77.1 1.6 0 4.9 0 0 21.3 0 1.6 3.3 1.6 0 0 1.6 11.5 0 6.6 3.3 4.9 0 14.8 ----502

75+ 0.2 1.5 2.2 0.5 0.6 0.5 0.9 0.8 0.2 2 3.9 0.2 4.1 3.8 0.2 2.4 0.6 1.5 0.1 1.9 5.6 0.1 0.6 0.2 0.9 0 0 0.3 0.2 0.3 3.9 0.9 0 1 0 0 1.8 0 0.1 1.7 0.6 0 0.2 0.6 3.3 0 0.5 1.4 1.9 0.3 1.2 ----56

Crude Rate 0.2 1.9 2.9 0.6 0.7 0.7 1.1 1 0.2 2.7 5.2 0.2 5.2 4.9 0.2 3.1 0.7 1.8 0.2 2.3 7.6 0.1 0.6 0.2 1.3 0 0 0.3 0.2 0.4 6.1 0.8 0 1.3 0 0 2.5 0 0.1 1.8 0.7 0.1 0.2 0.7 3.5 0 0.8 1.5 2 0.3 1.4 ----70.4

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

113

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

15 100 287 18 10 11 25 35 5 145 137 6 182 170 12 58 37 57 10 20 127 10 26 5 59 2 0 16 1705 10 14 327 204 60 277 4 1 27 1 0 24 0 3 78 119 1 8 25 105 1 24 45 72 20 58 ----4798

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0.3 0 0 1.9 0.3 1.6 0.3 ----5

0-9

0 0 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 1.2 0 0 0 0 0 0 0 2.1 0.5 0.7 0 ----6

50 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 0.9 0 0 0 0 0 0.2 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0.9 0.2 0 0 0 1.1 0 0 0.9 0.2 0 0 ----5

10-14 0 0 0 0 0 0 0.2 0 0 0 0.5 0 0.2 0 0 0 0 0 0 0 0 0 0.7 0 0.2 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0.5 0.5 0 0 0.5 0.7 0 0 0.2 0.5 0.5 0.2 ----6

15-19 0 0 0 0 0 0 0.2 0 0 0 0.4 0 0.4 0.4 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.7 0 0 0.7 0 0 2 0 0 0 0 0 0 0 0 0.4 2 0 0 0.9 0.7 0 0 0 0 0 0.2 ----9

20-24 0 0.2 0 0.5 0 0 0 0.5 0 0 0.9 0 0.7 0 0.2 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0.2 4.7 0 0 0.9 0.2 0 0.9 0 0 0.2 0 0 0 0 0 1.6 2.1 0 0 1.9 0.5 0 0 1.4 0.9 0 0.2 ----20

25-29 0 0.3 0 0 0 0 0 0 0 0 0.8 0.3 1.4 1.4 0 0.6 0 0.3 0 0.3 0.6 0.3 0.3 0 0.3 0 0 0.3 16 0 0 1.7 0.8 0.3 1.1 0 0 0.6 0 0 0 0 0 1.1 2.3 0 0 0.3 0.8 0 0 0.8 1.7 0.3 0.8 ----36

30-34 0.3 0.3 0.9 0.3 0 0 0 0 0 0.9 1.8 0 0.9 2.4 0 0.3 0.3 0.6 0.6 0 0.6 0.3 0 0 0.6 0 0 0.3 25.9 0.3 0.6 4.5 3.6 0 3.3 0.3 0 0 0 0 0 0 0 0.9 4.5 0 0 0.6 1.5 0 0 1.2 1.8 0.6 0.6 ----61

35-39 0 2.1 2.1 0.9 0.3 0 0.6 0.3 0 2.7 2.4 0 3.6 3.3 0 1.2 0.6 0.3 0 0.3 2.4 0.6 0.6 0 1.2 0 0 0.3 57.7 0 0 6.3 4.2 2.1 8.7 0 0 0.3 0.3 0 0.3 0 0 2.1 2.7 0 0.3 0.6 1.2 0 0 0 1.2 0.6 1.8 ----116

40-44 0.3 1.9 3.2 1 0.3 0 0.3 1.9 0.3 2.6 4.2 0.6 3.9 2.9 0.3 1 0.3 1.3 0 0.3 3.5 0 0.3 0.3 0.6 0 0 0.6 85 0.3 0.6 12.9 7.1 1.6 15.8 0.3 0 1.6 0 0 0.3 0 0 1.9 4.5 0.3 0.3 0 2.3 0 1 0.3 2.3 0.3 0.3 ----171

45-49 0.7 5.9 11.4 1.5 0.7 0 1.8 1.1 0 7.8 7 0.7 6.6 9.6 0 1.5 0.7 4.8 0 1.1 6.6 0 0.7 0 1.8 0 0 0 115.9 0.4 0.7 21.4 11.8 1.5 19.2 0.4 0 2.2 0 0 1.1 0 0 4.8 6.3 0 1.5 0.7 4.4 0 0.7 1.5 4.8 0.7 1.8 ----274

50-54 0.5 4.4 18.1 0.5 1 1 2.9 3.4 1 10.3 9.3 0 12.2 12.2 2 3.4 4.4 4.9 1 2.4 10.3 2 1 0.5 4.4 0.5 0 0 137.4 1.5 2 22 16.1 5.4 16.1 0 0.5 1.5 0 0 1 0 1 3.9 4.9 0 0.5 0.5 6.8 0 2.4 2 4.9 0 3.9 ----348

55-59 0 14.9 31.1 2 1.4 0.7 1.4 3.4 0.7 17.6 10.1 0 20.9 16.2 1.4 5.4 3.4 5.4 0 1.4 10.8 0 0 0.7 4.1 0 0 1.4 118.9 0.7 0 29.7 25.7 9.5 22.3 0.7 0 2 0 0 2 0 0 4.7 6.8 0 0.7 2 10.8 0 4.1 0.7 5.4 0 4.1 ----405

60-64 0 7.2 49.4 0 2.4 4.8 2.4 6 1.2 20.5 16.9 1.2 19.3 15.7 1.2 10.8 7.2 4.8 1.2 0 20.5 0 4.8 1.2 8.4 0 0 3.6 138.6 1.2 2.4 36.1 25.3 4.8 30.1 0 0 2.4 0 0 1.2 0 0 4.8 9.6 0 0 0 18.1 0 6 1.2 1.2 0 12 ----506

65-69 2.9 32.1 80.3 0 0 2.9 4.4 7.3 0 29.2 20.4 0 43.8 36.5 1.5 11.7 7.3 8.8 4.4 7.3 23.4 1.5 4.4 0 10.2 1.5 0 2.9 148.9 1.5 0 45.3 23.4 10.2 10.2 0 0 0 0 0 8.8 0 0 1.5 8.8 0 0 0 13.1 0 0 0 7.3 0 13.1 ----637

70-74

APPENDIX 34: CANCER INCIDENCE BY SITES AND AGE GROUP, INDIAN FEMALES, MALAYSIA, 2007-2011

10.3 11.6 73.6 0 0 2.6 1.3 1.3 0 25.8 23.2 0 29.7 28.4 2.6 15.5 7.7 9 0 2.6 20.6 1.3 2.6 1.3 19.4 0 0 2.6 120 1.3 2.6 38.7 15.5 9 18.1 0 0 2.6 0 0 9 0 1.3 1.3 1.3 0 0 0 7.7 1.3 3.9 0 2.6 1.3 5.2 ----536

75+ 0.3 2.1 6.1 0.4 0.2 0.2 0.5 0.7 0.1 3.1 2.9 0.1 3.8 3.6 0.3 1.2 0.8 1.2 0.2 0.4 2.7 0.2 0.5 0.1 1.2 0 0 0.3 36 0.2 0.3 6.9 4.3 1.3 5.8 0.1 0 0.6 0 0 0.5 0 0.1 1.6 2.5 0 0.2 0.5 2.2 0 0.5 0.9 1.5 0.4 1.2 ----101.2

Crude Rate 0.4 2.5 7.5 0.4 0.2 0.3 0.6 0.9 0.1 3.6 3.2 0.1 4.4 4 0.3 1.5 0.9 1.3 0.2 0.5 3.1 0.2 0.6 0.1 1.5 0 0 0.4 37.1 0.2 0.3 7.6 4.8 1.4 6.1 0.1 0 0.6 0 0 0.6 0 0.1 1.7 2.5 0 0.2 0.5 2.5 0 0.6 1 1.5 0.5 1.4 ----110.1

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

114

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

3 51 44 29 10 3 678 25 4 76 397 13 305 248 7 329 44 76 20 52 661 29 55 44 148 3 6 54 13 34 192 54 1 40 0 0 100 0 16 113 65 11 7 44 393 0 49 127 152 23 86 ----4934

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 13 0 4 0 0 0 0 9 10 0 4 3 1 10 0 0 40 10 3 3 ----117

0-9

0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 11 0 1 0 4 18 0 0 28 8 1 2 ----79

50 0 0 0 0 0 8 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 12 0 0 0 0 3 0 0 0 1 0 0 0 0 0 0 1 8 3 0 3 1 8 0 0 11 8 1 1 ----72

10-14 0 1 0 2 0 0 19 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 10 1 0 0 0 4 0 0 1 4 0 0 0 0 0 0 0 8 1 0 1 3 21 0 0 9 10 2 0 ----100

15-19 0 1 0 0 0 0 20 0 0 0 1 0 3 4 0 0 1 1 0 0 2 1 10 0 1 0 1 3 0 0 0 8 0 0 0 0 0 0 0 4 0 0 0 4 9 0 0 3 18 2 2 ----99

20-24 0 2 3 3 0 0 22 0 0 0 3 0 15 3 0 4 1 0 1 0 6 0 2 1 0 0 0 2 0 0 0 7 0 0 0 0 0 0 0 7 1 1 0 3 16 0 0 5 7 2 1 ----118

25-29 0 1 1 3 0 0 30 0 0 2 3 1 13 5 1 8 0 2 1 0 7 0 3 1 5 0 0 3 0 3 0 7 0 0 0 0 0 0 1 4 0 0 0 4 19 0 2 2 8 0 1 ----141

30-34 0 3 3 2 0 0 59 0 0 0 16 0 10 13 0 14 2 1 2 1 22 6 0 2 7 0 0 6 1 2 0 5 0 1 0 0 3 0 0 5 4 1 0 1 16 0 0 5 14 4 2 ----233

35-39 2 4 1 3 0 0 82 1 0 3 21 3 27 19 0 19 1 0 2 1 26 2 4 2 4 0 1 4 1 8 0 2 0 2 0 0 4 0 0 14 7 1 0 3 23 0 2 1 8 0 5 ----313

40-44 0 4 2 4 2 0 111 1 1 6 30 1 28 22 1 19 4 9 3 1 57 2 3 2 10 1 0 1 3 6 1 1 1 5 0 0 8 0 3 9 4 0 0 3 29 0 5 1 9 0 5 ----418

45-49 0 4 3 4 2 0 92 0 0 6 39 3 34 21 1 41 3 6 2 5 76 4 1 7 13 1 1 7 1 3 10 2 0 9 0 0 12 0 2 9 9 0 0 2 45 0 9 6 9 3 9 ----516

50-54 0 4 5 3 1 0 82 1 1 12 45 1 33 26 0 56 8 12 0 7 81 1 2 5 16 0 1 4 3 3 19 1 0 5 0 0 14 0 0 7 8 0 0 4 35 0 10 5 13 3 14 ----551

55-59 0 2 7 2 2 1 57 3 1 11 58 2 33 29 0 62 5 7 2 12 115 3 2 7 15 0 0 4 1 3 33 0 0 6 0 0 9 0 0 4 9 2 0 4 49 0 5 2 10 0 11 ----590

60-64 0 12 5 1 3 0 46 7 0 10 62 2 38 36 1 44 8 13 5 11 122 6 3 6 22 1 1 7 2 3 34 0 0 1 0 0 16 0 0 7 10 0 0 2 35 0 8 2 7 0 10 ----609

65-69 0 7 6 1 0 1 26 6 0 12 53 0 28 26 2 33 8 10 0 9 66 2 1 4 24 0 0 0 1 2 40 3 0 4 0 0 20 0 0 5 5 1 0 1 33 0 3 4 8 1 10 ----466

70-74 1 6 8 1 0 1 22 5 1 14 66 0 42 43 1 26 3 15 0 5 80 2 0 6 31 0 1 2 0 0 54 0 0 3 0 0 13 0 0 1 4 0 0 4 27 0 5 3 5 1 10 ----512

75+ 0.10% 1.00% 0.90% 0.60% 0.20% 0.10% 13.70% 0.50% 0.10% 1.50% 8.00% 0.30% 6.20% 5.00% 0.10% 6.70% 0.90% 1.50% 0.40% 1.10% 13.40% 0.60% 1.10% 0.90% 3.00% 0.10% 0.10% 1.10% 0.30% 0.70% 3.90% 1.10% 0.00% 0.80% 0.00% 0.00% 2.00% 0.00% 0.30% 2.30% 1.30% 0.20% 0.10% 0.90% 8.00% 0.00% 1.00% 2.60% 3.10% 0.50% 1.70% ----100.00%

% of Total

APPENDIX 35: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, OTHERS MALES, MALAYSIA, 2007-2011

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

115

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

16 39 60 36 10 3 268 13 2 53 273 14 230 186 13 128 46 58 12 14 393 24 44 26 177 3 0 51 943 15 20 791 160 57 334 5 17 26 0 0 40 4 17 111 210 9 1 20 272 0 48 87 137 17 80 ----5613

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 1 0 0 0 6 0 0 0 0 0 0 4 0 0 2 0 0 0 0 13 5 0 3 0 0 2 0 0 33 11 1 3 ----87

0-9

0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 9 1 0 0 0 6 0 0 18 8 1 1 ----51

50 1 0 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 3 0 0 0 0 0 0 8 0 0 1 0 0 0 0 0 10 2 0 0 0 10 0 0 11 3 1 1 ----63

10-14 0 1 0 0 0 0 6 0 0 0 2 0 1 0 0 0 0 0 0 0 1 0 10 0 1 0 0 4 0 0 0 0 0 0 11 0 1 2 0 0 0 0 2 6 7 0 0 3 12 0 0 5 7 2 3 ----87

15-19 0 0 1 4 0 0 14 1 0 0 3 2 5 2 1 1 0 1 0 0 2 1 5 0 2 0 0 0 9 0 0 3 0 2 22 0 3 2 0 0 1 0 0 6 9 0 0 6 10 0 0 0 13 1 4 ----136

20-24 0 3 2 2 0 0 11 0 0 0 4 0 8 8 0 1 0 1 0 0 7 0 2 1 3 0 0 3 24 0 1 19 4 2 15 1 4 2 0 0 0 0 0 5 12 0 0 4 9 0 0 2 4 0 2 ----166

25-29 0 1 1 3 0 0 18 0 0 0 6 0 9 3 0 6 2 1 0 0 5 1 2 0 2 0 0 3 42 1 0 40 9 1 18 0 2 2 0 0 3 0 1 6 18 1 0 1 12 0 0 0 7 1 1 ----229

30-34 0 1 3 3 0 0 29 0 0 1 9 2 9 8 0 7 0 0 0 0 10 1 2 1 3 0 0 4 94 1 2 103 14 3 22 1 5 2 0 0 0 0 0 4 17 2 0 1 12 0 4 2 9 0 6 ----397

35-39 1 5 4 3 0 0 31 0 1 3 11 0 12 11 1 5 1 7 3 0 15 2 3 3 5 0 0 2 169 0 3 134 20 14 39 1 1 0 0 0 1 0 0 9 22 0 0 0 18 0 3 2 16 1 5 ----587

40-44 0 2 1 3 1 1 41 1 0 3 20 0 29 20 1 11 2 7 0 2 32 1 3 0 14 0 0 7 202 3 2 142 26 13 52 0 1 4 0 0 4 0 1 11 26 1 0 1 26 0 4 2 7 1 11 ----742

45-49 2 7 3 3 1 0 41 1 0 4 33 1 33 21 4 10 3 6 2 1 37 4 1 3 15 0 0 2 148 0 0 124 30 6 48 2 0 1 0 0 6 1 0 13 24 0 0 0 37 0 8 3 13 2 9 ----713

50-54 2 3 7 3 3 0 16 2 1 11 37 2 30 32 3 18 3 10 2 1 52 4 1 3 16 1 0 4 105 2 6 76 25 7 28 0 0 3 0 0 4 0 0 8 23 0 1 0 31 0 5 0 17 2 10 ----620

55-59 3 2 4 4 1 2 20 2 0 9 31 2 24 19 0 20 6 7 0 3 65 1 3 3 12 1 0 2 64 2 1 53 15 3 23 0 0 2 0 0 5 1 0 5 11 1 0 1 32 0 13 0 9 0 8 ----495

60-64 3 3 14 3 1 0 19 1 0 6 41 2 25 23 1 13 14 5 0 3 76 2 1 4 29 0 0 3 40 2 1 44 5 1 19 0 0 2 0 0 9 0 0 5 21 0 0 1 22 0 6 4 5 2 6 ----487

65-69 3 7 11 2 1 0 13 5 0 8 36 2 21 15 1 19 5 7 3 0 56 4 0 3 29 1 0 3 28 1 2 29 5 4 9 0 0 1 0 0 3 0 0 6 9 1 0 1 14 0 3 1 3 1 5 ----381

70-74 2 3 9 0 2 0 6 0 0 8 40 1 24 24 1 14 10 6 2 4 35 3 2 4 46 0 0 3 18 3 2 24 7 1 14 0 0 0 0 0 4 2 0 3 8 0 0 1 19 0 2 4 5 1 5 ----372

75+ 0.30% 0.70% 1.10% 0.60% 0.20% 0.10% 4.80% 0.20% 0.00% 0.90% 4.90% 0.20% 4.10% 3.30% 0.20% 2.30% 0.80% 1.00% 0.20% 0.20% 7.00% 0.40% 0.80% 0.50% 3.20% 0.10% 0.00% 0.90% 16.80% 0.30% 0.40% 14.10% 2.90% 1.00% 6.00% 0.10% 0.30% 0.50% 0.00% 0.00% 0.70% 0.10% 0.30% 2.00% 3.70% 0.20% 0.00% 0.40% 4.80% 0.00% 0.90% 1.50% 2.40% 0.30% 1.40% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 36: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, OTHERS FEMALES, MALAYSIA, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

116

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

3 51 44 29 10 3 678 25 4 76 397 13 305 248 7 329 44 76 20 52 661 29 55 44 148 3 6 54 13 34 192 54 1 40 0 0 100 0 16 113 65 11 7 44 393 0 49 127 152 23 86 ----4934

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 1.2 0 0.4 0 0 0 0 0.8 0.9 0 0.4 0.3 0.1 0.9 0 0 3.8 0.9 0.3 0.3 ----11

0-9

0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0 1 0 0.1 0 0.4 1.7 0 0 2.7 0.8 0.1 0.2 ----8

50 0 0 0 0 0 0.8 0 0 0 0 0 0.1 0 0 0.1 0 0 0.1 0 0 0 1.2 0 0 0 0 0.3 0 0 0 0.1 0 0 0 0 0 0 0.1 0.8 0.3 0 0.3 0.1 0.8 0 0 1.1 0.8 0.1 0.1 ----7

10-14 0 0.1 0 0.2 0 0 1.9 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0.1 0 1 0.1 0 0 0 0.4 0 0 0.1 0.4 0 0 0 0 0 0 0 0.8 0.1 0 0.1 0.3 2.1 0 0 0.9 1 0.2 0 ----10

15-19 0 0.1 0 0 0 0 2.3 0 0 0 0.1 0 0.3 0.5 0 0 0.1 0.1 0 0 0.2 0.1 1.2 0 0.1 0 0.1 0.3 0 0 0 0.9 0 0 0 0 0 0 0 0.5 0 0 0 0.5 1 0 0 0.3 2.1 0.2 0.2 ----12

20-24 0 0.3 0.4 0.4 0 0 2.9 0 0 0 0.4 0 2 0.4 0 0.5 0.1 0 0.1 0 0.8 0 0.3 0.1 0 0 0 0.3 0 0 0 0.9 0 0 0 0 0 0 0 0.9 0.1 0.1 0 0.4 2.1 0 0 0.7 0.9 0.3 0.1 ----15

25-29 0 0.2 0.2 0.5 0 0 5.2 0 0 0.3 0.5 0.2 2.2 0.9 0.2 1.4 0 0.3 0.2 0 1.2 0 0.5 0.2 0.9 0 0 0.5 0 0.5 0 1.2 0 0 0 0 0 0 0.2 0.7 0 0 0 0.7 3.3 0 0.3 0.3 1.4 0 0.2 ----24

30-34 0 0.5 0.5 0.4 0 0 10.8 0 0 0 2.9 0 1.8 2.4 0 2.6 0.4 0.2 0.4 0.2 4 1.1 0 0.4 1.3 0 0 1.1 0.2 0.4 0 0.9 0 0.2 0 0 0.5 0 0 0.9 0.7 0.2 0 0.2 2.9 0 0 0.9 2.6 0.7 0.4 ----43

35-39 0.4 0.8 0.2 0.6 0 0 16.1 0.2 0 0.6 4.1 0.6 5.3 3.7 0 3.7 0.2 0 0.4 0.2 5.1 0.4 0.8 0.4 0.8 0 0.2 0.8 0.2 1.6 0 0.4 0 0.4 0 0 0.8 0 0 2.8 1.4 0.2 0 0.6 4.5 0 0.4 0.2 1.6 0 1 ----62

40-44 0 0.9 0.4 0.9 0.4 0 24.4 0.2 0.2 1.3 6.6 0.2 6.2 4.8 0.2 4.2 0.9 2 0.7 0.2 12.5 0.4 0.7 0.4 2.2 0.2 0 0.2 0.7 1.3 0.2 0.2 0.2 1.1 0 0 1.8 0 0.7 2 0.9 0 0 0.7 6.4 0 1.1 0.2 2 0 1.1 ----92

45-49 0 1.1 0.8 1.1 0.5 0 25.2 0 0 1.6 10.7 0.8 9.3 5.8 0.3 11.2 0.8 1.6 0.5 1.4 20.8 1.1 0.3 1.9 3.6 0.3 0.3 1.9 0.3 0.8 2.7 0.5 0 2.5 0 0 3.3 0 0.5 2.5 2.5 0 0 0.5 12.3 0 2.5 1.6 2.5 0.8 2.5 ----141

50-54 0 1.6 2 1.2 0.4 0 32.4 0.4 0.4 4.7 17.8 0.4 13 10.3 0 22.1 3.2 4.7 0 2.8 32 0.4 0.8 2 6.3 0 0.4 1.6 1.2 1.2 7.5 0.4 0 2 0 0 5.5 0 0 2.8 3.2 0 0 1.6 13.8 0 3.9 2 5.1 1.2 5.5 ----217

55-59 0 1.1 3.9 1.1 1.1 0.6 31.9 1.7 0.6 6.2 32.5 1.1 18.5 16.2 0 34.7 2.8 3.9 1.1 6.7 64.4 1.7 1.1 3.9 8.4 0 0 2.2 0.6 1.7 18.5 0 0 3.4 0 0 5 0 0 2.2 5 1.1 0 2.2 27.5 0 2.8 1.1 5.6 0 6.2 ----331

60-64 0 8.8 3.7 0.7 2.2 0 33.7 5.1 0 7.3 45.4 1.5 27.8 26.4 0.7 32.2 5.9 9.5 3.7 8.1 89.4 4.4 2.2 4.4 16.1 0.7 0.7 5.1 1.5 2.2 24.9 0 0 0.7 0 0 11.7 0 0 5.1 7.3 0 0 1.5 25.6 0 5.9 1.5 5.1 0 7.3 ----446

65-69 0 7.7 6.6 1.1 0 1.1 28.7 6.6 0 13.3 58.6 0 30.9 28.7 2.2 36.5 8.8 11.1 0 9.9 72.9 2.2 1.1 4.4 26.5 0 0 0 1.1 2.2 44.2 3.3 0 4.4 0 0 22.1 0 0 5.5 5.5 1.1 0 1.1 36.5 0 3.3 4.4 8.8 1.1 11.1 ----515

70-74

APPENDIX 37: CANCER INCIDENCE BY SITES AND AGE GROUP, OTHERS MALES, MALAYSIA, 2007-2011

0.9 5.2 6.9 0.9 0 0.9 19 4.3 0.9 12.1 56.9 0 36.2 37.1 0.9 22.4 2.6 12.9 0 4.3 69 1.7 0 5.2 26.7 0 0.9 1.7 0 0 46.6 0 0 2.6 0 0 11.2 0 0 0.9 3.4 0 0 3.4 23.3 0 4.3 2.6 4.3 0.9 8.6 ----441

75+ 0 0.6 0.5 0.3 0.1 0 7.6 0.3 0 0.8 4.4 0.1 3.4 2.8 0.1 3.7 0.5 0.8 0.2 0.6 7.4 0.3 0.6 0.5 1.6 0 0.1 0.6 0.1 0.4 2.1 0.6 0 0.4 0 0 1.1 0 0.2 1.3 0.7 0.1 0.1 0.5 4.4 0 0.5 1.4 1.7 0.3 1 ----55

Crude Rate 0 0.9 0.8 0.4 0.2 0.1 9.9 0.5 0.1 1.4 7.1 0.2 5 4.2 0.1 5.8 0.8 1.4 0.3 1 11.9 0.5 0.6 0.8 2.6 0 0.1 0.7 0.2 0.5 3.8 0.6 0 0.6 0 0 1.8 0 0.2 1.5 1.1 0.2 0.1 0.6 6.1 0 0.8 1.5 2 0.3 1.5 ----80.5

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

117

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

16 39 60 36 10 3 268 13 2 53 273 14 230 186 13 128 46 58 12 14 393 24 44 26 177 3 0 51 943 15 20 791 160 57 334 5 17 26 0 0 40 4 17 111 210 9 1 20 272 0 48 87 137 17 80 ----5613

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.1 0 0 0 0.6 0 0 0 0 0 0 0.4 0 0 0.2 0 0 0 0 1.3 0.5 0 0.3 0 0 0.2 0 0 3.3 1.1 0.1 0.3 ----9

0-9

0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.9 0.1 0 0 0 0.6 0 0 1.8 0.8 0.1 0.1 ----5

50 0.1 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.3 0 0 0 0 0 0 0.8 0 0 0.1 0 0 0 0 0 1 0.2 0 0 0 1 0 0 1.1 0.3 0.1 0.1 ----6

10-14 0 0.1 0 0 0 0 0.6 0 0 0 0.2 0 0.1 0 0 0 0 0 0 0 0.1 0 1 0 0.1 0 0 0.4 0 0 0 0 0 0 1.1 0 0.1 0.2 0 0 0 0 0.2 0.6 0.7 0 0 0.3 1.2 0 0 0.5 0.7 0.2 0.3 ----9

15-19 0 0 0.1 0.5 0 0 1.6 0.1 0 0 0.3 0.2 0.6 0.2 0.1 0.1 0 0.1 0 0 0.2 0.1 0.6 0 0.2 0 0 0 1 0 0 0.3 0 0.2 2.5 0 0.3 0.2 0 0 0.1 0 0 0.7 1 0 0 0.7 1.1 0 0 0 1.5 0.1 0.5 ----15

20-24 0 0.4 0.3 0.3 0 0 1.5 0 0 0 0.5 0 1.1 1.1 0 0.1 0 0.1 0 0 0.9 0 0.3 0.1 0.4 0 0 0.4 3.2 0 0.1 2.5 0.5 0.3 2 0.1 0.5 0.3 0 0 0 0 0 0.7 1.6 0 0 0.5 1.2 0 0 0.3 0.5 0 0.3 ----22

25-29 0 0.2 0.2 0.5 0 0 3.1 0 0 0 1 0 1.6 0.5 0 1 0.3 0.2 0 0 0.9 0.2 0.3 0 0.3 0 0 0.5 7.3 0.2 0 6.9 1.6 0.2 3.1 0 0.3 0.3 0 0 0.5 0 0.2 1 3.1 0.2 0 0.2 2.1 0 0 0 1.2 0.2 0.2 ----40

30-34 0 0.2 0.6 0.6 0 0 5.3 0 0 0.2 1.7 0.4 1.7 1.5 0 1.3 0 0 0 0 1.8 0.2 0.4 0.2 0.6 0 0 0.7 17.3 0.2 0.4 18.9 2.6 0.6 4 0.2 0.9 0.4 0 0 0 0 0 0.7 3.1 0.4 0 0.2 2.2 0 0.7 0.4 1.7 0 1.1 ----73

35-39 0.2 1 0.8 0.6 0 0 6.3 0 0.2 0.6 2.2 0 2.4 2.2 0.2 1 0.2 1.4 0.6 0 3.1 0.4 0.6 0.6 1 0 0 0.4 34.4 0 0.6 27.3 4.1 2.9 7.9 0.2 0.2 0 0 0 0.2 0 0 1.8 4.5 0 0 0 3.7 0 0.6 0.4 3.3 0.2 1 ----120

40-44 0 0.5 0.2 0.7 0.2 0.2 9.8 0.2 0 0.7 4.8 0 7 4.8 0.2 2.6 0.5 1.7 0 0.5 7.7 0.2 0.7 0 3.4 0 0 1.7 48.4 0.7 0.5 34.1 6.2 3.1 12.5 0 0.2 1 0 0 1 0 0.2 2.6 6.2 0.2 0 0.2 6.2 0 1 0.5 1.7 0.2 2.6 ----178

45-49 0.6 2.2 0.9 0.9 0.3 0 13 0.3 0 1.3 10.4 0.3 10.4 6.6 1.3 3.2 0.9 1.9 0.6 0.3 11.7 1.3 0.3 0.9 4.7 0 0 0.6 46.8 0 0 39.2 9.5 1.9 15.2 0.6 0 0.3 0 0 1.9 0.3 0 4.1 7.6 0 0 0 11.7 0 2.5 0.9 4.1 0.6 2.8 ----226

50-54 0.9 1.4 3.2 1.4 1.4 0 7.2 0.9 0.5 5 16.7 0.9 13.5 14.4 1.4 8.1 1.4 4.5 0.9 0.5 23.5 1.8 0.5 1.4 7.2 0.5 0 1.8 47.4 0.9 2.7 34.3 11.3 3.2 12.6 0 0 1.4 0 0 1.8 0 0 3.6 10.4 0 0.5 0 14 0 2.3 0 7.7 0.9 4.5 ----280

55-59 1.7 1.1 2.3 2.3 0.6 1.1 11.5 1.1 0 5.2 17.8 1.1 13.8 10.9 0 11.5 3.4 4 0 1.7 37.3 0.6 1.7 1.7 6.9 0.6 0 1.1 36.7 1.1 0.6 30.4 8.6 1.7 13.2 0 0 1.1 0 0 2.9 0.6 0 2.9 6.3 0.6 0 0.6 18.3 0 7.5 0 5.2 0 4.6 ----284

60-64 2.2 2.2 10.5 2.2 0.7 0 14.2 0.7 0 4.5 30.7 1.5 18.7 17.2 0.7 9.7 10.5 3.7 0 2.2 56.9 1.5 0.7 3 21.7 0 0 2.2 30 1.5 0.7 33 3.7 0.7 14.2 0 0 1.5 0 0 6.7 0 0 3.7 15.7 0 0 0.7 16.5 0 4.5 3 3.7 1.5 4.5 ----365

65-69 3.2 7.6 11.9 2.2 1.1 0 14.1 5.4 0 8.6 38.9 2.2 22.7 16.2 1.1 20.5 5.4 7.6 3.2 0 60.5 4.3 0 3.2 31.4 1.1 0 3.2 30.3 1.1 2.2 31.4 5.4 4.3 9.7 0 0 1.1 0 0 3.2 0 0 6.5 9.7 1.1 0 1.1 15.1 0 3.2 1.1 3.2 1.1 5.4 ----412

70-74

APPENDIX 38: CANCER INCIDENCE BY SITES AND AGE GROUP, OTHERS FEMALES, MALAYSIA, 2007-2011

1.6 2.4 7.3 0 1.6 0 4.9 0 0 6.5 32.7 0.8 19.6 19.6 0.8 11.4 8.2 4.9 1.6 3.3 28.6 2.4 1.6 3.3 37.6 0 0 2.4 14.7 2.4 1.6 19.6 5.7 0.8 11.4 0 0 0 0 0 3.3 1.6 0 2.4 6.5 0 0 0.8 15.5 0 1.6 3.3 4.1 0.8 4.1 ----304

75+ 0.2 0.4 0.7 0.4 0.1 0 3.1 0.1 0 0.6 3.1 0.2 2.6 2.1 0.1 1.5 0.5 0.7 0.1 0.2 4.5 0.3 0.5 0.3 2 0 0 0.6 10.8 0.2 0.2 9.1 1.8 0.7 3.8 0.1 0.2 0.3 0 0 0.5 0 0.2 1.3 2.4 0.1 0 0.2 3.1 0 0.6 1 1.6 0.2 0.9 ----64.4

Crude Rate 0.3 0.6 1.1 0.5 0.2 0.1 4 0.3 0 1 4.9 0.2 3.9 3.2 0.2 2.3 0.9 1 0.2 0.3 7.4 0.4 0.5 0.5 3.2 0.1 0 0.7 14.3 0.3 0.3 12 2.5 0.9 4.9 0.1 0.2 0.4 0 0 0.7 0.1 0.2 1.5 3.2 0.1 0 0.2 4.3 0 0.9 1 1.9 0.2 1.3 ----89.6

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

118

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

7 55 71 33 22 24 382 15 4 106 237 24 487 605 16 550 90 159 30 134 759 14 44 16 120 5 3 40 16 14 383 71 5 118 3 2 183 2 10 168 53 2 17 83 492 0 68 138 286 15 80 ----6261

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 4 8 0 0 0 1 1 0 0 21 4 2 0 ----43

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 1 2 0 0 12 4 1 0 ----30

50 0 1 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 0 2 2 6 0 0 9 9 1 0 ----46

10-14 0 1 0 0 0 1 3 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 7 0 1 0 0 2 0 0 0 7 0 0 0 0 1 0 0 4 1 0 3 10 15 0 0 9 23 2 1 ----94

15-19 0 1 0 2 0 0 6 0 0 1 1 1 5 1 0 2 0 0 1 0 2 3 8 2 0 0 1 1 0 0 1 14 0 1 0 0 0 0 0 8 2 0 0 17 20 0 0 15 22 2 1 ----141

20-24 0 2 1 1 0 0 11 0 0 0 6 1 6 5 0 5 1 1 0 0 4 1 3 1 1 0 0 1 1 0 0 19 2 0 0 0 0 0 0 6 4 0 0 9 25 0 0 8 19 1 2 ----147

25-29 0 3 0 3 0 0 27 0 0 0 7 1 5 16 0 9 0 2 0 0 11 1 0 0 4 0 0 5 1 0 1 12 0 1 0 0 0 0 1 10 1 0 1 6 24 0 2 8 16 0 3 ----181

30-34 0 1 0 2 2 0 32 0 0 0 7 1 13 17 1 14 1 3 3 3 24 1 4 0 1 0 1 1 0 3 0 8 0 6 0 0 2 0 2 19 2 0 2 6 20 0 3 8 21 0 5 ----239

35-39 0 2 2 1 0 2 54 0 0 5 12 0 30 25 2 31 7 7 3 3 38 0 5 1 6 1 0 2 0 1 2 2 0 8 0 0 8 0 0 11 4 0 2 8 29 0 2 9 32 1 4 ----362

40-44 0 9 12 9 3 1 64 0 0 10 16 1 35 50 1 49 8 12 2 7 50 1 1 1 14 0 0 3 2 0 5 1 0 12 1 0 4 0 0 13 7 0 2 6 50 0 7 6 27 0 7 ----509

45-49 3 5 13 3 3 3 55 5 0 11 36 0 52 67 1 85 12 22 4 23 83 1 2 2 6 1 0 4 4 2 9 3 0 14 0 0 15 0 1 19 7 0 0 4 56 0 9 5 17 0 14 ----681

50-54 1 9 11 3 2 2 55 3 1 17 24 7 81 73 4 89 14 31 6 16 102 0 2 2 18 0 0 9 3 1 38 0 0 25 0 0 24 0 0 15 5 0 1 5 67 0 17 12 25 1 12 ----833

55-59 1 10 6 3 6 4 32 2 2 24 28 4 73 91 1 87 15 30 4 30 129 1 5 1 19 0 0 4 3 2 63 3 1 18 0 1 28 1 0 12 8 1 2 2 71 0 9 7 14 1 9 ----868

60-64 1 5 7 4 3 2 23 1 0 14 38 2 62 94 3 74 16 22 2 24 122 2 3 2 13 2 0 3 0 1 85 0 1 9 1 0 35 0 1 12 8 0 1 1 50 0 7 4 22 1 7 ----790

65-69 1 5 6 0 3 4 10 4 0 11 31 5 71 91 2 63 11 16 2 17 107 1 1 3 8 1 0 1 1 1 91 0 1 16 1 1 27 0 0 8 2 1 0 3 32 0 7 3 15 2 10 ----697

70-74 0 2 12 2 0 5 8 0 1 13 31 1 54 75 1 40 5 13 2 11 87 0 0 1 28 0 1 1 1 3 88 2 0 7 0 0 39 1 1 7 2 0 1 2 24 0 5 2 16 0 5 ----600

75+ 0.10% 0.90% 1.10% 0.50% 0.40% 0.40% 6.10% 0.20% 0.10% 1.70% 3.80% 0.40% 7.80% 9.70% 0.30% 8.80% 1.40% 2.50% 0.50% 2.10% 12.10% 0.20% 0.70% 0.30% 1.90% 0.10% 0.00% 0.60% 0.30% 0.20% 6.10% 1.10% 0.10% 1.90% 0.00% 0.00% 2.90% 0.00% 0.20% 2.70% 0.80% 0.00% 0.30% 1.30% 7.90% 0.00% 1.10% 2.20% 4.60% 0.20% 1.30% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 39: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, SELANGOR, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

119

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

11 68 115 12 6 8 130 14 1 66 162 13 424 456 9 185 77 128 31 16 353 10 28 18 77 2 0 30 3159 18 12 537 336 68 508 9 1 62 2 2 58 1 6 131 210 7 14 74 338 0 59 101 227 22 72 ----8484

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 2 0 0 0 0 1 7 0 0 0 0 2 0 0 13 8 0 0 ----37

0-9

0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 6 0 0 0 0 2 0 0 10 1 1 0 ----26

50 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 7 0 0 1 0 0 0 0 1 2 2 0 1 0 7 0 0 4 6 2 0 ----38

10-14 0 0 1 0 0 0 3 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 16 0 0 2 0 0 0 0 0 5 7 0 2 9 9 0 0 15 11 1 1 ----88

15-19 0 0 1 1 0 0 6 0 0 0 1 0 4 2 0 0 1 0 1 0 0 1 2 1 0 0 0 2 9 0 0 3 0 0 13 0 0 0 0 0 0 0 0 5 16 0 0 16 19 0 0 9 16 0 3 ----132

20-24 0 1 0 1 0 1 6 0 0 0 2 1 6 4 0 2 1 3 0 0 5 0 2 0 1 0 0 1 54 0 0 7 1 1 20 0 0 2 1 0 0 0 1 7 18 0 1 15 18 0 1 3 14 0 0 ----201

25-29 0 3 0 0 0 0 4 0 0 0 5 1 11 7 0 5 1 1 0 1 4 1 3 1 2 0 0 4 149 0 0 14 15 4 13 0 0 3 0 0 0 0 0 9 16 0 0 12 17 0 0 5 18 2 1 ----332

30-34 1 2 1 0 0 1 14 0 0 1 5 0 11 12 0 7 2 5 4 1 6 0 1 4 5 0 0 3 253 1 1 41 14 2 31 1 1 1 0 0 2 0 0 13 23 1 3 4 19 0 1 6 23 3 2 ----532

35-39 0 5 5 2 0 0 18 0 0 5 7 1 23 19 2 10 3 5 1 0 20 1 7 1 6 0 0 1 432 0 0 55 31 4 58 2 0 4 0 0 2 0 1 9 27 3 1 5 20 0 7 4 13 2 5 ----827

40-44 2 8 4 3 0 1 21 1 0 4 13 1 35 39 0 13 4 10 1 0 22 0 1 2 5 0 0 1 537 2 2 87 33 6 75 2 0 5 0 0 2 0 0 12 17 0 0 3 27 0 2 6 25 1 8 ----1043

45-49 2 10 15 3 0 1 16 1 0 4 17 3 37 58 0 23 4 18 2 1 44 2 2 1 7 0 0 1 530 1 0 82 51 15 88 2 0 10 0 0 4 0 0 12 18 1 1 4 49 0 3 9 19 6 5 ----1182

50-54 1 7 13 0 2 2 21 3 0 8 21 3 56 69 1 26 22 24 7 2 56 3 3 1 4 1 0 4 431 2 4 67 72 17 61 1 0 9 0 0 12 0 0 9 17 0 1 0 45 0 12 6 25 1 17 ----1169

55-59 0 12 22 0 1 0 6 2 0 11 23 1 73 63 2 20 9 24 2 2 46 1 0 3 7 0 0 2 285 2 0 63 60 5 43 0 0 8 0 0 8 1 2 11 14 1 2 2 28 0 12 7 22 1 8 ----917

60-64 0 5 14 1 2 1 5 3 0 12 21 1 53 62 1 28 9 10 3 3 51 0 1 1 10 0 0 1 199 3 3 50 36 8 36 1 0 4 0 2 5 0 0 11 14 0 1 2 30 0 7 1 5 0 7 ----723

65-69 2 11 23 1 1 1 8 2 0 10 17 0 57 60 0 20 11 17 1 3 42 1 1 2 11 1 0 3 156 3 1 40 12 2 22 0 0 4 0 0 8 0 0 9 10 1 1 0 21 0 9 1 12 0 7 ----625

70-74 3 4 16 0 0 0 1 2 0 11 28 1 58 61 3 30 10 11 7 3 57 0 1 1 19 0 0 1 124 4 1 28 11 4 23 0 0 5 1 0 15 0 0 4 11 0 0 2 25 0 5 2 9 2 8 ----612

75+ 0.10% 0.80% 1.40% 0.10% 0.10% 0.10% 1.50% 0.20% 0.00% 0.80% 1.90% 0.20% 5.00% 5.40% 0.10% 2.20% 0.90% 1.50% 0.40% 0.20% 4.20% 0.10% 0.30% 0.20% 0.90% 0.00% 0.00% 0.40% 37.20% 0.20% 0.10% 6.30% 4.00% 0.80% 6.00% 0.10% 0.00% 0.70% 0.00% 0.00% 0.70% 0.00% 0.10% 1.50% 2.50% 0.10% 0.20% 0.90% 4.00% 0.00% 0.70% 1.20% 2.70% 0.30% 0.80% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 40: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, SELANGOR, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

120

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

7 55 71 33 22 24 382 15 4 106 237 24 487 605 16 550 90 159 30 134 759 14 44 16 120 5 3 40 16 14 383 71 5 118 3 2 183 2 10 168 53 2 17 83 492 0 68 138 286 15 80 ----6261

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0 0 0.3 0.7 0 0 0 0.1 0.1 0 0 1.8 0.3 0.2 0 ----4

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0.1 0.2 0 0 1 0.3 0.1 0 ----3

50 0 0.1 0 0 0 0.2 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0.2 0.2 0.5 0 0 0.8 0.8 0.1 0 ----4

10-14 0 0.1 0 0 0 0.1 0.3 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0.2 0.6 0 0.1 0 0 0.2 0 0 0 0.6 0 0 0 0 0.1 0 0 0.4 0.1 0 0.3 0.9 1.3 0 0 0.8 2 0.2 0.1 ----8

15-19 0 0.1 0 0.1 0 0 0.4 0 0 0.1 0.1 0.1 0.4 0.1 0 0.1 0 0 0.1 0 0.1 0.2 0.6 0.1 0 0 0.1 0.1 0 0 0.1 1 0 0.1 0 0 0 0 0 0.6 0.1 0 0 1.2 1.4 0 0 1.1 1.6 0.1 0.1 ----10

20-24 0 0.1 0.1 0.1 0 0 0.8 0 0 0 0.4 0.1 0.4 0.4 0 0.4 0.1 0.1 0 0 0.3 0.1 0.2 0.1 0.1 0 0 0.1 0.1 0 0 1.4 0.1 0 0 0 0 0 0 0.4 0.3 0 0 0.7 1.8 0 0 0.6 1.4 0.1 0.1 ----11

25-29 0 0.3 0 0.3 0 0 2.5 0 0 0 0.6 0.1 0.5 1.5 0 0.8 0 0.2 0 0 1 0.1 0 0 0.4 0 0 0.5 0.1 0 0.1 1.1 0 0.1 0 0 0 0 0.1 0.9 0.1 0 0.1 0.5 2.2 0 0.2 0.7 1.5 0 0.3 ----17

30-34 0 0.1 0 0.2 0.2 0 3.3 0 0 0 0.7 0.1 1.3 1.8 0.1 1.4 0.1 0.3 0.3 0.3 2.5 0.1 0.4 0 0.1 0 0.1 0.1 0 0.3 0 0.8 0 0.6 0 0 0.2 0 0.2 2 0.2 0 0.2 0.6 2.1 0 0.3 0.8 2.2 0 0.5 ----25

35-39 0 0.2 0.2 0.1 0 0.2 6.5 0 0 0.6 1.4 0 3.6 3 0.2 3.7 0.8 0.8 0.4 0.4 4.6 0 0.6 0.1 0.7 0.1 0 0.2 0 0.1 0.2 0.2 0 1 0 0 1 0 0 1.3 0.5 0 0.2 1 3.5 0 0.2 1.1 3.9 0.1 0.5 ----44

40-44 0 1.2 1.6 1.2 0.4 0.1 8.8 0 0 1.4 2.2 0.1 4.8 6.9 0.1 6.7 1.1 1.6 0.3 1 6.9 0.1 0.1 0.1 1.9 0 0 0.4 0.3 0 0.7 0.1 0 1.6 0.1 0 0.5 0 0 1.8 1 0 0.3 0.8 6.9 0 1 0.8 3.7 0 1 ----70

45-49 0.5 0.9 2.2 0.5 0.5 0.5 9.5 0.9 0 1.9 6.2 0 9 11.6 0.2 14.7 2.1 3.8 0.7 4 14.3 0.2 0.3 0.3 1 0.2 0 0.7 0.7 0.3 1.6 0.5 0 2.4 0 0 2.6 0 0.2 3.3 1.2 0 0 0.7 9.7 0 1.6 0.9 2.9 0 2.4 ----118

50-54 0.2 2.1 2.6 0.7 0.5 0.5 12.8 0.7 0.2 4 5.6 1.6 18.9 17 0.9 20.7 3.3 7.2 1.4 3.7 23.8 0 0.5 0.5 4.2 0 0 2.1 0.7 0.2 8.9 0 0 5.8 0 0 5.6 0 0 3.5 1.2 0 0.2 1.2 15.6 0 4 2.8 5.8 0.2 2.8 ----194

55-59 0.3 3.3 2 1 2 1.3 10.5 0.7 0.7 7.9 9.2 1.3 24 29.9 0.3 28.6 4.9 9.9 1.3 9.9 42.4 0.3 1.6 0.3 6.3 0 0 1.3 1 0.7 20.7 1 0.3 5.9 0 0.3 9.2 0.3 0 3.9 2.6 0.3 0.7 0.7 23.4 0 3 2.3 4.6 0.3 3 ----286

60-64 0.6 2.8 3.9 2.2 1.7 1.1 12.8 0.6 0 7.8 21.2 1.1 34.5 52.4 1.7 41.2 8.9 12.3 1.1 13.4 68 1.1 1.7 1.1 7.2 1.1 0 1.7 0 0.6 47.4 0 0.6 5 0.6 0 19.5 0 0.6 6.7 4.5 0 0.6 0.6 27.9 0 3.9 2.2 12.3 0.6 3.9 ----440

65-69 0.8 3.9 4.7 0 2.3 3.1 7.8 3.1 0 8.6 24.2 3.9 55.5 71.1 1.6 49.2 8.6 12.5 1.6 13.3 83.6 0.8 0.8 2.3 6.3 0.8 0 0.8 0.8 0.8 71.1 0 0.8 12.5 0.8 0.8 21.1 0 0 6.3 1.6 0.8 0 2.3 25 0 5.5 2.3 11.7 1.6 7.8 ----545

70-74 0 1.6 9.3 1.6 0 3.9 6.2 0 0.8 10.1 24.1 0.8 42 58.4 0.8 31.1 3.9 10.1 1.6 8.6 67.7 0 0 0.8 21.8 0 0.8 0.8 0.8 2.3 68.5 1.6 0 5.4 0 0 30.4 0.8 0.8 5.4 1.6 0 0.8 1.6 18.7 0 3.9 1.6 12.5 0 3.9 ----467

75+

APPENDIX 41: CANCER INCIDENCE BY SITES AND AGE GROUP, SELANGOR, ALL RESIDENTS, MALES, 2007-2011

0.1 0.4 0.6 0.3 0.2 0.2 3 0.1 0 0.8 1.9 0.2 3.8 4.8 0.1 4.3 0.7 1.3 0.2 1.1 6 0.1 0.3 0.1 0.9 0 0 0.3 0.1 0.1 3 0.6 0 0.9 0 0 1.4 0 0.1 1.3 0.4 0 0.1 0.7 3.9 0 0.5 1.1 2.3 0.1 0.6 ----49.3

Crude Rate 0.1 0.6 0.8 0.3 0.3 0.3 3.5 0.2 0.1 1.3 2.8 0.3 5.8 7.4 0.2 6.4 1.1 1.9 0.3 1.7 9.4 0.1 0.4 0.2 1.5 0.1 0 0.4 0.2 0.2 5.5 0.5 0.1 1.3 0 0 2.4 0 0.1 1.6 0.6 0 0.2 0.6 5.1 0 0.8 1.2 2.7 0.1 0.9 ----71.3

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

121

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

11 68 115 12 6 8 130 14 1 66 162 13 424 456 9 185 77 128 31 16 353 10 28 18 77 2 0 30 3159 18 12 537 336 68 508 9 1 62 2 2 58 1 6 131 210 7 14 74 338 0 59 101 227 22 72 ----8484

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0.1 0.6 0 0 0 0 0.2 0 0 1.1 0.7 0 0 ----3

0-9

0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0.9 0.1 0.1 0 ----2

50 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0.1 0.2 0.2 0 0.1 0 0.7 0 0 0.4 0.6 0.2 0 ----4

10-14 0 0 0.1 0 0 0 0.3 0 0 0 0.2 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 1.4 0 0 0.2 0 0 0 0 0 0.4 0.6 0 0.2 0.8 0.8 0 0 1.3 1 0.1 0.1 ----8

15-19 0 0 0.1 0.1 0 0 0.4 0 0 0 0.1 0 0.3 0.1 0 0 0.1 0 0.1 0 0 0.1 0.1 0.1 0 0 0 0.1 0.6 0 0 0.2 0 0 0.9 0 0 0 0 0 0 0 0 0.3 1.1 0 0 1.1 1.3 0 0 0.6 1.1 0 0.2 ----9

20-24 0 0.1 0 0.1 0 0.1 0.4 0 0 0 0.1 0.1 0.4 0.3 0 0.1 0.1 0.2 0 0 0.4 0 0.1 0 0.1 0 0 0.1 4 0 0 0.5 0.1 0.1 1.5 0 0 0.1 0.1 0 0 0 0.1 0.5 1.3 0 0.1 1.1 1.3 0 0.1 0.2 1 0 0 ----15

25-29 0 0.3 0 0 0 0 0.4 0 0 0 0.5 0.1 1.1 0.7 0 0.5 0.1 0.1 0 0.1 0.4 0.1 0.3 0.1 0.2 0 0 0.4 14.7 0 0 1.4 1.5 0.4 1.3 0 0 0.3 0 0 0 0 0 0.9 1.6 0 0 1.2 1.7 0 0 0.5 1.8 0.2 0.1 ----33

30-34 0.1 0.2 0.1 0 0 0.1 1.6 0 0 0.1 0.6 0 1.2 1.3 0 0.8 0.2 0.6 0.4 0.1 0.7 0 0.1 0.4 0.6 0 0 0.3 28.2 0.1 0.1 4.6 1.6 0.2 3.5 0.1 0.1 0.1 0 0 0.2 0 0 1.4 2.6 0.1 0.3 0.4 2.1 0 0.1 0.7 2.6 0.3 0.2 ----59

35-39 0 0.6 0.6 0.3 0 0 2.3 0 0 0.6 0.9 0.1 3 2.5 0.3 1.3 0.4 0.6 0.1 0 2.6 0.1 0.9 0.1 0.8 0 0 0.1 56.1 0 0 7.1 4 0.5 7.5 0.3 0 0.5 0 0 0.3 0 0.1 1.2 3.5 0.4 0.1 0.6 2.6 0 0.9 0.5 1.7 0.3 0.6 ----107

40-44 0.3 1.2 0.6 0.5 0 0.2 3.2 0.2 0 0.6 2 0.2 5.4 6 0 2 0.6 1.5 0.2 0 3.4 0 0.2 0.3 0.8 0 0 0.2 82.6 0.3 0.3 13.4 5.1 0.9 11.5 0.3 0 0.8 0 0 0.3 0 0 1.8 2.6 0 0 0.5 4.2 0 0.3 0.9 3.8 0.2 1.2 ----160

45-49 0.4 1.9 2.9 0.6 0 0.2 3.1 0.2 0 0.8 3.2 0.6 7.1 11.1 0 4.4 0.8 3.4 0.4 0.2 8.4 0.4 0.4 0.2 1.3 0 0 0.2 101.3 0.2 0 15.7 9.7 2.9 16.8 0.4 0 1.9 0 0 0.8 0 0 2.3 3.4 0.2 0.2 0.8 9.4 0 0.6 1.7 3.6 1.1 1 ----226

50-54 0.2 1.7 3.2 0 0.5 0.5 5.2 0.7 0 2 5.2 0.7 14 17.2 0.2 6.5 5.5 6 1.7 0.5 14 0.7 0.7 0.2 1 0.2 0 1 107.5 0.5 1 16.7 18 4.2 15.2 0.2 0 2.2 0 0 3 0 0 2.2 4.2 0 0.2 0 11.2 0 3 1.5 6.2 0.2 4.2 ----292

55-59 0 3.9 7.1 0 0.3 0 1.9 0.6 0 3.5 7.4 0.3 23.5 20.3 0.6 6.4 2.9 7.7 0.6 0.6 14.8 0.3 0 1 2.3 0 0 0.6 91.8 0.6 0 20.3 19.3 1.6 13.9 0 0 2.6 0 0 2.6 0.3 0.6 3.5 4.5 0.3 0.6 0.6 9 0 3.9 2.3 7.1 0.3 2.6 ----295

60-64 0 2.9 8.2 0.6 1.2 0.6 2.9 1.8 0 7 12.3 0.6 31.1 36.4 0.6 16.4 5.3 5.9 1.8 1.8 29.9 0 0.6 0.6 5.9 0 0 0.6 116.7 1.8 1.8 29.3 21.1 4.7 21.1 0.6 0 2.3 0 1.2 2.9 0 0 6.5 8.2 0 0.6 1.2 17.6 0 4.1 0.6 2.9 0 4.1 ----424

65-69 1.5 8.3 17.3 0.8 0.8 0.8 6 1.5 0 7.5 12.8 0 42.9 45.1 0 15 8.3 12.8 0.8 2.3 31.6 0.8 0.8 1.5 8.3 0.8 0 2.3 117.3 2.3 0.8 30.1 9 1.5 16.5 0 0 3 0 0 6 0 0 6.8 7.5 0.8 0.8 0 15.8 0 6.8 0.8 9 0 5.3 ----470

70-74 1.9 2.5 10 0 0 0 0.6 1.2 0 6.9 17.4 0.6 36.1 38 1.9 18.7 6.2 6.9 4.4 1.9 35.5 0 0.6 0.6 11.8 0 0 0.6 77.3 2.5 0.6 17.4 6.9 2.5 14.3 0 0 3.1 0.6 0 9.3 0 0 2.5 6.9 0 0 1.2 15.6 0 3.1 1.2 5.6 1.2 5 ----381

75+ 0.1 0.6 0.9 0.1 0 0.1 1.1 0.1 0 0.5 1.3 0.1 3.5 3.7 0.1 1.5 0.6 1 0.3 0.1 2.9 0.1 0.2 0.1 0.6 0 0 0.2 25.8 0.1 0.1 4.4 2.7 0.6 4.1 0.1 0 0.5 0 0 0.5 0 0 1.1 1.7 0.1 0.1 0.6 2.8 0 0.5 0.8 1.9 0.2 0.6 ----69.3

Crude Rate

APPENDIX 42: CANCER INCIDENCE BY SITES AND AGE GROUP, SELANGOR, ALL RESIDENTS, FEMALES, 2007-2011

0.1 0.8 1.4 0.1 0.1 0.1 1.2 0.2 0 0.8 1.9 0.1 5.1 5.5 0.1 2.2 0.9 1.5 0.3 0.2 4.3 0.1 0.2 0.2 0.9 0 0 0.3 31.7 0.2 0.1 5.7 3.7 0.7 5.1 0.1 0 0.7 0 0 0.7 0 0.1 1.3 1.9 0.1 0.1 0.5 3.4 0 0.7 0.9 2.1 0.2 0.8 ----89.7

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

122

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

3 59 51 35 16 10 524 21 0 105 310 27 571 584 18 413 48 157 33 116 1289 28 59 18 206 2 2 84 21 17 548 82 7 144 1 6 250 4 9 172 79 6 9 49 407 0 82 103 191 98 128 ----7202

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 1 1 0 0 0 3 0 0 0 5 1 2 0 0 0 0 6 17 0 2 0 0 5 0 0 23 18 24 2 ----117

0-9

0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 3 0 1 0 0 3 0 0 0 1 0 0 0 0 0 0 0 6 0 0 1 1 6 0 0 18 8 14 0 ----65

50 0 1 0 0 0 4 0 0 0 0 0 0 0 0 2 0 0 0 0 0 3 9 0 1 0 0 0 0 0 0 4 0 3 0 0 0 0 0 5 0 1 1 0 5 0 0 12 4 12 1 ----68

10-14 0 0 0 0 0 0 6 0 0 0 0 0 1 1 0 2 0 0 1 0 1 1 16 1 0 0 0 7 0 0 0 5 3 0 0 0 0 0 0 9 1 0 0 7 16 0 0 4 11 10 3 ----106

15-19 0 1 0 4 0 0 3 0 0 0 0 1 1 3 0 0 0 0 0 0 6 2 3 1 1 0 0 0 0 1 0 9 0 0 0 0 0 0 0 6 4 0 1 9 23 0 0 6 13 5 2 ----105

20-24 0 2 0 2 0 0 9 0 0 0 0 1 2 1 0 2 0 1 0 0 9 3 6 0 4 0 0 3 0 0 0 18 0 0 0 0 2 0 0 8 7 0 0 6 7 0 0 4 18 6 3 ----124

25-29 0 2 0 3 0 0 30 0 0 1 6 1 10 8 0 9 0 4 0 0 12 2 1 0 5 0 0 2 0 0 0 8 1 5 0 0 0 0 0 8 3 0 0 4 14 0 0 4 11 1 2 ----157

30-34 0 3 1 3 0 0 45 0 0 1 5 1 17 9 1 10 0 3 5 0 18 2 2 2 4 0 1 4 1 2 0 11 0 3 0 0 2 0 0 6 3 0 1 3 30 0 2 2 10 4 6 ----223

35-39 1 8 6 0 1 0 66 1 0 5 10 1 28 15 2 28 4 7 1 3 45 3 2 0 4 0 0 6 2 1 4 9 0 7 0 0 9 0 0 13 5 0 1 3 27 0 7 6 15 3 4 ----363

40-44 0 7 3 3 3 0 71 0 0 8 20 6 41 44 2 36 1 9 6 9 80 3 2 0 15 0 0 12 0 2 6 5 0 14 1 0 14 0 0 18 9 1 1 3 29 0 12 4 17 3 9 ----529

45-49 0 9 4 1 3 0 99 0 0 13 22 1 60 63 6 66 6 17 4 10 138 1 2 1 18 0 0 10 2 2 13 2 1 17 0 0 14 0 1 11 10 0 2 4 52 0 10 5 21 1 19 ----741

50-54 1 4 4 5 4 2 62 3 0 16 30 4 84 66 1 71 7 18 3 19 166 2 6 2 18 0 0 7 2 1 40 1 0 23 0 0 26 2 0 27 14 1 1 1 48 0 13 6 12 3 14 ----840

55-59 0 6 10 6 3 1 52 5 0 20 49 4 77 116 3 69 9 36 5 26 205 2 2 3 31 1 0 12 4 0 88 0 0 32 0 2 39 1 0 11 6 0 0 1 45 0 16 2 11 2 19 ----1032

60-64 0 7 6 1 0 1 45 4 0 14 50 3 73 105 1 42 6 28 3 17 212 1 2 3 33 0 1 6 3 6 125 2 1 19 0 4 36 1 1 10 10 0 0 2 45 0 11 3 9 3 20 ----975

65-69 0 5 5 4 1 2 20 5 0 17 53 3 88 69 1 38 6 19 2 13 216 2 2 2 34 1 0 3 2 1 128 1 0 16 0 0 46 0 0 9 2 0 0 1 32 0 6 1 6 5 10 ----877

70-74 1 5 11 2 1 3 10 3 0 10 65 1 89 84 1 33 9 15 2 19 181 1 0 2 37 0 0 6 5 1 144 1 0 3 0 0 62 0 1 8 5 1 0 4 23 0 5 3 7 2 14 ----880

75+ 0.00% 0.80% 0.70% 0.50% 0.20% 0.10% 7.30% 0.30% 0.00% 1.50% 4.30% 0.40% 7.90% 8.10% 0.20% 5.70% 0.70% 2.20% 0.50% 1.60% 17.90% 0.40% 0.80% 0.20% 2.90% 0.00% 0.00% 1.20% 0.30% 0.20% 7.60% 1.10% 0.10% 2.00% 0.00% 0.10% 3.50% 0.10% 0.10% 2.40% 1.10% 0.10% 0.10% 0.70% 5.70% 0.00% 1.10% 1.40% 2.70% 1.40% 1.80% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 43: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, JOHOR, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

123

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 40 40 35 6 2 172 10 3 47 208 12 490 420 10 144 55 119 14 10 487 12 41 18 157 2 0 69 2792 18 19 518 326 52 446 7 8 62 0 1 58 1 9 124 265 7 5 35 285 1 55 66 148 74 104 ----8110

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0 2 0 1 0 0 1 0 0 0 0 0 0 2 0 0 1 0 0 0 0 3 7 0 1 0 0 8 0 0 14 8 20 2 ----74

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 1 1 0 0 3 0 0 13 3 12 1 ----49

50 0 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 7 0 1 0 0 3 0 0 0 0 0 0 5 0 0 1 0 0 0 0 0 12 3 0 0 1 6 0 0 7 5 5 0 ----61

10-14 0 0 0 3 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 5 0 1 0 0 6 0 0 0 0 0 0 11 0 0 0 0 0 0 0 0 5 5 1 0 4 19 0 0 3 5 7 0 ----78

15-19 0 0 0 1 0 0 2 1 0 0 3 0 3 1 0 2 0 2 0 0 0 1 4 0 2 0 0 2 9 0 0 0 0 0 16 0 1 2 0 0 0 0 0 2 18 1 0 8 15 0 0 4 11 0 6 ----117

20-24 0 1 0 2 0 0 5 1 0 0 3 0 6 2 0 1 0 1 0 0 2 2 3 1 2 0 0 8 34 0 1 10 5 1 13 0 0 0 0 0 0 0 0 7 25 1 0 6 15 0 0 4 8 3 5 ----178

25-29 0 0 0 0 0 0 13 0 0 0 4 0 10 7 0 3 1 4 1 0 5 0 1 0 5 0 0 1 113 1 0 17 7 3 18 2 2 1 0 0 1 0 0 4 25 0 1 2 9 0 0 1 11 1 5 ----279

30-34 0 2 0 1 0 0 17 0 0 0 5 0 21 20 0 8 1 2 1 0 12 1 1 2 2 0 0 4 221 1 0 29 20 4 24 0 2 2 0 0 0 0 0 6 30 1 0 0 15 0 2 1 14 0 5 ----477

35-39 0 4 2 7 0 0 23 0 1 3 12 0 21 23 2 11 2 8 3 0 26 0 4 0 5 0 0 8 371 0 0 47 32 8 44 1 1 4 0 0 4 0 0 9 24 0 1 2 17 0 2 2 9 0 6 ----749

40-44 0 4 1 3 2 0 28 0 0 2 16 0 23 36 1 9 2 4 1 0 51 3 1 1 4 0 0 8 503 0 2 85 36 10 68 1 2 9 0 0 6 0 2 13 23 0 2 4 29 0 5 4 14 5 8 ----1031

45-49 0 8 4 2 2 0 30 1 0 7 21 1 41 52 1 13 4 5 2 0 42 0 1 3 12 0 0 3 474 3 1 79 52 2 72 0 0 7 0 1 7 0 1 17 33 0 0 1 31 0 7 4 15 2 13 ----1077

50-54 0 4 5 5 0 0 20 1 1 4 22 2 69 51 1 14 8 23 0 0 63 1 2 3 16 1 0 6 432 4 2 86 62 7 65 2 0 11 0 0 7 0 1 7 25 0 1 3 19 0 8 4 17 4 11 ----1100

55-59 0 5 5 3 1 0 20 2 1 11 23 1 69 49 0 19 7 18 1 2 73 1 1 1 16 0 0 7 281 2 1 59 44 11 41 0 0 10 0 0 8 1 1 8 19 0 0 0 31 1 10 2 11 5 11 ----893

60-64 0 2 7 3 1 0 5 0 0 7 25 3 56 48 1 19 6 20 2 1 67 0 2 3 13 0 0 4 160 2 3 31 27 2 28 1 0 4 0 0 4 0 0 12 18 0 0 0 27 0 6 1 3 4 7 ----635

65-69 1 5 5 4 0 1 2 4 0 3 28 1 68 59 2 16 9 11 2 4 65 1 2 1 25 1 0 3 104 3 5 40 24 2 25 0 0 3 0 0 10 0 0 4 8 0 0 1 21 0 7 1 4 2 13 ----600

70-74 0 5 11 1 0 1 4 0 0 10 44 4 101 71 2 26 15 21 1 2 81 0 4 3 52 0 0 3 90 2 4 35 17 2 14 0 0 7 0 0 11 0 0 2 8 1 0 3 20 0 8 1 10 4 11 ----712

75+ 0.00% 0.50% 0.50% 0.40% 0.10% 0.00% 2.10% 0.10% 0.00% 0.60% 2.60% 0.10% 6.00% 5.20% 0.10% 1.80% 0.70% 1.50% 0.20% 0.10% 6.00% 0.10% 0.50% 0.20% 1.90% 0.00% 0.00% 0.90% 34.40% 0.20% 0.20% 6.40% 4.00% 0.60% 5.50% 0.10% 0.10% 0.80% 0.00% 0.00% 0.70% 0.00% 0.10% 1.50% 3.30% 0.10% 0.10% 0.40% 3.50% 0.00% 0.70% 0.80% 1.80% 0.90% 1.30% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 44: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, JOHOR, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

124

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

3 59 51 35 16 10 524 21 0 105 310 27 571 584 18 413 48 157 33 116 1289 28 59 18 206 2 2 84 21 17 548 82 7 144 1 6 250 4 9 172 79 6 9 49 407 0 82 103 191 98 128 ----7202

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0.1 0.1 0 0 0 0.4 0 0 0 0.7 0.1 0.3 0 0 0 0 0.8 2.3 0 0.3 0 0 0.7 0 0 3.2 2.5 3.3 0.3 ----16

0-9

0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.4 0 0.1 0 0 0.4 0 0 0 0.1 0 0 0 0 0 0 0 0.8 0 0 0.1 0.1 0.8 0 0 2.3 1 1.8 0 ----8

50 0 0.1 0 0 0 0.5 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0.4 1.1 0 0.1 0 0 0 0 0 0 0.5 0 0.4 0 0 0 0 0 0.6 0 0.1 0.1 0 0.6 0 0 1.5 0.5 1.5 0.1 ----9

10-14 0 0 0 0 0 0 0.8 0 0 0 0 0 0.1 0.1 0 0.3 0 0 0.1 0 0.1 0.1 2.2 0.1 0 0 0 1 0 0 0 0.7 0.4 0 0 0 0 0 0 1.2 0.1 0 0 1 2.2 0 0 0.5 1.5 1.4 0.4 ----14

15-19 0 0.1 0 0.6 0 0 0.4 0 0 0 0 0.1 0.1 0.4 0 0 0 0 0 0 0.8 0.3 0.4 0.1 0.1 0 0 0 0 0.1 0 1.2 0 0 0 0 0 0 0 0.8 0.6 0 0.1 1.2 3.2 0 0 0.8 1.8 0.7 0.3 ----15

20-24 0 0.3 0 0.3 0 0 1.3 0 0 0 0 0.1 0.3 0.1 0 0.3 0 0.1 0 0 1.3 0.4 0.9 0 0.6 0 0 0.4 0 0 0 2.6 0 0 0 0 0.3 0 0 1.2 1 0 0 0.9 1 0 0 0.6 2.6 0.9 0.4 ----18

25-29 0 0.3 0 0.5 0 0 5.2 0 0 0.2 1 0.2 1.7 1.4 0 1.6 0 0.7 0 0 2.1 0.3 0.2 0 0.9 0 0 0.3 0 0 0 1.4 0.2 0.9 0 0 0 0 0 1.4 0.5 0 0 0.7 2.4 0 0 0.7 1.9 0.2 0.3 ----27

30-34 0 0.6 0.2 0.6 0 0 8.3 0 0 0.2 0.9 0.2 3.2 1.7 0.2 1.9 0 0.6 0.9 0 3.3 0.4 0.4 0.4 0.7 0 0.2 0.7 0.2 0.4 0 2 0 0.6 0 0 0.4 0 0 1.1 0.6 0 0.2 0.6 5.6 0 0.4 0.4 1.9 0.7 1.1 ----41

35-39 0.2 1.6 1.2 0 0.2 0 13.2 0.2 0 1 2 0.2 5.6 3 0.4 5.6 0.8 1.4 0.2 0.6 9 0.6 0.4 0 0.8 0 0 1.2 0.4 0.2 0.8 1.8 0 1.4 0 0 1.8 0 0 2.6 1 0 0.2 0.6 5.4 0 1.4 1.2 3 0.6 0.8 ----72

40-44 0 1.5 0.7 0.7 0.7 0 15.6 0 0 1.8 4.4 1.3 9 9.6 0.4 7.9 0.2 2 1.3 2 17.5 0.7 0.4 0 3.3 0 0 2.6 0 0.4 1.3 1.1 0 3.1 0.2 0 3.1 0 0 3.9 2 0.2 0.2 0.7 6.4 0 2.6 0.9 3.7 0.7 2 ----116

45-49 0 2.3 1 0.3 0.8 0 25.6 0 0 3.4 5.7 0.3 15.5 16.3 1.6 17.1 1.6 4.4 1 2.6 35.7 0.3 0.5 0.3 4.7 0 0 2.6 0.5 0.5 3.4 0.5 0.3 4.4 0 0 3.6 0 0.3 2.8 2.6 0 0.5 1 13.4 0 2.6 1.3 5.4 0.3 4.9 ----191

50-54 0.3 1.3 1.3 1.6 1.3 0.6 20.1 1 0 5.2 9.7 1.3 27.3 21.4 0.3 23.1 2.3 5.8 1 6.2 53.9 0.6 1.9 0.6 5.8 0 0 2.3 0.6 0.3 13 0.3 0 7.5 0 0 8.4 0.6 0 8.8 4.5 0.3 0.3 0.3 15.6 0 4.2 1.9 3.9 1 4.5 ----273

55-59 0 2.6 4.3 2.6 1.3 0.4 22.3 2.1 0 8.6 21 1.7 33.1 49.8 1.3 29.6 3.9 15.5 2.1 11.2 88 0.9 0.9 1.3 13.3 0.4 0 5.2 1.7 0 37.8 0 0 13.7 0 0.9 16.7 0.4 0 4.7 2.6 0 0 0.4 19.3 0 6.9 0.9 4.7 0.9 8.2 ----443

60-64 0 4.5 3.8 0.6 0 0.6 28.8 2.6 0 8.9 32 1.9 46.7 67.1 0.6 26.8 3.8 17.9 1.9 10.9 135.5 0.6 1.3 1.9 21.1 0 0.6 3.8 1.9 3.8 79.9 1.3 0.6 12.1 0 2.6 23 0.6 0.6 6.4 6.4 0 0 1.3 28.8 0 7 1.9 5.8 1.9 12.8 ----623

65-69 0 4.3 4.3 3.4 0.9 1.7 17 4.3 0 14.5 45.1 2.6 74.9 58.7 0.9 32.3 5.1 16.2 1.7 11.1 183.9 1.7 1.7 1.7 28.9 0.9 0 2.6 1.7 0.9 109 0.9 0 13.6 0 0 39.2 0 0 7.7 1.7 0 0 0.9 27.2 0 5.1 0.9 5.1 4.3 8.5 ----746

70-74 0.8 4.1 9 1.6 0.8 2.4 8.2 2.4 0 8.2 53.1 0.8 72.7 68.6 0.8 26.9 7.3 12.2 1.6 15.5 147.8 0.8 0 1.6 30.2 0 0 4.9 4.1 0.8 117.6 0.8 0 2.4 0 0 50.6 0 0.8 6.5 4.1 0.8 0 3.3 18.8 0 4.1 2.4 5.7 1.6 11.4 ----718

75+

APPENDIX 45: CANCER INCIDENCE BY SITES AND AGE GROUP, JOHOR, ALL RESIDENTS, MALES, 2007-2011

0 0.8 0.7 0.4 0.2 0.1 6.7 0.3 0 1.3 4 0.3 7.3 7.4 0.2 5.3 0.6 2 0.4 1.5 16.4 0.4 0.8 0.2 2.6 0 0 1.1 0.3 0.2 7 1 0.1 1.8 0 0.1 3.2 0.1 0.1 2.2 1 0.1 0.1 0.6 5.2 0 1 1.3 2.4 1.2 1.6 ----91.8

Crude Rate 0 0.8 0.8 0.5 0.2 0.2 7.2 0.3 0 1.6 4.9 0.4 8.8 9.2 0.3 6.1 0.7 2.5 0.5 1.8 20.3 0.4 0.8 0.3 3.2 0 0 1.2 0.3 0.3 9.3 1 0.1 2.2 0 0.1 4 0.1 0.1 2.4 1.1 0.1 0.1 0.6 5.8 0 1.2 1.4 2.6 1.3 1.9 ----109

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

125

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 40 40 35 6 2 172 10 3 47 208 12 490 420 10 144 55 119 14 10 487 12 41 18 157 2 0 69 2792 18 19 518 326 52 446 7 8 62 0 1 58 1 9 124 265 7 5 35 285 1 55 66 148 74 104 ----8110

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.3 0 0 0 0.1 0 0 0.3 0 0.1 0 0 0.1 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0 0.4 1 0 0.1 0 0 1.2 0 0 2.1 1.2 2.9 0.3 ----11

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.1 0.1 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 1.2 0.1 0.1 0 0 0.4 0 0 1.8 0.4 1.6 0.1 ----7

50 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.1 1 0 0.1 0 0 0.4 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0 1.6 0.4 0 0 0.1 0.8 0 0 1 0.7 0.7 0 ----8

10-14 0 0 0 0.4 0 0 0 0 0 0 0.3 0 0 0 0 0.1 0 0 0 0 0 0 0.7 0 0.1 0 0 0.9 0 0 0 0 0 0 1.6 0 0 0 0 0 0 0 0 0.7 0.7 0.1 0 0.6 2.8 0 0 0.4 0.7 1 0 ----11

15-19 0 0 0 0.1 0 0 0.3 0.1 0 0 0.4 0 0.4 0.1 0 0.3 0 0.3 0 0 0 0.1 0.6 0 0.3 0 0 0.3 1.3 0 0 0 0 0 2.4 0 0.1 0.3 0 0 0 0 0 0.3 2.6 0.1 0 1.2 2.2 0 0 0.6 1.6 0 0.9 ----17

20-24 0 0.2 0 0.3 0 0 0.8 0.2 0 0 0.5 0 0.9 0.3 0 0.2 0 0.2 0 0 0.3 0.3 0.5 0.2 0.3 0 0 1.2 5.2 0 0.2 1.5 0.8 0.2 2 0 0 0 0 0 0 0 0 1.1 3.9 0.2 0 0.9 2.3 0 0 0.6 1.2 0.5 0.8 ----27

25-29 0 0 0 0 0 0 2.5 0 0 0 0.8 0 1.9 1.3 0 0.6 0.2 0.8 0.2 0 0.9 0 0.2 0 0.9 0 0 0.2 21.4 0.2 0 3.2 1.3 0.6 3.4 0.4 0.4 0.2 0 0 0.2 0 0 0.8 4.7 0 0.2 0.4 1.7 0 0 0.2 2.1 0.2 0.9 ----53

30-34 0 0.4 0 0.2 0 0 3.3 0 0 0 1 0 4.1 3.9 0 1.6 0.2 0.4 0.2 0 2.4 0.2 0.2 0.4 0.4 0 0 0.8 43.3 0.2 0 5.7 3.9 0.8 4.7 0 0.4 0.4 0 0 0 0 0 1.2 5.9 0.2 0 0 2.9 0 0.4 0.2 2.7 0 1 ----93

35-39 0 0.8 0.4 1.5 0 0 4.8 0 0.2 0.6 2.5 0 4.4 4.8 0.4 2.3 0.4 1.7 0.6 0 5.4 0 0.8 0 1 0 0 1.7 77.1 0 0 9.8 6.6 1.7 9.1 0.2 0.2 0.8 0 0 0.8 0 0 1.9 5 0 0.2 0.4 3.5 0 0.4 0.4 1.9 0 1.2 ----156

40-44 0 0.9 0.2 0.7 0.5 0 6.6 0 0 0.5 3.8 0 5.5 8.5 0.2 2.1 0.5 0.9 0.2 0 12.1 0.7 0.2 0.2 0.9 0 0 1.9 119.2 0 0.5 20.1 8.5 2.4 16.1 0.2 0.5 2.1 0 0 1.4 0 0.5 3.1 5.5 0 0.5 0.9 6.9 0 1.2 0.9 3.3 1.2 1.9 ----244

45-49 0 2.2 1.1 0.5 0.5 0 8.1 0.3 0 1.9 5.7 0.3 11 14 0.3 3.5 1.1 1.3 0.5 0 11.3 0 0.3 0.8 3.2 0 0 0.8 127.6 0.8 0.3 21.3 14 0.5 19.4 0 0 1.9 0 0.3 1.9 0 0.3 4.6 8.9 0 0 0.3 8.3 0 1.9 1.1 4 0.5 3.5 ----290

50-54 0 1.4 1.7 1.7 0 0 6.9 0.3 0.3 1.4 7.6 0.7 23.7 17.5 0.3 4.8 2.7 7.9 0 0 21.7 0.3 0.7 1 5.5 0.3 0 2.1 148.5 1.4 0.7 29.6 21.3 2.4 22.3 0.7 0 3.8 0 0 2.4 0 0.3 2.4 8.6 0 0.3 1 6.5 0 2.7 1.4 5.8 1.4 3.8 ----378

55-59 0 2.2 2.2 1.3 0.4 0 8.9 0.9 0.4 4.9 10.2 0.4 30.7 21.8 0 8.5 3.1 8 0.4 0.9 32.5 0.4 0.4 0.4 7.1 0 0 3.1 125.2 0.9 0.4 26.3 19.6 4.9 18.3 0 0 4.5 0 0 3.6 0.4 0.4 3.6 8.5 0 0 0 13.8 0.4 4.5 0.9 4.9 2.2 4.9 ----398

60-64 0 1.4 4.8 2.1 0.7 0 3.4 0 0 4.8 17.1 2.1 38.4 32.9 0.7 13 4.1 13.7 1.4 0.7 45.9 0 1.4 2.1 8.9 0 0 2.7 109.6 1.4 2.1 21.2 18.5 1.4 19.2 0.7 0 2.7 0 0 2.7 0 0 8.2 12.3 0 0 0 18.5 0 4.1 0.7 2.1 2.7 4.8 ----435

65-69 0.9 4.3 4.3 3.4 0 0.9 1.7 3.4 0 2.6 23.8 0.9 57.9 50.2 1.7 13.6 7.7 9.4 1.7 3.4 55.3 0.9 1.7 0.9 21.3 0.9 0 2.6 88.5 2.6 4.3 34 20.4 1.7 21.3 0 0 2.6 0 0 8.5 0 0 3.4 6.8 0 0 0.9 17.9 0 6 0.9 3.4 1.7 11.1 ----511

70-74 0 3.5 7.6 0.7 0 0.7 2.8 0 0 6.9 30.5 2.8 69.9 49.1 1.4 18 10.4 14.5 0.7 1.4 56.1 0 2.8 2.1 36 0 0 2.1 62.3 1.4 2.8 24.2 11.8 1.4 9.7 0 0 4.8 0 0 7.6 0 0 1.4 5.5 0.7 0 2.1 13.8 0 5.5 0.7 6.9 2.8 7.6 ----493

75+

APPENDIX 46: CANCER INCIDENCE BY SITES AND AGE GROUP, JOHOR, ALL RESIDENTS, FEMALES, 2007-2011

0 0.5 0.5 0.5 0.1 0 2.3 0.1 0 0.6 2.8 0.2 6.6 5.7 0.1 1.9 0.7 1.6 0.2 0.1 6.6 0.2 0.6 0.2 2.1 0 0 0.9 37.7 0.2 0.3 7 4.4 0.7 6 0.1 0.1 0.8 0 0 0.8 0 0.1 1.7 3.6 0.1 0.1 0.5 3.8 0 0.7 0.9 2 1 1.4 ----109.5

Crude Rate 0 0.6 0.6 0.5 0.1 0 2.4 0.2 0 0.7 3.2 0.2 7.5 6.4 0.1 2.2 0.8 1.9 0.2 0.2 7.6 0.2 0.6 0.3 2.4 0 0 1 39.8 0.3 0.3 7.6 4.8 0.8 6.4 0.1 0.1 0.9 0 0 0.9 0 0.1 1.8 3.6 0.1 0.1 0.5 4.2 0 0.9 0.9 2 1.1 1.5 ----118.7

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

126

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 32 32 17 9 5 369 24 3 48 253 17 336 174 9 236 24 49 18 35 482 29 33 33 125 4 5 31 14 14 199 32 1 32 0 1 73 1 14 80 55 6 1 20 241 0 32 95 112 5 60 ----3522

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 8 0 3 0 0 0 0 9 8 0 0 0 0 3 0 0 32 10 0 4 ----82

0-9

0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 3 0 0 0 0 8 0 0 24 6 1 2 ----49

50 0 0 0 0 0 5 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 2 0 0 1 6 0 0 7 7 0 2 ----39

10-14 0 1 0 1 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 7 1 0 0 0 1 0 0 1 2 0 0 0 0 1 0 0 5 0 0 0 2 12 0 0 8 6 0 0 ----57

15-19 0 0 0 2 0 0 11 0 0 0 1 0 4 1 0 0 1 1 0 0 0 0 6 0 0 0 1 1 0 0 0 5 0 0 0 0 0 0 0 3 0 0 0 3 3 0 0 3 13 0 1 ----60

20-24 0 1 3 1 0 0 12 0 0 0 4 0 11 2 0 2 1 0 1 0 5 0 1 1 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 6 2 1 0 0 9 0 1 5 5 0 0 ----77

25-29 0 0 2 1 0 0 18 0 0 1 3 1 9 5 1 4 0 1 1 0 3 0 1 1 4 0 1 2 0 1 0 3 0 1 0 0 1 0 0 4 0 0 0 2 13 0 0 2 6 0 0 ----92

30-34 0 0 3 2 0 0 23 0 0 0 7 0 13 6 0 7 0 1 0 1 12 4 0 2 6 0 0 3 0 1 0 5 0 1 0 0 1 0 0 3 2 0 0 1 11 0 0 4 7 1 2 ----129

35-39 2 1 0 0 0 0 35 1 0 1 11 3 20 14 1 15 1 2 3 0 18 1 2 1 4 0 1 2 2 3 0 2 0 2 0 0 2 0 0 7 5 1 0 0 13 0 1 1 4 1 1 ----184

40-44 0 2 3 0 1 0 64 0 0 3 20 1 18 20 1 19 2 5 1 3 42 2 2 1 6 1 0 2 3 2 0 0 1 1 0 0 6 0 3 4 5 0 0 3 23 0 4 1 6 0 1 ----282

45-49 0 3 3 1 2 0 55 0 1 5 19 3 35 24 0 31 2 3 3 3 50 4 0 6 9 1 1 2 1 2 10 2 0 7 0 0 8 0 2 8 9 2 0 1 31 0 5 4 9 0 5 ----372

50-54 0 4 3 2 0 0 48 1 1 8 32 2 41 19 0 33 4 7 0 5 68 2 3 3 12 0 1 3 3 3 19 1 0 5 0 0 8 0 0 8 8 0 1 2 22 0 6 2 11 1 16 ----418

55-59 0 3 4 2 2 1 31 3 0 1 29 3 44 15 1 40 3 6 2 7 78 3 1 6 13 0 0 2 0 0 26 0 0 5 0 0 3 0 0 4 3 1 0 2 27 0 3 1 3 0 7 ----385

60-64 0 8 2 2 3 0 27 7 0 9 44 3 40 31 1 35 3 9 4 5 86 8 3 4 20 1 0 7 2 1 41 0 0 3 0 0 16 0 0 4 10 0 0 1 21 0 6 0 8 1 9 ----485

65-69 0 5 3 2 1 3 19 6 0 10 40 1 40 13 3 25 4 5 2 7 56 2 2 3 25 0 0 0 3 0 42 1 0 3 0 1 13 0 0 6 6 1 0 0 21 0 3 0 7 0 4 ----388

70-74 0 4 6 1 0 1 11 5 1 10 43 0 61 24 1 23 3 9 0 4 63 3 0 4 26 1 0 3 0 0 60 0 0 1 0 0 13 1 0 4 3 0 0 2 18 0 3 1 4 0 6 ----423

75+ 0.10% 0.90% 0.90% 0.50% 0.30% 0.10% 10.50% 0.70% 0.10% 1.40% 7.20% 0.50% 9.50% 4.90% 0.30% 6.70% 0.70% 1.40% 0.50% 1.00% 13.70% 0.80% 0.90% 0.90% 3.50% 0.10% 0.10% 0.90% 0.40% 0.40% 5.70% 0.90% 0.00% 0.90% 0.00% 0.00% 2.10% 0.00% 0.40% 2.30% 1.60% 0.20% 0.00% 0.60% 6.80% 0.00% 0.90% 2.70% 3.20% 0.10% 1.70% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 47: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, SABAH, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

127

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

17 22 41 18 3 4 152 10 0 28 183 14 253 104 10 84 16 40 7 6 294 27 27 16 148 1 0 35 805 7 18 471 119 81 259 4 9 17 0 0 30 4 10 68 135 9 1 18 177 0 31 64 87 2 59 ----4045

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 1 0 0 2 0 0 0 0 7 4 0 1 0 0 1 0 0 19 9 0 3 ----53

0-9

0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 4 1 1 0 0 5 0 0 18 4 0 2 ----40

50 1 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 3 0 0 0 0 0 0 4 0 0 1 0 0 0 0 0 5 0 0 0 0 6 0 0 9 2 0 1 ----41

10-14 0 1 0 0 0 0 2 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 8 0 1 0 0 2 0 0 0 0 0 0 13 0 1 0 0 0 0 0 2 1 2 0 0 5 7 0 0 4 5 0 4 ----61

15-19 0 0 1 3 0 0 6 1 0 0 4 1 4 1 1 1 0 1 0 0 1 0 1 0 1 0 0 2 6 0 0 2 0 2 18 0 2 2 0 0 0 0 0 5 9 0 0 4 10 0 0 0 8 0 3 ----100

20-24 0 1 2 1 0 0 4 0 0 0 4 0 10 3 0 1 0 1 0 0 5 0 1 1 3 0 0 3 13 0 1 13 3 2 8 0 1 1 0 0 0 0 0 4 7 0 0 3 6 0 0 2 2 0 1 ----107

25-29 0 1 1 1 0 0 4 0 0 0 3 0 5 1 0 1 2 1 0 0 4 1 1 0 3 0 0 1 35 1 0 21 5 1 9 0 2 0 0 0 3 0 0 3 8 1 0 1 7 0 0 0 5 0 2 ----134

30-34 0 1 2 1 0 0 15 0 0 0 9 2 10 3 0 3 0 0 0 0 9 0 0 1 1 0 0 3 77 0 2 44 10 7 19 1 3 1 0 0 0 0 0 1 16 1 0 0 8 0 2 3 8 0 2 ----265

35-39 1 2 2 1 0 0 15 0 0 1 8 0 13 7 0 1 1 6 1 0 9 2 1 1 4 0 0 0 126 0 3 75 10 14 28 1 0 1 0 0 1 0 0 5 15 0 0 0 12 0 3 3 10 0 5 ----388

40-44 0 2 0 2 0 1 27 1 0 3 12 1 24 10 1 5 0 5 1 0 26 1 2 0 15 0 0 3 170 2 1 86 19 14 45 0 0 1 0 0 4 0 1 7 19 1 0 1 17 0 2 1 5 1 5 ----544

45-49 2 6 4 1 0 0 28 2 0 2 21 2 33 14 3 4 2 3 1 1 30 4 1 2 12 0 0 2 128 1 0 83 22 15 36 1 0 2 0 0 3 1 0 8 17 1 0 0 24 0 6 1 10 1 8 ----548

50-54 2 1 3 3 2 0 15 2 0 6 24 1 30 15 1 14 1 4 1 0 34 5 1 2 15 1 0 2 96 1 4 52 22 12 28 0 0 2 0 0 4 0 0 4 13 0 1 0 16 0 3 0 9 0 6 ----458

55-59 3 1 2 1 0 1 8 2 0 3 13 1 28 9 0 16 1 4 1 2 37 2 2 2 12 0 0 0 55 1 1 32 9 5 19 0 0 1 0 0 6 1 0 3 5 0 0 1 17 0 6 0 6 0 5 ----324

60-64 3 1 12 0 1 0 10 0 0 2 27 2 30 12 1 9 5 7 0 0 58 3 1 2 26 0 0 2 42 0 3 27 6 1 16 1 0 0 0 0 4 0 0 5 12 2 0 1 10 0 4 1 0 0 3 ----352

65-69 4 2 7 2 0 1 10 2 0 6 22 2 30 11 2 18 0 4 0 1 43 5 0 2 18 0 0 4 33 0 2 21 6 5 6 0 0 2 0 0 1 0 0 6 4 1 0 1 14 0 4 0 3 0 3 ----308

70-74 2 2 5 0 0 1 5 0 0 5 35 2 35 18 1 9 4 4 2 2 38 4 1 3 37 0 0 2 24 1 1 15 7 3 8 0 0 1 0 0 4 2 0 3 7 0 0 1 17 0 1 3 1 0 6 ----322

75+ 0.40% 0.50% 1.00% 0.40% 0.10% 0.10% 3.80% 0.20% 0.00% 0.70% 4.50% 0.30% 6.30% 2.60% 0.20% 2.10% 0.40% 1.00% 0.20% 0.10% 7.30% 0.70% 0.70% 0.40% 3.70% 0.00% 0.00% 0.90% 19.90% 0.20% 0.40% 11.60% 2.90% 2.00% 6.40% 0.10% 0.20% 0.40% 0.00% 0.00% 0.70% 0.10% 0.20% 1.70% 3.30% 0.20% 0.00% 0.40% 4.40% 0.00% 0.80% 1.60% 2.20% 0.00% 1.50% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 48: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, SABAH, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

128

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 32 32 17 9 5 369 24 3 48 253 17 336 174 9 236 24 49 18 35 482 29 33 33 125 4 5 31 14 14 199 32 1 32 0 1 73 1 14 80 55 6 1 20 241 0 32 95 112 5 60 ----3522

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 1.1 0 0.4 0 0 0 0 1.3 1.1 0 0 0 0 0.4 0 0 4.6 1.4 0 0.6 ----12

0-9

0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0 0.4 0 0 0 0 1.1 0 0 3.4 0.9 0.1 0.3 ----7

50 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.3 0 0 0.1 0.9 0 0 1 1 0 0.3 ----6

10-14 0 0.1 0 0.1 0 0 1.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 1 0.1 0 0 0 0.1 0 0 0.1 0.3 0 0 0 0 0.1 0 0 0.7 0 0 0 0.3 1.8 0 0 1.2 0.9 0 0 ----8

15-19 0 0 0 0.3 0 0 1.9 0 0 0 0.2 0 0.7 0.2 0 0 0.2 0.2 0 0 0 0 1 0 0 0 0.2 0.2 0 0 0 0.9 0 0 0 0 0 0 0 0.5 0 0 0 0.5 0.5 0 0 0.5 2.3 0 0.2 ----10

20-24 0 0.2 0.6 0.2 0 0 2.2 0 0 0 0.7 0 2.1 0.4 0 0.4 0.2 0 0.2 0 0.9 0 0.2 0.2 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 1.1 0.4 0.2 0 0 1.7 0 0.2 0.9 0.9 0 0 ----14

25-29 0 0 0.5 0.3 0 0 4.7 0 0 0.3 0.8 0.3 2.4 1.3 0.3 1 0 0.3 0.3 0 0.8 0 0.3 0.3 1 0 0.3 0.5 0 0.3 0 0.8 0 0.3 0 0 0.3 0 0 1 0 0 0 0.5 3.4 0 0 0.5 1.6 0 0 ----24

30-34 0 0 0.9 0.6 0 0 6.6 0 0 0 2 0 3.7 1.7 0 2 0 0.3 0 0.3 3.4 1.1 0 0.6 1.7 0 0 0.9 0 0.3 0 1.4 0 0.3 0 0 0.3 0 0 0.9 0.6 0 0 0.3 3.2 0 0 1.1 2 0.3 0.6 ----37

35-39 0.6 0.3 0 0 0 0 10.5 0.3 0 0.3 3.3 0.9 6 4.2 0.3 4.5 0.3 0.6 0.9 0 5.4 0.3 0.6 0.3 1.2 0 0.3 0.6 0.6 0.9 0 0.6 0 0.6 0 0 0.6 0 0 2.1 1.5 0.3 0 0 3.9 0 0.3 0.3 1.2 0.3 0.3 ----55

40-44 0 0.7 1 0 0.3 0 20.8 0 0 1 6.5 0.3 5.9 6.5 0.3 6.2 0.7 1.6 0.3 1 13.7 0.7 0.7 0.3 2 0.3 0 0.7 1 0.7 0 0 0.3 0.3 0 0 2 0 1 1.3 1.6 0 0 1 7.5 0 1.3 0.3 2 0 0.3 ----92

45-49 0 1.2 1.2 0.4 0.8 0 22 0 0.4 2 7.6 1.2 14 9.6 0 12.4 0.8 1.2 1.2 1.2 20 1.6 0 2.4 3.6 0.4 0.4 0.8 0.4 0.8 4 0.8 0 2.8 0 0 3.2 0 0.8 3.2 3.6 0.8 0 0.4 12.4 0 2 1.6 3.6 0 2 ----149

50-54 0 2.4 1.8 1.2 0 0 28.5 0.6 0.6 4.7 19 1.2 24.3 11.3 0 19.6 2.4 4.2 0 3 40.4 1.2 1.8 1.8 7.1 0 0.6 1.8 1.8 1.8 11.3 0.6 0 3 0 0 4.7 0 0 4.7 4.7 0 0.6 1.2 13.1 0 3.6 1.2 6.5 0.6 9.5 ----248

55-59 0 2.8 3.7 1.9 1.9 0.9 29 2.8 0 0.9 27.1 2.8 41.1 14 0.9 37.4 2.8 5.6 1.9 6.5 72.9 2.8 0.9 5.6 12.2 0 0 1.9 0 0 24.3 0 0 4.7 0 0 2.8 0 0 3.7 2.8 0.9 0 1.9 25.2 0 2.8 0.9 2.8 0 6.5 ----360

60-64 0 9.5 2.4 2.4 3.6 0 32 8.3 0 10.7 52.1 3.6 47.3 36.7 1.2 41.4 3.6 10.7 4.7 5.9 101.8 9.5 3.6 4.7 23.7 1.2 0 8.3 2.4 1.2 48.5 0 0 3.6 0 0 18.9 0 0 4.7 11.8 0 0 1.2 24.9 0 7.1 0 9.5 1.2 10.7 ----574

65-69 0 8.9 5.3 3.5 1.8 5.3 33.6 10.6 0 17.7 70.8 1.8 70.8 23 5.3 44.3 7.1 8.9 3.5 12.4 99.1 3.5 3.5 5.3 44.3 0 0 0 5.3 0 74.3 1.8 0 5.3 0 1.8 23 0 0 10.6 10.6 1.8 0 0 37.2 0 5.3 0 12.4 0 7.1 ----687

70-74 0 6.2 9.2 1.5 0 1.5 16.9 7.7 1.5 15.4 66.2 0 93.9 36.9 1.5 35.4 4.6 13.8 0 6.2 96.9 4.6 0 6.2 40 1.5 0 4.6 0 0 92.3 0 0 1.5 0 0 20 1.5 0 6.2 4.6 0 0 3.1 27.7 0 4.6 1.5 6.2 0 9.2 ----651

75+

APPENDIX 49: CANCER INCIDENCE BY SITES AND AGE GROUP, SABAH, ALL RESIDENTS, MALES, 2007-2011

0 0.5 0.5 0.3 0.2 0.1 6.2 0.4 0.1 0.8 4.2 0.3 5.6 2.9 0.2 3.9 0.4 0.8 0.3 0.6 8.1 0.5 0.6 0.6 2.1 0.1 0.1 0.5 0.2 0.2 3.3 0.5 0 0.5 0 0 1.2 0 0.2 1.3 0.9 0.1 0 0.3 4 0 0.5 1.6 1.9 0.1 1 ----58.9

Crude Rate 0 0.9 0.8 0.4 0.3 0.2 8.5 0.8 0.1 1.4 7.4 0.5 9.3 4.7 0.3 6.6 0.7 1.4 0.5 1.1 14 0.8 0.6 0.9 3.7 0.1 0.1 0.8 0.4 0.3 6.4 0.5 0 0.8 0 0 2.1 0 0.3 1.7 1.4 0.1 0 0.4 5.9 0 0.9 1.5 2.3 0.1 1.6 ----93.6

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

129

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

17 22 41 18 3 4 152 10 0 28 183 14 253 104 10 84 16 40 7 6 294 27 27 16 148 1 0 35 805 7 18 471 119 81 259 4 9 17 0 0 30 4 10 68 135 9 1 18 177 0 31 64 87 2 59 ----4045

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0.2 0 0 0.3 0 0 0 0 1.1 0.6 0 0.2 0 0 0.2 0 0 2.9 1.4 0 0.5 ----8

0-9

0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.6 0.1 0.1 0 0 0.7 0 0 2.7 0.6 0 0.3 ----6

50 0.2 0 0.2 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.5 0 0 0 0 0 0 0.6 0 0 0.2 0 0 0 0 0 0.8 0 0 0 0 0.9 0 0 1.4 0.3 0 0.2 ----6

10-14 0 0.1 0 0 0 0 0.3 0 0 0 0.1 0 0.1 0 0 0.1 0 0 0 0 0 0 1.2 0 0.1 0 0 0.3 0 0 0 0 0 0 1.9 0 0.1 0 0 0 0 0 0.3 0.1 0.3 0 0 0.7 1 0 0 0.6 0.7 0 0.6 ----9

15-19 0 0 0.2 0.5 0 0 1 0.2 0 0 0.7 0.2 0.7 0.2 0.2 0.2 0 0.2 0 0 0.2 0 0.2 0 0.2 0 0 0.3 1 0 0 0.3 0 0.3 3 0 0.3 0.3 0 0 0 0 0 0.8 1.5 0 0 0.7 1.7 0 0 0 1.3 0 0.5 ----17

20-24 0 0.2 0.4 0.2 0 0 0.7 0 0 0 0.7 0 1.8 0.6 0 0.2 0 0.2 0 0 0.9 0 0.2 0.2 0.6 0 0 0.6 2.4 0 0.2 2.4 0.6 0.4 1.5 0 0.2 0.2 0 0 0 0 0 0.7 1.3 0 0 0.6 1.1 0 0 0.4 0.4 0 0.2 ----20

25-29 0 0.3 0.3 0.3 0 0 1 0 0 0 0.8 0 1.3 0.3 0 0.3 0.5 0.3 0 0 1 0.3 0.3 0 0.8 0 0 0.3 9 0.3 0 5.4 1.3 0.3 2.3 0 0.5 0 0 0 0.8 0 0 0.8 2.1 0.3 0 0.3 1.8 0 0 0 1.3 0 0.5 ----35

30-34 0 0.3 0.6 0.3 0 0 4.2 0 0 0 2.5 0.6 2.8 0.8 0 0.8 0 0 0 0 2.5 0 0 0.3 0.3 0 0 0.8 21.7 0 0.6 12.4 2.8 2 5.4 0.3 0.8 0.3 0 0 0 0 0 0.3 4.5 0.3 0 0 2.3 0 0.6 0.8 2.3 0 0.6 ----75

35-39 0.3 0.6 0.6 0.3 0 0 4.7 0 0 0.3 2.5 0 4.1 2.2 0 0.3 0.3 1.9 0.3 0 2.8 0.6 0.3 0.3 1.3 0 0 0 39.6 0 0.9 23.6 3.1 4.4 8.8 0.3 0 0.3 0 0 0.3 0 0 1.6 4.7 0 0 0 3.8 0 0.9 0.9 3.1 0 1.6 ----122

40-44 0 0.7 0 0.7 0 0.4 9.8 0.4 0 1.1 4.4 0.4 8.7 3.6 0.4 1.8 0 1.8 0.4 0 9.5 0.4 0.7 0 5.5 0 0 1.1 61.9 0.7 0.4 31.3 6.9 5.1 16.4 0 0 0.4 0 0 1.5 0 0.4 2.6 6.9 0.4 0 0.4 6.2 0 0.7 0.4 1.8 0.4 1.8 ----198

45-49 0.9 2.8 1.9 0.5 0 0 13 0.9 0 0.9 9.8 0.9 15.4 6.5 1.4 1.9 0.9 1.4 0.5 0.5 14 1.9 0.5 0.9 5.6 0 0 0.9 59.5 0.5 0 38.6 10.2 7 16.7 0.5 0 0.9 0 0 1.4 0.5 0 3.7 7.9 0.5 0 0 11.2 0 2.8 0.5 4.7 0.5 3.7 ----255

50-54 1.4 0.7 2.1 2.1 1.4 0 10.5 1.4 0 4.2 16.8 0.7 21.1 10.5 0.7 9.8 0.7 2.8 0.7 0 23.9 3.5 0.7 1.4 10.5 0.7 0 1.4 67.4 0.7 2.8 36.5 15.4 8.4 19.7 0 0 1.4 0 0 2.8 0 0 2.8 9.1 0 0.7 0 11.2 0 2.1 0 6.3 0 4.2 ----321

55-59 3 1 2 1 0 1 8 2 0 3 13.1 1 28.1 9 0 16.1 1 4 1 2 37.2 2 2 2 12.1 0 0 0 55.3 1 1 32.2 9 5 19.1 0 0 1 0 0 6 1 0 3 5 0 0 1 17.1 0 6 0 6 0 5 ----326

60-64 4 1.3 16 0 1.3 0 13.3 0 0 2.7 36 2.7 40 16 1.3 12 6.7 9.3 0 0 77.3 4 1.3 2.7 34.7 0 0 2.7 56 0 4 36 8 1.3 21.3 1.3 0 0 0 0 5.3 0 0 6.7 16 2.7 0 1.3 13.3 0 5.3 1.3 0 0 4 ----469

65-69 7 3.5 12.3 3.5 0 1.8 17.5 3.5 0 10.5 38.6 3.5 52.6 19.3 3.5 31.6 0 7 0 1.8 75.4 8.8 0 3.5 31.6 0 0 7 57.9 0 3.5 36.8 10.5 8.8 10.5 0 0 3.5 0 0 1.8 0 0 10.5 7 1.8 0 1.8 24.6 0 7 0 5.3 0 5.3 ----540

70-74 3.2 3.2 7.9 0 0 1.6 7.9 0 0 7.9 55.6 3.2 55.6 28.6 1.6 14.3 6.4 6.4 3.2 3.2 60.3 6.4 1.6 4.8 58.7 0 0 3.2 38.1 1.6 1.6 23.8 11.1 4.8 12.7 0 0 1.6 0 0 6.4 3.2 0 4.8 11.1 0 0 1.6 27 0 1.6 4.8 1.6 0 9.5 ----511

75+

APPENDIX 50: CANCER INCIDENCE BY SITES AND AGE GROUP, SABAH, ALL RESIDENTS, FEMALES, 2007-2011

0.3 0.4 0.7 0.3 0.1 0.1 2.6 0.2 0 0.5 3.2 0.2 4.4 1.8 0.2 1.4 0.3 0.7 0.1 0.1 5.1 0.5 0.5 0.3 2.6 0 0 0.6 13.9 0.1 0.3 8.1 2.1 1.4 4.5 0.1 0.2 0.3 0 0 0.5 0.1 0.2 1.2 2.3 0.2 0 0.3 3.1 0 0.5 1.1 1.5 0 1 ----69.8

Crude Rate C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

0.6 0.5 1.3 0.4 0.1 0.1 3.7 0.3 0 0.9 5.4 0.4 7.3 3 0.3 2.7 0.5 1.2 0.2 0.2 9.2 0.8 0.5 0.5 4.6 0 0 0.8 19.7 0.2 0.5 11.6 3.1 2 6.1 0.1 0.1 0.4 0 0 0.9 0.1 0.2 1.6 3.2 0.2 0 0.3 4.5 0 0.9 1.1 1.8 0 1.4 ----105.4 All

ICD (10th)

ASR World

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

130

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 32 23 28 7 1 665 9 2 57 337 6 349 288 1 289 54 88 18 75 619 8 48 30 110 1 2 57 11 26 206 54 1 67 0 0 95 0 9 96 41 9 11 49 310 0 38 96 121 31 73 ----4549

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 11 0 5 0 0 0 0 7 5 0 5 3 1 4 0 0 28 7 6 0 ----83

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 14 0 2 0 5 10 0 0 10 3 0 0 ----50

50 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 14 0 0 0 0 3 0 0 0 2 0 0 0 0 0 0 1 9 1 0 3 1 6 0 0 15 5 1 0 ----65

10-14 0 0 0 1 0 0 14 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 7 0 0 0 0 4 0 0 0 5 0 0 0 0 0 0 0 4 1 0 3 2 12 0 0 3 4 1 0 ----63

15-19 0 1 0 1 0 0 13 0 0 0 0 0 1 3 0 1 0 0 0 0 3 1 4 1 1 0 0 4 0 0 0 8 0 0 0 0 0 0 0 6 0 0 0 6 12 0 0 4 8 2 1 ----81

20-24 0 1 0 2 0 0 20 0 0 0 2 0 5 2 0 2 1 0 0 0 2 1 2 0 1 0 0 1 0 0 0 7 0 0 0 0 0 0 0 2 3 0 0 6 9 0 0 2 6 1 1 ----79

25-29 0 2 0 2 0 0 28 0 0 2 1 0 12 2 0 7 0 1 0 1 7 0 3 2 2 0 0 2 0 3 0 7 0 1 0 0 0 0 0 4 0 0 0 4 11 0 1 3 4 0 2 ----114

30-34 0 4 0 4 1 0 69 0 0 0 14 0 9 12 0 10 4 0 0 0 11 2 2 1 1 0 0 6 2 1 0 3 0 1 0 0 2 0 0 8 3 1 1 1 8 0 0 4 11 2 3 ----201

35-39 0 2 2 3 1 0 79 0 0 3 23 0 16 10 0 14 0 1 3 2 26 2 6 4 3 0 0 6 0 5 0 1 0 5 0 0 2 0 0 9 3 0 0 7 22 0 2 0 7 0 5 ----274

40-44 0 6 2 5 1 0 99 1 1 6 19 2 28 22 0 11 3 11 5 3 44 0 3 2 9 0 0 2 1 4 4 2 0 5 0 0 7 0 0 7 3 0 1 2 20 0 5 1 9 2 7 ----365

45-49 0 1 1 3 0 0 100 0 0 2 28 2 42 23 1 35 4 9 2 12 66 1 2 3 13 1 0 10 2 3 10 3 0 10 0 0 9 0 0 8 4 0 0 2 38 0 5 6 13 4 12 ----490

50-54 0 3 2 2 1 0 82 1 0 12 33 2 43 39 0 58 8 12 1 10 77 1 1 4 13 0 0 4 1 2 12 1 0 7 0 0 13 0 0 3 8 0 0 2 30 0 8 5 10 3 8 ----522

55-59 0 3 4 0 0 0 67 1 1 9 59 0 47 43 0 63 7 11 1 12 123 0 1 2 14 0 0 5 2 3 45 0 0 9 0 0 16 0 0 7 6 1 0 2 46 0 5 3 14 2 8 ----642

60-64 0 4 4 1 0 0 46 3 0 5 50 0 44 39 0 31 14 22 3 13 114 0 1 7 14 0 1 7 2 2 43 0 0 10 0 0 11 0 0 6 4 0 0 2 34 0 5 3 12 2 10 ----569

65-69 0 2 3 1 2 0 25 3 0 5 43 0 42 42 0 26 7 14 0 8 67 0 0 1 11 0 0 0 0 2 35 1 0 11 0 0 18 0 0 3 3 0 0 3 24 0 2 6 3 2 7 ----422

70-74 1 3 5 3 1 1 20 0 0 13 65 0 59 50 0 31 6 7 2 14 79 0 0 3 28 0 1 2 1 1 57 0 1 3 0 0 17 0 0 1 2 0 0 3 24 0 5 3 5 3 9 ----529

75+ 0.00% 0.70% 0.50% 0.60% 0.20% 0.00% 14.60% 0.20% 0.00% 1.30% 7.40% 0.10% 7.70% 6.30% 0.00% 6.40% 1.20% 1.90% 0.40% 1.60% 13.60% 0.20% 1.10% 0.70% 2.40% 0.00% 0.00% 1.30% 0.20% 0.60% 4.50% 1.20% 0.00% 1.50% 0.00% 0.00% 2.10% 0.00% 0.20% 2.10% 0.90% 0.20% 0.20% 1.10% 6.80% 0.00% 0.80% 2.10% 2.70% 0.70% 1.60% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 51: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, SARAWAK, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

131

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 30 30 44 8 0 258 4 1 34 195 2 275 229 5 88 52 51 12 19 347 12 31 24 90 4 1 40 1198 20 10 640 190 21 325 0 13 31 0 0 29 0 11 89 161 8 1 33 222 0 37 72 103 21 64 ----5185

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 7 0 0 2 0 0 0 0 8 5 0 3 0 0 2 0 0 36 6 1 1 ----77

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 9 0 2 0 1 4 0 0 9 6 1 0 ----36

50 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 7 2 0 0 1 6 0 0 5 6 3 0 ----45

10-14 0 0 0 2 0 0 6 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 6 1 1 0 0 2 1 0 0 0 0 0 6 0 0 1 0 0 0 0 0 6 7 0 0 4 10 0 0 2 2 1 0 ----61

15-19 0 0 0 1 0 0 12 0 0 0 1 0 1 1 0 1 0 0 1 0 2 1 4 0 0 0 0 1 5 0 0 4 1 0 16 0 1 1 0 0 0 0 0 3 5 0 0 7 7 0 0 0 7 1 1 ----85

20-24 0 2 1 2 0 0 9 0 0 0 0 0 1 5 0 0 0 0 0 0 1 0 2 1 1 0 0 1 21 0 0 6 2 0 15 0 4 1 0 0 0 0 0 2 11 0 0 4 5 0 0 0 7 0 1 ----105

25-29 0 1 1 2 1 0 20 0 0 0 3 1 9 3 0 4 2 0 0 0 4 0 4 1 0 0 0 2 36 0 0 27 8 1 16 0 1 1 0 0 1 0 1 3 11 0 0 4 7 0 0 0 3 0 2 ----180

30-34 0 3 1 4 1 0 27 0 0 1 3 0 8 5 1 3 1 0 0 0 8 2 2 1 2 0 0 3 100 1 0 76 8 1 19 0 4 2 0 0 0 0 0 7 10 1 0 4 7 0 3 1 7 1 4 ----332

35-39 0 2 1 5 0 0 33 0 0 1 7 0 13 10 1 7 0 5 3 0 14 0 2 4 3 0 0 1 198 2 0 86 18 2 31 0 1 0 0 0 0 0 1 8 18 1 0 1 19 0 1 2 4 1 1 ----507

40-44 0 1 3 4 1 0 38 0 0 1 15 0 22 19 0 8 3 2 0 3 22 0 1 0 4 0 1 6 216 0 1 112 33 4 47 0 2 4 0 0 1 0 0 5 18 0 1 1 15 0 3 2 12 0 10 ----641

45-49 0 4 1 4 1 0 37 1 0 5 19 0 21 13 1 6 5 12 2 1 38 2 3 1 8 0 0 3 178 2 1 96 36 6 44 0 0 5 0 0 4 0 0 10 24 0 0 2 25 0 6 4 12 2 4 ----649

50-54 0 3 6 4 0 0 22 1 1 5 25 0 54 34 1 10 6 8 2 1 45 0 0 3 6 0 0 5 176 3 2 68 33 4 44 0 0 3 0 0 2 0 0 10 19 0 0 0 34 0 5 2 11 1 7 ----666

55-59 0 3 1 4 0 0 23 0 0 6 36 1 29 34 1 16 5 9 0 4 70 3 2 2 9 2 0 4 120 4 0 55 23 2 32 0 0 5 0 0 2 0 0 6 8 1 0 1 22 0 12 0 6 1 8 ----572

60-64 0 2 4 3 0 0 17 1 0 4 26 0 33 34 0 13 12 3 0 6 66 2 0 3 12 1 0 5 68 3 2 37 14 0 14 0 0 4 0 0 10 0 0 5 19 0 0 0 26 0 5 4 7 2 5 ----472

65-69 0 4 4 5 1 0 6 1 0 4 24 0 33 26 0 6 5 3 3 2 38 0 1 2 13 1 0 1 43 0 1 40 8 1 9 0 0 1 0 0 3 0 0 1 6 0 0 2 16 0 1 1 2 4 8 ----330

70-74 0 5 7 2 3 0 8 0 0 7 35 0 51 45 0 10 13 9 1 2 38 1 1 4 31 0 0 3 36 5 3 33 6 0 14 0 0 1 0 0 6 0 0 2 3 0 0 1 17 0 1 4 5 2 12 ----427

75+ 0.00% 0.60% 0.60% 0.80% 0.20% 0.00% 5.00% 0.10% 0.00% 0.70% 3.80% 0.00% 5.30% 4.40% 0.10% 1.70% 1.00% 1.00% 0.20% 0.40% 6.70% 0.20% 0.60% 0.50% 1.70% 0.10% 0.00% 0.80% 23.10% 0.40% 0.20% 12.30% 3.70% 0.40% 6.30% 0.00% 0.30% 0.60% 0.00% 0.00% 0.60% 0.00% 0.20% 1.70% 3.10% 0.20% 0.00% 0.60% 4.30% 0.00% 0.70% 1.40% 2.00% 0.40% 1.20% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 52: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, SARAWAK, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

132

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 32 23 28 7 1 665 9 2 57 337 6 349 288 1 289 54 88 18 75 619 8 48 30 110 1 2 57 11 26 206 54 1 67 0 0 95 0 9 96 41 9 11 49 310 0 38 96 121 31 73 ----4549

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 1.9 0 0.9 0 0 0 0 1.2 0.9 0 0.9 0.5 0.2 0.7 0 0 4.8 1.2 1 0 ----14

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0.2 2.2 0 0.3 0 0.8 1.6 0 0 1.6 0.5 0 0 ----8

50 0 0 0 0 0 0.5 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 2.3 0 0 0 0 0.5 0 0 0 0.3 0 0 0 0 0 0 0.2 1.5 0.2 0 0.5 0.2 1 0 0 2.4 0.8 0.2 0 ----11

10-14 0 0 0 0.2 0 0 2.3 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 1.2 0 0 0 0 0.7 0 0 0 0.8 0 0 0 0 0 0 0 0.7 0.2 0 0.5 0.3 2 0 0 0.5 0.7 0.2 0 ----11

15-19 0 0.2 0 0.2 0 0 2.6 0 0 0 0 0 0.2 0.6 0 0.2 0 0 0 0 0.6 0.2 0.8 0.2 0.2 0 0 0.8 0 0 0 1.6 0 0 0 0 0 0 0 1.2 0 0 0 1.2 2.4 0 0 0.8 1.6 0.4 0.2 ----16

20-24 0 0.2 0 0.5 0 0 4.6 0 0 0 0.5 0 1.1 0.5 0 0.5 0.2 0 0 0 0.5 0.2 0.5 0 0.2 0 0 0.2 0 0 0 1.6 0 0 0 0 0 0 0 0.5 0.7 0 0 1.4 2.1 0 0 0.5 1.4 0.2 0.2 ----18

25-29 0 0.5 0 0.5 0 0 7.3 0 0 0.5 0.3 0 3.1 0.5 0 1.8 0 0.3 0 0.3 1.8 0 0.8 0.5 0.5 0 0 0.5 0 0.8 0 1.8 0 0.3 0 0 0 0 0 1 0 0 0 1 2.9 0 0.3 0.8 1 0 0.5 ----30

30-34 0 1 0 1 0.3 0 17.3 0 0 0 3.5 0 2.3 3 0 2.5 1 0 0 0 2.8 0.5 0.5 0.3 0.3 0 0 1.5 0.5 0.3 0 0.8 0 0.3 0 0 0.5 0 0 2 0.8 0.3 0.3 0.3 2 0 0 1 2.8 0.5 0.8 ----50

35-39 0 0.5 0.5 0.8 0.3 0 20.2 0 0 0.8 5.9 0 4.1 2.6 0 3.6 0 0.3 0.8 0.5 6.6 0.5 1.5 1 0.8 0 0 1.5 0 1.3 0 0.3 0 1.3 0 0 0.5 0 0 2.3 0.8 0 0 1.8 5.6 0 0.5 0 1.8 0 1.3 ----70

40-44 0 1.7 0.6 1.4 0.3 0 27.4 0.3 0.3 1.7 5.3 0.6 7.7 6.1 0 3 0.8 3 1.4 0.8 12.2 0 0.8 0.6 2.5 0 0 0.6 0.3 1.1 1.1 0.6 0 1.4 0 0 1.9 0 0 1.9 0.8 0 0.3 0.6 5.5 0 1.4 0.3 2.5 0.6 1.9 ----101

45-49 0 0.3 0.3 1 0 0 33 0 0 0.7 9.2 0.7 13.8 7.6 0.3 11.5 1.3 3 0.7 4 21.7 0.3 0.7 1 4.3 0.3 0 3.3 0.7 1 3.3 1 0 3.3 0 0 3 0 0 2.6 1.3 0 0 0.7 12.5 0 1.6 2 4.3 1.3 4 ----161

50-54 0 1.3 0.8 0.8 0.4 0 34.5 0.4 0 5.1 13.9 0.8 18.1 16.4 0 24.4 3.4 5.1 0.4 4.2 32.4 0.4 0.4 1.7 5.5 0 0 1.7 0.4 0.8 5.1 0.4 0 2.9 0 0 5.5 0 0 1.3 3.4 0 0 0.8 12.6 0 3.4 2.1 4.2 1.3 3.4 ----220

55-59 0 1.5 2 0 0 0 34 0.5 0.5 4.6 30 0 23.9 21.8 0 32 3.6 5.6 0.5 6.1 62.4 0 0.5 1 7.1 0 0 2.5 1 1.5 22.8 0 0 4.6 0 0 8.1 0 0 3.6 3 0.5 0 1 23.4 0 2.5 1.5 7.1 1 4.1 ----326

60-64 0 3.1 3.1 0.8 0 0 36.1 2.4 0 3.9 39.2 0 34.5 30.6 0 24.3 11 17.3 2.4 10.2 89.4 0 0.8 5.5 11 0 0.8 5.5 1.6 1.6 33.7 0 0 7.8 0 0 8.6 0 0 4.7 3.1 0 0 1.6 26.7 0 3.9 2.4 9.4 1.6 7.8 ----446

65-69 0 2.4 3.7 1.2 2.4 0 30.5 3.7 0 6.1 52.4 0 51.2 51.2 0 31.7 8.5 17.1 0 9.8 81.7 0 0 1.2 13.4 0 0 0 0 2.4 42.7 1.2 0 13.4 0 0 22 0 0 3.7 3.7 0 0 3.7 29.3 0 2.4 7.3 3.7 2.4 8.5 ----515

70-74 0.9 2.8 4.7 2.8 0.9 0.9 18.8 0 0 12.2 61 0 55.4 47 0 29.1 5.6 6.6 1.9 13.1 74.2 0 0 2.8 26.3 0 0.9 1.9 0.9 0.9 53.5 0 0.9 2.8 0 0 16 0 0 0.9 1.9 0 0 2.8 22.5 0 4.7 2.8 4.7 2.8 8.5 ----497

75+

APPENDIX 53: CANCER INCIDENCE BY SITES AND AGE GROUP, SARAWAK, ALL RESIDENTS, MALES, 2007-2011

0 0.5 0.4 0.5 0.1 0 11.2 0.2 0 1 5.7 0.1 5.9 4.8 0 4.9 0.9 1.5 0.3 1.3 10.4 0.1 0.8 0.5 1.8 0 0 1 0.2 0.4 3.5 0.9 0 1.1 0 0 1.6 0 0.2 1.6 0.7 0.2 0.2 0.8 5.2 0 0.6 1.6 2 0.5 1.2 ----76.4

Crude Rate 0 0.6 0.5 0.5 0.1 0 11.6 0.2 0 1.1 6.6 0.1 6.7 5.6 0 5.5 1.1 1.8 0.3 1.5 12.2 0.1 0.8 0.6 2.1 0 0 1 0.2 0.5 4.3 0.9 0 1.3 0 0 1.9 0 0.2 1.6 0.8 0.2 0.2 0.9 5.7 0 0.7 1.7 2.2 0.6 1.4 ----85.7

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

133

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 30 30 44 8 0 258 4 1 34 195 2 275 229 5 88 52 51 12 19 347 12 31 24 90 4 1 40 1198 20 10 640 190 21 325 0 13 31 0 0 29 0 11 89 161 8 1 33 222 0 37 72 103 21 64 ----5185

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 1.2 0 0 0.4 0 0 0 0 1.4 0.9 0 0.5 0 0 0.4 0 0 6.3 1.1 0.2 0.2 ----14

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.2 1.5 0 0.3 0 0.2 0.6 0 0 1.5 1 0.2 0 ----6

50 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 1.2 0.3 0 0 0.2 1 0 0 0.8 1 0.5 0 ----7

10-14 0 0 0 0.3 0 0 1 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.2 0.2 1 0.2 0.2 0 0 0.3 0.2 0 0 0 0 0 1 0 0 0.2 0 0 0 0 0 1 1.2 0 0 0.7 1.7 0 0 0.3 0.3 0.2 0 ----10

15-19 0 0 0 0.2 0 0 2.3 0 0 0 0.2 0 0.2 0.2 0 0.2 0 0 0.2 0 0.4 0.2 0.8 0 0 0 0 0.2 1 0 0 0.8 0.2 0 3.1 0 0.2 0.2 0 0 0 0 0 0.6 1 0 0 1.4 1.4 0 0 0 1.4 0.2 0.2 ----16

20-24 0 0.5 0.2 0.5 0 0 2.1 0 0 0 0 0 0.2 1.2 0 0 0 0 0 0 0.2 0 0.5 0.2 0.2 0 0 0.2 4.9 0 0 1.4 0.5 0 3.5 0 0.9 0.2 0 0 0 0 0 0.5 2.6 0 0 0.9 1.2 0 0 0 1.6 0 0.2 ----24

25-29 0 0.3 0.3 0.5 0.3 0 5.3 0 0 0 0.8 0.3 2.4 0.8 0 1.1 0.5 0 0 0 1.1 0 1.1 0.3 0 0 0 0.5 9.5 0 0 7.2 2.1 0.3 4.2 0 0.3 0.3 0 0 0.3 0 0.3 0.8 2.9 0 0 1.1 1.9 0 0 0 0.8 0 0.5 ----48

30-34 0 0.8 0.3 1 0.3 0 7 0 0 0.3 0.8 0 2.1 1.3 0.3 0.8 0.3 0 0 0 2.1 0.5 0.5 0.3 0.5 0 0 0.8 25.8 0.3 0 19.6 2.1 0.3 4.9 0 1 0.5 0 0 0 0 0 1.8 2.6 0.3 0 1 1.8 0 0.8 0.3 1.8 0.3 1 ----86

35-39 0 0.6 0.3 1.4 0 0 9.1 0 0 0.3 1.9 0 3.6 2.8 0.3 1.9 0 1.4 0.8 0 3.9 0 0.6 1.1 0.8 0 0 0.3 54.9 0.6 0 23.8 5 0.6 8.6 0 0.3 0 0 0 0 0 0.3 2.2 5 0.3 0 0.3 5.3 0 0.3 0.6 1.1 0.3 0.3 ----140

40-44 0 0.3 0.9 1.2 0.3 0 11.8 0 0 0.3 4.7 0 6.8 5.9 0 2.5 0.9 0.6 0 0.9 6.8 0 0.3 0 1.2 0 0.3 1.9 67.2 0 0.3 34.8 10.3 1.2 14.6 0 0.6 1.2 0 0 0.3 0 0 1.6 5.6 0 0.3 0.3 4.7 0 0.9 0.6 3.7 0 3.1 ----199

45-49 0 1.5 0.4 1.5 0.4 0 13.9 0.4 0 1.9 7.2 0 7.9 4.9 0.4 2.3 1.9 4.5 0.8 0.4 14.3 0.8 1.1 0.4 3 0 0 1.1 67.1 0.8 0.4 36.2 13.6 2.3 16.6 0 0 1.9 0 0 1.5 0 0 3.8 9 0 0 0.8 9.4 0 2.3 1.5 4.5 0.8 1.5 ----244

50-54 0 1.4 2.8 1.9 0 0 10.2 0.5 0.5 2.3 11.6 0 25.1 15.8 0.5 4.6 2.8 3.7 0.9 0.5 20.9 0 0 1.4 2.8 0 0 2.3 81.7 1.4 0.9 31.6 15.3 1.9 20.4 0 0 1.4 0 0 0.9 0 0 4.6 8.8 0 0 0 15.8 0 2.3 0.9 5.1 0.5 3.2 ----309

55-59 0 1.8 0.6 2.4 0 0 14.1 0 0 3.7 22 0.6 17.7 20.8 0.6 9.8 3.1 5.5 0 2.4 42.8 1.8 1.2 1.2 5.5 1.2 0 2.4 73.4 2.4 0 33.6 14.1 1.2 19.6 0 0 3.1 0 0 1.2 0 0 3.7 4.9 0.6 0 0.6 13.5 0 7.3 0 3.7 0.6 4.9 ----350

60-64 0 1.6 3.3 2.4 0 0 13.8 0.8 0 3.3 21.1 0 26.8 27.6 0 10.6 9.8 2.4 0 4.9 53.7 1.6 0 2.4 9.8 0.8 0 4.1 55.3 2.4 1.6 30.1 11.4 0 11.4 0 0 3.3 0 0 8.1 0 0 4.1 15.4 0 0 0 21.1 0 4.1 3.3 5.7 1.6 4.1 ----384

65-69 0 4.7 4.7 5.9 1.2 0 7.1 1.2 0 4.7 28.4 0 39.1 30.8 0 7.1 5.9 3.6 3.6 2.4 45 0 1.2 2.4 15.4 1.2 0 1.2 50.9 0 1.2 47.3 9.5 1.2 10.7 0 0 1.2 0 0 3.6 0 0 1.2 7.1 0 0 2.4 18.9 0 1.2 1.2 2.4 4.7 9.5 ----391

70-74 0 4 5.6 1.6 2.4 0 6.4 0 0 5.6 28 0 40.8 36 0 8 10.4 7.2 0.8 1.6 30.4 0.8 0.8 3.2 24.8 0 0 2.4 28.8 4 2.4 26.4 4.8 0 11.2 0 0 0.8 0 0 4.8 0 0 1.6 2.4 0 0 0.8 13.6 0 0.8 3.2 4 1.6 9.6 ----342

75+ 0 0.5 0.5 0.8 0.1 0 4.5 0.1 0 0.6 3.4 0 4.8 4 0.1 1.5 0.9 0.9 0.2 0.3 6 0.2 0.5 0.4 1.6 0.1 0 0.7 20.9 0.3 0.2 11.2 3.3 0.4 5.7 0 0.2 0.5 0 0 0.5 0 0.2 1.6 2.8 0.1 0 0.6 3.9 0 0.6 1.3 1.8 0.4 1.1 ----90.4

Crude Rate

APPENDIX 54: CANCER INCIDENCE BY SITES AND AGE GROUP, SARAWAK, ALL RESIDENTS, FEMALES, 2007-2011

0 0.6 0.6 0.8 0.1 0 4.8 0.1 0 0.7 4 0 5.4 4.6 0.1 1.8 1.1 1 0.2 0.4 7.3 0.2 0.5 0.5 1.8 0.1 0 0.8 22.7 0.4 0.2 12.1 3.7 0.4 6.1 0 0.2 0.6 0 0 0.6 0 0.2 1.6 3 0.2 0 0.6 4.3 0 0.8 1.4 1.9 0.4 1.3 ----100.2

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

134

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

5 62 43 30 13 10 459 19 5 80 155 8 338 310 9 226 42 98 32 87 788 25 53 17 208 5 1 15 15 12 325 36 6 94 2 3 116 5 6 192 42 1 31 23 196 1 18 64 58 25 51 ----4465

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 4 0 0 0 0 1 0 0 21 3 3 0 ----37

0-9

0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 2 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 2 0 0 0 0 6 0 0 12 6 1 0 ----34

50 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18 0 0 0 2 3 0 0 8 5 1 0 ----42

10-14 0 0 0 0 0 0 3 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 8 0 2 0 0 2 0 0 0 2 0 0 0 0 0 0 0 13 0 0 2 3 4 0 0 8 5 1 1 ----56

15-19 0 0 0 1 0 0 3 1 0 0 0 0 1 1 0 1 0 0 0 0 4 3 8 1 2 0 0 1 0 0 0 4 0 0 0 0 0 0 0 6 4 0 2 1 10 0 0 2 3 2 0 ----61

20-24 0 0 1 3 1 0 8 0 0 1 1 0 4 3 0 0 0 1 0 1 2 3 6 0 1 0 0 2 0 0 0 6 0 1 0 0 0 0 0 3 0 0 1 2 10 0 0 3 3 2 0 ----69

25-29 0 1 1 1 0 0 19 0 0 0 2 0 2 2 1 2 0 0 0 1 4 1 1 0 1 0 0 1 0 0 0 8 0 0 0 0 0 0 0 13 2 0 0 1 2 0 0 0 2 0 0 ----68

30-34 0 2 6 2 0 0 40 0 0 0 2 0 7 5 0 3 1 0 0 0 7 0 2 1 4 0 0 1 0 0 0 5 0 0 0 0 3 0 1 9 4 0 2 1 9 0 0 1 1 0 2 ----121

35-39 0 5 1 3 1 0 61 0 0 5 3 0 15 13 1 8 0 3 3 2 17 3 3 0 10 0 0 0 1 0 2 2 1 10 0 0 3 0 0 12 2 0 2 2 15 0 0 2 3 1 2 ----217

40-44 1 14 3 3 2 3 65 2 0 4 7 0 27 21 0 18 4 10 3 3 45 2 1 0 9 0 1 1 1 1 1 2 1 6 0 0 1 1 0 19 1 0 4 2 16 0 3 0 4 1 3 ----316

45-49 1 3 2 1 1 2 62 4 1 12 16 1 26 20 0 28 1 12 3 9 64 4 3 3 7 0 0 1 3 1 15 3 1 11 0 0 6 0 0 18 5 0 7 3 13 0 2 0 1 4 3 ----383

50-54 0 8 6 5 2 0 68 0 0 13 23 1 50 54 1 41 7 9 5 9 83 1 4 5 22 2 0 2 1 1 20 1 0 11 1 0 7 0 0 21 9 0 5 3 23 0 4 0 6 2 6 ----542

55-59 1 11 10 4 2 1 54 3 1 8 20 3 49 59 2 30 6 17 6 18 129 4 4 2 25 0 0 0 3 5 39 0 0 15 0 0 20 2 0 24 5 0 2 0 26 0 4 0 6 2 6 ----628

60-64 0 5 4 2 1 0 34 1 0 11 24 1 61 44 2 40 5 13 1 21 142 1 2 2 34 2 0 2 3 1 58 0 2 18 0 3 25 1 0 13 1 1 3 1 28 0 3 2 7 0 11 ----636

65-69 2 5 5 2 1 2 32 4 0 11 21 2 40 35 1 29 9 17 2 11 137 2 2 1 39 0 0 1 1 1 87 1 1 11 1 0 22 0 1 11 3 0 1 1 17 0 0 4 2 2 8 ----588

70-74 0 8 4 2 2 2 9 3 3 15 36 0 55 53 1 23 9 16 9 10 154 1 3 2 52 1 0 1 2 1 103 0 0 11 0 0 29 1 3 6 6 0 0 1 13 1 2 1 1 3 9 ----667

75+ 0.10% 1.40% 1.00% 0.70% 0.30% 0.20% 10.30% 0.40% 0.10% 1.80% 3.50% 0.20% 7.60% 6.90% 0.20% 5.10% 0.90% 2.20% 0.70% 1.90% 17.60% 0.60% 1.20% 0.40% 4.70% 0.10% 0.00% 0.30% 0.30% 0.30% 7.30% 0.80% 0.10% 2.10% 0.00% 0.10% 2.60% 0.10% 0.10% 4.30% 0.90% 0.00% 0.70% 0.50% 4.40% 0.00% 0.40% 1.40% 1.30% 0.60% 1.10% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 55: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PERAK, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

135

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

3 46 70 18 3 6 141 9 2 47 121 6 287 240 5 73 49 98 15 8 299 7 50 13 163 4 0 11 1809 14 14 380 190 90 359 4 9 44 1 0 28 0 5 204 149 0 16 23 150 0 22 43 91 17 48 ----5504

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 7 0 0 0 0 0 0 0 11 2 3 0 ----29

0-9

0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 1 0 0 9 6 0 1 ----32

50 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 6 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 13 3 0 0 0 3 0 0 6 2 0 0 ----39

10-14 0 0 0 1 0 0 3 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 5 3 0 1 3 0 0 0 6 7 1 0 ----46

15-19 0 0 0 0 0 0 4 0 0 0 0 0 2 1 0 0 0 0 0 0 1 1 3 0 2 0 0 0 4 0 0 0 0 2 11 0 2 0 0 0 0 0 0 7 9 0 0 6 6 0 0 2 1 0 1 ----65

20-24 0 1 0 0 0 0 0 0 0 0 2 0 6 1 0 2 0 1 0 0 3 0 0 0 1 0 0 0 15 0 0 3 1 2 15 0 3 0 0 0 0 0 0 5 8 0 0 3 6 0 0 2 5 1 1 ----87

25-29 0 1 0 0 0 1 4 0 0 0 3 1 6 6 0 1 0 0 0 1 2 0 0 0 2 0 0 0 50 0 0 9 3 4 13 0 1 0 0 0 0 0 0 8 10 0 0 2 3 0 0 1 4 1 2 ----139

30-34 0 2 2 2 0 0 5 0 0 1 2 0 7 10 0 2 1 3 0 0 8 1 2 1 1 1 0 1 113 0 0 17 8 0 13 1 0 2 0 0 0 0 0 17 8 0 1 0 10 0 0 0 10 2 2 ----256

35-39 0 7 1 2 1 0 16 0 0 1 8 0 9 6 0 1 1 3 0 0 18 0 1 2 5 0 0 3 194 0 0 31 11 5 26 0 1 0 1 0 0 0 0 14 11 0 1 2 6 0 2 0 8 0 4 ----402

40-44 0 3 4 3 0 0 17 1 0 2 10 0 22 7 0 4 2 5 1 1 27 1 1 0 6 0 0 0 306 1 0 51 19 9 56 1 1 5 0 0 0 0 0 25 22 0 2 3 16 0 0 1 8 1 2 ----646

45-49 0 4 3 1 0 0 21 1 1 4 7 2 26 23 1 4 4 8 1 3 27 0 4 1 10 1 0 2 317 5 0 65 37 20 58 1 0 4 0 0 0 0 0 26 17 0 7 4 23 0 4 0 8 1 2 ----758

50-54 0 6 6 2 1 0 20 1 1 5 15 0 36 33 1 9 9 15 3 1 31 1 3 2 15 2 0 0 314 1 2 47 28 12 56 0 0 6 0 0 3 0 0 24 18 0 2 0 17 0 5 1 11 3 8 ----776

55-59 0 8 14 3 0 2 24 1 0 9 17 0 39 35 0 10 9 17 1 0 37 0 9 2 14 0 0 0 191 1 6 44 33 11 34 0 1 6 0 0 5 0 0 15 18 0 1 0 20 0 3 1 6 0 8 ----655

60-64 0 5 8 1 0 1 11 2 0 4 13 1 29 31 0 11 4 13 2 1 43 0 6 2 25 0 0 1 135 2 1 44 24 7 28 0 0 4 0 0 3 0 1 13 13 0 1 0 13 0 5 1 2 1 5 ----517

65-69 0 5 16 2 1 0 8 0 0 5 9 0 42 40 1 11 9 16 3 0 48 1 7 0 24 0 0 1 87 0 2 36 14 13 20 0 0 3 0 0 9 0 1 5 4 0 0 0 12 0 1 1 7 1 3 ----468

70-74 3 4 15 0 0 2 8 3 0 16 35 2 62 47 2 16 10 17 3 1 54 0 4 3 57 0 0 1 83 4 2 33 12 5 19 1 0 10 0 0 8 0 2 8 5 0 0 0 14 0 2 1 4 2 9 ----589

75+ 0.10% 0.80% 1.30% 0.30% 0.10% 0.10% 2.60% 0.20% 0.00% 0.90% 2.20% 0.10% 5.20% 4.40% 0.10% 1.30% 0.90% 1.80% 0.30% 0.10% 5.40% 0.10% 0.90% 0.20% 3.00% 0.10% 0.00% 0.20% 32.90% 0.30% 0.30% 6.90% 3.50% 1.60% 6.50% 0.10% 0.20% 0.80% 0.00% 0.00% 0.50% 0.00% 0.10% 3.70% 2.70% 0.00% 0.30% 0.40% 2.70% 0.00% 0.40% 0.80% 1.70% 0.30% 0.90% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 56: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PERAK, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

136

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

5 62 43 30 13 10 459 19 5 80 155 8 338 310 9 226 42 98 32 87 788 25 53 17 208 5 1 15 15 12 325 36 6 94 2 3 116 5 6 192 42 1 31 23 196 1 18 64 58 25 51 ----4465

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0.8 0 0 0 0 0.2 0 0 4.4 0.6 0.6 0 ----8

0-9

0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0.3 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 0.3 0 0 0 0 1 0 0 2.1 1 0.2 0 ----6

50 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0.3 0.5 0 0 1.3 0.8 0.2 0 ----7

10-14 0 0 0 0 0 0 0.5 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 1.4 0 0.3 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 2.2 0 0 0.3 0.5 0.7 0 0 1.4 0.9 0.2 0.2 ----10

15-19 0 0 0 0.2 0 0 0.6 0.2 0 0 0 0 0.2 0.2 0 0.2 0 0 0 0 0.8 0.6 1.6 0.2 0.4 0 0 0.2 0 0 0 0.8 0 0 0 0 0 0 0 1.2 0.8 0 0.4 0.2 2 0 0 0.4 0.6 0.4 0 ----12

20-24 0 0 0.3 0.8 0.3 0 2.1 0 0 0.3 0.3 0 1.1 0.8 0 0 0 0.3 0 0.3 0.5 0.8 1.6 0 0.3 0 0 0.5 0 0 0 1.6 0 0.3 0 0 0 0 0 0.8 0 0 0.3 0.5 2.7 0 0 0.8 0.8 0.5 0 ----19

25-29 0 0.3 0.3 0.3 0 0 5.7 0 0 0 0.6 0 0.6 0.6 0.3 0.6 0 0 0 0.3 1.2 0.3 0.3 0 0.3 0 0 0.3 0 0 0 2.4 0 0 0 0 0 0 0 3.9 0.6 0 0 0.3 0.6 0 0 0 0.6 0 0 ----20

30-34 0 0.6 1.8 0.6 0 0 12.2 0 0 0 0.6 0 2.1 1.5 0 0.9 0.3 0 0 0 2.1 0 0.6 0.3 1.2 0 0 0.3 0 0 0 1.5 0 0 0 0 0.9 0 0.3 2.7 1.2 0 0.6 0.3 2.7 0 0 0.3 0.3 0 0.6 ----37

35-39 0 1.4 0.3 0.9 0.3 0 17.4 0 0 1.4 0.9 0 4.3 3.7 0.3 2.3 0 0.9 0.9 0.6 4.8 0.9 0.9 0 2.8 0 0 0 0.3 0 0.6 0.6 0.3 2.8 0 0 0.9 0 0 3.4 0.6 0 0.6 0.6 4.3 0 0 0.6 0.9 0.3 0.6 ----62

40-44 0.3 3.9 0.8 0.8 0.6 0.8 18.3 0.6 0 1.1 2 0 7.6 5.9 0 5.1 1.1 2.8 0.8 0.8 12.7 0.6 0.3 0 2.5 0 0.3 0.3 0.3 0.3 0.3 0.6 0.3 1.7 0 0 0.3 0.3 0 5.4 0.3 0 1.1 0.6 4.5 0 0.8 0 1.1 0.3 0.8 ----89

45-49 0.3 0.9 0.6 0.3 0.3 0.6 18.7 1.2 0.3 3.6 4.8 0.3 7.8 6 0 8.4 0.3 3.6 0.9 2.7 19.3 1.2 0.9 0.9 2.1 0 0 0.3 0.9 0.3 4.5 0.9 0.3 3.3 0 0 1.8 0 0 5.4 1.5 0 2.1 0.9 3.9 0 0.6 0 0.3 1.2 0.9 ----115

50-54 0 2.8 2.1 1.8 0.7 0 24.2 0 0 4.6 8.2 0.4 17.8 19.2 0.4 14.6 2.5 3.2 1.8 3.2 29.5 0.4 1.4 1.8 7.8 0.7 0 0.7 0.4 0.4 7.1 0.4 0 3.9 0.4 0 2.5 0 0 7.5 3.2 0 1.8 1.1 8.2 0 1.4 0 2.1 0.7 2.1 ----193

55-59 0.4 4.9 4.4 1.8 0.9 0.4 24 1.3 0.4 3.5 8.9 1.3 21.7 26.2 0.9 13.3 2.7 7.5 2.7 8 57.2 1.8 1.8 0.9 11.1 0 0 0 1.3 2.2 17.3 0 0 6.7 0 0 8.9 0.9 0 10.6 2.2 0 0.9 0 11.5 0 1.8 0 2.7 0.9 2.7 ----279

60-64 0 3.2 2.5 1.3 0.6 0 21.6 0.6 0 7 15.2 0.6 38.7 27.9 1.3 25.4 3.2 8.3 0.6 13.3 90.2 0.6 1.3 1.3 21.6 1.3 0 1.3 1.9 0.6 36.8 0 1.3 11.4 0 1.9 15.9 0.6 0 8.3 0.6 0.6 1.9 0.6 17.8 0 1.9 1.3 4.4 0 7 ----404

65-69 1.6 4 4 1.6 0.8 1.6 25.9 3.2 0 8.9 17 1.6 32.4 28.3 0.8 23.5 7.3 13.8 1.6 8.9 110.9 1.6 1.6 0.8 31.6 0 0 0.8 0.8 0.8 70.5 0.8 0.8 8.9 0.8 0 17.8 0 0.8 8.9 2.4 0 0.8 0.8 13.8 0 0 3.2 1.6 1.6 6.5 ----476

70-74 0 6.3 3.2 1.6 1.6 1.6 7.1 2.4 2.4 11.8 28.4 0 43.3 41.7 0.8 18.1 7.1 12.6 7.1 7.9 121.3 0.8 2.4 1.6 41 0.8 0 0.8 1.6 0.8 81.1 0 0 8.7 0 0 22.8 0.8 2.4 4.7 4.7 0 0 0.8 10.2 0.8 1.6 0.8 0.8 2.4 7.1 ----525

75+

APPENDIX 57: CANCER INCIDENCE BY SITES AND AGE GROUP, PERAK, ALL RESIDENTS, MALES, 2007-2011

0.1 1.1 0.8 0.5 0.2 0.2 8 0.3 0.1 1.4 2.7 0.1 5.9 5.4 0.2 3.9 0.7 1.7 0.6 1.5 13.7 0.4 0.9 0.3 3.6 0.1 0 0.3 0.3 0.2 5.7 0.6 0.1 1.6 0 0.1 2 0.1 0.1 3.3 0.7 0 0.5 0.4 3.4 0 0.3 1.1 1 0.4 0.9 ----77.9

Crude Rate 0.1 1 0.7 0.5 0.2 0.2 7.7 0.3 0.1 1.3 2.6 0.1 5.6 5.1 0.2 3.7 0.7 1.6 0.5 1.5 13.1 0.4 0.9 0.3 3.5 0.1 0 0.3 0.3 0.2 5.4 0.6 0.1 1.6 0 0.1 2 0.1 0.1 3.2 0.7 0 0.5 0.4 3.3 0 0.3 1.2 1 0.4 0.9 ----74.7

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

137

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

3 46 70 18 3 6 141 9 2 47 121 6 287 240 5 73 49 98 15 8 299 7 50 13 163 4 0 11 1809 14 14 380 190 90 359 4 9 44 1 0 28 0 5 204 149 0 16 23 150 0 22 43 91 17 48 ----5504

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.2 1.5 0 0 0 0 0 0 0 2.4 0.4 0.6 0 ----6

0-9

0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 0 0 0 0 0.2 0 0 1.6 1.1 0 0.2 ----6

50 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.3 1 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 0 0 2.2 0.5 0 0 0 0.5 0 0 1 0.3 0 0 ----7

10-14 0 0 0 0.2 0 0 0.5 0 0 0 0 0 0.2 0 0 0.3 0 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 0.9 0.5 0 0.2 0.5 0 0 0 1 1.2 0.2 0 ----8

15-19 0 0 0 0 0 0 0.9 0 0 0 0 0 0.4 0.2 0 0 0 0 0 0 0.2 0.2 0.6 0 0.4 0 0 0 0.9 0 0 0 0 0.4 2.4 0 0.4 0 0 0 0 0 0 1.5 1.9 0 0 1.3 1.3 0 0 0.4 0.2 0 0.2 ----14

20-24 0 0.3 0 0 0 0 0 0 0 0 0.6 0 1.7 0.3 0 0.6 0 0.3 0 0 0.8 0 0 0 0.3 0 0 0 4.2 0 0 0.8 0.3 0.6 4.2 0 0.8 0 0 0 0 0 0 1.4 2.3 0 0 0.8 1.7 0 0 0.6 1.4 0.3 0.3 ----25

25-29 0 0.3 0 0 0 0.3 1.2 0 0 0 0.9 0.3 1.8 1.8 0 0.3 0 0 0 0.3 0.6 0 0 0 0.6 0 0 0 15.3 0 0 2.7 0.9 1.2 4 0 0.3 0 0 0 0 0 0 2.4 3.1 0 0 0.6 0.9 0 0 0.3 1.2 0.3 0.6 ----42

30-34 0 0.6 0.6 0.6 0 0 1.5 0 0 0.3 0.6 0 2.1 3 0 0.6 0.3 0.9 0 0 2.4 0.3 0.6 0.3 0.3 0.3 0 0.3 34.2 0 0 5.2 2.4 0 3.9 0.3 0 0.6 0 0 0 0 0 5.2 2.4 0 0.3 0 3 0 0 0 3 0.6 0.6 ----78

35-39 0 1.9 0.3 0.6 0.3 0 4.4 0 0 0.3 2.2 0 2.5 1.7 0 0.3 0.3 0.8 0 0 5 0 0.3 0.6 1.4 0 0 0.8 53.4 0 0 8.5 3 1.4 7.2 0 0.3 0 0.3 0 0 0 0 3.9 3 0 0.3 0.6 1.7 0 0.6 0 2.2 0 1.1 ----111

40-44 0 0.9 1.1 0.9 0 0 4.9 0.3 0 0.6 2.9 0 6.3 2 0 1.1 0.6 1.4 0.3 0.3 7.7 0.3 0.3 0 1.7 0 0 0 87.4 0.3 0 14.6 5.4 2.6 16 0.3 0.3 1.4 0 0 0 0 0 7.1 6.3 0 0.6 0.9 4.6 0 0 0.3 2.3 0.3 0.6 ----185

45-49 0 1.2 0.9 0.3 0 0 6.5 0.3 0.3 1.2 2.2 0.6 8 7.1 0.3 1.2 1.2 2.5 0.3 0.9 8.3 0 1.2 0.3 3.1 0.3 0 0.6 97.4 1.5 0 20 11.4 6.1 17.8 0.3 0 1.2 0 0 0 0 0 8 5.2 0 2.2 1.2 7.1 0 1.2 0 2.5 0.3 0.6 ----233

50-54 0 2.1 2.1 0.7 0.4 0 7.1 0.4 0.4 1.8 5.3 0 12.7 11.7 0.4 3.2 3.2 5.3 1.1 0.4 11 0.4 1.1 0.7 5.3 0.7 0 0 111 0.4 0.7 16.6 9.9 4.2 19.8 0 0 2.1 0 0 1.1 0 0 8.5 6.4 0 0.7 0 6 0 1.8 0.4 3.9 1.1 2.8 ----274

55-59 0 3.5 6.1 1.3 0 0.9 10.4 0.4 0 3.9 7.4 0 16.9 15.2 0 4.3 3.9 7.4 0.4 0 16 0 3.9 0.9 6.1 0 0 0 82.7 0.4 2.6 19.1 14.3 4.8 14.7 0 0.4 2.6 0 0 2.2 0 0 6.5 7.8 0 0.4 0 8.7 0 1.3 0.4 2.6 0 3.5 ----284

60-64 0 3.2 5 0.6 0 0.6 6.9 1.3 0 2.5 8.2 0.6 18.3 19.6 0 6.9 2.5 8.2 1.3 0.6 27.1 0 3.8 1.3 15.8 0 0 0.6 85.2 1.3 0.6 27.8 15.1 4.4 17.7 0 0 2.5 0 0 1.9 0 0.6 8.2 8.2 0 0.6 0 8.2 0 3.2 0.6 1.3 0.6 3.2 ----326

65-69 0 3.6 11.4 1.4 0.7 0 5.7 0 0 3.6 6.4 0 29.9 28.5 0.7 7.8 6.4 11.4 2.1 0 34.2 0.7 5 0 17.1 0 0 0.7 61.9 0 1.4 25.6 10 9.3 14.2 0 0 2.1 0 0 6.4 0 0.7 3.6 2.8 0 0 0 8.5 0 0.7 0.7 5 0.7 2.1 ----333

70-74 1.9 2.5 9.5 0 0 1.3 5 1.9 0 10.1 22.1 1.3 39.1 29.7 1.3 10.1 6.3 10.7 1.9 0.6 34.1 0 2.5 1.9 36 0 0 0.6 52.4 2.5 1.3 20.8 7.6 3.2 12 0.6 0 6.3 0 0 5 0 1.3 5 3.2 0 0 0 8.8 0 1.3 0.6 2.5 1.3 5.7 ----372

75+

APPENDIX 58: CANCER INCIDENCE BY SITES AND AGE GROUP, PERAK, ALL RESIDENTS, FEMALES, 2007-2011

0.1 0.8 1.2 0.3 0.1 0.1 2.5 0.2 0 0.8 2.1 0.1 5 4.2 0.1 1.3 0.9 1.7 0.3 0.1 5.2 0.1 0.9 0.2 2.9 0.1 0 0.2 31.8 0.2 0.2 6.7 3.3 1.6 6.3 0.1 0.2 0.8 0 0 0.5 0 0.1 3.6 2.6 0 0.3 0.4 2.6 0 0.4 0.8 1.6 0.3 0.8 ----96.6

Crude Rate 0 0.7 1.1 0.3 0 0.1 2.3 0.1 0 0.7 1.9 0.1 4.5 3.7 0.1 1.1 0.7 1.5 0.2 0.1 4.7 0.1 0.8 0.2 2.5 0.1 0 0.2 29.3 0.2 0.2 6.1 3.1 1.4 5.9 0.1 0.2 0.7 0 0 0.4 0 0.1 3.4 2.5 0 0.3 0.4 2.4 0 0.4 0.8 1.5 0.3 0.8 ----88.5

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

138

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 41 39 24 17 9 182 18 10 61 80 3 341 201 3 128 14 61 25 53 400 6 39 4 88 0 0 22 6 0 216 40 2 69 0 0 130 0 7 59 38 4 2 8 145 1 14 19 72 61 10 ----2774

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 3 0 5 0 0 0 0 3 9 0 2 0 0 3 0 0 7 6 12 0 ----56

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 6 0 0 0 0 2 0 0 3 3 12 0 ----29

50 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 2 4 0 0 0 4 11 0 ----33

10-14 0 0 0 0 0 0 3 0 0 0 2 0 1 0 0 0 0 0 0 0 0 1 5 0 2 0 0 2 0 0 1 5 0 0 0 0 0 0 0 5 2 0 0 2 5 0 0 1 1 3 0 ----41

15-19 0 0 1 0 1 0 5 0 0 0 0 0 4 0 0 0 0 0 0 0 4 1 1 0 1 0 0 1 0 0 0 8 0 0 0 0 2 0 0 1 0 0 0 1 6 0 0 0 4 3 0 ----44

20-24 0 0 2 0 0 1 3 0 0 0 0 0 8 2 0 1 0 2 0 0 2 0 2 0 0 0 0 1 0 0 1 8 0 0 0 0 2 0 0 1 1 0 0 0 2 0 1 0 6 2 0 ----48

25-29 0 2 1 2 0 0 4 0 0 0 2 0 5 1 0 3 0 1 0 0 6 0 4 0 1 0 0 0 0 0 0 5 0 1 0 0 3 0 0 4 1 0 0 0 10 0 0 0 4 3 0 ----63

30-34 0 2 1 0 0 0 14 0 0 1 3 0 12 7 0 3 0 3 3 0 10 1 2 0 2 0 0 1 0 0 0 2 0 2 0 0 1 0 0 4 1 0 0 0 3 0 0 0 5 2 1 ----86

35-39 0 7 4 1 2 0 15 1 0 1 3 0 17 7 1 4 1 3 5 0 15 0 1 1 4 0 0 1 1 0 3 2 0 2 0 0 3 0 0 5 5 0 1 1 12 0 1 0 4 1 1 ----136

40-44 0 2 2 1 2 1 31 1 0 4 5 2 29 15 0 11 1 4 3 2 18 0 3 1 6 0 0 0 0 0 2 2 0 7 0 0 2 0 0 5 8 0 0 0 11 0 0 1 3 2 4 ----191

45-49 0 5 3 4 1 0 27 1 2 8 3 0 45 13 0 16 4 9 0 5 41 0 2 0 5 0 0 3 1 0 5 2 0 14 0 0 9 0 0 4 1 0 1 1 16 0 0 2 14 3 0 ----270

50-54 0 5 3 1 1 0 26 1 2 3 13 1 43 34 1 21 3 10 1 8 45 1 1 0 16 0 0 4 3 0 11 0 0 8 0 0 14 0 0 4 5 1 0 1 11 0 3 2 3 0 1 ----311

55-59 0 6 7 5 3 2 18 3 2 9 7 0 41 39 0 18 2 7 4 10 52 0 3 1 8 0 0 1 1 0 26 0 1 13 0 0 18 0 0 4 6 0 0 0 9 0 4 1 7 1 0 ----339

60-64 2 2 4 2 1 1 15 3 3 9 8 0 43 33 0 16 0 7 3 12 70 2 5 0 13 0 0 2 0 0 39 1 0 9 0 0 22 0 0 3 2 0 0 0 20 0 2 1 5 3 1 ----364

65-69 0 7 3 4 3 1 10 4 1 10 12 0 37 31 0 21 1 3 2 7 62 0 1 1 13 0 0 1 0 0 65 0 0 3 0 0 31 0 2 1 4 1 0 0 12 0 1 0 3 0 0 ----358

70-74 0 3 7 4 3 3 7 4 0 16 22 0 56 19 1 11 2 12 4 8 75 0 5 0 16 0 0 2 0 0 63 1 1 4 0 0 23 0 2 1 2 0 0 0 19 1 2 1 0 3 2 ----405

75+ 0.10% 1.50% 1.40% 0.90% 0.60% 0.30% 6.60% 0.60% 0.40% 2.20% 2.90% 0.10% 12.30% 7.20% 0.10% 4.60% 0.50% 2.20% 0.90% 1.90% 14.40% 0.20% 1.40% 0.10% 3.20% 0.00% 0.00% 0.80% 0.20% 0.00% 7.80% 1.40% 0.10% 2.50% 0.00% 0.00% 4.70% 0.00% 0.30% 2.10% 1.40% 0.10% 0.10% 0.30% 5.20% 0.00% 0.50% 0.70% 2.60% 2.20% 0.40% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 59: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, KEDAH, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

139

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

5 40 46 28 9 1 48 8 1 43 77 4 291 129 2 66 18 31 8 6 193 3 29 3 48 0 1 16 1220 5 9 295 127 19 233 4 4 28 1 1 37 0 4 74 101 1 0 6 79 1 23 14 50 64 11 ----3565

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 2 0 0 0 0 1 0 0 5 4 22 0 ----38

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 8 0 0 0 0 1 0 0 3 0 2 1 ----20

50 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 9 0 0 0 0 5 0 0 1 4 7 0 ----37

10-14 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 0 3 0 0 1 0 0 0 0 0 0 9 0 1 0 0 0 0 0 0 3 3 0 0 2 2 0 0 1 1 5 0 ----37

15-19 0 1 0 0 0 0 3 0 0 0 0 0 4 0 0 0 0 2 0 0 1 0 2 0 0 0 0 1 8 0 0 1 1 0 5 0 0 0 0 0 0 0 0 6 3 0 0 0 6 0 0 1 1 4 1 ----51

20-24 0 1 1 0 0 0 1 0 0 0 1 0 3 2 0 0 0 0 0 0 2 0 2 0 0 0 0 2 19 0 0 8 3 0 6 1 0 0 0 0 0 0 1 1 7 0 0 1 1 0 0 0 3 2 0 ----68

25-29 0 2 0 1 0 0 4 0 0 0 1 0 3 3 0 1 1 1 1 0 2 0 0 0 0 0 0 1 57 0 0 4 2 0 3 0 0 1 0 0 0 0 0 3 11 0 0 1 7 0 0 1 2 0 0 ----113

30-34 0 1 2 2 0 0 1 0 0 0 1 0 11 2 0 3 1 0 1 0 5 0 1 0 1 0 0 2 94 0 1 23 3 1 21 0 0 0 0 0 0 0 0 1 11 0 0 0 5 0 0 0 4 3 0 ----201

35-39 0 6 3 1 0 0 7 2 0 1 2 0 16 5 0 4 0 3 0 1 10 0 2 0 4 0 0 0 170 3 0 39 14 2 18 1 2 2 0 0 2 0 0 8 13 0 0 0 3 0 1 0 4 6 0 ----355

40-44 0 2 2 2 1 0 7 1 0 3 9 0 15 9 0 4 1 1 0 0 25 0 3 0 1 0 0 1 243 1 1 47 19 3 30 1 1 2 0 0 2 0 0 8 10 0 0 1 6 0 2 0 7 3 2 ----476

45-49 0 2 3 5 0 0 4 0 0 6 13 0 35 12 0 8 0 3 1 1 20 0 1 0 3 0 0 2 198 0 1 42 19 2 44 0 0 4 1 0 3 0 1 9 13 0 0 0 4 0 4 0 4 2 0 ----470

50-54 0 7 3 3 1 0 7 0 0 9 7 1 39 11 1 11 4 5 2 0 15 0 2 0 4 0 0 1 172 0 5 43 24 4 21 0 0 4 0 0 3 0 1 3 12 1 0 0 9 0 5 1 5 1 2 ----449

55-59 0 5 6 5 1 1 4 0 0 6 9 0 40 11 0 11 1 3 0 1 30 1 3 1 0 0 0 0 95 0 0 24 17 5 24 1 0 4 0 0 6 0 0 7 3 0 0 1 4 1 2 0 5 2 1 ----341

60-64 0 4 5 2 0 0 3 0 0 6 8 0 38 28 0 3 1 4 1 1 21 1 2 2 5 0 0 2 71 0 1 25 13 2 16 0 0 1 0 1 6 0 1 2 10 0 0 0 9 0 5 0 1 0 1 ----302

65-69 2 2 8 3 3 0 6 4 1 7 14 1 46 23 0 11 4 5 2 1 30 1 1 0 14 0 1 0 50 0 0 25 9 0 15 0 0 4 0 0 6 0 0 3 4 0 0 0 11 0 3 1 3 1 2 ----327

70-74 3 7 11 3 3 0 1 1 0 5 12 2 40 23 1 8 5 4 0 1 32 0 2 0 13 0 0 1 43 1 0 14 3 0 14 0 0 3 0 0 9 0 0 1 1 0 0 0 5 0 1 0 2 4 1 ----280

75+ 0.10% 1.10% 1.30% 0.80% 0.30% 0.00% 1.30% 0.20% 0.00% 1.20% 2.20% 0.10% 8.20% 3.60% 0.10% 1.90% 0.50% 0.90% 0.20% 0.20% 5.40% 0.10% 0.80% 0.10% 1.30% 0.00% 0.00% 0.40% 34.20% 0.10% 0.30% 8.30% 3.60% 0.50% 6.50% 0.10% 0.10% 0.80% 0.00% 0.00% 1.00% 0.00% 0.10% 2.10% 2.80% 0.00% 0.00% 0.20% 2.20% 0.00% 0.60% 0.40% 1.40% 1.80% 0.30% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 60: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, KEDAH, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

140

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 41 39 24 17 9 182 18 10 61 80 3 341 201 3 128 14 61 25 53 400 6 39 4 88 0 0 22 6 0 216 40 2 69 0 0 130 0 7 59 38 4 2 8 145 1 14 19 72 61 10 ----2774

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0.2 0 0 0 0 0.5 0 0 0 0.7 0 1.1 0 0 0 0 0.7 2.1 0 0.5 0 0 0.7 0 0 1.6 1.4 2.7 0 ----13

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0.2 0 0 0 0 0 1.2 0 0 0 0 0.4 0 0 0.6 0.6 2.4 0 ----6

50 0 0.2 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.5 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0.4 0.7 0 0 0 0.7 2 0 ----6

10-14 0 0 0 0 0 0 0.6 0 0 0 0.4 0 0.2 0 0 0 0 0 0 0 0 0.2 1 0 0.4 0 0 0.4 0 0 0.2 1 0 0 0 0 0 0 0 1 0.4 0 0 0.4 1 0 0 0.2 0.2 0.6 0 ----9

15-19 0 0 0.3 0 0.3 0 1.3 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0.3 0.3 0 0.3 0 0 0.3 0 0 0 2.1 0 0 0 0 0.5 0 0 0.3 0 0 0 0.3 1.6 0 0 0 1 0.8 0 ----11

20-24 0 0 0.6 0 0 0.3 0.9 0 0 0 0 0 2.4 0.6 0 0.3 0 0.6 0 0 0.6 0 0.6 0 0 0 0 0.3 0 0 0.3 2.4 0 0 0 0 0.6 0 0 0.3 0.3 0 0 0 0.6 0 0.3 0 1.8 0.6 0 ----15

25-29 0 0.7 0.3 0.7 0 0 1.4 0 0 0 0.7 0 1.7 0.3 0 1 0 0.3 0 0 2.1 0 1.4 0 0.3 0 0 0 0 0 0 1.7 0 0.3 0 0 1 0 0 1.4 0.3 0 0 0 3.5 0 0 0 1.4 1 0 ----22

30-34 0 0.7 0.4 0 0 0 4.9 0 0 0.4 1.1 0 4.2 2.5 0 1.1 0 1.1 1.1 0 3.5 0.4 0.7 0 0.7 0 0 0.4 0 0 0 0.7 0 0.7 0 0 0.4 0 0 1.4 0.4 0 0 0 1.1 0 0 0 1.8 0.7 0.4 ----30

35-39 0 2.4 1.4 0.3 0.7 0 5.2 0.3 0 0.3 1 0 5.9 2.4 0.3 1.4 0.3 1 1.7 0 5.2 0 0.3 0.3 1.4 0 0 0.3 0.3 0 1 0.7 0 0.7 0 0 1 0 0 1.7 1.7 0 0.3 0.3 4.2 0 0.3 0 1.4 0.3 0.3 ----47

40-44 0 0.7 0.7 0.4 0.7 0.4 11.2 0.4 0 1.4 1.8 0.7 10.5 5.4 0 4 0.4 1.4 1.1 0.7 6.5 0 1.1 0.4 2.2 0 0 0 0 0 0.7 0.7 0 2.5 0 0 0.7 0 0 1.8 2.9 0 0 0 4 0 0 0.4 1.1 0.7 1.4 ----69

45-49 0 2.1 1.2 1.7 0.4 0 11.2 0.4 0.8 3.3 1.2 0 18.6 5.4 0 6.6 1.7 3.7 0 2.1 17 0 0.8 0 2.1 0 0 1.2 0.4 0 2.1 0.8 0 5.8 0 0 3.7 0 0 1.7 0.4 0 0.4 0.4 6.6 0 0 0.8 5.8 1.2 0 ----112

50-54 0 2.5 1.5 0.5 0.5 0 13.1 0.5 1 1.5 6.5 0.5 21.6 17.1 0.5 10.6 1.5 5 0.5 4 22.6 0.5 0.5 0 8 0 0 2 1.5 0 5.5 0 0 4 0 0 7 0 0 2 2.5 0.5 0 0.5 5.5 0 1.5 1 1.5 0 0.5 ----156

55-59 0 4.1 4.8 3.4 2 1.4 12.3 2 1.4 6.1 4.8 0 28 26.6 0 12.3 1.4 4.8 2.7 6.8 35.5 0 2 0.7 5.5 0 0 0.7 0.7 0 17.7 0 0.7 8.9 0 0 12.3 0 0 2.7 4.1 0 0 0 6.1 0 2.7 0.7 4.8 0.7 0 ----231

60-64 2.1 2.1 4.1 2.1 1 1 15.4 3.1 3.1 9.2 8.2 0 44.1 33.9 0 16.4 0 7.2 3.1 12.3 71.8 2.1 5.1 0 13.3 0 0 2.1 0 0 40 1 0 9.2 0 0 22.6 0 0 3.1 2.1 0 0 0 20.5 0 2.1 1 5.1 3.1 1 ----373

65-69 0 8.5 3.6 4.8 3.6 1.2 12.1 4.8 1.2 12.1 14.5 0 44.9 37.6 0 25.5 1.2 3.6 2.4 8.5 75.2 0 1.2 1.2 15.8 0 0 1.2 0 0 78.8 0 0 3.6 0 0 37.6 0 2.4 1.2 4.8 1.2 0 0 14.5 0 1.2 0 3.6 0 0 ----434

70-74 0 3.7 8.6 4.9 3.7 3.7 8.6 4.9 0 19.6 27 0 68.7 23.3 1.2 13.5 2.5 14.7 4.9 9.8 92 0 6.1 0 19.6 0 0 2.5 0 0 77.3 1.2 1.2 4.9 0 0 28.2 0 2.5 1.2 2.5 0 0 0 23.3 1.2 2.5 1.2 0 3.7 2.5 ----497

75+

APPENDIX 61: CANCER INCIDENCE BY SITES AND AGE GROUP, KEDAH, ALL RESIDENTS, MALES, 2007-2011

0 0.9 0.8 0.5 0.4 0.2 3.9 0.4 0.2 1.3 1.7 0.1 7.3 4.3 0.1 2.8 0.3 1.3 0.5 1.1 8.6 0.1 0.8 0.1 1.9 0 0 0.5 0.1 0 4.6 0.9 0 1.5 0 0 2.8 0 0.2 1.3 0.8 0.1 0 0.2 3.1 0 0.3 0.4 1.5 1.3 0.2 ----59.6

Crude Rate 0.1 0.9 0.9 0.6 0.4 0.2 4.1 0.5 0.3 1.5 1.9 0.1 8.1 4.9 0.1 3.1 0.3 1.4 0.6 1.3 9.8 0.1 0.9 0.1 2.1 0 0 0.5 0.1 0 5.5 0.9 0.1 1.7 0 0 3.2 0 0.2 1.3 0.9 0.1 0 0.2 3.4 0 0.3 0.5 1.6 1.3 0.2 ----66.6

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

141

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

5 40 46 28 9 1 48 8 1 43 77 4 291 129 2 66 18 31 8 6 193 3 29 3 48 0 1 16 1220 5 9 295 127 19 233 4 4 28 1 1 37 0 4 74 101 1 0 6 79 1 23 14 50 64 11 ----3565

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 1.2 1 5.3 0 ----9

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0.2 0 0 0.6 0 0.4 0.2 ----4

50 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.6 0 0 0 0 0.2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1.8 0 0 0 0 1 0 0 0.2 0.8 1.4 0 ----7

10-14 0 0 0.2 0.2 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.6 0 0.6 0 0 0.2 0 0 0 0 0 0 1.9 0 0.2 0 0 0 0 0 0 0.6 0.6 0 0 0.4 0.4 0 0 0.2 0.2 1.1 0 ----8

15-19 0 0.3 0 0 0 0 0.8 0 0 0 0 0 1.1 0 0 0 0 0.5 0 0 0.3 0 0.5 0 0 0 0 0.3 2.1 0 0 0.3 0.3 0 1.3 0 0 0 0 0 0 0 0 1.6 0.8 0 0 0 1.6 0 0 0.3 0.3 1.1 0.3 ----13

20-24 0 0.3 0.3 0 0 0 0.3 0 0 0 0.3 0 0.9 0.6 0 0 0 0 0 0 0.6 0 0.6 0 0 0 0 0.6 5.8 0 0 2.5 0.9 0 1.8 0.3 0 0 0 0 0 0 0.3 0.3 2.2 0 0 0.3 0.3 0 0 0 0.9 0.6 0 ----21

25-29 0 0.7 0 0.3 0 0 1.4 0 0 0 0.3 0 1 1 0 0.3 0.3 0.3 0.3 0 0.7 0 0 0 0 0 0 0.3 19.6 0 0 1.4 0.7 0 1 0 0 0.3 0 0 0 0 0 1 3.8 0 0 0.3 2.4 0 0 0.3 0.7 0 0 ----39

30-34 0 0.3 0.7 0.7 0 0 0.3 0 0 0 0.3 0 3.7 0.7 0 1 0.3 0 0.3 0 1.7 0 0.3 0 0.3 0 0 0.7 31.3 0 0.3 7.7 1 0.3 7 0 0 0 0 0 0 0 0 0.3 3.7 0 0 0 1.7 0 0 0 1.3 1 0 ----67

35-39 0 2 1 0.3 0 0 2.3 0.7 0 0.3 0.7 0 5.3 1.7 0 1.3 0 1 0 0.3 3.3 0 0.7 0 1.3 0 0 0 56.4 1 0 12.9 4.6 0.7 6 0.3 0.7 0.7 0 0 0.7 0 0 2.7 4.3 0 0 0 1 0 0.3 0 1.3 2 0 ----118

40-44 0 0.7 0.7 0.7 0.4 0 2.5 0.4 0 1.1 3.2 0 5.4 3.2 0 1.4 0.4 0.4 0 0 8.9 0 1.1 0 0.4 0 0 0.4 86.8 0.4 0.4 16.8 6.8 1.1 10.7 0.4 0.4 0.7 0 0 0.7 0 0 2.9 3.6 0 0 0.4 2.1 0 0.7 0 2.5 1.1 0.7 ----170

45-49 0 0.8 1.2 2 0 0 1.6 0 0 2.4 5.1 0 13.8 4.7 0 3.2 0 1.2 0.4 0.4 7.9 0 0.4 0 1.2 0 0 0.8 78.1 0 0.4 16.6 7.5 0.8 17.4 0 0 1.6 0.4 0 1.2 0 0.4 3.6 5.1 0 0 0 1.6 0 1.6 0 1.6 0.8 0 ----185

50-54 0 3.4 1.5 1.5 0.5 0 3.4 0 0 4.4 3.4 0.5 19.1 5.4 0.5 5.4 2 2.5 1 0 7.4 0 1 0 2 0 0 0.5 84.3 0 2.5 21.1 11.8 2 10.3 0 0 2 0 0 1.5 0 0.5 1.5 5.9 0.5 0 0 4.4 0 2.5 0.5 2.5 0.5 1 ----220

55-59 0 3.3 4 3.3 0.7 0.7 2.7 0 0 4 6 0 26.8 7.4 0 7.4 0.7 2 0 0.7 20.1 0.7 2 0.7 0 0 0 0 63.6 0 0 16.1 11.4 3.3 16.1 0.7 0 2.7 0 0 4 0 0 4.7 2 0 0 0.7 2.7 0.7 1.3 0 3.3 1.3 0.7 ----228

60-64 0 3.7 4.7 1.9 0 0 2.8 0 0 5.6 7.5 0 35.5 26.2 0 2.8 0.9 3.7 0.9 0.9 19.6 0.9 1.9 1.9 4.7 0 0 1.9 66.4 0 0.9 23.4 12.2 1.9 15 0 0 0.9 0 0.9 5.6 0 0.9 1.9 9.3 0 0 0 8.4 0 4.7 0 0.9 0 0.9 ----282

65-69 2.1 2.1 8.5 3.2 3.2 0 6.4 4.2 1.1 7.4 14.8 1.1 48.7 24.3 0 11.6 4.2 5.3 2.1 1.1 31.8 1.1 1.1 0 14.8 0 1.1 0 52.9 0 0 26.5 9.5 0 15.9 0 0 4.2 0 0 6.4 0 0 3.2 4.2 0 0 0 11.6 0 3.2 1.1 3.2 1.1 2.1 ----346

70-74 2.7 6.4 10 2.7 2.7 0 0.9 0.9 0 4.6 11 1.8 36.5 21 0.9 7.3 4.6 3.7 0 0.9 29.2 0 1.8 0 11.9 0 0 0.9 39.3 0.9 0 12.8 2.7 0 12.8 0 0 2.7 0 0 8.2 0 0 0.9 0.9 0 0 0 4.6 0 0.9 0 1.8 3.7 0.9 ----256

75+

APPENDIX 62: CANCER INCIDENCE BY SITES AND AGE GROUP, KEDAH, ALL RESIDENTS, FEMALES, 2007-2011

0.1 0.9 1 0.6 0.2 0 1 0.2 0 0.9 1.7 0.1 6.3 2.8 0 1.4 0.4 0.7 0.2 0.1 4.2 0.1 0.6 0.1 1 0 0 0.3 26.2 0.1 0.2 6.3 2.7 0.4 5 0.1 0.1 0.6 0 0 0.8 0 0.1 1.6 2.2 0 0 0.1 1.7 0 0.5 0.3 1.1 1.4 0.2 ----76.7

Crude Rate 0.1 0.9 1 0.6 0.2 0 1 0.2 0 0.9 1.7 0.1 6.4 2.9 0 1.4 0.4 0.7 0.2 0.1 4.2 0.1 0.6 0.1 1 0 0 0.3 25.9 0.1 0.2 6.3 2.8 0.4 5 0.1 0.1 0.6 0 0 0.8 0 0.1 1.6 2.2 0 0 0.1 1.7 0 0.5 0.3 1.1 1.5 0.2 ----77

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

142

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 37 28 12 7 5 210 7 5 32 80 10 166 260 2 79 16 53 11 49 383 14 28 0 42 0 1 18 7 3 187 37 0 39 0 1 39 0 6 74 23 1 8 23 112 2 24 15 67 9 43 ----2277

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 3 0 1 0 0 1 0 0 3 0 0 0 ----10

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 4 0 2 0 ----14

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 5 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 1 3 0 0 ----14

10-14 0 0 1 0 1 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 5 0 0 2 5 3 0 0 1 6 1 0 ----34

15-19 0 1 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 0 0 0 2 2 1 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 2 4 0 0 2 7 0 0 ----31

20-24 0 1 1 0 0 0 4 0 0 1 2 1 1 0 0 1 0 0 0 0 1 4 3 0 1 0 0 2 0 0 0 11 0 0 0 0 0 0 0 6 1 0 1 5 9 0 0 0 1 2 2 ----61

25-29 0 3 0 1 1 0 18 1 0 0 3 0 1 3 0 1 1 1 2 1 2 2 1 0 0 0 0 3 0 0 0 6 0 1 0 0 2 0 1 8 2 0 0 1 3 0 0 1 4 1 0 ----75

30-34 0 1 2 1 1 0 21 0 1 2 2 0 4 5 0 1 0 1 0 0 9 0 1 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 7 0 0 0 3 3 0 0 0 4 1 1 ----74

35-39 0 0 1 1 0 0 18 0 0 3 1 1 4 17 1 5 0 1 1 0 10 0 0 0 0 0 1 4 1 0 0 1 0 2 0 0 1 0 0 3 2 0 0 1 9 0 1 0 3 0 7 ----100

40-44 0 4 2 1 1 1 25 0 0 3 6 2 6 11 0 8 1 6 0 4 33 1 2 0 1 0 0 1 2 0 0 3 0 6 0 0 0 0 0 4 1 0 2 0 8 0 2 1 5 1 6 ----160

45-49 1 5 4 1 1 0 30 2 0 2 7 1 20 28 0 14 1 4 3 6 51 2 1 0 0 0 0 2 0 0 8 2 0 10 0 0 5 0 2 8 5 0 0 2 12 1 6 0 2 0 3 ----252

50-54 1 8 4 0 0 1 26 0 1 1 8 1 22 36 0 10 3 8 1 10 45 1 3 0 6 0 0 1 2 0 19 0 0 4 0 0 4 0 1 10 4 0 1 1 16 0 3 1 12 0 4 ----279

55-59 0 4 5 3 1 1 26 2 1 4 7 2 28 48 0 17 3 11 2 2 60 0 2 0 4 0 0 0 2 0 31 1 0 6 0 0 5 0 0 6 2 0 1 0 14 0 6 0 5 1 8 ----321

60-64 0 3 4 3 0 2 21 0 1 8 17 0 25 49 0 8 1 6 1 11 61 1 1 0 12 0 0 1 0 1 50 1 0 2 0 0 6 0 0 1 3 0 1 1 15 0 3 0 5 0 6 ----331

65-69 0 4 3 1 1 0 5 1 0 4 12 2 23 38 1 10 2 10 0 8 55 0 2 0 5 0 0 0 0 1 47 0 0 4 0 0 6 0 1 6 3 0 0 2 8 0 1 1 5 0 3 ----275

70-74 0 3 1 0 0 0 11 1 1 4 15 0 30 25 0 3 4 5 1 7 54 1 1 0 13 0 0 2 0 1 32 0 0 4 0 1 9 0 0 2 0 0 0 0 4 1 2 0 5 0 3 ----246

75+ 0.10% 1.60% 1.20% 0.50% 0.30% 0.20% 9.20% 0.30% 0.20% 1.40% 3.50% 0.40% 7.30% 11.40% 0.10% 3.50% 0.70% 2.30% 0.50% 2.20% 16.80% 0.60% 1.20% 0.00% 1.80% 0.00% 0.00% 0.80% 0.30% 0.10% 8.20% 1.60% 0.00% 1.70% 0.00% 0.00% 1.70% 0.00% 0.30% 3.20% 1.00% 0.00% 0.40% 1.00% 4.90% 0.10% 1.10% 0.70% 2.90% 0.40% 1.90% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 63: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, WPKL & PUTRAJAYA, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

143

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 42 40 10 4 0 71 1 1 14 65 5 159 184 5 24 10 35 13 9 175 3 21 4 33 1 0 17 1453 4 10 222 112 44 118 2 0 20 0 0 18 1 3 51 70 2 3 14 92 3 15 12 54 9 28 ----3307

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 5 0 0 0 ----11

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 1 2 0 ----7

50 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 2 0 0 1 2 1 0 ----11

10-14 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 5 3 0 0 3 2 0 0 0 1 1 1 ----24

15-19 0 1 0 1 0 0 2 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 3 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0 7 0 0 4 5 1 0 0 4 1 0 ----36

20-24 0 1 1 0 0 0 4 0 0 0 2 0 1 1 0 1 0 0 1 0 2 0 2 0 1 0 0 2 14 0 0 2 0 0 2 0 0 0 0 0 0 0 0 5 8 0 0 4 9 0 0 0 9 1 0 ----73

25-29 0 2 1 0 0 0 4 0 0 0 2 1 0 2 0 1 1 2 0 0 3 0 1 0 0 0 0 2 64 0 0 10 4 1 7 0 0 0 0 0 0 0 0 0 3 0 0 0 1 0 0 0 3 0 2 ----117

30-34 0 1 0 2 0 0 6 0 0 0 1 0 4 5 0 0 0 1 2 0 4 0 2 0 2 0 0 2 95 0 1 12 5 0 4 0 0 1 0 0 0 0 1 5 8 0 0 0 3 0 0 1 4 0 4 ----176

35-39 0 2 3 2 0 0 6 0 0 1 8 0 8 9 0 2 1 0 0 1 9 0 1 1 0 0 0 2 190 0 1 23 6 3 12 0 0 0 0 0 0 0 0 3 3 0 0 0 3 0 1 1 5 0 3 ----310

40-44 0 3 0 1 1 0 10 0 1 2 5 0 17 10 0 4 0 1 1 2 12 0 2 0 1 0 0 4 272 0 3 39 12 10 21 2 0 4 0 0 1 0 0 3 6 0 0 1 9 0 1 0 5 0 1 ----467

45-49 1 8 1 0 0 0 11 0 0 1 1 2 12 17 0 3 0 1 2 1 19 0 0 0 2 0 0 0 242 0 1 33 27 6 22 0 0 1 0 0 3 1 0 5 8 1 1 1 8 1 2 0 6 1 5 ----457

50-54 0 4 6 1 2 0 7 1 0 2 8 0 26 35 2 5 2 7 0 1 24 0 3 0 3 0 0 1 207 1 3 23 19 5 15 0 0 1 0 0 2 0 0 4 4 0 0 1 13 0 2 2 5 1 2 ----450

55-59 0 6 6 1 0 0 6 0 0 1 8 1 23 30 1 4 2 9 2 1 29 0 2 0 4 0 0 0 153 0 0 18 17 3 9 0 0 3 0 0 4 0 1 3 3 0 1 0 10 0 3 1 2 1 1 ----369

60-64 0 3 5 0 1 0 8 0 0 1 14 1 24 26 1 0 1 5 1 2 28 0 3 1 3 0 0 2 90 1 0 24 9 8 14 0 0 0 0 0 2 0 0 5 7 0 1 0 12 0 2 1 3 0 2 ----311

65-69 0 5 6 1 0 0 1 0 0 3 6 0 19 23 0 2 1 3 1 0 20 1 1 0 4 0 0 0 71 1 1 15 8 6 5 0 0 7 0 0 0 0 0 6 5 0 0 0 10 0 3 0 4 0 2 ----241

70-74 0 6 9 0 0 0 4 0 0 3 10 0 24 25 1 2 2 6 2 1 24 2 1 1 13 1 0 1 52 1 0 21 5 2 4 0 0 3 0 0 5 0 0 0 4 1 0 0 4 1 1 0 0 0 5 ----247

75+ 0.00% 1.30% 1.20% 0.30% 0.10% 0.00% 2.10% 0.00% 0.00% 0.40% 2.00% 0.20% 4.80% 5.60% 0.20% 0.70% 0.30% 1.10% 0.40% 0.30% 5.30% 0.10% 0.60% 0.10% 1.00% 0.00% 0.00% 0.50% 43.90% 0.10% 0.30% 6.70% 3.40% 1.30% 3.60% 0.10% 0.00% 0.60% 0.00% 0.00% 0.50% 0.00% 0.10% 1.50% 2.10% 0.10% 0.10% 0.40% 2.80% 0.10% 0.50% 0.40% 1.60% 0.30% 0.80% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

IDC (10th)

APPENDIX 64: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, WPKL & PUTRAJAYA, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

144

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 37 28 12 7 5 210 7 5 32 80 10 166 260 2 79 16 53 11 49 383 14 28 0 42 0 1 18 7 3 187 37 0 39 0 1 39 0 6 74 23 1 8 23 112 2 24 15 67 9 43 ----2277

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.3 0.9 0 0.3 0 0 0.3 0 0 0.9 0 0 0 ----3

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 1.2 0 0 0 0 0.3 0 0 1.2 0 0.6 0 ----4

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 1.7 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0.7 0 0 0.3 1 0 0 ----5

10-14 0 0 0.3 0 0.3 0 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.3 0 0 0 0.6 0 0 0 0 0 0 0 1.4 0 0 0.6 1.4 0.9 0 0 0.3 1.7 0.3 0 ----10

15-19 0 0.3 0 0 0 0 0.5 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0.5 0.3 0 0 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 0 0 0 0.5 1 0 0 0.5 1.8 0 0 ----8

20-24 0 0.3 0.3 0 0 0 1 0 0 0.3 0.5 0.3 0.3 0 0 0.3 0 0 0 0 0.3 1 0.8 0 0.3 0 0 0.5 0 0 0 2.8 0 0 0 0 0 0 0 1.5 0.3 0 0.3 1.3 2.3 0 0 0 0.3 0.5 0.5 ----15

25-29 0 0.9 0 0.3 0.3 0 5.3 0.3 0 0 0.9 0 0.3 0.9 0 0.3 0.3 0.3 0.6 0.3 0.6 0.6 0.3 0 0 0 0 0.9 0 0 0 1.8 0 0.3 0 0 0.6 0 0.3 2.3 0.6 0 0 0.3 0.9 0 0 0.3 1.2 0.3 0 ----22

30-34 0 0.4 0.7 0.4 0.4 0 7.5 0 0.4 0.7 0.7 0 1.4 1.8 0 0.4 0 0.4 0 0 3.2 0 0.4 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0.4 0 0 2.5 0 0 0 1.1 1.1 0 0 0 1.4 0.4 0.4 ----27

35-39 0 0 0.4 0.4 0 0 7.4 0 0 1.2 0.4 0.4 1.6 7 0.4 2.1 0 0.4 0.4 0 4.1 0 0 0 0 0 0.4 1.6 0.4 0 0 0.4 0 0.8 0 0 0.4 0 0 1.2 0.8 0 0 0.4 3.7 0 0.4 0 1.2 0 2.9 ----41

40-44 0 1.6 0.8 0.4 0.4 0.4 10 0 0 1.2 2.4 0.8 2.4 4.4 0 3.2 0.4 2.4 0 1.6 13.2 0.4 0.8 0 0.4 0 0 0.4 0.8 0 0 1.2 0 2.4 0 0 0 0 0 1.6 0.4 0 0.8 0 3.2 0 0.8 0.4 2 0.4 2.4 ----64

45-49 0.5 2.5 2 0.5 0.5 0 15.1 1 0 1 3.5 0.5 10.1 14.1 0 7.1 0.5 2 1.5 3 25.7 1 0.5 0 0 0 0 1 0 0 4 1 0 5 0 0 2.5 0 1 4 2.5 0 0 1 6 0.5 3 0 1 0 1.5 ----127

50-54 0.6 5.2 2.6 0 0 0.6 16.8 0 0.6 0.6 5.2 0.6 14.2 23.3 0 6.5 1.9 5.2 0.6 6.5 29.1 0.6 1.9 0 3.9 0 0 0.6 1.3 0 12.3 0 0 2.6 0 0 2.6 0 0.6 6.5 2.6 0 0.6 0.6 10.4 0 1.9 0.6 7.8 0 2.6 ----181

55-59 0 3.6 4.4 2.7 0.9 0.9 23.1 1.8 0.9 3.6 6.2 1.8 24.9 42.7 0 15.1 2.7 9.8 1.8 1.8 53.3 0 1.8 0 3.6 0 0 0 1.8 0 27.6 0.9 0 5.3 0 0 4.4 0 0 5.3 1.8 0 0.9 0 12.4 0 5.3 0 4.4 0.9 7.1 ----285

60-64 0 4.3 5.7 4.3 0 2.9 30 0 1.4 11.4 24.3 0 35.7 70 0 11.4 1.4 8.6 1.4 15.7 87.2 1.4 1.4 0 17.1 0 0 1.4 0 1.4 71.4 1.4 0 2.9 0 0 8.6 0 0 1.4 4.3 0 1.4 1.4 21.4 0 4.3 0 7.1 0 8.6 ----473

65-69 0 7.6 5.7 1.9 1.9 0 9.5 1.9 0 7.6 22.9 3.8 43.8 72.4 1.9 19.1 3.8 19.1 0 15.2 104.8 0 3.8 0 9.5 0 0 0 0 1.9 89.5 0 0 7.6 0 0 11.4 0 1.9 11.4 5.7 0 0 3.8 15.2 0 1.9 1.9 9.5 0 5.7 ----524

70-74 0 6.3 2.1 0 0 0 22.9 2.1 2.1 8.3 31.3 0 62.5 52.1 0 6.3 8.3 10.4 2.1 14.6 112.5 2.1 2.1 0 27.1 0 0 4.2 0 2.1 66.7 0 0 8.3 0 2.1 18.8 0 0 4.2 0 0 0 0 8.3 2.1 4.2 0 10.4 0 6.3 ----513

75+ 0.1 1 0.7 0.3 0.2 0.1 5.5 0.2 0.1 0.8 2.1 0.3 4.3 6.8 0.1 2.1 0.4 1.4 0.3 1.3 10 0.4 0.7 0 1.1 0 0 0.5 0.2 0.1 4.9 1 0 1 0 0 1 0 0.2 1.9 0.6 0 0.2 0.6 2.9 0.1 0.6 0.4 1.8 0.2 1.1 ----59.5

Crude Rate 0.1 1.1 0.9 0.4 0.2 0.2 5.9 0.2 0.2 1.1 2.7 0.3 5.7 8.8 0.1 2.5 0.5 1.8 0.3 1.7 12.9 0.3 0.8 0 1.6 0 0 0.5 0.2 0.1 7.1 0.8 0 1.2 0 0 1.3 0 0.2 2 0.7 0 0.2 0.6 3.3 0.1 0.8 0.4 1.9 0.2 1.3 ----73.1

ASR World

APPENDIX 65: CANCER INCIDENCE BY SITES AND AGE GROUP, WPKL & PUTRAJAYA, ALL RESIDENTS, MALES, 2007-2011

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

145

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 42 40 10 4 0 71 1 1 14 65 5 159 184 5 24 10 35 13 9 175 3 21 4 33 1 0 17 1453 4 10 222 112 44 118 2 0 20 0 0 18 1 3 51 70 2 3 14 92 3 15 12 54 9 28 ----3307

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.3 0 0 0 0 0.3 0 0 1.7 0 0 0 ----4

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0.3 0.7 0 ----2

50 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0.3 0 0 0 0.7 0 0 0.3 0.7 0.3 0 ----4

10-14 0 0 0.6 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0.3 1.4 0.9 0 0 0.9 0.6 0 0 0 0.3 0.3 0.3 ----7

15-19 0 0.2 0 0.2 0 0 0.5 0 0 0 0 0 0.2 0.2 0 0 0 0 0 0 0.2 0 0 0.2 0 0 0 0 0.7 0 0 0.5 0 0 0.2 0 0 0 0 0 0 0 0 0 1.7 0 0 1 1.2 0.2 0 0 1 0.2 0 ----9

20-24 0 0.2 0.2 0 0 0 1 0 0 0 0.5 0 0.2 0.2 0 0.2 0 0 0.2 0 0.5 0 0.5 0 0.2 0 0 0.5 3.4 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0 0 1.2 2 0 0 1 2.2 0 0 0 2.2 0.2 0 ----18

25-29 0 0.6 0.3 0 0 0 1.3 0 0 0 0.6 0.3 0 0.6 0 0.3 0.3 0.6 0 0 1 0 0.3 0 0 0 0 0.6 20.4 0 0 3.2 1.3 0.3 2.2 0 0 0 0 0 0 0 0 0 1 0 0 0 0.3 0 0 0 1 0 0.6 ----37

30-34 0 0.4 0 0.7 0 0 2.2 0 0 0 0.4 0 1.5 1.8 0 0 0 0.4 0.7 0 1.5 0 0.7 0 0.7 0 0 0.7 34.9 0 0.4 4.4 1.8 0 1.5 0 0 0.4 0 0 0 0 0.4 1.8 2.9 0 0 0 1.1 0 0 0.4 1.5 0 1.5 ----65

35-39 0 0.7 1.1 0.7 0 0 2.1 0 0 0.4 2.9 0 2.9 3.2 0 0.7 0.4 0 0 0.4 3.2 0 0.4 0.4 0 0 0 0.7 67.7 0 0.4 8.2 2.1 1.1 4.3 0 0 0 0 0 0 0 0 1.1 1.1 0 0 0 1.1 0 0.4 0.4 1.8 0 1.1 ----111

40-44 0 1.4 0 0.5 0.5 0 4.6 0 0.5 0.9 2.3 0 7.8 4.6 0 1.8 0 0.5 0.5 0.9 5.5 0 0.9 0 0.5 0 0 1.8 125.1 0 1.4 17.9 5.5 4.6 9.7 0.9 0 1.8 0 0 0.5 0 0 1.4 2.8 0 0 0.5 4.1 0 0.5 0 2.3 0 0.5 ----215

45-49 0.5 4.3 0.5 0 0 0 5.9 0 0 0.5 0.5 1.1 6.5 9.2 0 1.6 0 0.5 1.1 0.5 10.3 0 0 0 1.1 0 0 0 130.8 0 0.5 17.8 14.6 3.2 11.9 0 0 0.5 0 0 1.6 0.5 0 2.7 4.3 0.5 0.5 0.5 4.3 0.5 1.1 0 3.2 0.5 2.7 ----247

50-54 0 2.8 4.2 0.7 1.4 0 4.9 0.7 0 1.4 5.6 0 18.2 24.6 1.4 3.5 1.4 4.9 0 0.7 16.8 0 2.1 0 2.1 0 0 0.7 145.3 0.7 2.1 16.1 13.3 3.5 10.5 0 0 0.7 0 0 1.4 0 0 2.8 2.8 0 0 0.7 9.1 0 1.4 1.4 3.5 0.7 1.4 ----316

55-59 0 5.7 5.7 1 0 0 5.7 0 0 1 7.7 1 22 28.7 1 3.8 1.9 8.6 1.9 1 27.8 0 1.9 0 3.8 0 0 0 146.4 0 0 17.2 16.3 2.9 8.6 0 0 2.9 0 0 3.8 0 1 2.9 2.9 0 1 0 9.6 0 2.9 1 1.9 1 1 ----353

60-64 0 4.3 7.2 0 1.4 0 11.5 0 0 1.4 20.1 1.4 34.5 37.4 1.4 0 1.4 7.2 1.4 2.9 40.3 0 4.3 1.4 4.3 0 0 2.9 129.5 1.4 0 34.5 13 11.5 20.1 0 0 0 0 0 2.9 0 0 7.2 10.1 0 1.4 0 17.3 0 2.9 1.4 4.3 0 2.9 ----448

65-69 0 10.6 12.8 2.1 0 0 2.1 0 0 6.4 12.8 0 40.4 48.9 0 4.3 2.1 6.4 2.1 0 42.6 2.1 2.1 0 8.5 0 0 0 151.1 2.1 2.1 31.9 17 12.8 10.6 0 0 14.9 0 0 0 0 0 12.8 10.6 0 0 0 21.3 0 6.4 0 8.5 0 4.3 ----513

70-74 0 10.9 16.4 0 0 0 7.3 0 0 5.5 18.2 0 43.6 45.5 1.8 3.6 3.6 10.9 3.6 1.8 43.6 3.6 1.8 1.8 23.6 1.8 0 1.8 94.6 1.8 0 38.2 9.1 3.6 7.3 0 0 5.5 0 0 9.1 0 0 0 7.3 1.8 0 0 7.3 1.8 1.8 0 0 0 9.1 ----449

75+ 0 1.1 1.1 0.3 0.1 0 1.9 0 0 0.4 1.7 0.1 4.2 4.9 0.1 0.6 0.3 0.9 0.3 0.2 4.7 0.1 0.6 0.1 0.9 0 0 0.5 38.8 0.1 0.3 5.9 3 1.2 3.2 0.1 0 0.5 0 0 0.5 0 0.1 1.4 1.9 0.1 0.1 0.4 2.5 0.1 0.4 0.3 1.4 0.2 0.7 ----88.3

Crude Rate 0 1.3 1.4 0.3 0.1 0 2 0 0 0.5 2.2 0.2 5.4 6.3 0.2 0.7 0.3 1.2 0.4 0.3 6 0.1 0.6 0.1 1.2 0 0 0.5 42.2 0.2 0.3 6.8 3.5 1.5 3.5 0.1 0 0.7 0 0 0.6 0 0.1 1.6 2 0.1 0.1 0.3 2.9 0.1 0.5 0.4 1.4 0.3 0.8 ----101.2

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 66: CANCER INCIDENCE BY SITES AND AGE GROUP, WPKL & PUTRAJAYA, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

146

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 21 7 15 4 0 77 4 0 33 35 8 152 204 1 166 18 43 14 35 333 9 38 12 64 0 0 12 4 5 170 27 3 30 0 1 124 0 12 56 46 4 7 1 131 0 31 26 73 46 3 ----2105

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 0 0 0 2 0 1 0 2 0 0 0 0 1 0 8 10 0 0 0 0 2 0 0 11 5 11 0 ----57

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 5 1 0 0 0 4 0 0 9 3 10 0 ----36

50 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 5 1 0 1 0 11 0 0 3 2 4 0 ----36

10-14 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 9 0 1 0 0 0 0 0 0 2 0 2 0 0 0 0 0 5 1 0 0 0 4 0 0 1 4 4 1 ----39

15-19 0 1 1 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 1 0 1 0 6 0 1 0 0 0 0 0 2 3 0 1 0 0 0 0 0 4 0 0 0 0 8 0 0 1 6 2 1 ----43

20-24 0 1 1 1 0 0 6 0 0 0 1 0 4 2 0 3 0 0 0 0 2 1 2 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 2 0 0 0 6 0 0 0 2 2 0 ----40

25-29 0 1 0 1 0 0 4 0 0 0 1 0 4 6 0 4 0 0 0 2 4 0 1 0 2 0 0 1 1 0 0 1 0 0 0 0 0 0 0 3 1 0 0 0 4 0 0 1 5 2 0 ----49

30-34 0 0 0 0 0 0 1 0 0 0 3 0 7 6 0 8 2 4 0 1 6 1 1 0 4 0 0 1 0 0 1 3 0 0 0 0 1 0 0 2 3 0 0 0 8 0 1 0 4 1 0 ----69

35-39 0 1 1 0 1 0 8 0 0 1 1 0 7 9 0 7 1 2 1 1 14 1 1 0 2 0 0 2 0 0 1 0 0 3 0 0 2 0 0 3 3 1 1 0 14 0 3 0 3 1 0 ----96

40-44 0 2 1 2 0 0 11 0 0 3 4 0 18 17 0 20 2 5 0 0 27 0 0 2 6 0 0 0 0 0 4 1 0 1 0 0 11 0 0 2 5 0 2 0 10 0 2 0 7 0 0 ----165

45-49 0 2 0 0 0 0 11 1 0 2 6 1 18 19 0 28 3 5 5 8 35 1 3 3 4 0 0 2 0 0 10 1 0 4 0 0 9 0 0 5 3 0 0 0 11 0 3 0 7 4 0 ----214

50-54 0 3 0 1 0 0 6 0 0 5 4 2 22 30 0 23 2 3 0 4 46 1 0 3 4 0 0 1 0 3 12 4 2 4 0 0 10 0 1 4 3 1 1 1 15 0 9 0 9 1 0 ----240

55-59 0 3 0 4 1 0 8 0 0 7 4 2 16 33 1 28 1 7 3 9 65 1 5 0 6 0 0 0 3 0 26 1 0 5 0 0 26 0 0 2 6 1 2 0 16 0 5 0 5 3 0 ----305

60-64 0 2 0 1 0 0 6 0 0 2 2 1 22 29 0 21 3 11 0 2 46 1 2 3 10 0 0 1 0 1 31 3 0 6 0 0 21 0 0 1 7 1 0 0 10 0 4 0 3 0 0 ----253

65-69 0 3 0 3 1 0 6 0 0 3 2 2 14 22 0 7 3 3 1 5 38 1 2 0 10 0 0 1 0 0 36 3 1 1 0 1 14 0 0 2 9 0 0 0 4 0 3 0 2 0 0 ----203

70-74 0 2 3 2 1 0 3 3 0 10 7 0 19 31 0 12 1 3 0 3 49 1 2 1 12 0 0 0 0 0 47 0 0 3 0 0 29 0 1 1 1 0 0 0 4 0 1 0 6 1 1 ----260

75+ 0.00% 1.00% 0.30% 0.70% 0.20% 0.00% 3.70% 0.20% 0.00% 1.60% 1.70% 0.40% 7.20% 9.70% 0.00% 7.90% 0.90% 2.00% 0.70% 1.70% 15.80% 0.40% 1.80% 0.60% 3.00% 0.00% 0.00% 0.60% 0.20% 0.20% 8.10% 1.30% 0.10% 1.40% 0.00% 0.00% 5.90% 0.00% 0.60% 2.70% 2.20% 0.20% 0.30% 0.00% 6.20% 0.00% 1.50% 1.20% 3.50% 2.20% 0.10% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 67: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, KELANTAN, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

147

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 17 5 9 2 2 28 3 0 27 23 5 124 140 2 69 12 29 7 8 141 9 22 10 54 0 0 14 594 7 4 132 88 24 184 1 1 21 1 0 22 1 4 49 170 0 3 2 80 0 14 11 65 40 1 ----2281

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 4 0 0 0 0 3 0 0 6 7 9 0 ----39

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 3 0 0 2 0 7 0 ----15

50 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 0 8 0 2 0 0 1 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 3 0 0 0 0 4 0 0 2 3 6 0 ----36

10-14 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 3 0 1 0 0 2 0 0 0 0 0 0 6 0 0 2 0 0 1 0 0 1 8 0 0 0 3 0 0 1 3 1 0 ----35

15-19 0 0 0 1 0 0 1 0 0 0 0 0 2 3 0 1 0 0 0 0 0 0 1 0 1 0 0 1 1 0 0 1 0 0 4 0 0 0 1 0 1 0 0 4 4 0 1 0 4 0 0 0 8 1 1 ----42

20-24 0 1 0 1 0 0 1 0 0 0 1 0 3 0 0 1 0 0 0 0 0 0 1 0 2 0 0 1 13 0 0 2 0 0 10 0 0 0 0 0 0 0 0 0 9 0 0 0 4 0 0 0 3 2 0 ----55

25-29 0 1 0 0 0 0 1 0 0 0 1 1 3 3 0 1 0 1 0 0 4 0 2 0 1 0 0 1 24 0 0 4 2 0 12 0 0 1 0 0 0 0 0 2 7 0 0 0 3 0 0 0 3 0 0 ----78

30-34 0 0 1 1 0 0 0 0 0 0 1 0 5 4 0 0 0 2 1 0 2 0 0 0 1 0 0 0 51 0 1 8 10 2 8 0 1 0 0 0 0 0 0 1 19 0 0 0 3 0 0 0 2 3 0 ----127

35-39 0 1 0 0 0 0 0 1 0 0 0 0 2 6 0 1 0 1 0 1 9 1 0 0 4 0 0 1 90 0 0 19 10 2 23 0 0 2 0 0 1 0 0 3 23 0 1 0 2 0 1 0 4 1 0 ----210

40-44 0 2 0 0 0 0 3 1 0 1 2 0 16 9 0 7 0 3 0 1 10 1 2 1 5 0 0 2 122 2 0 19 8 4 16 0 0 5 0 0 2 0 1 12 19 0 0 1 6 0 1 0 6 3 0 ----293

45-49 0 3 1 2 0 0 5 0 0 3 4 2 16 10 1 8 2 4 0 0 16 1 1 1 1 0 0 0 91 1 0 19 14 5 33 0 0 2 0 0 2 0 1 4 24 0 0 0 2 0 2 0 5 0 0 ----286

50-54 0 0 1 0 1 0 3 1 0 4 2 0 14 27 0 12 3 2 1 1 25 0 0 0 3 0 0 1 75 1 1 23 16 4 19 0 0 2 0 0 4 0 0 3 17 0 1 1 10 0 5 0 5 2 0 ----290

55-59 0 2 1 2 1 1 2 0 0 1 1 0 15 15 0 8 3 6 0 1 15 2 2 2 8 0 0 0 45 0 0 16 11 3 13 0 0 2 0 0 1 1 0 1 16 0 0 0 14 0 2 0 6 1 0 ----220

60-64 0 2 0 1 0 0 4 0 0 3 4 1 11 17 1 10 3 2 0 1 26 1 0 3 5 0 0 1 41 0 0 9 9 2 17 1 0 1 0 0 4 0 0 7 15 0 0 0 9 0 1 0 4 1 0 ----217

65-69 0 3 1 0 0 0 5 0 0 5 0 1 16 26 0 7 0 6 0 1 12 1 0 1 10 0 0 1 26 1 1 7 2 2 12 0 0 2 0 0 2 0 0 1 5 0 0 0 2 0 1 0 4 2 0 ----166

70-74 0 2 0 1 0 1 1 0 0 10 5 0 20 20 0 9 1 2 3 2 22 2 1 2 9 0 0 1 15 2 1 5 6 0 8 0 0 0 0 0 4 0 0 1 4 0 0 0 8 0 1 0 2 1 0 ----172

75+ 0.00% 0.70% 0.20% 0.40% 0.10% 0.10% 1.20% 0.10% 0.00% 1.20% 1.00% 0.20% 5.40% 6.10% 0.10% 3.00% 0.50% 1.30% 0.30% 0.40% 6.20% 0.40% 1.00% 0.40% 2.40% 0.00% 0.00% 0.60% 26.00% 0.30% 0.20% 5.80% 3.90% 1.10% 8.10% 0.00% 0.00% 0.90% 0.00% 0.00% 1.00% 0.00% 0.20% 2.10% 7.50% 0.00% 0.10% 0.10% 3.50% 0.00% 0.60% 0.50% 2.80% 1.80% 0.00% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 68: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, KELANTAN, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

148

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 21 7 15 4 0 77 4 0 33 35 8 152 204 1 166 18 43 14 35 333 9 38 12 64 0 0 12 4 5 170 27 3 30 0 1 124 0 12 56 46 4 7 1 131 0 31 26 73 46 3 ----2105

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0.2 0 0 0 0 0 0 0 0 0.5 0 0.2 0 0.5 0 0 0 0 0.2 0 1.8 2.3 0 0 0 0 0.5 0 0 2.5 1.2 2.5 0 ----13

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 1.1 0.2 0 0 0 0.9 0 0 1.9 0.6 2.1 0 ----8

50 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.2 0 0 0 0.4 0 0 0 0 0 0 0 1 0.2 0 0.2 0 2.2 0 0 0.6 0.4 0.8 0 ----7

10-14 0 0 0 0 0 0 0.6 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 1.9 0 0.2 0 0 0 0 0 0 0.4 0 0.4 0 0 0 0 0 1.1 0.2 0 0 0 0.8 0 0 0.2 0.8 0.8 0.2 ----8

15-19 0 0.3 0.3 0 0 0 0.7 0 0 0 0 0 0 0 0 0.7 0 0 0.3 0 0.3 0 2 0 0.3 0 0 0 0 0 0.7 1 0 0.3 0 0 0 0 0 1.3 0 0 0 0 2.6 0 0 0.3 2 0.7 0.3 ----14

20-24 0 0.4 0.4 0.4 0 0 2.3 0 0 0 0.4 0 1.6 0.8 0 1.2 0 0 0 0 0.8 0.4 0.8 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.8 0.8 0 0 0 2.3 0 0 0 0.8 0.8 0 ----16

25-29 0 0.5 0 0.5 0 0 2 0 0 0 0.5 0 2 3 0 2 0 0 0 1 2 0 0.5 0 1 0 0 0.5 0.5 0 0 0.5 0 0 0 0 0 0 0 1.5 0.5 0 0 0 2 0 0 0.5 2.5 1 0 ----25

30-34 0 0 0 0 0 0 0.5 0 0 0 1.6 0 3.8 3.3 0 4.4 1.1 2.2 0 0.5 3.3 0.5 0.5 0 2.2 0 0 0.5 0 0 0.5 1.6 0 0 0 0 0.5 0 0 1.1 1.6 0 0 0 4.4 0 0.5 0 2.2 0.5 0 ----38

35-39 0 0.5 0.5 0 0.5 0 4 0 0 0.5 0.5 0 3.5 4.5 0 3.5 0.5 1 0.5 0.5 7.1 0.5 0.5 0 1 0 0 1 0 0 0.5 0 0 1.5 0 0 1 0 0 1.5 1.5 0.5 0.5 0 7.1 0 1.5 0 1.5 0.5 0 ----48

40-44 0 1 0.5 1 0 0 5.6 0 0 1.5 2 0 9.2 8.7 0 10.2 1 2.6 0 0 13.8 0 0 1 3.1 0 0 0 0 0 2 0.5 0 0.5 0 0 5.6 0 0 1 2.6 0 1 0 5.1 0 1 0 3.6 0 0 ----84

45-49 0 1.2 0 0 0 0 6.4 0.6 0 1.2 3.5 0.6 10.5 11 0 16.3 1.7 2.9 2.9 4.7 20.4 0.6 1.7 1.7 2.3 0 0 1.2 0 0 5.8 0.6 0 2.3 0 0 5.2 0 0 2.9 1.7 0 0 0 6.4 0 1.7 0 4.1 2.3 0 ----124

50-54 0 2.2 0 0.7 0 0 4.3 0 0 3.6 2.9 1.4 15.8 21.5 0 16.5 1.4 2.2 0 2.9 33 0.7 0 2.2 2.9 0 0 0.7 0 2.2 8.6 2.9 1.4 2.9 0 0 7.2 0 0.7 2.9 2.2 0.7 0.7 0.7 10.8 0 6.5 0 6.5 0.7 0 ----172

55-59 0 2.6 0 3.5 0.9 0 6.9 0 0 6.1 3.5 1.7 13.9 28.6 0.9 24.2 0.9 6.1 2.6 7.8 56.3 0.9 4.3 0 5.2 0 0 0 2.6 0 22.5 0.9 0 4.3 0 0 22.5 0 0 1.7 5.2 0.9 1.7 0 13.9 0 4.3 0 4.3 2.6 0 ----264

60-64 0 2.8 0 1.4 0 0 8.3 0 0 2.8 2.8 1.4 30.6 40.3 0 29.2 4.2 15.3 0 2.8 63.9 1.4 2.8 4.2 13.9 0 0 1.4 0 1.4 43.1 4.2 0 8.3 0 0 29.2 0 0 1.4 9.7 1.4 0 0 13.9 0 5.6 0 4.2 0 0 ----351

65-69 0 5.7 0 5.7 1.9 0 11.4 0 0 5.7 3.8 3.8 26.7 41.9 0 13.3 5.7 5.7 1.9 9.5 72.4 1.9 3.8 0 19.1 0 0 1.9 0 0 68.6 5.7 1.9 1.9 0 1.9 26.7 0 0 3.8 17.1 0 0 0 7.6 0 5.7 0 3.8 0 0 ----387

70-74 0 3.2 4.8 3.2 1.6 0 4.8 4.8 0 15.9 11.1 0 30.2 49.2 0 19.1 1.6 4.8 0 4.8 77.8 1.6 3.2 1.6 19.1 0 0 0 0 0 74.6 0 0 4.8 0 0 46 0 1.6 1.6 1.6 0 0 0 6.4 0 1.6 0 9.5 1.6 1.6 ----413

75+

APPENDIX 69: CANCER INCIDENCE BY SITES AND AGE GROUP, KELANTAN, ALL RESIDENTS, MALES, 2007-2011

0 0.5 0.2 0.4 0.1 0 2 0.1 0 0.9 0.9 0.2 4 5.3 0 4.3 0.5 1.1 0.4 0.9 8.7 0.2 1 0.3 1.7 0 0 0.3 0.1 0.1 4.4 0.7 0.1 0.8 0 0 3.2 0 0.3 1.5 1.2 0.1 0.2 0 3.4 0 0.8 0.7 1.9 1.2 0.1 ----54.8

Crude Rate 0 0.7 0.2 0.5 0.1 0 2.4 0.1 0 1.1 1.1 0.3 5 6.8 0 5.4 0.6 1.5 0.4 1.2 11.2 0.3 1 0.4 2.2 0 0 0.4 0.1 0.2 5.9 0.8 0.1 1 0 0 4.2 0 0.3 1.5 1.5 0.1 0.2 0 3.9 0 1 0.6 2.1 1.2 0.1 ----68

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

149

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 17 5 9 2 2 28 3 0 27 23 5 124 140 2 69 12 29 7 8 141 9 22 10 54 0 0 14 594 7 4 132 88 24 184 1 1 21 1 0 22 1 4 49 170 0 3 2 80 0 14 11 65 40 1 ----2281

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.7 0 0 0.2 0 0 0 0 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.5 1 0 0 0 0 0.7 0 0 1.5 1.7 2.2 0 ----10

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0.7 0 0 0.4 0 1.6 0 ----3

50 0 0 0 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0.2 0 0 0 1.7 0 0.4 0 0 0.2 0 0 0 0 0 0 0.6 0 0 0.2 0 0 0 0 0 0.6 0 0 0 0 0.8 0 0 0.4 0.6 1.3 0 ----8

10-14 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0.7 0 0.2 0 0 0.5 0 0 0 0 0 0 1.4 0 0 0.5 0 0 0.2 0 0 0.2 1.8 0 0 0 0.7 0 0 0.2 0.7 0.2 0 ----8

15-19 0 0 0 0.4 0 0 0.4 0 0 0 0 0 0.7 1.1 0 0.4 0 0 0 0 0 0 0.4 0 0.4 0 0 0.4 0.4 0 0 0.4 0 0 1.4 0 0 0 0.4 0 0.4 0 0 1.4 1.4 0 0.4 0 1.4 0 0 0 2.8 0.4 0.4 ----15

20-24 0 0.4 0 0.4 0 0 0.4 0 0 0 0.4 0 1.3 0 0 0.4 0 0 0 0 0 0 0.4 0 0.9 0 0 0.4 5.6 0 0 0.9 0 0 4.3 0 0 0 0 0 0 0 0 0 3.9 0 0 0 1.7 0 0 0 1.3 0.9 0 ----24

25-29 0 0.5 0 0 0 0 0.5 0 0 0 0.5 0.5 1.5 1.5 0 0.5 0 0.5 0 0 2 0 1 0 0.5 0 0 0.5 11.7 0 0 2 1 0 5.9 0 0 0.5 0 0 0 0 0 1 3.4 0 0 0 1.5 0 0 0 1.5 0 0 ----38

30-34 0 0 0.5 0.5 0 0 0 0 0 0 0.5 0 2.3 1.9 0 0 0 0.9 0.5 0 0.9 0 0 0 0.5 0 0 0 23.6 0 0.5 3.7 4.6 0.9 3.7 0 0.5 0 0 0 0 0 0 0.5 8.8 0 0 0 1.4 0 0 0 0.9 1.4 0 ----59

35-39 0 0.4 0 0 0 0 0 0.4 0 0 0 0 0.9 2.6 0 0.4 0 0.4 0 0.4 4 0.4 0 0 1.8 0 0 0.4 39.7 0 0 8.4 4.4 0.9 10.2 0 0 0.9 0 0 0.4 0 0 1.3 10.2 0 0.4 0 0.9 0 0.4 0 1.8 0.4 0 ----93

40-44 0 0.9 0 0 0 0 1.4 0.5 0 0.5 0.9 0 7.4 4.1 0 3.2 0 1.4 0 0.5 4.6 0.5 0.9 0.5 2.3 0 0 0.9 56.1 0.9 0 8.7 3.7 1.8 7.4 0 0 2.3 0 0 0.9 0 0.5 5.5 8.7 0 0 0.5 2.8 0 0.5 0 2.8 1.4 0 ----135

45-49 0 1.6 0.5 1.1 0 0 2.6 0 0 1.6 2.1 1.1 8.4 5.3 0.5 4.2 1.1 2.1 0 0 8.4 0.5 0.5 0.5 0.5 0 0 0 47.9 0.5 0 10 7.4 2.6 17.4 0 0 1.1 0 0 1.1 0 0.5 2.1 12.6 0 0 0 1.1 0 1.1 0 2.6 0 0 ----151

50-54 0 0 0.7 0 0.7 0 2.1 0.7 0 2.7 1.4 0 9.6 18.6 0 8.2 2.1 1.4 0.7 0.7 17.2 0 0 0 2.1 0 0 0.7 51.6 0.7 0.7 15.8 11 2.7 13.1 0 0 1.4 0 0 2.7 0 0 2.1 11.7 0 0.7 0.7 6.9 0 3.4 0 3.4 1.4 0 ----199

55-59 0 1.7 0.9 1.7 0.9 0.9 1.7 0 0 0.9 0.9 0 12.9 12.9 0 6.9 2.6 5.2 0 0.9 12.9 1.7 1.7 1.7 6.9 0 0 0 38.8 0 0 13.8 9.5 2.6 11.2 0 0 1.7 0 0 0.9 0.9 0 0.9 13.8 0 0 0 12.1 0 1.7 0 5.2 0.9 0 ----190

60-64 0 2.4 0 1.2 0 0 4.7 0 0 3.6 4.7 1.2 13 20.1 1.2 11.8 3.6 2.4 0 1.2 30.8 1.2 0 3.6 5.9 0 0 1.2 48.5 0 0 10.7 10.7 2.4 20.1 1.2 0 1.2 0 0 4.7 0 0 8.3 17.8 0 0 0 10.7 0 1.2 0 4.7 1.2 0 ----257

65-69 0 5 1.7 0 0 0 8.3 0 0 8.3 0 1.7 26.4 43 0 11.6 0 9.9 0 1.7 19.8 1.7 0 1.7 16.5 0 0 1.7 43 1.7 1.7 11.6 3.3 3.3 19.8 0 0 3.3 0 0 3.3 0 0 1.7 8.3 0 0 0 3.3 0 1.7 0 6.6 3.3 0 ----274

70-74 0 2.4 0 1.2 0 1.2 1.2 0 0 12 6 0 24 24 0 10.8 1.2 2.4 3.6 2.4 26.4 2.4 1.2 2.4 10.8 0 0 1.2 18 2.4 1.2 6 7.2 0 9.6 0 0 0 0 0 4.8 0 0 1.2 4.8 0 0 0 9.6 0 1.2 0 2.4 1.2 0 ----206

75+ 0 0.4 0.1 0.2 0.1 0.1 0.7 0.1 0 0.7 0.6 0.1 3.2 3.7 0.1 1.8 0.3 0.8 0.2 0.2 3.7 0.2 0.6 0.3 1.4 0 0 0.4 15.5 0.2 0.1 3.5 2.3 0.6 4.8 0 0 0.5 0 0 0.6 0 0.1 1.3 4.4 0 0.1 0.1 2.1 0 0.4 0.3 1.7 1 0 ----59.6

Crude Rate

APPENDIX 70: CANCER INCIDENCE BY SITES AND AGE GROUP, KELANTAN, ALL RESIDENTS, FEMALES, 2007-2011

0 0.5 0.1 0.3 0.1 0.1 0.8 0.1 0 0.8 0.6 0.2 3.6 4.2 0.1 2 0.4 0.9 0.2 0.2 4.2 0.3 0.5 0.3 1.6 0 0 0.4 17 0.2 0.1 3.8 2.5 0.7 5.3 0 0 0.6 0 0 0.6 0 0.1 1.4 4.9 0 0.1 0.1 2.3 0 0.4 0.3 1.9 1.1 0 ----65.8

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

150

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

5 38 33 38 15 7 394 20 3 85 238 19 442 357 11 361 38 145 28 106 861 22 42 11 184 0 3 45 17 10 447 31 4 146 5 3 177 2 11 90 50 6 8 28 244 1 28 86 101 30 169 ----5245

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 4 0 4 0 0 0 0 3 8 0 2 1 0 4 0 0 21 3 9 0 ----65

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 0 0 1 10 0 0 11 1 4 3 ----37

50 0 0 0 0 0 4 0 0 0 1 0 1 0 0 1 0 0 1 0 0 0 6 0 0 0 0 2 0 0 0 3 0 0 0 0 0 0 0 9 0 0 0 0 10 0 0 8 3 0 0 ----49

10-14 0 0 2 1 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 0 2 0 0 0 0 1 0 0 4 2 0 0 4 7 0 0 5 5 1 1 ----45

15-19 0 0 0 0 0 1 7 0 0 1 0 0 1 0 1 1 0 0 1 1 2 2 6 0 1 0 0 3 0 1 0 3 0 0 0 0 0 0 0 5 2 0 2 4 8 0 0 5 9 0 1 ----68

20-24 0 1 1 1 1 0 9 0 0 0 0 0 0 2 0 1 0 0 0 0 7 0 1 0 2 0 1 6 0 0 0 3 0 3 0 0 0 0 0 2 1 0 0 2 5 0 1 5 9 1 3 ----68

25-29 0 0 0 1 0 0 19 0 0 1 1 1 2 3 0 4 0 0 0 1 4 0 2 0 3 0 0 3 1 0 1 5 0 1 0 0 2 0 0 6 2 0 1 2 7 0 0 2 3 0 2 ----80

30-34 0 2 0 3 0 0 37 0 0 0 5 0 6 8 0 8 0 3 2 1 14 2 0 0 2 0 0 2 0 0 0 6 0 6 0 0 2 0 0 5 4 0 1 2 16 0 1 1 8 1 4 ----152

35-39 0 2 1 3 1 0 49 0 0 1 4 1 18 11 0 13 2 8 2 3 19 1 5 0 7 0 2 3 0 0 0 1 0 12 0 0 8 1 0 9 6 0 2 0 9 0 0 3 10 1 9 ----227

40-44 0 3 0 4 1 0 58 0 1 8 17 3 29 25 0 21 2 12 3 4 47 1 1 1 10 0 0 3 2 0 4 1 0 21 1 0 8 0 0 7 6 0 0 3 22 0 2 2 6 0 7 ----346

45-49 0 5 2 4 1 0 55 1 1 4 25 0 37 46 0 39 5 6 7 9 72 2 4 0 14 0 0 5 0 0 7 1 0 7 0 1 14 0 0 9 4 1 0 5 28 0 1 3 9 2 10 ----446

50-54 0 8 3 5 3 0 53 3 0 9 20 2 52 44 2 65 9 20 2 11 102 6 4 3 15 0 0 5 1 2 24 0 1 23 1 0 18 0 1 5 4 1 1 3 21 0 3 4 8 1 27 ----595

55-59 0 5 7 5 5 3 36 1 0 20 37 3 60 57 3 64 3 20 5 19 140 3 2 3 27 0 0 4 2 4 59 2 2 17 0 1 18 0 1 2 5 0 0 0 24 0 6 5 4 3 21 ----708

60-64 1 3 6 5 1 1 33 2 0 18 32 6 67 52 2 46 5 28 1 22 163 2 1 3 36 0 0 2 3 2 106 0 0 24 1 1 34 0 1 7 9 1 0 2 35 1 5 6 7 2 21 ----806

65-69 1 3 1 4 1 2 19 7 0 8 35 3 70 39 0 41 5 18 1 19 141 0 0 1 25 0 0 2 4 0 104 0 0 14 0 0 30 1 2 2 1 0 0 0 14 0 5 3 11 3 23 ----663

70-74 3 6 10 2 1 0 10 6 1 15 61 0 99 70 3 54 7 30 3 15 150 2 4 0 41 0 0 3 4 1 142 0 1 14 2 0 42 0 3 7 3 1 0 0 24 0 4 2 5 2 37 ----890

75+ 0.10% 0.70% 0.60% 0.70% 0.30% 0.10% 7.50% 0.40% 0.10% 1.60% 4.50% 0.40% 8.40% 6.80% 0.20% 6.90% 0.70% 2.80% 0.50% 2.00% 16.40% 0.40% 0.80% 0.20% 3.50% 0.00% 0.10% 0.90% 0.30% 0.20% 8.50% 0.60% 0.10% 2.80% 0.10% 0.10% 3.40% 0.00% 0.20% 1.70% 1.00% 0.10% 0.20% 0.50% 4.70% 0.00% 0.50% 1.60% 1.90% 0.60% 3.20% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 71: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PENANG, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

151

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

6 32 43 15 9 2 127 9 3 44 184 14 451 248 21 135 52 119 3 10 341 27 31 19 125 2 0 45 1958 12 11 399 273 50 332 3 6 79 3 6 53 1 5 83 124 3 3 15 176 0 24 60 99 24 166 ----6085

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 3 0 0 1 0 0 0 0 0 0 2 0 0 0 0 1 9 0 1 0 0 1 0 0 16 10 4 3 ----53

0-9

0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 3 0 0 11 4 1 0 ----29

51 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 1 1 0 0 0 0 0 4 0 0 0 0 0 0 0 0 5 2 0 0 2 4 0 0 7 1 1 1 ----37

10-14 0 0 0 1 0 0 4 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 1 0 0 2 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 3 0 0 3 5 0 0 2 6 2 0 ----38

15-19 0 0 0 1 0 1 5 0 0 0 0 1 4 2 0 0 0 0 0 0 0 0 1 1 2 0 0 3 4 0 0 1 0 0 7 0 1 0 0 0 0 0 0 4 5 0 1 3 6 0 0 3 5 0 2 ----63

20-24 0 1 0 3 0 0 10 0 0 0 0 0 5 1 0 0 0 1 0 0 2 0 0 0 0 0 0 2 20 0 0 7 8 2 13 0 1 1 0 0 0 0 0 5 10 0 0 0 8 0 0 0 1 0 3 ----104

25-29 1 1 0 1 0 0 2 0 0 0 4 2 1 5 0 1 0 1 1 0 1 2 4 2 5 0 0 1 60 0 0 9 2 1 4 0 2 2 0 0 0 0 0 4 15 0 0 2 6 0 0 3 2 1 1 ----149

30-34 0 0 0 0 0 0 4 0 0 0 5 0 7 3 0 4 1 2 1 2 8 0 1 0 2 0 0 4 110 0 0 36 10 4 16 0 2 4 0 0 3 0 0 4 17 0 0 0 10 0 0 4 5 2 6 ----277

35-39 0 5 1 1 2 0 17 0 0 2 8 1 19 11 0 2 0 3 0 0 9 1 5 3 4 0 0 2 207 1 1 42 25 6 21 0 0 1 0 0 0 0 0 6 12 0 0 1 9 0 1 2 9 3 6 ----449

40-44 0 1 0 1 0 0 15 3 0 3 15 3 31 15 2 6 4 5 0 0 23 2 3 1 3 0 0 7 315 1 0 44 37 5 64 2 0 8 0 0 4 0 0 5 18 1 0 0 8 0 0 3 9 1 11 ----679

45-49 1 2 1 1 1 0 12 0 1 4 19 2 45 26 0 7 2 17 0 2 35 1 1 2 4 0 0 3 313 0 1 56 44 3 51 0 0 10 0 1 2 0 1 6 8 1 1 0 24 0 2 1 11 1 13 ----739

50-54 0 4 5 0 2 0 21 2 0 6 18 2 55 33 1 12 4 12 0 2 53 5 2 1 14 0 0 0 269 2 1 54 44 9 48 0 0 6 0 0 5 1 0 6 9 0 1 2 20 0 4 2 10 2 17 ----766

55-59 0 5 4 0 2 0 14 0 1 2 17 1 52 29 6 19 10 16 0 1 47 3 1 2 12 1 0 3 247 2 1 43 43 8 39 0 0 13 1 0 9 0 0 8 6 0 0 1 18 0 5 2 7 0 22 ----723

60-64 0 2 11 0 0 0 10 1 1 7 20 0 60 22 3 20 8 17 0 0 49 5 1 2 24 1 0 5 151 1 2 29 20 1 32 0 0 11 1 2 10 0 1 5 9 0 0 0 18 0 6 1 5 2 21 ----597

65-69 2 5 11 2 1 1 9 1 0 8 26 0 63 40 3 26 13 13 0 2 39 2 1 2 18 0 0 5 118 4 1 44 19 5 12 0 0 7 1 1 6 0 0 4 2 0 0 1 20 0 4 1 3 1 24 ----571

70-74 1 6 8 3 1 0 4 2 0 12 52 2 108 61 6 37 10 32 1 1 75 5 1 3 35 0 0 4 142 1 3 34 21 6 19 1 0 14 0 2 14 0 2 4 8 0 0 0 16 0 2 2 11 3 36 ----811

75+ 0.10% 0.50% 0.70% 0.20% 0.10% 0.00% 2.10% 0.10% 0.00% 0.70% 3.00% 0.20% 7.40% 4.10% 0.30% 2.20% 0.90% 2.00% 0.00% 0.20% 5.60% 0.40% 0.50% 0.30% 2.10% 0.00% 0.00% 0.70% 32.20% 0.20% 0.20% 6.60% 4.50% 0.80% 5.50% 0.00% 0.10% 1.30% 0.00% 0.10% 0.90% 0.00% 0.10% 1.40% 2.00% 0.00% 0.00% 0.20% 2.90% 0.00% 0.40% 1.00% 1.60% 0.40% 2.70% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 72: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PENANG, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

152

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

5 38 33 38 15 7 394 20 3 85 238 19 442 357 11 361 38 145 28 106 861 22 42 11 184 0 3 45 17 10 447 31 4 146 5 3 177 2 11 90 50 6 8 28 244 1 28 86 101 30 169 ----5245

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0.3 0 0 0 0 0.7 0 0 0 1.4 0 1.4 0 0 0 0 1 2.7 0 0.7 0.3 0 1.4 0 0 7.2 1 3.1 0 ----22

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0.3 0 0 0.3 3.2 0 0 3.5 0.3 1.3 1 ----12

50 0 0 0 0 0 1.2 0 0 0 0.3 0 0.3 0 0 0.3 0 0 0.3 0 0 0 1.8 0 0 0 0 0.6 0 0 0 0.9 0 0 0 0 0 0 0 2.8 0 0 0 0 3.1 0 0 2.5 0.9 0 0 ----15

10-14 0 0 0.6 0.3 0 0 1.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.9 0 0.3 0 0 0 0 0 0 0.6 0 0 0 0 0.3 0 0 1.2 0.6 0 0 1.2 2.1 0 0 1.5 1.5 0.3 0.3 ----14

15-19 0 0 0 0 0 0.3 2.3 0 0 0.3 0 0 0.3 0 0.3 0.3 0 0 0.3 0.3 0.7 0.7 2 0 0.3 0 0 1 0 0.3 0 1 0 0 0 0 0 0 0 1.7 0.7 0 0.7 1.3 2.7 0 0 1.7 3 0 0.3 ----23

20-24 0 0.3 0.3 0.3 0.3 0 2.9 0 0 0 0 0 0 0.6 0 0.3 0 0 0 0 2.3 0 0.3 0 0.6 0 0.3 1.9 0 0 0 1 0 1 0 0 0 0 0 0.6 0.3 0 0 0.6 1.6 0 0.3 1.6 2.9 0.3 1 ----22

25-29 0 0 0 0.4 0 0 6.7 0 0 0.4 0.4 0.4 0.7 1.1 0 1.4 0 0 0 0.4 1.4 0 0.7 0 1.1 0 0 1.1 0.4 0 0.4 1.8 0 0.4 0 0 0.7 0 0 2.1 0.7 0 0.4 0.7 2.5 0 0 0.7 1.1 0 0.7 ----28

30-34 0 0.7 0 1.1 0 0 13.6 0 0 0 1.8 0 2.2 2.9 0 2.9 0 1.1 0.7 0.4 5.1 0.7 0 0 0.7 0 0 0.7 0 0 0 2.2 0 2.2 0 0 0.7 0 0 1.8 1.5 0 0.4 0.7 5.9 0 0.4 0.4 2.9 0.4 1.5 ----56

35-39 0 0.8 0.4 1.2 0.4 0 19.4 0 0 0.4 1.6 0.4 7.1 4.3 0 5.1 0.8 3.2 0.8 1.2 7.5 0.4 2 0 2.8 0 0.8 1.2 0 0 0 0.4 0 4.7 0 0 3.2 0.4 0 3.6 2.4 0 0.8 0 3.6 0 0 1.2 4 0.4 3.6 ----90

40-44 0 1.3 0 1.7 0.4 0 24.7 0 0.4 3.4 7.2 1.3 12.3 10.6 0 8.9 0.9 5.1 1.3 1.7 20 0.4 0.4 0.4 4.3 0 0 1.3 0.9 0 1.7 0.4 0 8.9 0.4 0 3.4 0 0 3 2.6 0 0 1.3 9.4 0 0.9 0.9 2.6 0 3 ----147

45-49 0 2.5 1 2 0.5 0 27 0.5 0.5 2 12.3 0 18.2 22.6 0 19.2 2.5 2.9 3.4 4.4 35.4 1 2 0 6.9 0 0 2.5 0 0 3.4 0.5 0 3.4 0 0.5 6.9 0 0 4.4 2 0.5 0 2.5 13.8 0 0.5 1.5 4.4 1 4.9 ----219

50-54 0 4.7 1.8 3 1.8 0 31.5 1.8 0 5.3 11.9 1.2 30.9 26.1 1.2 38.6 5.3 11.9 1.2 6.5 60.5 3.6 2.4 1.8 8.9 0 0 3 0.6 1.2 14.2 0 0.6 13.7 0.6 0 10.7 0 0.6 3 2.4 0.6 0.6 1.8 12.5 0 1.8 2.4 4.7 0.6 16 ----353

55-59 0 3.7 5.2 3.7 3.7 2.2 26.6 0.7 0 14.8 27.3 2.2 44.3 42.1 2.2 47.2 2.2 14.8 3.7 14 103.3 2.2 1.5 2.2 19.9 0 0 3 1.5 3 43.5 1.5 1.5 12.5 0 0.7 13.3 0 0.7 1.5 3.7 0 0 0 17.7 0 4.4 3.7 3 2.2 15.5 ----523

60-64 1.1 3.4 6.9 5.7 1.1 1.1 37.9 2.3 0 20.7 36.8 6.9 77 59.8 2.3 52.9 5.7 32.2 1.1 25.3 187.4 2.3 1.1 3.4 41.4 0 0 2.3 3.4 2.3 121.9 0 0 27.6 1.1 1.1 39.1 0 1.1 8 10.3 1.1 0 2.3 40.2 1.1 5.7 6.9 8 2.3 24.1 ----927

65-69 1.5 4.5 1.5 6.1 1.5 3 28.8 10.6 0 12.1 53 4.5 106.1 59.1 0 62.1 7.6 27.3 1.5 28.8 213.7 0 0 1.5 37.9 0 0 3 6.1 0 157.6 0 0 21.2 0 0 45.5 1.5 3 3 1.5 0 0 0 21.2 0 7.6 4.5 16.7 4.5 34.9 ----1005

70-74 4.6 9.2 15.4 3.1 1.5 0 15.4 9.2 1.5 23.1 93.9 0 152.3 107.7 4.6 83.1 10.8 46.2 4.6 23.1 230.8 3.1 6.2 0 63.1 0 0 4.6 6.2 1.5 218.5 0 1.5 21.5 3.1 0 64.6 0 4.6 10.8 4.6 1.5 0 0 36.9 0 6.2 3.1 7.7 3.1 56.9 ----1369

75+

APPENDIX 73: CANCER INCIDENCE BY SITES AND AGE GROUP, PENANG, ALL RESIDENTS, MALES, 2007-2011

0.1 1 0.9 1 0.4 0.2 10.8 0.5 0.1 2.3 6.5 0.5 12.1 9.8 0.3 9.9 1 4 0.8 2.9 23.7 0.6 1.2 0.3 5.1 0 0.1 1.2 0.5 0.3 12.3 0.9 0.1 4 0.1 0.1 4.9 0.1 0.3 2.5 1.4 0.2 0.2 0.8 6.7 0 0.8 2.4 2.8 0.8 4.6 ----144.1

Crude Rate 0.2 1 1 1 0.4 0.2 10.2 0.6 0.1 2.5 6.9 0.6 12.8 10.2 0.3 10.2 1.1 4.2 0.7 3.1 25.1 0.6 1.1 0.3 5.4 0 0.1 1.2 0.5 0.3 13.8 0.8 0.1 4.1 0.1 0.1 5.2 0.1 0.4 2.5 1.4 0.2 0.2 0.7 6.8 0 0.8 2.7 2.7 1 4.8 ----150.5

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

153

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

6 32 43 15 9 2 127 9 3 44 184 14 451 248 21 135 52 119 3 10 341 27 31 19 125 2 0 45 1958 12 11 399 273 50 332 3 6 79 3 6 53 1 5 83 124 3 3 15 176 0 24 60 99 24 166 ----6085

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 1.1 0 0 0.4 0 0 0 0 0 0 0.7 0 0 0 0 0.4 3.2 0 0.4 0 0 0.4 0 0 5.8 3.6 1.4 1.1 ----19

0-9

0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.3 0 0 0 0 1 0 0 3.7 1.3 0.3 0 ----10

50.3 0 0.3 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.6 0 0 0 0 0.3 0.3 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 1.6 0.6 0 0 0.6 1.3 0 0 2.2 0.3 0.3 0.3 ----12

10-14 0 0 0 0.3 0 0 1.2 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 1.2 0 0.3 0 0 0.6 0.3 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.3 0.9 0 0 0.9 1.6 0 0 0.6 1.9 0.6 0 ----12

15-19 0 0 0 0.3 0 0.3 1.6 0 0 0 0 0.3 1.3 0.6 0 0 0 0 0 0 0 0 0.3 0.3 0.6 0 0 1 1.3 0 0 0.3 0 0 2.3 0 0.3 0 0 0 0 0 0 1.3 1.6 0 0.3 1 1.9 0 0 1 1.6 0 0.6 ----20

20-24 0 0.3 0 1 0 0 3.2 0 0 0 0 0 1.6 0.3 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0 0.6 6.4 0 0 2.2 2.5 0.6 4.1 0 0.3 0.3 0 0 0 0 0 1.6 3.2 0 0 0 2.5 0 0 0 0.3 0 1 ----33

25-29 0.4 0.4 0 0.4 0 0 0.7 0 0 0 1.4 0.7 0.4 1.8 0 0.4 0 0.4 0.4 0 0.4 0.7 1.4 0.7 1.8 0 0 0.4 21.3 0 0 3.2 0.7 0.4 1.4 0 0.7 0.7 0 0 0 0 0 1.4 5.3 0 0 0.7 2.1 0 0 1.1 0.7 0.4 0.4 ----53

30-34 0 0 0 0 0 0 1.5 0 0 0 1.8 0 2.6 1.1 0 1.5 0.4 0.7 0.4 0.7 2.9 0 0.4 0 0.7 0 0 1.5 40.2 0 0 13.1 3.7 1.5 5.8 0 0.7 1.5 0 0 1.1 0 0 1.5 6.2 0 0 0 3.7 0 0 1.5 1.8 0.7 2.2 ----101

35-39 0 1.9 0.4 0.4 0.8 0 6.6 0 0 0.8 3.1 0.4 7.4 4.3 0 0.8 0 1.2 0 0 3.5 0.4 1.9 1.2 1.6 0 0 0.8 80.2 0.4 0.4 16.3 9.7 2.3 8.1 0 0 0.4 0 0 0 0 0 2.3 4.7 0 0 0.4 3.5 0 0.4 0.8 3.5 1.2 2.3 ----174

40-44 0 0.4 0 0.4 0 0 6.6 1.3 0 1.3 6.6 1.3 13.5 6.6 0.9 2.6 1.7 2.2 0 0 10 0.9 1.3 0.4 1.3 0 0 3.1 137.6 0.4 0 19.2 16.2 2.2 28 0.9 0 3.5 0 0 1.7 0 0 2.2 7.9 0.4 0 0 3.5 0 0 1.3 3.9 0.4 4.8 ----297

45-49 0.5 1 0.5 0.5 0.5 0 5.8 0 0.5 1.9 9.2 1 21.9 12.7 0 3.4 1 8.3 0 1 17 0.5 0.5 1 1.9 0 0 1.5 152.3 0 0.5 27.3 21.4 1.5 24.8 0 0 4.9 0 0.5 1 0 0.5 2.9 3.9 0.5 0.5 0 11.7 0 1 0.5 5.4 0.5 6.3 ----360

50-54 0 2.3 2.9 0 1.2 0 12.3 1.2 0 3.5 10.5 1.2 32.2 19.3 0.6 7 2.3 7 0 1.2 31 2.9 1.2 0.6 8.2 0 0 0 157.3 1.2 0.6 31.6 25.7 5.3 28.1 0 0 3.5 0 0 2.9 0.6 0 3.5 5.3 0 0.6 1.2 11.7 0 2.3 1.2 5.8 1.2 9.9 ----448

55-59 0 3.7 3 0 1.5 0 10.3 0 0.7 1.5 12.5 0.7 38.4 21.4 4.4 14 7.4 11.8 0 0.7 34.7 2.2 0.7 1.5 8.9 0.7 0 2.2 182.3 1.5 0.7 31.7 31.7 5.9 28.8 0 0 9.6 0.7 0 6.6 0 0 5.9 4.4 0 0 0.7 13.3 0 3.7 1.5 5.2 0 16.2 ----534

60-64 0 2.2 11.8 0 0 0 10.8 1.1 1.1 7.5 21.5 0 64.5 23.7 3.2 21.5 8.6 18.3 0 0 52.7 5.4 1.1 2.2 25.8 1.1 0 5.4 162.4 1.1 2.2 31.2 21.5 1.1 34.4 0 0 11.8 1.1 2.2 10.8 0 1.1 5.4 9.7 0 0 0 19.4 0 6.5 1.1 5.4 2.2 22.6 ----642

65-69 2.8 7 15.4 2.8 1.4 1.4 12.6 1.4 0 11.2 36.4 0 88.1 56 4.2 36.4 18.2 18.2 0 2.8 54.6 2.8 1.4 2.8 25.2 0 0 7 165.1 5.6 1.4 61.5 26.6 7 16.8 0 0 9.8 1.4 1.4 8.4 0 0 5.6 2.8 0 0 1.4 28 0 5.6 1.4 4.2 1.4 33.6 ----799

70-74 1.1 6.7 9 3.4 1.1 0 4.5 2.2 0 13.5 58.4 2.2 121.4 68.5 6.7 41.6 11.2 36 1.1 1.1 84.3 5.6 1.1 3.4 39.3 0 0 4.5 159.6 1.1 3.4 38.2 23.6 6.7 21.4 1.1 0 15.7 0 2.2 15.7 0 2.2 4.5 9 0 0 0 18 0 2.2 2.2 12.4 3.4 40.5 ----911

75+ 0.2 0.9 1.2 0.4 0.2 0.1 3.5 0.2 0.1 1.2 5 0.4 12.4 6.8 0.6 3.7 1.4 3.3 0.1 0.3 9.3 0.7 0.8 0.5 3.4 0.1 0 1.2 53.6 0.3 0.3 10.9 7.5 1.4 9.1 0.1 0.2 2.2 0.1 0.2 1.5 0 0.1 2.3 3.4 0.1 0.1 0.4 4.8 0 0.7 1.6 2.7 0.7 4.5 ----166.7

Crude Rate

APPENDIX 74: CANCER INCIDENCE BY SITES AND AGE GROUP, PENANG, ALL RESIDENTS, FEMALES, 2007-2011

0.2 0.8 1.2 0.4 0.2 0.1 3.3 0.2 0.1 1.1 4.7 0.3 11.7 6.4 0.6 3.6 1.4 3.1 0.1 0.2 8.9 0.7 0.8 0.5 3.3 0.1 0 1.2 50 0.3 0.3 10.1 7 1.3 8.6 0.1 0.1 2.1 0.1 0.2 1.4 0 0.1 2.3 3.1 0.1 0.1 0.4 4.6 0 0.7 1.9 2.7 0.7 4.4 ----157.8

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

154

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 16 34 12 5 3 135 7 2 37 65 8 168 185 2 150 18 38 25 33 444 3 38 9 60 2 0 33 6 5 106 20 1 50 0 0 69 1 5 51 41 3 2 11 149 0 13 38 56 22 12 ----2193

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 0 2 0 0 0 0 1 3 0 0 0 0 4 0 0 3 5 4 0 ----25

0-9

0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 2 0 0 8 1 1 0 ----19

50 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 2 0 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 2 2 0 0 2 1 1 0 ----19

10-14 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 9 0 0 0 0 4 0 0 0 2 0 0 0 0 0 0 0 6 0 1 0 1 4 0 0 6 3 0 0 ----38

15-19 0 0 0 1 0 0 2 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 3 0 0 0 0 2 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 0 4 0 0 1 6 1 0 ----28

20-24 0 0 0 0 0 0 3 0 0 0 0 0 1 3 0 1 0 0 0 0 1 0 4 0 0 0 0 1 0 0 1 3 0 1 0 0 0 0 0 1 5 0 0 3 4 0 1 4 5 1 0 ----43

25-29 0 1 0 0 0 0 2 0 0 0 1 0 4 4 0 2 0 0 0 0 7 0 2 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 5 2 0 0 1 9 0 0 1 2 1 0 ----48

30-34 0 0 1 0 0 0 5 0 0 0 3 0 7 2 0 5 1 0 2 2 8 0 2 0 0 0 0 3 0 0 0 2 0 2 0 0 1 0 0 4 1 0 0 0 6 0 0 0 2 3 0 ----62

35-39 0 0 0 3 0 0 12 0 0 1 2 1 11 6 0 15 0 0 1 0 12 0 1 1 1 0 0 3 1 0 0 2 0 0 0 0 2 0 1 3 4 0 0 1 5 0 0 2 3 1 1 ----96

40-44 0 1 3 1 1 0 28 1 0 2 6 0 19 12 0 13 2 1 3 0 33 1 2 1 3 1 0 4 0 0 0 0 0 5 0 0 5 0 1 2 3 0 0 1 11 0 0 1 4 1 3 ----175

45-49 0 5 6 2 0 3 25 0 0 2 5 2 23 26 0 22 1 6 2 0 47 0 1 3 3 0 0 3 1 0 1 1 0 5 0 0 10 0 1 9 4 0 1 1 14 0 1 1 5 0 2 ----244

50-54 0 3 6 1 1 0 18 1 0 5 12 1 21 25 0 30 2 5 2 4 50 1 4 0 6 0 0 4 0 0 12 1 1 7 0 0 7 1 0 1 3 0 0 1 15 0 2 5 3 2 0 ----263

55-59 0 1 2 1 2 0 17 1 1 5 6 1 24 33 0 23 5 12 8 10 79 1 3 0 7 0 0 3 0 2 18 0 0 7 0 0 10 0 1 7 8 0 0 0 20 0 5 1 8 2 2 ----336

60-64 0 2 7 1 1 0 16 2 0 7 12 2 22 35 0 12 2 8 1 7 79 0 1 1 6 0 0 0 2 0 19 0 0 4 0 0 12 0 0 3 2 1 1 0 20 0 1 1 2 2 3 ----297

65-69 0 2 6 2 0 0 5 1 0 9 11 1 19 21 2 14 3 3 2 5 68 0 3 1 19 1 0 2 1 2 27 0 0 12 0 0 13 0 0 1 3 1 0 0 12 0 2 2 4 1 1 ----282

70-74 0 1 3 0 0 0 1 1 0 6 7 0 14 18 0 10 2 3 2 5 59 0 0 2 13 0 0 1 1 1 28 0 0 4 0 0 8 0 0 2 5 0 0 0 17 0 1 0 2 1 0 ----218

75+ 0.00% 0.70% 1.60% 0.50% 0.20% 0.10% 6.20% 0.30% 0.10% 1.70% 3.00% 0.40% 7.70% 8.40% 0.10% 6.80% 0.80% 1.70% 1.10% 1.50% 20.20% 0.10% 1.70% 0.40% 2.70% 0.10% 0.00% 1.50% 0.30% 0.20% 4.80% 0.90% 0.00% 2.30% 0.00% 0.00% 3.10% 0.00% 0.20% 2.30% 1.90% 0.10% 0.10% 0.50% 6.80% 0.00% 0.60% 1.70% 2.60% 1.00% 0.50% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 75: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PAHANG, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

155

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 15 21 9 8 1 40 4 1 19 45 3 130 107 2 57 17 27 13 5 164 2 20 8 40 0 0 27 790 3 6 193 78 33 158 2 3 21 0 1 23 0 1 63 96 4 1 6 100 0 16 21 56 19 18 ----2499

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 3 0 0 0 0 0 5 1 1 0 ----14

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 1 1 0 0 ----9

50 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 3 1 0 0 0 3 0 0 1 5 0 0 ----20

10-14 0 0 0 0 1 0 0 0 0 0 1 0 2 0 0 0 0 0 1 0 0 0 2 0 0 0 0 3 1 0 0 0 0 0 2 0 0 1 0 0 0 0 0 1 3 0 0 1 1 0 0 2 4 1 0 ----27

15-19 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 4 0 0 0 0 0 3 0 0 1 0 0 1 0 0 5 7 0 0 2 7 0 0 1 2 2 1 ----41

20-24 0 1 0 1 0 0 0 0 0 0 1 0 3 3 0 0 0 0 2 0 0 1 1 0 1 0 0 2 10 0 0 1 3 0 5 0 0 0 0 0 0 0 0 6 12 0 0 1 5 0 0 2 3 1 0 ----65

25-29 0 0 0 1 1 0 0 0 0 0 1 0 5 2 0 3 0 1 0 0 1 0 3 1 0 0 0 3 39 0 0 2 2 1 8 0 1 1 0 0 1 0 0 0 3 0 0 1 2 0 0 0 10 1 0 ----94

30-34 0 0 0 1 0 0 3 0 0 2 3 0 5 2 0 4 0 0 1 1 5 0 1 1 3 0 0 3 65 0 1 20 2 4 10 0 1 1 0 0 0 0 0 3 6 0 0 0 3 0 0 2 3 1 0 ----157

35-39 0 0 0 0 0 0 5 0 0 1 0 0 5 10 0 3 0 1 2 0 6 1 4 0 1 0 0 3 95 0 1 26 4 4 20 0 0 0 0 0 1 0 0 8 5 0 0 0 8 0 0 1 5 1 1 ----222

40-44 0 4 1 0 1 0 4 0 0 1 1 0 17 12 0 2 3 2 0 0 10 0 0 1 4 0 0 1 155 0 0 28 12 5 22 1 1 0 0 0 2 0 0 5 19 0 0 0 13 0 3 0 5 1 2 ----338

45-49 0 3 1 0 1 0 8 0 0 1 6 1 15 8 0 12 0 3 1 0 22 0 1 0 0 0 0 2 139 0 3 33 14 8 27 0 0 4 0 0 2 0 0 5 11 1 0 0 11 0 2 3 4 1 3 ----356

50-54 0 1 1 1 1 0 9 0 0 1 4 1 19 14 0 11 6 2 3 1 17 0 2 0 3 0 0 2 97 1 0 27 19 5 25 0 0 2 0 1 1 0 0 9 8 0 1 0 9 0 1 0 5 1 3 ----314

55-59 0 1 4 0 0 0 4 1 0 3 7 0 18 20 1 5 3 8 0 0 19 0 1 2 5 0 0 2 59 0 0 22 9 4 12 0 0 3 0 0 1 0 0 4 9 0 0 0 12 0 1 0 3 2 5 ----250

60-64 0 0 6 1 1 1 3 0 0 2 9 0 6 10 1 5 1 4 2 2 31 0 0 0 6 0 0 2 70 0 0 14 4 1 8 0 0 2 0 0 0 0 0 0 6 0 0 1 9 0 3 2 2 3 0 ----218

65-69 0 4 1 1 1 0 3 2 0 5 4 0 15 16 0 5 2 2 1 0 21 0 0 2 6 0 0 0 29 1 0 12 4 1 8 1 0 1 0 0 5 0 0 6 4 0 0 0 9 0 4 1 3 1 2 ----183

70-74 2 1 7 2 1 0 1 1 1 3 8 0 19 9 0 7 2 4 0 1 31 0 0 1 11 0 0 1 27 1 1 8 5 0 6 0 0 4 0 0 9 0 0 2 2 0 0 0 8 0 2 0 0 2 1 ----191

75+ 0.10% 0.60% 0.80% 0.40% 0.30% 0.00% 1.60% 0.20% 0.00% 0.80% 1.80% 0.10% 5.20% 4.30% 0.10% 2.30% 0.70% 1.10% 0.50% 0.20% 6.60% 0.10% 0.80% 0.30% 1.60% 0.00% 0.00% 1.10% 31.60% 0.10% 0.20% 7.70% 3.10% 1.30% 6.30% 0.10% 0.10% 0.80% 0.00% 0.00% 0.90% 0.00% 0.00% 2.50% 3.80% 0.20% 0.00% 0.20% 4.00% 0.00% 0.60% 0.80% 2.20% 0.80% 0.70% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 76: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PAHANG, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

156

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 16 34 12 5 3 135 7 2 37 65 8 168 185 2 150 18 38 25 33 444 3 38 9 60 2 0 33 6 5 106 20 1 50 0 0 69 1 5 51 41 3 2 11 149 0 13 38 56 22 12 ----2193

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.5 0 0.5 0 0 0 0 0.3 0.8 0 0 0 0 1.1 0 0 0.8 1.3 1.1 0 ----7

0-9

0 0 0 0 0 0 0.3 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0.5 0 0 0 0 0.5 0 0 2.1 0.3 0.3 0 ----5

50 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.2 0 0 0.2 0 0 0 0.5 0 0.5 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0.2 0.2 0 0 0.5 0.5 0 0 0.5 0.2 0.2 0 ----5

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0.2 0 2.2 0 0 0 0 1 0 0 0 0.5 0 0 0 0 0 0 0 1.5 0 0.2 0 0.2 1 0 0 1.5 0.7 0 0 ----9

15-19 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0.3 0 0 0.3 0 0 0.3 0 0 0 0.9 0 0 0 0 0.6 0 0 0 1.2 0 0 0 0 0 0 0 0.3 0 0 0 0 1.2 0 0 0.3 1.8 0.3 0 ----8

20-24 0 0 0 0 0 0 1 0 0 0 0 0 0.3 1 0 0.3 0 0 0 0 0.3 0 1.3 0 0 0 0 0.3 0 0 0.3 1 0 0.3 0 0 0 0 0 0.3 1.6 0 0 1 1.3 0 0.3 1.3 1.6 0.3 0 ----14

25-29 0 0.4 0 0 0 0 0.9 0 0 0 0.4 0 1.8 1.8 0 0.9 0 0 0 0 3.1 0 0.9 0 0 0 0 0 0 0 0 1.3 0 0 0 0 0.4 0 0 2.2 0.9 0 0 0.4 4 0 0 0.4 0.9 0.4 0 ----21

30-34 0 0 0.5 0 0 0 2.5 0 0 0 1.5 0 3.5 1 0 2.5 0.5 0 1 1 4 0 1 0 0 0 0 1.5 0 0 0 1 0 1 0 0 0.5 0 0 2 0.5 0 0 0 3 0 0 0 1 1.5 0 ----31

35-39 0 0 0 1.6 0 0 6.5 0 0 0.5 1.1 0.5 5.9 3.2 0 8.1 0 0 0.5 0 6.5 0 0.5 0.5 0.5 0 0 1.6 0.5 0 0 1.1 0 0 0 0 1.1 0 0.5 1.6 2.2 0 0 0.5 2.7 0 0 1.1 1.6 0.5 0.5 ----52

40-44 0 0.6 1.8 0.6 0.6 0 16.6 0.6 0 1.2 3.6 0 11.3 7.1 0 7.7 1.2 0.6 1.8 0 19.6 0.6 1.2 0.6 1.8 0.6 0 2.4 0 0 0 0 0 3 0 0 3 0 0.6 1.2 1.8 0 0 0.6 6.5 0 0 0.6 2.4 0.6 1.8 ----104

45-49 0 2.9 3.5 1.2 0 1.7 14.5 0 0 1.2 2.9 1.2 13.3 15 0 12.7 0.6 3.5 1.2 0 27.2 0 0.6 1.7 1.7 0 0 1.7 0.6 0 0.6 0.6 0 2.9 0 0 5.8 0 0.6 5.2 2.3 0 0.6 0.6 8.1 0 0.6 0.6 2.9 0 1.2 ----141

50-54 0 2.1 4.2 0.7 0.7 0 12.7 0.7 0 3.5 8.5 0.7 14.8 17.6 0 21.1 1.4 3.5 1.4 2.8 35.2 0.7 2.8 0 4.2 0 0 2.8 0 0 8.5 0.7 0.7 4.9 0 0 4.9 0.7 0 0.7 2.1 0 0 0.7 10.6 0 1.4 3.5 2.1 1.4 0 ----185

55-59 0 0.9 1.7 0.9 1.7 0 14.8 0.9 0.9 4.4 5.2 0.9 21 28.8 0 20.1 4.4 10.5 7 8.7 69 0.9 2.6 0 6.1 0 0 2.6 0 1.7 15.7 0 0 6.1 0 0 8.7 0 0.9 6.1 7 0 0 0 17.5 0 4.4 0.9 7 1.7 1.7 ----293

60-64 0 2.7 9.5 1.4 1.4 0 21.6 2.7 0 9.5 16.2 2.7 29.7 47.3 0 16.2 2.7 10.8 1.4 9.5 106.8 0 1.4 1.4 8.1 0 0 0 2.7 0 25.7 0 0 5.4 0 0 16.2 0 0 4.1 2.7 1.4 1.4 0 27 0 1.4 1.4 2.7 2.7 4.1 ----401

65-69 0 3.8 11.3 3.8 0 0 9.4 1.9 0 17 20.8 1.9 35.9 39.6 3.8 26.4 5.7 5.7 3.8 9.4 128.3 0 5.7 1.9 35.9 1.9 0 3.8 1.9 3.8 51 0 0 22.6 0 0 24.5 0 0 1.9 5.7 1.9 0 0 22.6 0 3.8 3.8 7.5 1.9 1.9 ----532

70-74 0 2.2 6.5 0 0 0 2.2 2.2 0 12.9 15.1 0 30.1 38.7 0 21.5 4.3 6.5 4.3 10.8 126.9 0 0 4.3 28 0 0 2.2 2.2 2.2 60.2 0 0 8.6 0 0 17.2 0 0 4.3 10.8 0 0 0 36.6 0 2.2 0 4.3 2.2 0 ----469

75+

APPENDIX 77: CANCER INCIDENCE BY SITES AND AGE GROUP, PAHANG, ALL RESIDENTS, MALES, 2007-2011

0 0.4 0.9 0.3 0.1 0.1 3.7 0.2 0.1 1 1.8 0.2 4.7 5.1 0.1 4.2 0.5 1.1 0.7 0.9 12.3 0.1 1.1 0.2 1.7 0.1 0 0.9 0.2 0.1 2.9 0.6 0 1.4 0 0 1.9 0 0.1 1.4 1.1 0.1 0.1 0.3 4.1 0 0.4 1.1 1.6 0.6 0.3 ----60.9

Crude Rate 0 0.5 1.2 0.4 0.2 0.1 4.4 0.3 0.1 1.4 2.3 0.3 5.7 6.5 0.1 5 0.6 1.3 0.8 1.2 15.9 0.1 1.1 0.3 2.2 0.1 0 1 0.2 0.2 4 0.5 0 1.7 0 0 2.5 0 0.2 1.6 1.4 0.1 0.1 0.3 5 0 0.4 1.1 1.7 0.7 0.4 ----75.1

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

157

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 15 21 9 8 1 40 4 1 19 45 3 130 107 2 57 17 27 13 5 164 2 20 8 40 0 0 27 790 3 6 193 78 33 158 2 3 21 0 1 23 0 1 63 96 4 1 6 100 0 16 21 56 19 18 ----2499

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.9 0 0.9 0 0 0 0 0 1.5 0.3 0.3 0 ----4

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0.3 0.3 0 0 ----3

50 0 0 0.3 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.3 0 0 0 0 0 0.8 0.3 0 0 0 0.8 0 0 0.3 1.3 0 0 ----5

10-14 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0.6 0 0 0 0 0 0.3 0 0 0 0.6 0 0 0 0 0.8 0.3 0 0 0 0 0 0.6 0 0 0.3 0 0 0 0 0 0.3 0.8 0 0 0.3 0.3 0 0 0.6 1.1 0.3 0 ----7

15-19 0 0 0 0 0 0 0 0 0 0 0 0.3 0.3 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.7 1.3 0 0 0 0 0 1 0 0 0.3 0 0 0.3 0 0 1.7 2.4 0 0 0.7 2.4 0 0 0.3 0.7 0.7 0.3 ----14

20-24 0 0.3 0 0.3 0 0 0 0 0 0 0.3 0 1 1 0 0 0 0 0.7 0 0 0.3 0.3 0 0.3 0 0 0.7 3.5 0 0 0.3 1 0 1.7 0 0 0 0 0 0 0 0 2.1 4.2 0 0 0.3 1.7 0 0 0.7 1 0.3 0 ----23

25-29 0 0 0 0.5 0.5 0 0 0 0 0 0.5 0 2.5 1 0 1.5 0 0.5 0 0 0.5 0 1.5 0.5 0 0 0 1.5 19.5 0 0 1 1 0.5 4 0 0.5 0.5 0 0 0.5 0 0 0 1.5 0 0 0.5 1 0 0 0 5 0.5 0 ----47

30-34 0 0 0 0.5 0 0 1.5 0 0 1 1.5 0 2.5 1 0 2 0 0 0.5 0.5 2.5 0 0.5 0.5 1.5 0 0 1.5 32.3 0 0.5 9.9 1 2 5 0 0.5 0.5 0 0 0 0 0 1.5 3 0 0 0 1.5 0 0 1 1.5 0.5 0 ----78

35-39 0 0 0 0 0 0 2.5 0 0 0.5 0 0 2.5 5.1 0 1.5 0 0.5 1 0 3 0.5 2 0 0.5 0 0 1.5 48.2 0 0.5 13.2 2 2 10.2 0 0 0 0 0 0.5 0 0 4.1 2.5 0 0 0 4.1 0 0 0.5 2.5 0.5 0.5 ----113

40-44 0 2 0.5 0 0.5 0 2 0 0 0.5 0.5 0 8.7 6.1 0 1 1.5 1 0 0 5.1 0 0 0.5 2 0 0 0.5 79.1 0 0 14.3 6.1 2.6 11.2 0.5 0.5 0 0 0 1 0 0 2.6 9.7 0 0 0 6.6 0 1.5 0 2.6 0.5 1 ----172

45-49 0 1.7 0.6 0 0.6 0 4.7 0 0 0.6 3.5 0.6 8.7 4.7 0 7 0 1.7 0.6 0 12.8 0 0.6 0 0 0 0 1.2 81.1 0 1.7 19.2 8.2 4.7 15.7 0 0 2.3 0 0 1.2 0 0 2.9 6.4 0.6 0 0 6.4 0 1.2 1.7 2.3 0.6 1.7 ----208

50-54 0 0.7 0.7 0.7 0.7 0 6.7 0 0 0.7 3 0.7 14.2 10.4 0 8.2 4.5 1.5 2.2 0.7 12.7 0 1.5 0 2.2 0 0 1.5 72.4 0.7 0 20.2 14.2 3.7 18.7 0 0 1.5 0 0.7 0.7 0 0 6.7 6 0 0.7 0 6.7 0 0.7 0 3.7 0.7 2.2 ----234

55-59 0 0.9 3.8 0 0 0 3.8 0.9 0 2.8 6.6 0 17 18.9 0.9 4.7 2.8 7.5 0 0 17.9 0 0.9 1.9 4.7 0 0 1.9 55.7 0 0 20.8 8.5 3.8 11.3 0 0 2.8 0 0 0.9 0 0 3.8 8.5 0 0 0 11.3 0 0.9 0 2.8 1.9 4.7 ----236

60-64 0 0 9.3 1.6 1.6 1.6 4.7 0 0 3.1 14 0 9.3 15.5 1.6 7.8 1.6 6.2 3.1 3.1 48.1 0 0 0 9.3 0 0 3.1 108.5 0 0 21.7 6.2 1.6 12.4 0 0 3.1 0 0 0 0 0 0 9.3 0 0 1.6 14 0 4.7 3.1 3.1 4.7 0 ----338

65-69 0 7.6 1.9 1.9 1.9 0 5.7 3.8 0 9.5 7.6 0 28.6 30.5 0 9.5 3.8 3.8 1.9 0 40 0 0 3.8 11.4 0 0 0 55.2 1.9 0 22.9 7.6 1.9 15.2 1.9 0 1.9 0 0 9.5 0 0 11.4 7.6 0 0 0 17.1 0 7.6 1.9 5.7 1.9 3.8 ----349

70-74 3.6 1.8 12.7 3.6 1.8 0 1.8 1.8 1.8 5.5 14.5 0 34.6 16.4 0 12.7 3.6 7.3 0 1.8 56.4 0 0 1.8 20 0 0 1.8 49.1 1.8 1.8 14.5 9.1 0 10.9 0 0 7.3 0 0 16.4 0 0 3.6 3.6 0 0 0 14.5 0 3.6 0 0 3.6 1.8 ----347

75+ 0.1 0.4 0.6 0.3 0.2 0 1.2 0.1 0 0.6 1.3 0.1 3.8 3.2 0.1 1.7 0.5 0.8 0.4 0.1 4.8 0.1 0.6 0.2 1.2 0 0 0.8 23.3 0.1 0.2 5.7 2.3 1 4.7 0.1 0.1 0.6 0 0 0.7 0 0 1.9 2.8 0.1 0 0.2 2.9 0 0.5 0.6 1.7 0.6 0.5 ----73.7

Crude Rate

APPENDIX 78: CANCER INCIDENCE BY SITES AND AGE GROUP, PAHANG, ALL RESIDENTS, FEMALES, 2007-2011

0.1 0.5 0.8 0.3 0.3 0 1.3 0.2 0 0.7 1.6 0.1 4.4 3.7 0.1 1.9 0.6 1 0.4 0.2 5.9 0.1 0.6 0.3 1.5 0 0 0.8 25.7 0.1 0.2 6.3 2.5 1 5 0.1 0.1 0.7 0 0 0.8 0 0 1.9 3 0.1 0 0.2 3.3 0 0.6 0.7 1.7 0.6 0.6 ----82.7

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

158

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 16 5 11 0 2 70 5 1 21 35 4 113 110 4 157 18 36 10 21 313 1 35 5 58 0 0 28 2 0 96 12 1 27 1 1 69 0 5 39 26 2 4 14 93 0 10 11 57 63 55 ----1668

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 3 1 0 0 0 5 7 0 1 0 1 2 0 0 4 9 12 0 ----49

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 0 0 0 0 0 0 2 0 0 0 0 0 5 0 1 0 1 0 0 0 2 3 9 1 ----28

50 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 4 0 0 1 2 4 0 0 1 7 4 3 ----35

10-14 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 1 4 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 1 1 6 0 0 2 4 8 3 ----42

15-19 0 0 1 1 0 0 1 0 0 1 1 0 0 1 0 2 0 0 0 0 3 0 3 0 3 0 0 1 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 1 6 0 0 0 1 4 2 ----37

20-24 0 1 0 0 0 0 2 0 0 0 3 0 1 0 0 1 0 0 0 0 3 0 1 1 2 0 0 3 0 0 0 5 0 0 0 0 0 0 0 3 1 0 1 0 2 0 0 0 3 5 1 ----39

25-29 1 1 0 0 0 0 0 0 0 0 0 0 3 5 0 5 0 1 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 4 0 0 1 3 0 0 ----30

30-34 0 1 0 2 0 0 3 0 0 1 0 0 1 2 0 8 1 1 1 0 2 0 2 0 1 0 0 0 0 0 0 1 0 0 0 0 2 0 0 1 1 0 0 1 3 0 0 0 2 1 1 ----39

35-39 0 0 0 1 0 0 8 0 0 1 1 1 7 7 0 10 0 4 1 0 15 0 2 1 2 0 0 1 0 0 0 0 0 0 0 0 2 0 0 1 3 0 0 2 10 0 1 0 5 3 4 ----93

40-44 0 3 1 1 0 1 6 1 0 0 3 0 8 9 0 18 2 7 0 2 28 0 2 0 4 0 0 5 0 0 0 0 0 4 0 0 6 0 0 4 4 0 1 1 8 0 0 0 5 0 5 ----139

45-49 0 2 0 2 0 0 18 0 1 1 3 0 9 14 1 28 3 4 4 2 38 1 2 0 3 0 0 0 0 0 5 0 1 7 0 0 5 0 0 6 4 0 0 1 4 0 2 0 1 8 1 ----181

50-54 0 1 0 3 0 0 10 2 0 1 3 2 15 15 1 25 4 3 1 3 36 0 1 1 4 0 0 3 2 0 9 0 0 3 0 0 9 0 0 1 3 0 0 0 13 0 2 1 5 3 8 ----193

55-59 0 1 0 0 0 0 3 0 0 5 2 0 18 13 2 24 3 7 1 3 46 0 2 0 13 0 0 2 0 0 14 0 0 4 0 0 7 0 0 3 3 0 0 0 10 0 1 0 4 0 7 ----198

60-64 0 3 2 1 0 1 4 1 0 3 8 0 16 20 0 10 1 5 1 3 51 0 3 0 7 0 0 4 0 0 18 0 0 3 0 0 13 0 0 2 3 0 0 2 8 0 3 0 0 1 5 ----202

65-69 0 1 1 0 0 0 5 1 0 4 7 1 18 17 0 15 3 3 1 2 51 0 1 0 4 0 0 1 0 0 25 0 0 0 0 0 14 0 0 1 1 0 0 0 8 0 1 0 1 1 5 ----193

70-74 0 2 0 0 0 0 5 0 0 4 4 0 16 7 0 10 1 1 0 6 38 0 4 1 6 0 0 3 0 0 25 1 0 1 0 1 11 0 0 0 1 0 0 0 5 0 0 0 4 4 9 ----170

75+ 0.10% 1.00% 0.30% 0.70% 0.00% 0.10% 4.20% 0.30% 0.10% 1.30% 2.10% 0.20% 6.80% 6.60% 0.20% 9.40% 1.10% 2.20% 0.60% 1.30% 18.80% 0.10% 2.10% 0.30% 3.50% 0.00% 0.00% 1.70% 0.10% 0.00% 5.80% 0.70% 0.10% 1.60% 0.10% 0.10% 4.10% 0.00% 0.30% 2.30% 1.60% 0.10% 0.20% 0.80% 5.60% 0.00% 0.60% 0.70% 3.40% 3.80% 3.30% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 79: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, TERENGGANU, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

159

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 12 12 5 1 1 35 5 2 15 33 2 90 83 2 49 14 23 3 2 113 5 29 4 35 0 0 28 534 4 0 120 97 37 173 0 6 19 0 0 15 0 7 41 111 0 1 4 56 0 15 8 52 36 37 ----1977

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 1 0 2 0 0 0 0 2 0 0 0 0 0 0 0 0 0 4 0 0 0 0 3 3 0 0 0 0 3 0 0 5 5 6 0 ----37

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 4 0 0 0 0 0 0 0 0 3 6 1 ----21

50 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 4 0 0 0 1 3 0 ----20

10-14 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 5 0 2 0 0 7 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 3 6 0 0 0 3 0 0 1 6 0 1 ----44

15-19 0 1 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 2 1 3 0 0 0 0 0 12 0 0 0 0 0 10 0 1 0 0 0 1 0 0 1 12 0 0 2 3 0 0 0 2 2 3 ----60

20-24 0 0 0 0 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 1 0 0 2 13 0 0 3 3 1 4 0 0 0 0 0 1 0 1 1 6 0 0 0 4 0 0 1 1 3 1 ----50

25-29 0 2 0 0 0 0 1 1 2 0 0 0 4 1 0 1 0 0 0 0 1 1 1 0 2 0 0 2 25 1 0 2 5 2 11 0 1 0 0 0 0 0 0 2 4 0 0 1 3 0 0 0 4 1 1 ----82

30-34 0 1 1 1 0 0 2 0 0 0 2 0 1 3 0 1 0 1 1 0 6 0 1 0 0 0 0 0 39 0 0 4 7 4 9 0 1 2 0 0 2 0 0 3 5 0 0 1 3 0 1 0 4 0 1 ----107

35-39 0 2 0 0 0 0 2 1 0 0 1 1 10 6 1 2 0 1 0 0 8 0 1 0 3 0 0 2 72 0 0 14 18 8 14 0 1 1 0 0 0 0 0 1 15 0 1 0 1 0 2 0 2 1 3 ----195

40-44 0 1 0 2 0 0 5 1 0 0 3 0 8 6 0 3 1 0 0 0 11 0 3 1 3 0 0 2 106 0 0 24 16 12 26 0 1 1 0 0 1 0 0 5 11 0 0 0 4 0 1 0 2 2 4 ----266

45-49 0 2 3 2 0 0 3 0 0 1 6 0 10 15 0 4 3 3 0 0 13 0 2 0 3 0 0 2 95 2 0 19 16 4 24 0 1 2 0 0 1 0 0 5 11 0 0 0 2 0 3 0 5 3 4 ----269

50-54 0 0 0 0 0 0 7 0 0 2 4 0 14 8 0 7 2 6 2 2 18 1 1 1 1 0 0 2 72 0 0 18 14 2 17 0 0 1 0 0 0 0 0 1 3 0 0 0 8 0 4 0 5 3 4 ----230

55-59 0 1 2 0 0 0 4 1 0 2 4 0 13 14 0 5 1 3 0 0 14 1 0 0 4 0 0 1 41 0 0 15 10 3 13 0 0 2 0 0 0 0 0 4 15 0 0 0 8 0 1 0 4 3 5 ----194

60-64 0 0 2 0 0 0 0 1 0 4 2 0 5 13 0 6 3 2 0 0 15 1 0 2 4 0 0 1 26 0 0 8 5 1 22 0 0 4 0 0 4 0 0 5 8 0 0 0 0 0 0 0 2 1 3 ----150

65-69 0 0 3 0 0 0 5 0 0 2 3 1 12 10 0 7 3 5 0 0 15 0 2 0 4 0 0 1 16 1 0 8 2 0 7 0 0 2 0 0 2 0 1 0 7 0 0 0 6 0 2 0 3 1 4 ----135

70-74 1 1 1 0 1 0 1 0 0 4 6 0 12 6 1 11 1 1 0 0 9 0 1 0 7 0 0 1 16 0 0 5 1 0 7 0 0 0 0 0 3 0 0 1 7 0 0 0 4 0 1 1 3 1 2 ----117

75+ 0.10% 0.60% 0.60% 0.30% 0.10% 0.10% 1.80% 0.30% 0.10% 0.80% 1.70% 0.10% 4.60% 4.20% 0.10% 2.50% 0.70% 1.20% 0.20% 0.10% 5.70% 0.30% 1.50% 0.20% 1.80% 0.00% 0.00% 1.40% 27.00% 0.20% 0.00% 6.10% 4.90% 1.90% 8.80% 0.00% 0.30% 1.00% 0.00% 0.00% 0.80% 0.00% 0.40% 2.10% 5.60% 0.00% 0.10% 0.20% 2.80% 0.00% 0.80% 0.40% 2.60% 1.80% 1.90% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 80: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, TERENGGANU, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

160

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 16 5 11 0 2 70 5 1 21 35 4 113 110 4 157 18 36 10 21 313 1 35 5 58 0 0 28 2 0 96 12 1 27 1 1 69 0 5 39 26 2 4 14 93 0 10 11 57 63 55 ----1668

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.3 0 0 0.7 0 0 0 0 0 1 0.3 0 0 0 1.7 2.4 0 0.3 0 0.3 0.7 0 0 1.4 3.1 4.2 0 ----17

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.3 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 1.6 0 0.3 0 0.3 0 0 0 0.7 1 3 0.3 ----9

50 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 1.3 0 0.3 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 1.3 0 0 0.3 0.7 1.3 0 0 0.3 2.3 1.3 1 ----11

10-14 0 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.6 0.3 1.3 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0.3 0 0.3 0.3 2 0 0 0.7 1.3 2.6 1 ----14

15-19 0 0 0.4 0.4 0 0 0.4 0 0 0.4 0.4 0 0 0.4 0 0.8 0 0 0 0 1.2 0 1.2 0 1.2 0 0 0.4 0 0 0 1.6 0 0 0 0 0 0 0 0.4 0 0 0 0.4 2.4 0 0 0 0.4 1.6 0.8 ----15

20-24 0 0.5 0 0 0 0 1 0 0 0 1.6 0 0.5 0 0 0.5 0 0 0 0 1.6 0 0.5 0.5 1 0 0 1.6 0 0 0 2.6 0 0 0 0 0 0 0 1.6 0.5 0 0.5 0 1 0 0 0 1.6 2.6 0.5 ----20

25-29 0.7 0.7 0 0 0 0 0 0 0 0 0 0 2 3.3 0 3.3 0 0.7 0 0 1.3 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0.7 2.7 0 0 0.7 2 0 0 ----20

30-34 0 0.7 0 1.5 0 0 2.2 0 0 0.7 0 0 0.7 1.5 0 5.8 0.7 0.7 0.7 0 1.5 0 1.5 0 0.7 0 0 0 0 0 0 0.7 0 0 0 0 1.5 0 0 0.7 0.7 0 0 0.7 2.2 0 0 0 1.5 0.7 0.7 ----28

35-39 0 0 0 0.7 0 0 5.8 0 0 0.7 0.7 0.7 5.1 5.1 0 7.3 0 2.9 0.7 0 10.9 0 1.5 0.7 1.5 0 0 0.7 0 0 0 0 0 0 0 0 1.5 0 0 0.7 2.2 0 0 1.5 7.3 0 0.7 0 3.6 2.2 2.9 ----68

40-44 0 2.2 0.7 0.7 0 0.7 4.5 0.7 0 0 2.2 0 5.9 6.7 0 13.4 1.5 5.2 0 1.5 20.8 0 1.5 0 3 0 0 3.7 0 0 0 0 0 3 0 0 4.5 0 0 3 3 0 0.7 0.7 5.9 0 0 0 3.7 0 3.7 ----103

45-49 0 1.4 0 1.4 0 0 12.4 0 0.7 0.7 2.1 0 6.2 9.6 0.7 19.2 2.1 2.7 2.7 1.4 26.1 0.7 1.4 0 2.1 0 0 0 0 0 3.4 0 0.7 4.8 0 0 3.4 0 0 4.1 2.7 0 0 0.7 2.7 0 1.4 0 0.7 5.5 0.7 ----124

50-54 0 1.1 0 3.4 0 0 11.2 2.2 0 1.1 3.4 2.2 16.9 16.9 1.1 28.1 4.5 3.4 1.1 3.4 40.5 0 1.1 1.1 4.5 0 0 3.4 2.2 0 10.1 0 0 3.4 0 0 10.1 0 0 1.1 3.4 0 0 0 14.6 0 2.2 1.1 5.6 3.4 9 ----217

55-59 0 1.5 0 0 0 0 4.5 0 0 7.5 3 0 26.9 19.4 3 35.8 4.5 10.4 1.5 4.5 68.7 0 3 0 19.4 0 0 3 0 0 20.9 0 0 6 0 0 10.4 0 0 4.5 4.5 0 0 0 14.9 0 1.5 0 6 0 10.4 ----296

60-64 0 6.6 4.4 2.2 0 2.2 8.8 2.2 0 6.6 17.6 0 35.2 44 0 22 2.2 11 2.2 6.6 112.1 0 6.6 0 15.4 0 0 8.8 0 0 39.6 0 0 6.6 0 0 28.6 0 0 4.4 6.6 0 0 4.4 17.6 0 6.6 0 0 2.2 11 ----444

65-69 0 3.1 3.1 0 0 0 15.6 3.1 0 12.5 21.9 3.1 56.3 53.1 0 46.9 9.4 9.4 3.1 6.3 159.4 0 3.1 0 12.5 0 0 3.1 0 0 78.1 0 0 0 0 0 43.8 0 0 3.1 3.1 0 0 0 25 0 3.1 0 3.1 3.1 15.6 ----603

70-74 0 5.8 0 0 0 0 14.5 0 0 11.6 11.6 0 46.4 20.3 0 29 2.9 2.9 0 17.4 110.2 0 11.6 2.9 17.4 0 0 8.7 0 0 72.5 2.9 0 2.9 0 2.9 31.9 0 0 0 2.9 0 0 0 14.5 0 0 0 11.6 11.6 26.1 ----493

75+ 0 0.6 0.2 0.4 0 0.1 2.7 0.2 0 0.8 1.3 0.2 4.3 4.2 0.2 6 0.7 1.4 0.4 0.8 11.9 0 1.3 0.2 2.2 0 0 1.1 0.1 0 3.7 0.5 0 1 0 0 2.6 0 0.2 1.5 1 0.1 0.2 0.5 3.5 0 0.4 0.4 2.2 2.4 2.1 ----63.7

Crude Rate

APPENDIX 81: CANCER INCIDENCE BY SITES AND AGE GROUP, TERENGGANU, ALL RESIDENTS, MALES, 2007-2011

0 0.8 0.3 0.5 0 0.1 3.1 0.3 0 1.2 1.9 0.2 6.1 5.7 0.2 7.6 0.9 1.8 0.5 1.1 16.7 0 1.5 0.2 2.9 0 0 1.4 0.1 0 5.6 0.5 0 1.2 0 0.1 3.8 0 0.2 1.6 1.2 0.1 0.1 0.6 4.4 0 0.5 0.4 2.4 2.4 2.7 ----83.2

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

161

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 12 12 5 1 1 35 5 2 15 33 2 90 83 2 49 14 23 3 2 113 5 29 4 35 0 0 28 534 4 0 120 97 37 173 0 6 19 0 0 15 0 7 41 111 0 1 4 56 0 15 8 52 36 37 ----1977

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0.4 0 0 0.4 0 0.7 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 1.5 0 0 0 0 1.1 1.1 0 0 0 0 1.1 0 0 1.8 1.8 2.2 0 ----14

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.3 0 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.3 1.4 0 0 0 0 0 0 0 0 1 2.1 0.3 ----7

50 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0.7 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.7 0.3 0 0 0 1.4 0 0 0 0.3 1 0 ----7

10-14 0 0 0 0 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0.7 0 0 2.4 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 1 2.1 0 0 0 1 0 0 0.3 2.1 0 0.3 ----15

15-19 0 0.4 0 0 0 0 1.3 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.9 0.4 1.3 0 0 0 0 0 5.1 0 0 0 0 0 4.3 0 0.4 0 0 0 0.4 0 0 0.4 5.1 0 0 0.9 1.3 0 0 0 0.9 0.9 1.3 ----26

20-24 0 0 0 0 0 0 0.6 0 0 0 0.6 0 0 0.6 0 0 0 0 0 0 0 0 0.6 0 0.6 0 0 1.2 7.6 0 0 1.7 1.7 0.6 2.3 0 0 0 0 0 0.6 0 0.6 0.6 3.5 0 0 0 2.3 0 0 0.6 0.6 1.7 0.6 ----29

25-29 0 1.4 0 0 0 0 0.7 0.7 1.4 0 0 0 2.8 0.7 0 0.7 0 0 0 0 0.7 0.7 0.7 0 1.4 0 0 1.4 17.7 0.7 0 1.4 3.5 1.4 7.8 0 0.7 0 0 0 0 0 0 1.4 2.8 0 0 0.7 2.1 0 0 0 2.8 0.7 0.7 ----58

30-34 0 0.7 0.7 0.7 0 0 1.4 0 0 0 1.4 0 0.7 2.1 0 0.7 0 0.7 0.7 0 4.2 0 0.7 0 0 0 0 0 27.2 0 0 2.8 4.9 2.8 6.3 0 0.7 1.4 0 0 1.4 0 0 2.1 3.5 0 0 0.7 2.1 0 0.7 0 2.8 0 0.7 ----75

35-39 0 1.4 0 0 0 0 1.4 0.7 0 0 0.7 0.7 6.9 4.2 0.7 1.4 0 0.7 0 0 5.5 0 0.7 0 2.1 0 0 1.4 49.8 0 0 9.7 12.5 5.5 9.7 0 0.7 0.7 0 0 0 0 0 0.7 10.4 0 0.7 0 0.7 0 1.4 0 1.4 0.7 2.1 ----135

40-44 0 0.7 0 1.5 0 0 3.7 0.7 0 0 2.2 0 5.9 4.4 0 2.2 0.7 0 0 0 8.1 0 2.2 0.7 2.2 0 0 1.5 77.7 0 0 17.6 11.7 8.8 19.1 0 0.7 0.7 0 0 0.7 0 0 3.7 8.1 0 0 0 2.9 0 0.7 0 1.5 1.5 2.9 ----195

45-49 0 1.8 2.6 1.8 0 0 2.6 0 0 0.9 5.3 0 8.8 13.2 0 3.5 2.6 2.6 0 0 11.5 0 1.8 0 2.6 0 0 1.8 83.7 1.8 0 16.7 14.1 3.5 21.1 0 0.9 1.8 0 0 0.9 0 0 4.4 9.7 0 0 0 1.8 0 2.6 0 4.4 2.6 3.5 ----237

50-54 0 0 0 0 0 0 8.3 0 0 2.4 4.8 0 16.7 9.5 0 8.3 2.4 7.1 2.4 2.4 21.4 1.2 1.2 1.2 1.2 0 0 2.4 85.7 0 0 21.4 16.7 2.4 20.2 0 0 1.2 0 0 0 0 0 1.2 3.6 0 0 0 9.5 0 4.8 0 6 3.6 4.8 ----274

55-59 0 1.6 3.2 0 0 0 6.4 1.6 0 3.2 6.4 0 20.6 22.2 0 7.9 1.6 4.8 0 0 22.2 1.6 0 0 6.4 0 0 1.6 65.1 0 0 23.8 15.9 4.8 20.6 0 0 3.2 0 0 0 0 0 6.4 23.8 0 0 0 12.7 0 1.6 0 6.4 4.8 7.9 ----308

60-64 0 0 4.1 0 0 0 0 2.1 0 8.2 4.1 0 10.3 26.8 0 12.4 6.2 4.1 0 0 30.9 2.1 0 4.1 8.2 0 0 2.1 53.6 0 0 16.5 10.3 2.1 45.4 0 0 8.2 0 0 8.2 0 0 10.3 16.5 0 0 0 0 0 0 0 4.1 2.1 6.2 ----309

65-69 0 0 8.5 0 0 0 14.1 0 0 5.6 8.5 2.8 33.8 28.2 0 19.7 8.5 14.1 0 0 42.3 0 5.6 0 11.3 0 0 2.8 45.1 2.8 0 22.5 5.6 0 19.7 0 0 5.6 0 0 5.6 0 2.8 0 19.7 0 0 0 16.9 0 5.6 0 8.5 2.8 11.3 ----380

70-74 2.3 2.3 2.3 0 2.3 0 2.3 0 0 9.1 13.6 0 27.3 13.6 2.3 25 2.3 2.3 0 0 20.5 0 2.3 0 15.9 0 0 2.3 36.4 0 0 11.4 2.3 0 15.9 0 0 0 0 0 6.8 0 0 2.3 15.9 0 0 0 9.1 0 2.3 2.3 6.8 2.3 4.5 ----266

75+ 0 0.5 0.5 0.2 0 0 1.4 0.2 0.1 0.6 1.3 0.1 3.6 3.3 0.1 2 0.6 0.9 0.1 0.1 4.5 0.2 1.2 0.2 1.4 0 0 1.1 21.4 0.2 0 4.8 3.9 1.5 6.9 0 0.2 0.8 0 0 0.6 0 0.3 1.6 4.4 0 0 0.2 2.2 0 0.6 0.3 2.1 1.4 1.5 ----79.1

Crude Rate 0 0.5 0.6 0.2 0 0 1.7 0.3 0.1 0.8 1.6 0.1 4.5 4.3 0.1 2.5 0.7 1.2 0.1 0.1 5.7 0.2 1.1 0.2 1.7 0 0 1.2 24.8 0.2 0 5.8 4.6 1.7 8.1 0 0.2 1 0 0 0.7 0 0.3 1.9 5.2 0 0 0.2 2.6 0 0.7 0.3 2.3 1.6 1.8 ----93.8

ASR World

APPENDIX 82: CANCER INCIDENCE BY SITES AND AGE GROUP, TERENGGANU, ALL RESIDENTS, FEMALES, 2007-2011

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

162

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 24 17 5 6 2 143 9 1 48 98 12 153 240 7 127 14 43 10 35 270 2 13 6 52 0 0 18 8 4 100 24 0 30 0 0 45 0 5 47 19 0 3 22 117 0 15 31 42 13 36 ----1917

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 3 1 0 0 0 0 2 0 0 5 0 2 0 ----14

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 4 0 0 3 1 1 0 ----13

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 1 0 0 0 0 0 0 6 2 1 0 ----14

10-14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 3 2 0 0 3 2 0 0 ----17

15-19 0 1 0 0 0 0 0 0 0 0 0 1 0 2 0 1 0 0 0 0 0 0 1 0 0 0 0 4 0 0 0 6 0 0 0 0 0 0 0 4 1 0 0 4 6 0 0 1 1 1 1 ----35

20-24 0 0 0 0 0 0 3 0 0 1 1 0 1 1 0 3 0 1 1 0 0 0 0 0 1 0 0 1 0 0 0 5 0 0 0 0 1 0 0 0 1 0 0 4 4 0 0 3 1 1 1 ----35

25-29 0 0 0 0 0 0 6 0 0 0 2 1 2 1 0 0 0 1 0 0 2 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 4 0 0 1 0 0 0 ----25

30-34 0 2 0 1 0 0 7 0 0 1 3 0 7 5 0 1 0 0 1 0 5 0 0 0 1 0 0 0 0 0 0 4 0 0 0 0 1 0 0 3 0 0 0 2 8 0 0 0 2 0 0 ----54

35-39 0 2 0 1 0 0 18 0 0 0 5 0 5 7 0 8 1 3 1 1 10 1 0 1 3 0 0 3 2 0 0 0 0 3 0 0 2 0 0 1 1 0 1 0 14 0 0 0 3 0 0 ----97

40-44 1 2 1 0 0 0 30 0 0 2 5 1 11 15 0 14 1 3 0 4 13 0 2 0 2 0 0 2 2 0 0 4 0 3 0 0 1 0 0 9 1 0 0 0 9 0 4 2 4 0 2 ----150

45-49 0 4 3 1 0 0 26 2 0 7 9 2 16 20 0 16 2 8 2 2 29 1 0 0 5 0 0 0 2 0 4 0 0 4 0 0 3 0 0 4 0 0 0 2 12 0 2 3 6 2 6 ----205

50-54 0 2 4 0 2 1 16 0 1 12 8 1 20 31 0 20 1 8 1 7 35 0 0 2 7 0 0 1 0 1 9 0 0 6 0 0 4 0 0 5 5 0 0 2 18 0 2 1 2 0 2 ----237

55-59 0 5 4 1 1 1 13 2 0 7 11 0 26 38 2 20 4 9 1 9 35 0 0 0 6 0 0 0 0 1 13 2 0 2 0 0 6 0 0 3 0 0 0 2 12 0 4 1 7 1 8 ----257

60-64 0 2 0 0 0 0 14 5 0 9 17 3 18 51 2 11 2 3 2 6 46 0 2 2 5 0 0 2 0 0 28 0 0 4 0 0 5 0 0 3 2 0 1 1 8 0 2 1 4 3 4 ----268

65-69 0 1 1 0 1 0 6 0 0 2 15 1 28 33 2 16 3 3 1 2 41 0 0 0 6 0 0 3 0 0 26 0 0 4 0 0 7 0 1 4 4 0 0 0 5 0 0 0 3 1 6 ----226

70-74 0 3 4 1 2 0 3 0 0 7 22 2 19 36 1 17 0 4 0 4 54 0 2 0 16 0 0 0 2 2 20 1 0 3 0 0 15 0 0 5 2 0 0 2 9 0 1 1 4 0 6 ----270

75+ 0.10% 1.30% 0.90% 0.30% 0.30% 0.10% 7.50% 0.50% 0.10% 2.50% 5.10% 0.60% 8.00% 12.50% 0.40% 6.60% 0.70% 2.20% 0.50% 1.80% 14.10% 0.10% 0.70% 0.30% 2.70% 0.00% 0.00% 0.90% 0.40% 0.20% 5.20% 1.30% 0.00% 1.60% 0.00% 0.00% 2.30% 0.00% 0.30% 2.50% 1.00% 0.00% 0.20% 1.10% 6.10% 0.00% 0.80% 1.60% 2.20% 0.70% 1.90% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 83: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, NEGERI SEMBILAN, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

163

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

4 18 42 8 3 2 38 5 1 31 75 5 172 143 7 49 13 36 2 7 122 1 16 7 34 1 0 17 883 3 1 190 96 27 168 2 1 10 0 0 10 0 1 33 43 0 0 19 72 0 11 25 44 7 23 ----2528

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 4 2 2 0 ----12

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 2 0 0 ----10

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 0 0 2 0 0 10 1 0 0 ----17

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 2 0 0 3 1 0 0 0 5 1 0 ----19

15-19 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 1 1 0 0 2 0 0 8 0 0 0 0 0 0 0 0 3 2 0 0 2 3 0 0 1 2 0 1 ----32

20-24 0 1 0 3 0 0 0 0 0 0 1 0 2 0 1 2 0 0 0 0 4 0 0 0 0 0 0 0 15 0 0 2 0 0 6 0 0 1 0 0 0 0 0 1 1 0 0 7 1 0 0 1 3 0 1 ----53

25-29 0 2 0 0 0 0 2 0 0 0 1 0 2 3 0 0 0 1 0 0 3 1 1 0 1 0 0 1 27 0 0 9 1 0 8 0 0 0 0 0 0 0 0 2 3 0 0 1 4 0 0 1 2 0 1 ----77

30-34 0 0 0 0 0 0 1 0 0 0 4 0 2 1 0 0 1 1 0 0 3 0 0 0 0 0 0 2 52 0 0 12 3 0 8 1 0 1 0 0 0 0 0 0 4 0 0 1 2 0 0 1 2 1 1 ----104

35-39 0 1 1 0 1 0 3 0 0 2 7 2 3 3 0 1 0 0 0 0 2 0 1 2 2 0 0 1 109 0 0 7 2 2 14 0 0 0 0 0 0 0 0 1 3 0 0 1 0 0 0 2 4 0 3 ----180

40-44 0 2 1 1 0 0 9 0 0 0 6 1 7 18 0 4 2 4 0 0 14 0 0 0 1 0 0 2 160 1 0 24 14 3 25 0 0 0 0 0 1 0 0 2 4 0 0 0 7 0 1 0 4 0 1 ----319

45-49 0 4 7 1 1 0 8 1 0 9 6 1 12 20 3 3 1 2 0 0 9 0 0 1 2 1 0 2 162 0 0 28 20 7 35 0 0 1 0 0 1 0 0 3 3 0 0 0 5 0 0 1 4 0 3 ----367

50-54 2 0 4 0 0 0 7 1 0 4 10 0 24 16 1 7 1 4 0 2 16 0 5 2 4 0 0 1 136 1 0 35 25 4 18 0 1 1 0 0 0 0 1 4 7 0 0 0 11 0 3 1 3 0 3 ----365

55-59 0 1 7 2 1 0 4 3 0 6 11 0 18 13 0 7 1 6 0 2 13 0 1 0 1 0 0 2 86 0 0 26 11 5 14 0 0 0 0 0 0 0 0 3 2 0 0 3 16 0 2 0 4 0 3 ----274

60-64 0 2 4 1 0 1 0 0 0 4 11 0 25 28 0 11 2 5 1 0 15 0 2 1 8 0 0 0 54 0 0 18 8 1 13 1 0 1 0 0 1 0 0 5 5 0 0 1 6 0 2 1 1 2 1 ----242

65-69 0 3 7 0 0 0 0 0 0 3 9 1 26 23 0 6 4 7 0 1 22 0 0 1 3 0 0 1 40 1 1 16 7 4 10 0 0 3 0 0 3 0 0 1 4 0 0 0 6 0 2 0 3 0 2 ----220

70-74 2 2 11 0 0 1 3 0 0 3 8 0 50 17 2 7 1 5 1 2 20 0 2 0 11 0 0 3 41 0 0 11 5 1 3 0 0 2 0 0 4 0 0 1 3 0 0 0 8 0 1 0 2 1 3 ----237

75+ 0.20% 0.70% 1.70% 0.30% 0.10% 0.10% 1.50% 0.20% 0.00% 1.20% 3.00% 0.20% 6.80% 5.70% 0.30% 1.90% 0.50% 1.40% 0.10% 0.30% 4.80% 0.00% 0.60% 0.30% 1.30% 0.00% 0.00% 0.70% 34.90% 0.10% 0.00% 7.50% 3.80% 1.10% 6.60% 0.10% 0.00% 0.40% 0.00% 0.00% 0.40% 0.00% 0.00% 1.30% 1.70% 0.00% 0.00% 0.80% 2.80% 0.00% 0.40% 1.00% 1.70% 0.30% 0.90% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 84: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, NEGERI SEMBILAN, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

164

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 24 17 5 6 2 143 9 1 48 98 12 153 240 7 127 14 43 10 35 270 2 13 6 52 0 0 18 8 4 100 24 0 30 0 0 45 0 5 47 19 0 3 22 117 0 15 31 42 13 36 ----1917

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 1.3 0.4 0 0 0 0 0.9 0 0 2.2 0 0.9 0 ----6

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.8 0 0 0 0 1.6 0 0 1.2 0.4 0.4 0 ----5

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.8 0.4 0 0 0 0 0 0 2.4 0.8 0.4 0 ----6

10-14 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0.4 0 0 0 0.4 0 0 0 0.4 0 0 0 0 0 0 0 0 0.4 0 0 1.2 0.8 0 0 1.2 0.8 0 0 ----7

15-19 0 0.4 0 0 0 0 0 0 0 0 0 0.4 0 0.9 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 1.8 0 0 0 2.6 0 0 0 0 0 0 0 1.8 0.4 0 0 1.8 2.6 0 0 0.4 0.4 0.4 0.4 ----15

20-24 0 0 0 0 0 0 1.6 0 0 0.5 0.5 0 0.5 0.5 0 1.6 0 0.5 0.5 0 0 0 0 0 0.5 0 0 0.5 0 0 0 2.7 0 0 0 0 0.5 0 0 0 0.5 0 0 2.2 2.2 0 0 1.6 0.5 0.5 0.5 ----19

25-29 0 0 0 0 0 0 3.8 0 0 0 1.3 0.6 1.3 0.6 0 0 0 0.6 0 0 1.3 0 1.3 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0.6 0 2.5 0 0 0.6 0 0 0 ----16

30-34 0 1.4 0 0.7 0 0 4.9 0 0 0.7 2.1 0 4.9 3.5 0 0.7 0 0 0.7 0 3.5 0 0 0 0.7 0 0 0 0 0 0 2.8 0 0 0 0 0.7 0 0 2.1 0 0 0 1.4 5.6 0 0 0 1.4 0 0 ----38

35-39 0 1.4 0 0.7 0 0 12.8 0 0 0 3.5 0 3.5 5 0 5.7 0.7 2.1 0.7 0.7 7.1 0.7 0 0.7 2.1 0 0 2.1 1.4 0 0 0 0 2.1 0 0 1.4 0 0 0.7 0.7 0 0.7 0 9.9 0 0 0 2.1 0 0 ----69

40-44 0.7 1.4 0.7 0 0 0 21.2 0 0 1.4 3.5 0.7 7.8 10.6 0 9.9 0.7 2.1 0 2.8 9.2 0 1.4 0 1.4 0 0 1.4 1.4 0 0 2.8 0 2.1 0 0 0.7 0 0 6.4 0.7 0 0 0 6.4 0 2.8 1.4 2.8 0 1.4 ----106

45-49 0 3 2.3 0.8 0 0 19.6 1.5 0 5.3 6.8 1.5 12 15 0 12 1.5 6 1.5 1.5 21.8 0.8 0 0 3.8 0 0 0 1.5 0 3 0 0 3 0 0 2.3 0 0 3 0 0 0 1.5 9 0 1.5 2.3 4.5 1.5 4.5 ----154

50-54 0 1.8 3.6 0 1.8 0.9 14.4 0 0.9 10.8 7.2 0.9 18 27.9 0 18 0.9 7.2 0.9 6.3 31.5 0 0 1.8 6.3 0 0 0.9 0 0.9 8.1 0 0 5.4 0 0 3.6 0 0 4.5 4.5 0 0 1.8 16.2 0 1.8 0.9 1.8 0 1.8 ----214

55-59 0 6.5 5.2 1.3 1.3 1.3 16.9 2.6 0 9.1 14.3 0 33.8 49.4 2.6 26 5.2 11.7 1.3 11.7 45.5 0 0 0 7.8 0 0 0 0 1.3 16.9 2.6 0 2.6 0 0 7.8 0 0 3.9 0 0 0 2.6 15.6 0 5.2 1.3 9.1 1.3 10.4 ----334

60-64 0 4 0 0 0 0 27.7 9.9 0 17.8 33.7 5.9 35.6 101 4 21.8 4 5.9 4 11.9 91.1 0 4 4 9.9 0 0 4 0 0 55.5 0 0 7.9 0 0 9.9 0 0 5.9 4 0 2 2 15.8 0 4 2 7.9 5.9 7.9 ----531

65-69 0 2.5 2.5 0 2.5 0 15 0 0 5 37.5 2.5 70 82.5 5 40 7.5 7.5 2.5 5 102.5 0 0 0 15 0 0 7.5 0 0 65 0 0 10 0 0 17.5 0 2.5 10 10 0 0 0 12.5 0 0 0 7.5 2.5 15 ----565

70-74 0 7.5 10 2.5 5 0 7.5 0 0 17.5 55 5 47.5 90 2.5 42.5 0 10 0 10 135 0 5 0 40 0 0 0 5 5 50 2.5 0 7.5 0 0 37.5 0 0 12.5 5 0 0 5 22.5 0 2.5 2.5 10 0 15 ----675

75+ 0 1 0.7 0.2 0.2 0.1 5.9 0.4 0 2 4 0.5 6.3 9.9 0.3 5.2 0.6 1.8 0.4 1.4 11.1 0.1 0.5 0.2 2.1 0 0 0.7 0.3 0.2 4.1 1 0 1.2 0 0 1.9 0 0.2 1.9 0.8 0 0.1 0.9 4.8 0 0.6 1.3 1.7 0.5 1.5 ----79

Crude Rate 0 1.1 0.8 0.2 0.3 0.1 6.2 0.5 0 2.2 4.7 0.6 7.2 11.6 0.4 5.8 0.7 1.9 0.5 1.7 12.9 0.1 0.6 0.3 2.4 0 0 0.8 0.3 0.2 5.1 1 0 1.4 0 0 2.2 0 0.2 2 0.8 0 0.1 0.9 5.1 0 0.7 1.3 1.9 0.6 1.7 ----89.2

ASR World

APPENDIX 85: CANCER INCIDENCE BY SITES AND AGE GROUP, NEGERI SEMBILAN, ALL RESIDENTS, MALES, 2007-2011

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

165

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

4 18 42 8 3 2 38 5 1 31 75 5 172 143 7 49 13 36 2 7 122 1 16 7 34 1 0 17 883 3 1 190 96 27 168 2 1 10 0 0 10 0 1 33 43 0 0 19 72 0 11 25 44 7 23 ----2528

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 1.9 1 1 0 ----6

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0.4 0 0 0.4 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.9 0.9 0 0 ----4

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.9 0 0 4.3 0.4 0 0 ----7

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 1.2 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0 0 0.4 0.8 0 0 1.2 0.4 0 0 0 2.1 0.4 0 ----8

15-19 0 0 0 0 0 0 0.5 0 0 0 0.5 0 0.5 0.5 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0.5 0.5 0 0 0.9 0 0 3.7 0 0 0 0 0 0 0 0 1.4 0.9 0 0 0.9 1.4 0 0 0.5 0.9 0 0.5 ----15

20-24 0 0.6 0 1.7 0 0 0 0 0 0 0.6 0 1.1 0 0.6 1.1 0 0 0 0 2.3 0 0 0 0 0 0 0 8.6 0 0 1.1 0 0 3.4 0 0 0.6 0 0 0 0 0 0.6 0.6 0 0 4 0.6 0 0 0.6 1.7 0 0.6 ----30

25-29 0 1.3 0 0 0 0 1.3 0 0 0 0.6 0 1.3 1.9 0 0 0 0.6 0 0 1.9 0.6 0.6 0 0.6 0 0 0.6 17.5 0 0 5.8 0.6 0 5.2 0 0 0 0 0 0 0 0 1.3 1.9 0 0 0.6 2.6 0 0 0.6 1.3 0 0.6 ----50

30-34 0 0 0 0 0 0 0.7 0 0 0 2.7 0 1.4 0.7 0 0 0.7 0.7 0 0 2 0 0 0 0 0 0 1.4 35.5 0 0 8.2 2 0 5.5 0.7 0 0.7 0 0 0 0 0 0 2.7 0 0 0.7 1.4 0 0 0.7 1.4 0.7 0.7 ----71

35-39 0 0.7 0.7 0 0.7 0 2 0 0 1.3 4.7 1.3 2 2 0 0.7 0 0 0 0 1.3 0 0.7 1.3 1.3 0 0 0.7 72.7 0 0 4.7 1.3 1.3 9.3 0 0 0 0 0 0 0 0 0.7 2 0 0 0.7 0 0 0 1.3 2.7 0 2 ----120

40-44 0 1.4 0.7 0.7 0 0 6.1 0 0 0 4.1 0.7 4.7 12.2 0 2.7 1.4 2.7 0 0 9.5 0 0 0 0.7 0 0 1.4 108.5 0.7 0 16.3 9.5 2 17 0 0 0 0 0 0.7 0 0 1.4 2.7 0 0 0 4.7 0 0.7 0 2.7 0 0.7 ----216

45-49 0 2.9 5.1 0.7 0.7 0 5.9 0.7 0 6.6 4.4 0.7 8.8 14.7 2.2 2.2 0.7 1.5 0 0 6.6 0 0 0.7 1.5 0.7 0 1.5 118.7 0 0 20.5 14.7 5.1 25.6 0 0 0.7 0 0 0.7 0 0 2.2 2.2 0 0 0 3.7 0 0 0.7 2.9 0 2.2 ----269

50-54 1.9 0 3.8 0 0 0 6.6 0.9 0 3.8 9.4 0 22.5 15 0.9 6.6 0.9 3.8 0 1.9 15 0 4.7 1.9 3.8 0 0 0.9 127.7 0.9 0 32.9 23.5 3.8 16.9 0 0.9 0.9 0 0 0 0 0.9 3.8 6.6 0 0 0 10.3 0 2.8 0.9 2.8 0 2.8 ----343

55-59 0 1.3 9.3 2.6 1.3 0 5.3 4 0 7.9 14.6 0 23.8 17.2 0 9.3 1.3 7.9 0 2.6 17.2 0 1.3 0 1.3 0 0 2.6 113.9 0 0 34.4 14.6 6.6 18.5 0 0 0 0 0 0 0 0 4 2.6 0 0 4 21.2 0 2.6 0 5.3 0 4 ----363

60-64 0 3.9 7.8 1.9 0 1.9 0 0 0 7.8 21.4 0 48.6 54.4 0 21.4 3.9 9.7 1.9 0 29.1 0 3.9 1.9 15.5 0 0 0 104.9 0 0 35 15.5 1.9 25.2 1.9 0 1.9 0 0 1.9 0 0 9.7 9.7 0 0 1.9 11.7 0 3.9 1.9 1.9 3.9 1.9 ----470

65-69 0 6.8 15.9 0 0 0 0 0 0 6.8 20.5 2.3 59.1 52.3 0 13.6 9.1 15.9 0 2.3 50 0 0 2.3 6.8 0 0 2.3 90.9 2.3 2.3 36.4 15.9 9.1 22.7 0 0 6.8 0 0 6.8 0 0 2.3 9.1 0 0 0 13.6 0 4.5 0 6.8 0 4.5 ----500

70-74 4 4 22.2 0 0 2 6.1 0 0 6.1 16.2 0 101 34.3 4 14.1 2 10.1 2 4 40.4 0 4 0 22.2 0 0 6.1 82.8 0 0 22.2 10.1 2 6.1 0 0 4 0 0 8.1 0 0 2 6.1 0 0 0 16.2 0 2 0 4 2 6.1 ----479

75+ 0.2 0.8 1.8 0.3 0.1 0.1 1.6 0.2 0 1.3 3.2 0.2 7.3 6 0.3 2.1 0.5 1.5 0.1 0.3 5.2 0 0.7 0.3 1.4 0 0 0.7 37.4 0.1 0 8 4.1 1.1 7.1 0.1 0 0.4 0 0 0.4 0 0 1.4 1.8 0 0 0.8 3 0 0.5 1.1 1.9 0.3 1 ----107

Crude Rate 0.2 0.8 1.9 0.4 0.1 0.1 1.5 0.2 0.1 1.4 3.4 0.2 7.6 6.4 0.3 2.3 0.6 1.6 0.1 0.3 5.4 0 0.7 0.3 1.5 0 0 0.7 37 0.1 0 8.2 4.1 1.2 7.1 0.1 0 0.4 0 0 0.4 0 0 1.5 1.8 0 0 0.8 3.2 0 0.5 1.1 1.9 0.4 1 ----108.9

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 86: CANCER INCIDENCE BY SITES AND AGE GROUP, NEGERI SEMBILAN, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

166

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 21 6 12 6 0 112 11 1 12 65 4 144 149 5 126 14 46 13 30 343 3 16 3 52 1 0 25 6 4 101 21 0 37 1 1 63 2 3 34 25 3 4 37 108 0 12 44 62 12 10 ----1811

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 1 3 0 1 0 0 0 0 0 15 2 3 0 ----29

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 3 0 0 5 2 0 0 ----12

50 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 1 1 4 1 0 0 2 5 0 0 ----22

10-14 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 5 0 0 0 3 2 2 0 ----19

15-19 0 0 0 1 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 1 2 0 0 3 2 0 1 2 4 0 0 ----27

20-24 0 0 1 1 0 0 1 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 3 0 1 0 0 2 0 0 0 4 0 0 0 0 0 0 0 1 1 1 0 3 3 0 0 4 3 0 0 ----32

25-29 0 1 0 1 0 0 5 0 0 0 0 1 3 3 0 1 0 1 0 1 2 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 3 2 0 0 2 5 1 0 ----36

30-34 0 0 0 1 0 0 12 0 0 1 2 0 4 1 1 3 0 0 0 0 7 1 1 0 1 0 0 1 0 0 0 2 0 0 0 1 0 0 0 1 4 0 0 4 6 0 1 1 6 1 0 ----63

35-39 1 2 0 1 0 0 12 0 0 0 2 0 7 8 1 8 0 0 1 1 10 0 1 0 1 0 0 0 1 1 2 3 0 1 0 0 1 0 0 3 3 0 0 1 10 0 0 3 3 0 1 ----89

40-44 0 1 1 0 0 0 13 2 0 0 2 0 5 15 1 10 1 3 5 1 16 0 0 1 0 0 0 6 0 0 0 2 0 2 0 0 4 0 0 0 3 0 1 1 9 0 1 1 2 1 1 ----111

45-49 0 3 0 2 1 0 16 1 0 1 7 1 12 17 1 24 1 5 3 5 30 0 1 1 4 0 0 0 2 0 1 0 0 1 0 0 7 0 0 7 2 0 1 4 13 0 2 0 7 1 0 ----184

50-54 0 4 2 3 0 0 20 2 0 1 7 1 23 26 0 19 5 12 2 4 44 0 0 1 7 0 0 2 0 3 2 0 0 4 0 0 7 0 0 7 3 0 0 3 21 0 1 1 6 1 3 ----247

55-59 0 2 0 0 1 0 13 1 0 0 7 0 23 26 0 16 3 9 1 5 58 0 2 0 7 1 0 3 1 0 20 1 0 8 0 0 13 1 0 0 2 0 0 2 11 0 1 2 4 0 0 ----244

60-64 0 2 0 0 1 0 6 2 0 1 6 0 17 23 0 15 1 5 1 4 49 0 2 0 8 0 0 4 0 0 19 0 0 9 1 0 9 1 1 3 1 0 0 1 11 0 2 2 4 0 2 ----213

65-69 0 3 2 2 0 0 4 2 1 6 14 0 20 17 1 13 1 8 0 2 58 0 0 0 7 0 0 3 1 0 20 0 0 6 0 0 7 0 0 2 2 0 0 3 7 0 2 1 3 0 1 ----219

70-74 0 3 0 0 3 0 6 1 0 2 16 1 30 12 0 13 2 3 0 7 68 1 0 0 13 0 0 2 1 0 37 2 0 4 0 0 14 0 0 2 2 0 1 0 9 0 1 0 4 2 2 ----264

75+ 0.10% 1.20% 0.30% 0.70% 0.30% 0.00% 6.20% 0.60% 0.10% 0.70% 3.60% 0.20% 8.00% 8.20% 0.30% 7.00% 0.80% 2.50% 0.70% 1.70% 18.90% 0.20% 0.90% 0.20% 2.90% 0.10% 0.00% 1.40% 0.30% 0.20% 5.60% 1.20% 0.00% 2.00% 0.10% 0.10% 3.50% 0.10% 0.20% 1.90% 1.40% 0.20% 0.20% 2.00% 6.00% 0.00% 0.70% 2.40% 3.40% 0.70% 0.60% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 87: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, MELAKA, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

167

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 9 14 9 2 1 53 3 2 7 58 3 153 93 5 35 18 39 5 3 92 3 16 7 33 2 0 22 731 5 5 162 109 19 161 2 3 12 0 0 13 0 0 27 62 3 3 19 78 2 18 18 58 7 8 ----2214

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 6 4 3 1 ----21

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 4 0 0 0 0 0 0 0 3 1 1 0 ----13

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 2 1 0 0 ----7

10-14 0 0 0 1 0 0 2 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 4 0 2 0 0 2 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 1 2 0 0 1 0 0 0 1 2 1 0 ----27

15-19 0 0 0 1 0 0 3 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 3 0 0 0 0 0 3 0 1 1 0 0 0 0 0 0 3 0 0 4 5 0 0 1 4 1 0 ----33

20-24 0 0 0 1 0 0 1 1 0 0 4 0 1 1 0 1 0 0 0 0 1 0 1 0 0 0 0 0 9 0 0 0 0 0 10 0 1 0 0 0 0 0 0 0 6 0 0 3 6 0 0 1 3 0 0 ----51

25-29 0 0 0 1 0 0 0 0 0 0 0 0 4 2 0 0 2 1 0 0 1 0 0 0 0 0 0 0 19 0 0 5 2 0 7 0 0 0 0 0 0 0 0 1 6 0 0 1 3 0 0 0 4 0 0 ----59

30-34 0 0 0 1 0 0 6 0 0 0 0 0 2 1 0 0 1 3 1 0 1 0 0 0 0 0 0 0 39 0 0 9 3 2 12 0 1 0 0 0 0 0 0 1 5 0 1 0 2 0 0 1 6 0 0 ----98

35-39 0 1 0 1 0 0 9 0 0 1 3 0 4 8 0 1 0 1 0 0 5 0 1 2 2 0 0 3 75 0 1 17 8 0 15 0 0 1 0 0 0 0 0 4 3 0 0 1 5 0 1 1 4 0 0 ----178

40-44 0 2 1 1 0 0 4 0 0 0 1 0 6 5 0 3 0 2 0 0 3 0 2 2 1 0 0 5 132 1 3 22 15 6 26 1 0 1 0 0 0 0 0 4 7 0 1 2 8 0 1 0 5 0 1 ----274

45-49 0 1 5 0 1 0 8 0 0 1 3 0 15 12 1 3 3 4 1 0 12 1 0 0 3 0 0 3 116 0 1 26 25 5 17 1 0 1 0 0 0 0 0 0 7 0 1 2 9 0 5 1 7 1 1 ----303

50-54 0 1 2 0 0 1 7 0 1 1 7 2 23 14 2 5 1 3 1 1 6 1 0 0 1 0 0 2 123 1 0 30 24 3 27 0 0 1 0 0 6 0 0 2 2 0 0 3 10 1 1 0 3 0 1 ----320

55-59 0 2 1 1 0 0 5 1 0 1 8 0 23 10 0 5 0 3 0 1 9 0 0 0 3 0 0 1 106 0 0 23 15 1 21 0 0 2 0 0 0 0 0 2 5 1 0 1 7 0 4 0 2 0 0 ----264

60-64 1 0 1 1 0 0 4 0 0 0 9 0 18 10 1 2 3 7 1 0 17 1 1 0 4 0 0 2 49 0 0 10 7 1 7 0 0 2 0 0 2 0 0 4 4 0 0 0 8 0 0 0 8 0 1 ----186

65-69 0 0 2 0 0 0 3 0 0 1 9 0 23 14 0 5 2 8 0 0 16 0 2 1 9 1 0 0 34 2 0 12 3 1 6 0 0 1 0 0 2 0 0 1 6 0 0 0 6 0 5 1 2 0 0 ----178

70-74 1 2 2 0 1 0 1 1 1 2 13 1 31 16 1 8 6 7 0 1 21 0 2 1 8 1 0 2 26 1 0 8 7 0 3 0 0 1 0 0 2 0 0 2 6 0 0 1 8 1 1 0 2 0 3 ----202

75+ 0.10% 0.40% 0.60% 0.40% 0.10% 0.00% 2.40% 0.10% 0.10% 0.30% 2.60% 0.10% 6.90% 4.20% 0.20% 1.60% 0.80% 1.80% 0.20% 0.10% 4.20% 0.10% 0.70% 0.30% 1.50% 0.10% 0.00% 1.00% 33.00% 0.20% 0.20% 7.30% 4.90% 0.90% 7.30% 0.10% 0.10% 0.50% 0.00% 0.00% 0.60% 0.00% 0.00% 1.20% 2.80% 0.10% 0.10% 0.90% 3.50% 0.10% 0.80% 0.80% 2.60% 0.30% 0.40% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 88: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, MELAKA, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

168

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 21 6 12 6 0 112 11 1 12 65 4 144 149 5 126 14 46 13 30 343 3 16 3 52 1 0 25 6 4 101 21 0 37 1 1 63 2 3 34 25 3 4 37 108 0 12 44 62 12 10 ----1811

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0.6 0 0.6 1.7 0 0.6 0 0 0 0 0 8.6 1.1 1.7 0 ----17

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 0 0 0 0 1.6 0 0 2.6 1.1 0 0 ----6

50 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0 0.5 0.5 2 0.5 0 0 1 2.4 0 0 ----11

10-14 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.9 0 0 0 2.3 0 0 0 1.4 0.9 0.9 0 ----9

15-19 0 0 0 0.6 0 0 0.6 0 0 0 0.6 0 0 0.6 0 0 0 0 0 0 0.6 0 1.1 0 0 0 0 0 0 0 0 2.9 0 0 0 0 0 0 0 0.6 1.1 0 0 1.7 1.1 0 0.6 1.1 2.3 0 0 ----15

20-24 0 0 0.7 0.7 0 0 0.7 0 0 0 0.7 0 0 0 0 1.3 0 0 0 0 0 0 2 0 0.7 0 0 1.3 0 0 0 2.7 0 0 0 0 0 0 0 0.7 0.7 0.7 0 2 2 0 0 2.7 2 0 0 ----22

25-29 0 0.8 0 0.8 0 0 4.2 0 0 0 0 0.8 2.5 2.5 0 0.8 0 0.8 0 0.8 1.7 0 0 0 1.7 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 2.5 1.7 0 0 1.7 4.2 0.8 0 ----30

30-34 0 0 0 0.9 0 0 10.4 0 0 0.9 1.7 0 3.5 0.9 0.9 2.6 0 0 0 0 6.1 0.9 0.9 0 0.9 0 0 0.9 0 0 0 1.7 0 0 0 0.9 0 0 0 0.9 3.5 0 0 3.5 5.2 0 0.9 0.9 5.2 0.9 0 ----55

35-39 0.9 1.7 0 0.9 0 0 10.5 0 0 0 1.7 0 6.1 7 0.9 7 0 0 0.9 0.9 8.7 0 0.9 0 0.9 0 0 0 0.9 0.9 1.7 2.6 0 0.9 0 0 0.9 0 0 2.6 2.6 0 0 0.9 8.7 0 0 2.6 2.6 0 0.9 ----78

40-44 0 0.9 0.9 0 0 0 11.1 1.7 0 0 1.7 0 4.3 12.8 0.9 8.5 0.9 2.6 4.3 0.9 13.6 0 0 0.9 0 0 0 5.1 0 0 0 1.7 0 1.7 0 0 3.4 0 0 0 2.6 0 0.9 0.9 7.7 0 0.9 0.9 1.7 0.9 0.9 ----94

45-49 0 3 0 2 1 0 16.2 1 0 1 7.1 1 12.2 17.3 1 24.4 1 5.1 3 5.1 30.5 0 1 1 4.1 0 0 0 2 0 1 0 0 1 0 0 7.1 0 0 7.1 2 0 1 4.1 13.2 0 2 0 7.1 1 0 ----187

50-54 0 5 2.5 3.7 0 0 24.8 2.5 0 1.2 8.7 1.2 28.6 32.3 0 23.6 6.2 14.9 2.5 5 54.7 0 0 1.2 8.7 0 0 2.5 0 3.7 2.5 0 0 5 0 0 8.7 0 0 8.7 3.7 0 0 3.7 26.1 0 1.2 1.2 7.5 1.2 3.7 ----307

55-59 0 3.2 0 0 1.6 0 20.6 1.6 0 0 11.1 0 36.5 41.3 0 25.4 4.8 14.3 1.6 7.9 92.1 0 3.2 0 11.1 1.6 0 4.8 1.6 0 31.8 1.6 0 12.7 0 0 20.6 1.6 0 0 3.2 0 0 3.2 17.5 0 1.6 3.2 6.4 0 0 ----387

60-64 0 5 0 0 2.5 0 15 5 0 2.5 15 0 42.5 57.5 0 37.5 2.5 12.5 2.5 10 122.5 0 5 0 20 0 0 10 0 0 47.5 0 0 22.5 2.5 0 22.5 2.5 2.5 7.5 2.5 0 0 2.5 27.5 0 5 5 10 0 5 ----533

65-69 0 9 6 6 0 0 11.9 6 3 17.9 41.8 0 59.7 50.8 3 38.8 3 23.9 0 6 173.2 0 0 0 20.9 0 0 9 3 0 59.7 0 0 17.9 0 0 20.9 0 0 6 6 0 0 9 20.9 0 6 3 9 0 3 ----654

70-74 0 9 0 0 9 0 17.9 3 0 6 47.8 3 89.6 35.8 0 38.8 6 9 0 20.9 203 3 0 0 38.8 0 0 6 3 0 110.5 6 0 11.9 0 0 41.8 0 0 6 6 0 3 0 26.9 0 3 0 11.9 6 6 ----788

75+

APPENDIX 89: CANCER INCIDENCE BY SITES AND AGE GROUP, MELAKA, ALL RESIDENTS, MALES, 2007-2011

0.1 1.1 0.3 0.6 0.3 0 5.8 0.6 0.1 0.6 3.4 0.2 7.5 7.8 0.3 6.6 0.7 2.4 0.7 1.6 17.8 0.2 0.8 0.2 2.7 0.1 0 1.3 0.3 0.2 5.3 1.1 0 1.9 0.1 0.1 3.3 0.1 0.2 1.8 1.3 0.2 0.2 1.9 5.6 0 0.6 2.3 3.2 0.6 0.5 ----94.2

Crude Rate 0.1 1.2 0.3 0.6 0.4 0 6.1 0.6 0.1 0.7 3.8 0.2 8.5 8.7 0.3 7.2 0.8 2.7 0.7 1.8 20.4 0.2 0.9 0.2 3.1 0.1 0 1.5 0.3 0.2 6.4 1.1 0 2.3 0.1 0.1 3.8 0.1 0.2 1.9 1.4 0.2 0.2 1.9 6 0 0.7 2.6 3.3 0.7 0.6 ----104.7

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

169

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

2 9 14 9 2 1 53 3 2 7 58 3 153 93 5 35 18 39 5 3 92 3 16 7 33 2 0 22 731 5 5 162 109 19 161 2 3 12 0 0 13 0 0 27 62 3 3 19 78 2 18 18 58 7 8 ----2214

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.2 0 0 0.6 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 1.2 0 0 0 0 0 3.6 2.4 1.8 0.6 ----13

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 2.3 0 0 0 0 0 0 0 1.7 0.6 0.6 0 ----7

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0.6 0 0 1.1 0.6 0 0 ----4

10-14 0 0 0 0.4 0 0 0.9 0 0 0 0.4 0 0.4 0 0 0 0 0 0 0 0 0 1.8 0 0.9 0 0 0.9 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 0.4 0.9 0 0 0.4 0 0 0 0.4 0.9 0.4 0 ----12

15-19 0 0 0 0.5 0 0 1.6 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 1.6 0 0 0 0 0 1.6 0 0.5 0.5 0 0 0 0 0 0 1.6 0 0 2.1 2.6 0 0 0.5 2.1 0.5 0 ----17

20-24 0 0 0 0.6 0 0 0.6 0.6 0 0 2.4 0 0.6 0.6 0 0.6 0 0 0 0 0.6 0 0.6 0 0 0 0 0 5.4 0 0 0 0 0 6 0 0.6 0 0 0 0 0 0 0 3.6 0 0 1.8 3.6 0 0 0.6 1.8 0 0 ----31

25-29 0 0 0 0.8 0 0 0 0 0 0 0 0 3.1 1.5 0 0 1.5 0.8 0 0 0.8 0 0 0 0 0 0 0 14.7 0 0 3.9 1.5 0 5.4 0 0 0 0 0 0 0 0 0.8 4.6 0 0 0.8 2.3 0 0 0 3.1 0 0 ----46

30-34 0 0 0 0.9 0 0 5.2 0 0 0 0 0 1.7 0.9 0 0 0.9 2.6 0.9 0 0.9 0 0 0 0 0 0 0 33.6 0 0 7.8 2.6 1.7 10.3 0 0.9 0 0 0 0 0 0 0.9 4.3 0 0.9 0 1.7 0 0 0.9 5.2 0 0 ----84

35-39 0 0.8 0 0.8 0 0 6.8 0 0 0.8 2.3 0 3 6 0 0.8 0 0.8 0 0 3.8 0 0.8 1.5 1.5 0 0 2.3 56.4 0 0.8 12.8 6 0 11.3 0 0 0.8 0 0 0 0 0 3 2.3 0 0 0.8 3.8 0 0.8 0.8 3 0 0 ----134

40-44 0 1.7 0.8 0.8 0 0 3.3 0 0 0 0.8 0 5 4.1 0 2.5 0 1.7 0 0 2.5 0 1.7 1.7 0.8 0 0 4.1 109.1 0.8 2.5 18.2 12.4 5 21.5 0.8 0 0.8 0 0 0 0 0 3.3 5.8 0 0.8 1.7 6.6 0 0.8 0 4.1 0 0.8 ----226

45-49 0 0.9 4.6 0 0.9 0 7.4 0 0 0.9 2.8 0 13.8 11.1 0.9 2.8 2.8 3.7 0.9 0 11.1 0.9 0 0 2.8 0 0 2.8 106.9 0 0.9 24 23 4.6 15.7 0.9 0 0.9 0 0 0 0 0 0 6.5 0 0.9 1.8 8.3 0 4.6 0.9 6.5 0.9 0.9 ----279

50-54 0 1.1 2.3 0 0 1.1 7.9 0 1.1 1.1 7.9 2.3 26 15.8 2.3 5.7 1.1 3.4 1.1 1.1 6.8 1.1 0 0 1.1 0 0 2.3 139 1.1 0 33.9 27.1 3.4 30.5 0 0 1.1 0 0 6.8 0 0 2.3 2.3 0 0 3.4 11.3 1.1 1.1 0 3.4 0 1.1 ----362

55-59 0 2.6 1.3 1.3 0 0 6.6 1.3 0 1.3 10.5 0 30.3 13.2 0 6.6 0 3.9 0 1.3 11.8 0 0 0 3.9 0 0 1.3 139.5 0 0 30.3 19.7 1.3 27.6 0 0 2.6 0 0 0 0 0 2.6 6.6 1.3 0 1.3 9.2 0 5.3 0 2.6 0 0 ----347

60-64 2 0 2 2 0 0 8 0 0 0 18 0 36 20 2 4 6 14 2 0 34 2 2 0 8 0 0 4 98 0 0 20 14 2 14 0 0 4 0 0 4 0 0 8 8 0 0 0 16 0 0 0 16 0 2 ----372

65-69 0 0 5.3 0 0 0 7.9 0 0 2.6 23.7 0 60.5 36.8 0 13.2 5.3 21.1 0 0 42.1 0 5.3 2.6 23.7 2.6 0 0 89.5 5.3 0 31.6 7.9 2.6 15.8 0 0 2.6 0 0 5.3 0 0 2.6 15.8 0 0 0 15.8 0 13.2 2.6 5.3 0 0 ----468

70-74 2.1 4.1 4.1 0 2.1 0 2.1 2.1 2.1 4.1 26.8 2.1 63.9 33 2.1 16.5 12.4 14.4 0 2.1 43.3 0 4.1 2.1 16.5 2.1 0 4.1 53.6 2.1 0 16.5 14.4 0 6.2 0 0 2.1 0 0 4.1 0 0 4.1 12.4 0 0 2.1 16.5 2.1 2.1 0 4.1 0 6.2 ----417

75+ 0.1 0.4 0.7 0.4 0.1 0 2.6 0.1 0.1 0.3 2.9 0.1 7.6 4.6 0.2 1.7 0.9 1.9 0.2 0.1 4.6 0.1 0.8 0.3 1.6 0.1 0 1.1 36.4 0.2 0.2 8.1 5.4 0.9 8 0.1 0.1 0.6 0 0 0.6 0 0 1.3 3.1 0.1 0.1 0.9 3.9 0.1 0.9 0.9 2.9 0.3 0.4 ----110.2

Crude Rate

APPENDIX 90: CANCER INCIDENCE BY SITES AND AGE GROUP, MELAKA, ALL RESIDENTS, FEMALES, 2007-2011

0.1 0.4 0.7 0.4 0.1 0 2.6 0.1 0.1 0.3 2.8 0.1 7.4 4.5 0.2 1.7 0.9 2 0.3 0.1 4.5 0.2 0.8 0.3 1.6 0.1 0 1.1 35.7 0.2 0.2 7.9 5.2 0.9 7.8 0.1 0.1 0.6 0 0 0.7 0 0 1.4 3 0.2 0.1 0.9 3.8 0.1 0.9 1 2.9 0.4 0.4 ----108.2

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

170

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 4 1 0 0 3 23 2 0 8 12 2 34 34 1 20 2 13 3 11 69 1 3 1 5 1 0 3 2 1 24 3 0 7 0 0 26 0 0 9 7 0 0 9 15 0 7 10 16 6 7 ----405

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 5 1 2 0 ----10

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 ----3

50 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 ----3

10-14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 2 0 0 ----6

15-19 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 ----9

20-24 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 ----2

25-29 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 ----7

30-34 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 ----7

35-39 0 0 0 0 0 0 1 0 0 0 0 0 3 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 0 0 ----12

40-44 0 0 0 0 0 1 5 0 0 0 0 2 4 4 0 4 0 2 1 2 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 4 0 0 0 1 0 0 0 2 0 0 0 0 0 0 ----37

45-49 0 0 1 0 0 0 0 0 0 1 1 0 3 2 0 4 0 4 1 0 5 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 2 0 0 1 0 0 0 1 1 0 0 0 3 0 0 ----32

50-54 0 2 0 0 0 0 6 1 0 0 0 0 6 4 0 3 0 1 0 2 6 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 2 0 3 0 0 ----42

55-59 0 0 0 0 0 1 0 0 0 1 1 0 5 3 0 3 0 1 1 4 10 0 1 0 1 0 0 0 0 0 1 0 0 0 0 0 4 0 0 1 2 0 0 1 2 0 2 2 0 1 3 ----51

60-64 0 1 0 0 0 0 4 0 0 1 2 0 6 9 0 3 1 1 0 1 12 0 0 0 1 0 0 2 1 1 5 1 0 2 0 0 4 0 0 1 1 0 0 1 2 0 0 1 1 0 0 ----65

65-69 0 0 0 0 0 0 2 0 0 2 3 0 3 5 0 1 1 1 0 1 14 0 0 1 1 0 0 0 0 0 7 0 0 1 0 0 6 0 0 0 2 0 0 4 3 0 1 0 1 0 2 ----62

70-74 0 1 0 0 0 1 1 1 0 3 5 0 4 3 1 1 0 1 0 1 12 0 0 0 2 1 0 1 0 0 7 0 0 0 0 0 5 0 0 0 0 0 0 0 1 0 1 1 0 1 2 ----57

75+ 0.00% 1.00% 0.20% 0.00% 0.00% 0.70% 5.70% 0.50% 0.00% 2.00% 3.00% 0.50% 8.40% 8.40% 0.20% 4.90% 0.50% 3.20% 0.70% 2.70% 17.00% 0.20% 0.70% 0.20% 1.20% 0.20% 0.00% 0.70% 0.50% 0.20% 5.90% 0.70% 0.00% 1.70% 0.00% 0.00% 6.40% 0.00% 0.00% 2.20% 1.70% 0.00% 0.00% 2.20% 3.70% 0.00% 1.70% 2.50% 4.00% 1.50% 1.70% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 91: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PERLIS, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

171

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 9 4 5 3 0 3 0 1 3 6 0 29 18 0 11 4 8 4 3 27 1 0 3 4 0 0 4 151 2 1 55 20 13 23 1 1 4 0 0 4 0 1 14 20 1 0 8 5 0 5 4 3 4 4 ----495

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 1 0 0 1 0 3 0 ----9

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 ----2

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 ----2

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 1 0 0 2 0 0 0 0 0 0 0 ----6

15-19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 ----4

20-24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 0 0 ----8

25-29 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 1 1 1 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 ----14

30-34 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 0 0 5 1 2 0 0 0 3 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 ----28

35-39 0 1 0 1 0 0 0 0 0 0 0 0 0 2 0 1 0 1 0 0 0 1 0 0 0 0 0 0 18 0 0 7 0 0 1 0 0 0 0 0 1 0 0 1 3 0 0 1 0 0 0 0 0 0 0 ----39

40-44 0 0 1 1 0 0 2 0 0 0 0 0 2 1 0 1 0 0 0 1 2 0 0 0 0 0 0 1 27 0 0 9 1 4 2 1 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 1 1 0 ----61

45-49 1 2 0 0 1 0 0 0 1 0 0 0 5 3 0 0 0 0 1 0 3 0 0 0 1 0 0 0 22 1 0 10 3 0 4 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 1 1 0 0 ----62

50-54 0 2 1 0 0 0 0 0 0 1 2 0 3 3 0 0 1 1 1 0 1 0 0 0 0 0 0 1 24 0 0 9 4 4 3 0 0 1 0 0 1 0 0 3 2 1 0 0 1 0 2 0 0 0 0 ----72

55-59 0 0 2 2 0 0 1 0 0 0 0 0 4 3 0 2 2 1 1 0 9 0 0 0 0 0 0 0 19 0 0 8 4 1 3 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 ----66

60-64 0 0 0 1 0 0 0 0 0 1 1 0 1 3 0 1 0 0 0 1 2 0 0 0 0 0 0 1 10 0 0 3 2 1 3 0 0 0 0 0 1 0 0 1 2 0 0 0 0 0 1 0 0 0 0 ----36

65-69 0 1 0 0 0 0 0 0 0 0 2 0 4 2 0 3 0 1 1 0 4 0 0 1 0 0 0 0 8 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 1 2 0 0 0 0 0 2 ----36

70-74 0 2 0 0 2 0 0 0 0 1 1 0 9 0 0 3 1 3 0 1 6 0 0 1 3 0 0 0 4 1 1 2 3 0 0 0 0 0 0 0 1 0 0 1 0 0 0 1 1 0 0 0 1 0 1 ----50

75+ 0.20% 1.80% 0.80% 1.00% 0.60% 0.00% 0.60% 0.00% 0.20% 0.60% 1.20% 0.00% 5.90% 3.60% 0.00% 2.20% 0.80% 1.60% 0.80% 0.60% 5.50% 0.20% 0.00% 0.60% 0.80% 0.00% 0.00% 0.80% 30.50% 0.40% 0.20% 11.10% 4.00% 2.60% 4.60% 0.20% 0.20% 0.80% 0.00% 0.00% 0.80% 0.00% 0.20% 2.80% 4.00% 0.20% 0.00% 1.60% 1.00% 0.00% 1.00% 0.80% 0.60% 0.80% 0.80% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 92: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, PERLIS, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

172

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 4 1 0 0 3 23 2 0 8 12 2 34 34 1 20 2 13 3 11 69 1 3 1 5 1 0 3 2 1 24 3 0 7 0 0 26 0 0 9 7 0 0 9 15 0 7 10 16 6 7 ----405

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 10.1 2 4 0 ----20

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.9 3.8 0 ----6

50 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0 ----5

10-14 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0 1.4 0 0 0 1.4 0 0 0 0 2.8 0 0 ----8

15-19 0 0 0 0 0 0 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 3.7 1.9 3.7 0 0 0 0 0 0 0 0 1.9 0 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 1.9 0 0 0 ----17

20-24 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 ----1

25-29 0 0 0 0 0 0 3.5 0 0 0 0 0 0 7 0 3.5 0 0 0 0 3.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.5 0 0 0 0 3.5 0 0 0 0 0 0 ----25

30-34 0 0 0 0 0 0 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 7.3 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 0 7.3 0 0 ----25

35-39 0 0 0 0 0 0 3.1 0 0 0 0 0 9.4 0 0 0 0 6.3 0 0 3.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.1 0 0 0 3.1 3.1 0 3.1 0 3.1 0 0 ----38

40-44 0 0 0 0 0 3.1 15.4 0 0 0 0 6.2 12.3 12.3 0 12.3 0 6.2 3.1 6.2 12.3 0 0 0 0 0 0 0 0 0 0 0 0 3.1 0 0 12.3 0 0 0 3.1 0 0 0 6.2 0 0 0 0 0 0 ----114

45-49 0 0 3.3 0 0 0 0 0 0 3.3 3.3 0 10 6.7 0 13.3 0 13.3 3.3 0 16.7 0 0 0 0 0 0 0 0 0 0 0 0 6.7 0 0 6.7 0 0 3.3 0 0 0 3.3 3.3 0 0 0 10 0 0 ----107

50-54 0 7.8 0 0 0 0 23.5 3.9 0 0 0 0 23.5 15.7 0 11.8 0 3.9 0 7.8 23.5 0 0 0 0 0 0 0 0 0 11.8 0 0 0 0 0 3.9 0 0 0 0 0 0 0 7.8 0 7.8 0 11.8 0 0 ----165

55-59 0 0 0 0 0 4.9 0 0 0 4.9 4.9 0 24.4 14.6 0 14.6 0 4.9 4.9 19.5 48.8 0 4.9 0 4.9 0 0 0 0 0 4.9 0 0 0 0 0 19.5 0 0 4.9 9.8 0 0 4.9 9.8 0 9.8 9.8 0 4.9 14.6 ----249

60-64 0 6.7 0 0 0 0 26.7 0 0 6.7 13.3 0 40 60 0 20 6.7 6.7 0 6.7 80 0 0 0 6.7 0 0 13.3 6.7 6.7 33.3 6.7 0 13.3 0 0 26.7 0 0 6.7 6.7 0 0 6.7 13.3 0 0 6.7 6.7 0 0 ----433

65-69 0 0 0 0 0 0 17.4 0 0 17.4 26.1 0 26.1 43.5 0 8.7 8.7 8.7 0 8.7 121.8 0 0 8.7 8.7 0 0 0 0 0 60.9 0 0 8.7 0 0 52.2 0 0 0 17.4 0 0 34.8 26.1 0 8.7 0 8.7 0 17.4 ----539

70-74 0 8.3 0 0 0 8.3 8.3 8.3 0 25 41.7 0 33.3 25 8.3 8.3 0 8.3 0 8.3 100 0 0 0 16.7 8.3 0 8.3 0 0 58.3 0 0 0 0 0 41.7 0 0 0 0 0 0 0 8.3 0 8.3 8.3 0 8.3 16.7 ----475

75+

APPENDIX 93: CANCER INCIDENCE BY SITES AND AGE GROUP, PERLIS, ALL RESIDENTS, MALES, 2007-2011

0 0.5 0.1 0 0 0.3 2.6 0.2 0 0.9 1.4 0.2 3.9 3.9 0.1 2.3 0.2 1.5 0.3 1.3 7.9 0.1 0.3 0.1 0.6 0.1 0 0.3 0.2 0.1 2.7 0.3 0 0.8 0 0 3 0 0 1 0.8 0 0 1 1.7 0 0.8 1.1 1.8 0.7 0.8 ----46.2

Crude Rate 0 0.7 0.2 0 0 0.5 4 0.3 0 1.4 2.1 0.4 6.1 6.1 0.2 3.6 0.4 2.3 0.5 2 12.4 0.1 0.5 0.2 0.9 0.2 0 0.6 0.4 0.2 4.2 0.6 0 1.2 0 0 4.7 0 0 1.6 1.3 0 0 1.6 2.7 0 1.2 2.1 2.7 1.2 1.3 ----72.8

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

173

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 9 4 5 3 0 3 0 1 3 6 0 29 18 0 11 4 8 4 3 27 1 0 3 4 0 0 4 151 2 1 55 20 13 23 1 1 4 0 0 4 0 1 14 20 1 0 8 5 0 5 4 3 4 4 ----495

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 4.2 0 0 0 0 2.1 0 0 2.1 0 6.3 0 ----19

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 ----4

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0 0 ----3

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.5 0 0 0 0 0 0 0 0 1.3 1.3 0 0 2.5 0 0 0 0 0 0 0 ----8

15-19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 ----8

20-24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.7 0 0 0 0 0 2.7 0 0 0 0 2.7 0 0 0 2.7 0 0 0 0 0 0 0 0 0 0 0 8.1 0 0 2.7 0 0 0 0 0 0 0 ----22

25-29 0 3.4 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13.6 0 0 3.4 3.4 3.4 3.4 0 3.4 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 3.4 0 0 3.4 ----47

30-34 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 44.1 0 0 17 3.4 6.8 0 0 0 10.2 0 0 0 0 0 0 10.2 0 0 0 0 0 0 0 0 0 0 ----95

35-39 0 2.9 0 2.9 0 0 0 0 0 0 0 0 0 5.9 0 2.9 0 2.9 0 0 0 2.9 0 0 0 0 0 0 52.9 0 0 20.6 0 0 2.9 0 0 0 0 0 2.9 0 0 2.9 8.8 0 0 2.9 0 0 0 0 0 0 0 ----115

40-44 0 0 2.9 2.9 0 0 5.9 0 0 0 0 0 5.9 2.9 0 2.9 0 0 0 2.9 5.9 0 0 0 0 0 0 2.9 79.4 0 0 26.5 2.9 11.8 5.9 2.9 0 0 0 0 0 0 0 2.9 2.9 0 0 2.9 0 0 0 0 2.9 2.9 0 ----179

45-49 3.2 6.4 0 0 3.2 0 0 0 3.2 0 0 0 15.9 9.5 0 0 0 0 3.2 0 9.5 0 0 0 3.2 0 0 0 69.9 3.2 0 31.8 9.5 0 12.7 0 0 0 0 0 0 0 0 3.2 0 0 0 3.2 0 0 0 3.2 3.2 0 0 ----197

50-54 0 7.5 3.8 0 0 0 0 0 0 3.8 7.5 0 11.3 11.3 0 0 3.8 3.8 3.8 0 3.8 0 0 0 0 0 0 3.8 90.6 0 0 34 15.1 15.1 11.3 0 0 3.8 0 0 3.8 0 0 11.3 7.5 3.8 0 0 3.8 0 7.5 0 0 0 0 ----272

55-59 0 0 10 10 0 0 5 0 0 0 0 0 20 15 0 10 10 5 5 0 45 0 0 0 0 0 0 0 95 0 0 40 20 5 15 0 0 0 0 0 0 0 0 0 10 0 0 0 0 0 10 0 0 0 0 ----330

60-64 0 0 0 6.7 0 0 0 0 0 6.7 6.7 0 6.7 20 0 6.7 0 0 0 6.7 13.3 0 0 0 0 0 0 6.7 66.7 0 0 20 13.3 6.7 20 0 0 0 0 0 6.7 0 0 6.7 13.3 0 0 0 0 0 6.7 0 0 0 0 ----240

65-69 0 8 0 0 0 0 0 0 0 0 16 0 32 16 0 24 0 8 8 0 32 0 0 8 0 0 0 0 64 0 0 8 0 0 8 0 0 0 0 0 0 0 0 8 8 0 0 8 16 0 0 0 0 0 16 ----288

70-74 0 11.8 0 0 11.8 0 0 0 0 5.9 5.9 0 52.9 0 0 17.6 5.9 17.6 0 5.9 35.3 0 0 5.9 17.6 0 0 0 23.5 5.9 5.9 11.8 17.6 0 0 0 0 0 0 0 5.9 0 0 5.9 0 0 0 5.9 5.9 0 0 0 5.9 0 5.9 ----294

75+

APPENDIX 94: CANCER INCIDENCE BY SITES AND AGE GROUP, PERLIS, ALL RESIDENTS, FEMALES, 2007-2011

0.2 1.6 0.7 0.9 0.5 0 0.5 0 0.2 0.5 1 0 5.1 3.1 0 1.9 0.7 1.4 0.7 0.5 4.7 0.2 0 0.5 0.7 0 0 0.7 26.4 0.3 0.2 9.6 3.5 2.3 4 0.2 0.2 0.7 0 0 0.7 0 0.2 2.4 3.5 0.2 0 1.4 0.9 0 0.9 0.7 0.5 0.7 0.7 ----86.4

Crude Rate 0.2 1.4 0.7 1 0.4 0 0.6 0 0.2 0.5 0.9 0 4.5 3.2 0 1.8 0.7 1.3 0.7 0.5 4.5 0.2 0 0.5 0.5 0 0 0.8 26.4 0.3 0.1 9.6 3.4 2.3 3.9 0.2 0.2 0.8 0 0 0.6 0 0.3 2.5 3.7 0.2 0 1.2 0.8 0 0.9 0.8 0.5 0.9 0.6 ----85

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

174

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 0 0 0 0 0 9 0 0 2 3 0 5 5 0 2 0 2 0 1 5 0 0 0 1 0 0 0 0 0 2 3 0 0 0 0 2 0 1 3 0 0 0 0 5 0 0 0 0 0 2 ----53

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----1

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 ----1

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 ----2

15-19 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----1

20-24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

25-29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 ----1

30-34 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 ----4

35-39 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----3

40-44 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 ----4

45-49 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 ----4

50-54 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 ----7

55-59 0 0 0 0 0 0 3 0 0 0 1 0 1 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----8

60-64 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 ----7

65-69 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----5

70-74 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 ----5

75+ 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 17.00% 0.00% 0.00% 3.80% 5.70% 0.00% 9.40% 9.40% 0.00% 3.80% 0.00% 3.80% 0.00% 1.90% 9.40% 0.00% 0.00% 0.00% 1.90% 0.00% 0.00% 0.00% 0.00% 0.00% 3.80% 5.70% 0.00% 0.00% 0.00% 0.00% 3.80% 0.00% 1.90% 5.70% 0.00% 0.00% 0.00% 0.00% 9.40% 0.00% 0.00% 0.00% 0.00% 0.00% 3.80% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 95: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, W.P. LABUAN, ALL RESIDENTS, MALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

175

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 0 0 0 0 0 1 0 0 2 2 0 2 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 17 0 0 7 2 0 2 0 0 0 0 0 0 0 0 1 0 0 0 1 5 0 0 0 4 0 1 ----51

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 ----1

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 ----1

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

15-19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----1

20-24 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----1

25-29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 ----4

30-34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 ----5

35-39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0 ----5

40-44 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 ----9

45-49 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----7

50-54 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 ----7

55-59 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----3

60-64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 ----2

65-69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----3

70-74 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----2

75+ 2.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.00% 0.00% 0.00% 3.90% 3.90% 0.00% 3.90% 2.00% 0.00% 0.00% 0.00% 2.00% 0.00% 0.00% 2.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 33.30% 0.00% 0.00% 13.70% 3.90% 0.00% 3.90% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.00% 0.00% 0.00% 0.00% 2.00% 9.80% 0.00% 0.00% 0.00% 7.80% 0.00% 2.00% ----100.00%

% of Total

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

APPENDIX 96: NUMBER OF NEW CANCER CASES BY SITES AND AGE GROUP, W.P. LABUAN, ALL RESIDENTS, FEMALES, 2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

176

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Penis Prostate Testis Other male genital Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

0 0 0 0 0 0 9 0 0 2 3 0 5 5 0 2 0 2 0 1 5 0 0 0 1 0 0 0 0 0 2 3 0 0 0 0 2 0 1 3 0 0 0 0 5 0 0 0 0 0 2 ----53

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----4

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.9 0 0 0 0 0 0 0 0 0 0 0 ----5

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.4 0 0 0 0 0 0 0 5.4 0 0 0 0 0 0 0 0 0 0 0 ----11

15-19 0 0 0 0 0 0 4.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----5

20-24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

25-29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6.9 0 0 0 0 0 0 0 0 0 0 0 0 ----7

30-34 0 0 0 0 0 0 8 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 ----32

35-39 0 0 0 0 0 0 8.3 0 0 0 0 0 8.3 0 0 0 0 8.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----25

40-44 0 0 0 0 0 0 0 0 0 8.7 0 0 0 0 0 8.7 0 8.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.7 ----35

45-49 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 ----50

50-54 0 0 0 0 0 0 0 0 0 20 20 0 0 20 0 0 0 0 0 20 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 0 0 20 0 0 0 0 0 0 ----140

55-59 0 0 0 0 0 0 100 0 0 0 33.3 0 33.3 33.3 0 0 0 0 0 0 66.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----267

60-64 0 0 0 0 0 0 50 0 0 0 0 0 50 50 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 50 0 0 0 0 0 0 0 50 0 0 0 0 0 0 ----350

65-69 0 0 0 0 0 0 0 0 0 0 66.7 0 66.7 0 0 0 0 0 0 0 0 0 0 0 66.7 0 0 0 0 0 66.7 0 0 0 0 0 66.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----333

70-74 0 0 0 0 0 0 0 0 0 0 0 0 66.7 66.7 0 66.7 0 0 0 0 66.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 66.7 ----333

75+ 0 0 0 0 0 0 4.5 0 0 1 1.5 0 2.5 2.5 0 1 0 1 0 0.5 2.5 0 0 0 0.5 0 0 0 0 0 1 1.5 0 0 0 0 1 0 0.5 1.5 0 0 0 0 2.5 0 0 0 0 0 1 ----26.5

Crude Rate

APPENDIX 97: CANCER INCIDENCE BY SITES AND AGE GROUP, W.P. LABUAN, ALL RESIDENTS, MALES, 2007-2011

0 0 0 0 0 0 8.1 0 0 1.3 3.5 0 6 5.4 0 1.9 0 1 0 0.8 6.3 0 0 0 1.3 0 0 0 0 0 2.8 1.5 0 0 0 0 2.8 0 0.4 1.8 0 0 0 0 4 0 0 0 0 0 1.9 ----50.9

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C60 C61 C62 C63 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

177

All sites Total

Lip Tongue Mouth Salivary glands Tonsil Other Oropharynx Nasopharynx Hypopharynx Pharynx unspec.

Oesophagus Stomach Small intestine Colon Rectum Anus Liver Gallbladder etc.

Pancreas Nose, sinuses etc.

Larynx Trachea,Bronchus,Lung Other Thoracic organs Bone Melanoma of Skin Other Skin Mesothelioma Kaposi sarcoma Connective,Soft tissue Breast Vulva Vagina Cervix Uteri Corpus Uteri Uterus unspec.

Ovary Other Female Genital Placenta Kidney Renal Pelvis Ureter Bladder Other Urinary organs Eye Brain, Nervous system Thyroid Adrenal gland Other Endocrine Hodgkin disease Non-Hodgkin lymphoma Immunoproliferative dis.

Multiple Myeloma Lymphoid Leukaemia Myeloid Leukaemia Leukaemia unspec.

Other & unspecified

Site

1 0 0 0 0 0 1 0 0 2 2 0 2 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 17 0 0 7 2 0 2 0 0 0 0 0 0 0 0 1 0 0 0 1 5 0 0 0 4 0 1 ----51

All Ages 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

Age Unk. -4

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.8 0 0 ----5

0-9

0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.1 0 0 0 0 0 0 ----5

10-14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----0

15-19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----5

20-24 0 0 0 0 0 0 0 0 0 0 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----4

25-29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.4 0 0 14.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.4 0 0 0 0 0 0 0 ----30

30-34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 8 0 8 ----40

35-39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5 0 0 9.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19.1 0 0 0 9.5 0 0 ----48

40-44 0 0 0 0 0 0 11.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 55.6 0 0 11.1 0 0 11.1 0 0 0 0 0 0 0 0 11.1 0 0 0 0 0 0 0 0 0 0 0 ----100

45-49 0 0 0 0 0 0 0 0 0 0 11.8 0 23.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 47.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----82

50-54 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 75 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 ----175

55-59 0 0 0 0 0 0 0 0 0 0 0 0 0 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----120

60-64 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 ----100

65-69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 100 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----300

70-74 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ----100

75+ 0.5 0 0 0 0 0 0.5 0 0 1.1 1.1 0 1.1 0.5 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0 8.9 0 0 3.7 1.1 0 1.1 0 0 0 0 0 0 0 0 0.5 0 0 0 0.5 2.6 0 0 0 2.1 0 0.5 ----26.8

Crude Rate

APPENDIX 98: CANCER INCIDENCE BY SITES AND AGE GROUP, W.P. LABUAN, ALL RESIDENTS, FEMALES, 2007-2011

1 0 0 0 0 0 0.7 0 0 2 0.9 0 1.2 1.6 0 0 0 2 0 0 1.5 0 0 0 0 0 0 0 12.6 0 0 6.3 2.5 0 1.7 0 0 0 0 0 0 0 0 0.7 0 0 0 0.4 3.1 0 0 0 3.1 0 0.5 ----41.7

ASR World

All

C00 C01-C02 C03-C06 C07-C08 C09 C10 C11 C12-C13 C14 C15 C16 C17 C18 C19-C20 C21 C22 C23-C24 C25 C30-C31 C32 C33-C34 C37-C38 C40-C41 C43 C44 C45 C46 C47;C49 C50 C51 C52 C53 C54 C55 C56 C57 C58 C64 C65 C66 C67 C68 C69 C70-C72 C73 C74 C75 C81 C82-C85;C96 C88 C90 C91 C92-C94 C95 Other

ICD (10th)

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 99: MORPHOLOGICALLY VERIFIED CASES BY HISTOLOGY TYPES, ALL SITES, MALAYSIA, 2007-2011

178

ICD10

Sites

C00

LIP

C01-C02

TONGUE

C03-C06

MOUTH

Histology

No.

%

8010 8051 8070 8071 8140 8147 8200 8430 8480 8550 8800 8850

Carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Adenocarcinoma, NOS Basal cell adenocarcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma Mucinous adenocarcinoma Acinar cell carcinoma Sarcoma, NOS Liposarcoma, NOS

4 1 65 2 4 1 3 1 1 1 1 1 85

4.7 1.2 76.5 2.4 4.7 1.2 3.5 1.2 1.2 1.2 1.2 1.2 100.0

8001 8010 8011 8020 8032 8050 8051 8070 8071 8072 8073 8075 8140 8200 8260 8430 8550 8560 8810 8852 8900 8980

Tumor cells, malignant Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Spindle cell carcinoma, NOS Papillary carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Adenocarcinoma, NOS Adenoid cystic carcinoma Papillary adenocarcinoma, NOS Mucoepidermoid carcinoma Acinar cell carcinoma Adenosquamous carcinoma Fibrosarcoma, NOS Myxoid liposarcoma Rhabdomyosarcoma, NOS Carcinosarcoma, NOS

1 38 1 25 2 1 3 729 9 2 1 5 25 1 1 2 1 1 2 1 1 2 854

0.1 4.4 0.1 2.9 0.2 0.1 0.4 85.4 1.1 0.2 0.1 0.6 2.9 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.1 0.2 100.0

8001 8010 8020 8032 8051 8070 8071 8072 8073 8075 8076 8082 8083 8140 8147 8200 8263 8310 8430 8480 8550 8560 8562 8800 8802 8830 8850 8851 8852 8920 8940 8941 8980 9170 9581

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Spindle cell carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Squamous cell carcinoma, microinvasive Lymphoepithelial carcinoma Basaloid squamous cell carcinoma Adenocarcinoma, NOS Basal cell adenocarcinoma Adenoid cystic carcinoma Adenocarcinoma in tubulovillous adenoma Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Mucinous adenocarcinoma Acinar cell carcinoma Adenosquamous carcinoma Epithelial-myoepithelial carcinoma Sarcoma, NOS Giant cell sarcoma Malignant fibrous histiocytoma Liposarcoma, NOS Liposarcoma, well differentiated Myxoid liposarcoma Alveolar rhabdomyosarcoma Mixed tumor, malignant, NOS Carcinoma in pleomorphic adenoma Carcinosarcoma, NOS Lymphangiosarcoma Alveolar soft part sarcoma

1 34 27 1 7 710 11 5 3 2 1 1 1 38 1 18 1 2 26 1 3 1 2 3 1 1 2 1 1 1 1 1 2 1 1 913

0.1 3.7 3.0 0.1 0.8 77.8 1.2 0.5 0.3 0.2 0.1 0.1 0.1 4.2 0.1 2.0 0.1 0.2 2.8 0.1 0.3 0.1 0.2 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C07-C08

SALIVARY GLANDS

C09

TONSIL

C10

OTHER OROPHARYNX

C11

NASOPHARYNX

8000 8001 8010 8011 8013 8020 8021 8022 8050 8070 8071 8072 8075 8082 8140 8147 8200 8201 8290 8310 8430 8440 8480 8500 8550 8560 8562 8802 8830 8940 8941 8980 8982

Neoplasm, malignant Tumor cells, malignant Carcinoma, NOS Epithelioma, malignant Large cell neuroendocrine carcinoma Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Pleomorphic carcinoma Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, adenoid Lymphoepithelial carcinoma Adenocarcinoma, NOS Basal cell adenocarcinoma Adenoid cystic carcinoma Cribriform carcinoma, NOS Oxyphilic adenocarcinoma Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Cystadenocarcinoma, NOS Mucinous adenocarcinoma Infiltrating duct carcinoma, NOS Acinar cell carcinoma Adenosquamous carcinoma Epithelial-myoepithelial carcinoma Giant cell sarcoma Malignant fibrous histiocytoma Mixed tumor, malignant, NOS Carcinoma in pleomorphic adenoma Carcinosarcoma, NOS Malignant myoepithelioma

1 8 42 2 1 21 1 5 1 87 1 3 1 10 63 5 42 1 6 2 65 1 5 1 27 1 5 1 1 18 57 1 1 487

0.2 1.6 8.6 0.4 0.2 4.3 0.2 1.0 0.2 17.9 0.2 0.6 0.2 2.1 12.9 1.0 8.6 0.2 1.2 0.4 13.3 0.2 1.0 0.2 5.5 0.2 1.0 0.2 0.2 3.7 11.7 0.2 0.2 100.0

8010 8020 8052 8070 8071 8072 8073 8140 8200 8800 8801 9581

Carcinoma, NOS Carcinoma, undifferentiated, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Adenocarcinoma, NOS Adenoid cystic carcinoma Sarcoma, NOS Spindle cell sarcoma Alveolar soft part sarcoma

9 4 1 149 4 4 2 14 2 1 1 1 192

4.7 2.1 0.5 77.6 2.1 2.1 1.0 7.3 1.0 0.5 0.5 0.5 100.0

8010 8020 8070 8072 8076 8140 8200 8310 8430 8890 8980 9120

Carcinoma, NOS Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, microinvasive Adenocarcinoma, NOS Adenoid cystic carcinoma Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Leiomyosarcoma, NOS Carcinosarcoma, NOS Hemangiosarcoma

13 2 77 2 1 7 1 1 1 1 3 1 110

11.8 1.8 70.0 1.8 0.9 6.4 0.9 0.9 0.9 0.9 2.7 0.9 100.0

8000 8001 8002 8010 8020 8021 8022 8032 8033 8050 8070 8071

Neoplasm, malignant Tumor cells, malignant Malignant tumor, small cell type Carcinoma, NOS Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Pleomorphic carcinoma Spindle cell carcinoma, NOS Pseudosarcomatous carcinoma Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS

1 3 1 887 2,143 4 1 5 1 22 594 77

0.0 0.1 0.0 17.7 42.7 0.1 0.0 0.1 0.0 0.4 11.8 1.5

179

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

180

C12-C13

HYPOPHARYNX

C14

PHARYNX UNSPEC

C15

OESOPHAGUS

8072 8073 8075 8082 8083 8120 8121 8140 8200 8230 8260 8440 8490 8800 8840 8851 8890 8900 8910 8920 8980

Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Lymphoepithelial carcinoma Basaloid squamous cell carcinoma Transitional cell carcinoma, NOS Schneiderian carcinoma Adenocarcinoma, NOS Adenoid cystic carcinoma Solid carcinoma, NOS Papillary adenocarcinoma, NOS Cystadenocarcinoma, NOS Signet ring cell carcinoma Sarcoma, NOS Myxosarcoma Liposarcoma, well differentiated Leiomyosarcoma, NOS Rhabdomyosarcoma, NOS Embryonal rhabdomyosarcoma, NOS Alveolar rhabdomyosarcoma Carcinosarcoma, NOS

941 54 1 15 1 1 1 214 10 1 2 1 1 3 1 2 1 3 1 1 30 5,024

18.7 1.1 0.0 0.3 0.0 0.0 0.0 4.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 100.0

8010 8020 8021 8032 8052 8070 8071 8072 8075 8140 8900

Carcinoma, NOS Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Spindle cell carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, adenoid Adenocarcinoma, NOS Rhabdomyosarcoma, NOS

15 17 1 1 1 193 4 9 1 9 1 252

6.0 6.7 0.4 0.4 0.4 76.6 1.6 3.6 0.4 3.6 0.4 100.0

8001 8010 8020 8070 8072 8140 8810 8890 8910

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Adenocarcinoma, NOS Fibrosarcoma, NOS Leiomyosarcoma, NOS Embryonal rhabdomyosarcoma, NOS

1 4 5 32 2 7 1 1 1 54

1.9 7.4 9.3 59.3 3.7 13.0 1.9 1.9 1.9 100.0

8001 8010 8020 8033 8050 8070 8071 8072 8073 8076 8140 8144 8145 8200 8240 8246 8260 8480 8490 8560 8936 8980

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Pseudosarcomatous carcinoma Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, microinvasive Adenocarcinoma, NOS Adenocarcinoma, intestinal type Carcinoma, diffuse type Adenoid cystic carcinoma Carcinoid tumor, NOS Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Mucinous adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Gastrointestinal stromal sarcoma Carcinosarcoma, NOS

1 109 32 1 1 567 7 11 1 1 381 1 3 1 1 1 6 3 10 3 2 3 1,146

0.1 9.5 2.8 0.1 0.1 49.5 0.6 1.0 0.1 0.1 33.2 0.1 0.3 0.1 0.1 0.1 0.5 0.3 0.9 0.3 0.2 0.3 100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C16

STOMACH

C17

SMALL INTESTINE

C18-C21

COLORECTAL

8001 8002 8003 8010 8011 8020 8021 8032 8070 8072 8073 8075 8140 8141 8144 8145 8153 8211 8214 8240 8246 8260 8263 8440 8480 8481 8490 8510 8550 8560 8800 8801 8810 8830 8852 8853 8890 8936 8941 8963 8980

Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, giant cell type Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Spindle cell carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Adenocarcinoma, NOS Scirrhous adenocarcinoma Adenocarcinoma, intestinal type Carcinoma, diffuse type Gastrinoma, malignant Tubular adenocarcinoma Parietal cell carcinoma Carcinoid tumor, NOS Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Adenocarcinoma in tubulovillous adenoma Cystadenocarcinoma, NOS Mucinous adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell carcinoma Medullary carcinoma, NOS Acinar cell carcinoma Adenosquamous carcinoma Sarcoma, NOS Spindle cell sarcoma Fibrosarcoma, NOS Malignant fibrous histiocytoma Myxoid liposarcoma Round cell liposarcoma Leiomyosarcoma, NOS Gastrointestinal stromal sarcoma Carcinoma in pleomorphic adenoma Malignant rhabdoid tumor Carcinosarcoma, NOS

9 2 2 227 1 67 1 2 92 3 2 1 2,433 1 52 62 7 3 2 2 6 3 2 1 35 3 137 2 1 5 4 1 1 1 1 1 7 185 1 2 7 3,377

0.3 0.1 0.1 6.7 0.0 2.0 0.0 0.1 2.7 0.1 0.1 0.0 72.0 0.0 1.5 1.8 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.0 1.0 0.1 4.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.1 0.2 100.0

8001 8010 8020 8021 8070 8140 8144 8145 8153 8211 8240 8245 8246 8260 8480 8800 8890 8936

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Squamous cell carcinoma, NOS Adenocarcinoma, NOS Adenocarcinoma, intestinal type Carcinoma, diffuse type Gastrinoma, malignant Tubular adenocarcinoma Carcinoid tumor, NOS Adenocarcinoid tumor Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Mucinous adenocarcinoma Sarcoma, NOS Leiomyosarcoma, NOS Gastrointestinal stromal sarcoma

1 23 4 1 3 138 2 1 1 1 8 1 3 2 3 5 3 40 240

0.4 9.6 1.7 0.4 1.3 57.5 0.8 0.4 0.4 0.4 3.3 0.4 1.3 0.8 1.3 2.1 1.3 16.7 100.0

8001 8003 8004 8010 8013 8014 8020 8021 8050 8051 8070 8071

Tumor cells, malignant Malignant tumor, giant cell type Malignant tumor, spindle cell type Carcinoma, NOS Large cell neuroendocrine carcinoma Large cell carcinoma with rhabdoid phenotype Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Papillary carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS

10 1 1 903 1 1 227 1 15 3 218 1

0.1 0.0 0.0 6.7 0.0 0.0 1.7 0.0 0.1 0.0 1.6 0.0

181

C22

182

LIVER

8072 8075 8076 8082 8084 8120 8123 8140 8141 8144 8145 8147 8210 8211 8215 8220 8221 8240 8243 8244 8245 8246 8260 8261 8262 8263 8310 8430 8440 8480 8481 8490 8560 8573 8574 8720 8800 8804 8821 8851 8890 8900 8936 8941 8980

Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, adenoid Squamous cell carcinoma, microinvasive Lymphoepithelial carcinoma Squamous cell carcinoma, clear cell type Transitional cell carcinoma, NOS Basaloid carcinoma Adenocarcinoma, NOS Scirrhous adenocarcinoma Adenocarcinoma, intestinal type Carcinoma, diffuse type Basal cell adenocarcinoma Adenocarcinoma in adenomatous polyp Tubular adenocarcinoma Adenocarcinoma of anal glands Adenocarcinoma in adenomatous polyposis Adenocarcinoma in multiple adenomatous polyps Carcinoid tumor, NOS Goblet cell carcinoid Composite carcinoid Adenocarcinoid tumor Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Adenocarcinoma in villous adenoma Villous adenocarcinoma Adenocarcinoma in situ tubulovillous adenoma Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Cystadenocarcinoma, NOS Mucinous adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Adenocarcinoma with apocrine metaplasia Adenocarcinoma with neuroendocrine differentiation Malignant melanoma, NOS Sarcoma, NOS Epithelioid sarcoma Aggressive fibromatosis Liposarcoma, well differentiated Leiomyosarcoma, NOS Rhabdomyosarcoma, NOS Gastrointestinal stromal sarcoma Carcinoma in pleomorphic adenoma Carcinosarcoma, NOS

1 3 1 1 3 3 3 11,443 4 18 4 2 20 28 4 8 2 56 1 2 2 14 26 6 10 44 1 1 7 261 7 51 3 1 1 11 5 1 1 2 5 1 8 1 31 13,490

0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.8 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.0 0.1 1.9 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 100.0

8001 8010 8020 8030 8033 8050 8070 8072 8082 8140 8160 8161 8162 8170 8171 8172 8180 8200 8246 8260 8310 8480 8500 8560 8800 8805 8852 8890 8891

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Giant cell and spindle cell carcinoma Pseudosarcomatous carcinoma Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Lymphoepithelial carcinoma Adenocarcinoma, NOS Cholangiocarcinoma Bile duct cystadenocarcinoma Klatskin tumor Hepatocellular carcinoma, NOS Hepatocellular carcinoma, fibrolamellar Hepatocellular carcinoma, scirrhous Combined hepatocellular carcinoma and cholangiocarcinoma Adenoid cystic carcinoma Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Mucinous adenocarcinoma Infiltrating duct carcinoma, NOS Adenosquamous carcinoma Sarcoma, NOS Undifferentiated sarcoma Myxoid liposarcoma Leiomyosarcoma, NOS Epithelioid leiomyosarcoma

3 102 28 1 1 2 14 1 1 120 289 3 32 2,524 31 2 43 1 6 2 1 1 1 1 1 1 1 3 1

0.1 3.1 0.9 0.0 0.0 0.1 0.4 0.0 0.0 3.7 8.9 0.1 1.0 77.4 1.0 0.1 1.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C23-C24

GALLBLADDER ETC.

C25

PANCREAS

C30- C31

NOSE, SINUSES ETC.

8970 8981 8991 9120 9130 9170

Hepatoblastoma Carcinosarcoma, embryonal Embryonal sarcoma Hemangiosarcoma Hemangioendothelioma, malignant Lymphangiosarcoma

34 1 1 4 1 2 3,260

1.0 0.0 0.0 0.1 0.0 0.1 100.0

8001 8010 8011 8020 8050 8070 8140 8141 8160 8246 8260 8262 8440 8480 8490 8500 8503 8504 8560 8800

Tumor cells, malignant Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Adenocarcinoma, NOS Scirrhous adenocarcinoma Cholangiocarcinoma Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Villous adenocarcinoma Cystadenocarcinoma, NOS Mucinous adenocarcinoma Signet ring cell carcinoma Infiltrating duct carcinoma, NOS Intraductal papillary adenocarcinoma with invasion Intracystic carcinoma, NOS Adenosquamous carcinoma Sarcoma, NOS

1 102 2 26 7 25 317 1 274 3 6 1 1 2 1 1 1 1 6 1 779

0.1 13.1 0.3 3.3 0.9 3.2 40.7 0.1 35.2 0.4 0.8 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.8 0.1 100.0

8001 8010 8013 8020 8021 8033 8050 8052 8070 8072 8140 8141 8150 8152 8154 8200 8240 8246 8260 8263 8310 8430 8440 8452 8453 8480 8490 8500 8550 8560 8971 8980

Tumor cells, malignant Carcinoma, NOS Large cell neuroendocrine carcinoma Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Pseudosarcomatous carcinoma Papillary carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Adenocarcinoma, NOS Scirrhous adenocarcinoma Islet cell carcinoma Glucagonoma, malignant Mixed islet cell and exocrine adenocarcinoma Adenoid cystic carcinoma Carcinoid tumor, NOS Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Adenocarcinoma in tubulovillous adenoma Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Cystadenocarcinoma, NOS Solid pseudopapillary carcinoma Intraductal papillary-mucinous carcinoma, invasive Mucinous adenocarcinoma Signet ring cell carcinoma Infiltrating duct carcinoma, NOS Acinar cell carcinoma Adenosquamous carcinoma Pancreatoblastoma Carcinosarcoma, NOS

12 328 1 93 2 2 3 1 53 1 943 2 4 3 4 3 4 23 6 2 1 1 10 6 2 15 1 10 8 1 21 7 1,573

0.8 20.9 0.1 5.9 0.1 0.1 0.2 0.1 3.4 0.1 59.9 0.1 0.3 0.2 0.3 0.2 0.3 1.5 0.4 0.1 0.1 0.1 0.6 0.4 0.1 1.0 0.1 0.6 0.5 0.1 1.3 0.4 100.0

8010 8020 8050 8070 8071 8072 8073 8074 8076

Carcinoma, NOS Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, spindle cell Squamous cell carcinoma, microinvasive

31 48 3 155 10 11 4 1 1

7.8 12.0 0.8 38.8 2.5 2.8 1.0 0.3 0.3

183

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

184

C32

LARYNX

C33- C34

TRACHEA, BRONCHUS, LUNG

8082 8083 8120 8121 8140 8147 8200 8260 8430 8510 8720 8800 8801 8803 8813 8900 8910 8980 9120 9371 9520 9521 9522 9523

Lymphoepithelial carcinoma Basaloid squamous cell carcinoma Transitional cell carcinoma, NOS Schneiderian carcinoma Adenocarcinoma, NOS Basal cell adenocarcinoma Adenoid cystic carcinoma Papillary adenocarcinoma, NOS Mucoepidermoid carcinoma Medullary carcinoma, NOS Malignant melanoma, NOS Sarcoma, NOS Spindle cell sarcoma Small cell sarcoma Fascial fibrosarcoma Rhabdomyosarcoma, NOS Embryonal rhabdomyosarcoma, NOS Carcinosarcoma, NOS Hemangiosarcoma Chondroid chordoma Olfactory neurogenic tumor Olfactory neurocytoma Olfactory neuroblastoma Olfactory neuroepithelioma

1 1 4 9 43 7 23 2 3 1 3 5 1 1 1 3 1 3 2 1 1 2 16 2 400

0.3 0.3 1.0 2.3 10.8 1.8 5.8 0.5 0.8 0.3 0.8 1.3 0.3 0.3 0.3 0.8 0.3 0.8 0.5 0.3 0.3 0.5 4.0 0.5 100.0

8000 8001 8004 8010 8020 8050 8051 8052 8070 8071 8072 8073 8075 8076 8083 8140 8200 8560 8800 8810 8890 8894 8941 8980

Neoplasm, malignant Tumor cells, malignant Malignant tumor, spindle cell type Carcinoma, NOS Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Verrucous carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Squamous cell carcinoma, microinvasive Basaloid squamous cell carcinoma Adenocarcinoma, NOS Adenoid cystic carcinoma Adenosquamous carcinoma Sarcoma, NOS Fibrosarcoma, NOS Leiomyosarcoma, NOS Angiomyosarcoma Carcinoma in pleomorphic adenoma Carcinosarcoma, NOS

1 2 1 66 27 5 4 2 741 8 11 2 2 1 1 39 1 2 3 1 1 1 1 1 924

0.1 0.2 0.1 7.1 2.9 0.5 0.4 0.2 80.2 0.9 1.2 0.2 0.2 0.1 0.1 4.2 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 100.0

8000 8001 8002 8003 8004 8010 8011 8012 8013 8020 8021 8030 8032 8033 8041 8042 8043 8044 8045 8046 8050 8051 8052

Neoplasm, malignant Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, giant cell type Malignant tumor, spindle cell type Carcinoma, NOS Epithelioma, malignant Large cell carcinoma, NOS Large cell neuroendocrine carcinoma Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Giant cell and spindle cell carcinoma Spindle cell carcinoma, NOS Pseudosarcomatous carcinoma Small cell carcinoma, NOS Oat cell carcinoma Small cell carcinoma, fusiform cell Small cell carcinoma, intermediate cell Combined small cell carcinoma Non-small cell carcinoma Papillary carcinoma, NOS Verrucous carcinoma, NOS Papillary squamous cell carcinoma

1 18 2 2 1 1,165 20 114 8 308 3 1 7 9 823 9 4 1 38 503 33 1 1

0.0 0.2 0.0 0.0 0.0 11.9 0.2 1.2 0.1 3.1 0.0 0.0 0.1 0.1 8.4 0.1 0.0 0.0 0.4 5.1 0.3 0.0 0.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C37-C38

OTHER THORACIC ORGANS

8070 8071 8072 8073 8074 8075 8082 8083 8140 8141 8147 8200 8240 8246 8249 8250 8251 8252 8253 8260 8310 8430 8440 8480 8481 8490 8510 8560 8570 8574 8800 8803 8830 8850 8851 8854 8890 8900 8963 8972 8980 9130 9133 9364 9580

Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, spindle cell Squamous cell carcinoma, adenoid Lymphoepithelial carcinoma Basaloid squamous cell carcinoma Adenocarcinoma, NOS Scirrhous adenocarcinoma Basal cell adenocarcinoma Adenoid cystic carcinoma Carcinoid tumor, NOS Neuroendocrine carcinoma, NOS Atypical carcinoid tumor Bronchiolo-alveolar adenocarcinoma, NOS Alveolar adenocarcinoma Bronchiolo-alveolar carcinoma, non-mucinous Bronchiolo-alveolar carcinoma, mucinous Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Cystadenocarcinoma, NOS Mucinous adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell carcinoma Medullary carcinoma, NOS Adenosquamous carcinoma Adenocarcinoma with squamous metaplasia Adenocarcinoma with neuroendocrine differentiation Sarcoma, NOS Small cell sarcoma Malignant fibrous histiocytoma Liposarcoma, NOS Liposarcoma, well differentiated Pleomorphic liposarcoma Leiomyosarcoma, NOS Rhabdomyosarcoma, NOS Malignant rhabdoid tumor Pulmonary blastoma Carcinosarcoma, NOS Hemangioendothelioma, malignant Epithelioid hemangioendothelioma, malignant Peripheral neuroectodermal tumor Granular cell tumor, malignant

1,909 12 37 18 2 8 1 1 4,445 3 1 6 11 18 2 138 5 3 2 28 10 4 1 11 1 2 1 24 2 1 7 1 1 1 1 1 1 4 1 2 22 1 2 1 1 9,826

19.4 0.1 0.4 0.2 0.0 0.1 0.0 0.0 45.2 0.0 0.0 0.1 0.1 0.2 0.0 1.4 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 100.0

8001 8002 8010 8013 8020 8050 8070 8072 8082 8140 8141 8231 8240 8246 8260 8490 8560 8580 8581 8584 8586 8589 8800 8805 8830 8900 8980 9064

Tumor cells, malignant Malignant tumor, small cell type Carcinoma, NOS Large cell neuroendocrine carcinoma Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Lymphoepithelial carcinoma Adenocarcinoma, NOS Scirrhous adenocarcinoma Carcinoma simplex Carcinoid tumor, NOS Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Signet ring cell carcinoma Adenosquamous carcinoma Thymoma, malignant, NOS Thymoma, type A, malignant Thymoma, type B2, malignant Thymic carcinoma, NOS Carcinoma showing thymus-like element Sarcoma, NOS Undifferentiated sarcoma Malignant fibrous histiocytoma Rhabdomyosarcoma, NOS Carcinosarcoma, NOS Germinoma

5 1 17 1 4 1 24 1 1 102 1 1 1 6 5 1 1 57 1 2 8 1 3 1 1 2 1 10

1.8 0.4 6.0 0.4 1.4 0.4 8.5 0.4 0.4 35.9 0.4 0.4 0.4 2.1 1.8 0.4 0.4 20.1 0.4 0.7 2.8 0.4 1.1 0.4 0.4 0.7 0.4 3.5

185

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

186

C40-C41

BONE

C43

MELANOMA OF SKIN

9065 9070 9071 9080 9082 9085 9120 9150 9540

Germ cell tumor, nonseminomatous Embryonal carcinoma, NOS Yolk sac tumor Teratoma, malignant, NOS Malignant teratoma, undifferentiated Mixed germ cell tumor Hemangiosarcoma Hemangiopericytoma, malignant Malignant peripheral nerve sheath tumor

1 1 5 3 1 9 1 1 2 284

0.4 0.4 1.8 1.1 0.4 3.2 0.4 0.4 0.7 100.0

8000 8001 8002 8004 8012 8800 8801 8803 8804 8806 8810 8812 8830 8850 8852 8854 8890 8895 8900 8910 9040 9120 9130 9133 9180 9181 9182 9183 9184 9185 9186 9192 9200 9220 9221 9230 9231 9240 9242 9243 9250 9251 9260 9261 9270 9310 9330 9364 9370 9371 9581

Neoplasm, malignant Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, spindle cell type Large cell carcinoma, NOS Sarcoma, NOS Spindle cell sarcoma Small cell sarcoma Epithelioid sarcoma Desmoplastic small round cell tumor Fibrosarcoma, NOS Periosteal fibrosarcoma Malignant fibrous histiocytoma Liposarcoma, NOS Myxoid liposarcoma Pleomorphic liposarcoma Leiomyosarcoma, NOS Myosarcoma Rhabdomyosarcoma, NOS Embryonal rhabdomyosarcoma, NOS Synovial sarcoma, NOS Hemangiosarcoma Hemangioendothelioma, malignant Epithelioid hemangioendothelioma, malignant Osteosarcoma, NOS Chondroblastic osteosarcoma Fibroblastic osteosarcoma Telangiectatic osteosarcoma Osteosarcoma in Paget disease of bone Small cell osteosarcoma Central osteosarcoma Parosteal osteosarcoma Aggressive osteoblastoma Chondrosarcoma, NOS Juxtacortical chondrosarcoma Chondroblastoma, malignant Myxoid chondrosarcoma Mesenchymal chondrosarcoma Clear cell chondrosarcoma Dedifferentiated chondrosarcoma Giant cell tumor of bone, malignant Malignant giant cell tumor of soft parts Ewing sarcoma Adamantinoma of long bones Odontogenic tumor, malignant Ameloblastoma, malignant Ameloblastic fibrosarcoma Peripheral neuroectodermal tumor Chordoma, NOS Chondroid chordoma Alveolar soft part sarcoma

1 10 2 2 1 24 5 2 1 2 8 8 8 12 2 3 6 1 2 1 8 1 1 1 403 6 2 1 3 5 1 1 22 61 1 2 4 3 1 2 50 1 81 1 16 11 2 4 4 1 1 802

0.1 1.2 0.2 0.2 0.1 3.0 0.6 0.2 0.1 0.2 1.0 1.0 1.0 1.5 0.2 0.4 0.7 0.1 0.2 0.1 1.0 0.1 0.1 0.1 50.2 0.7 0.2 0.1 0.4 0.6 0.1 0.1 2.7 7.6 0.1 0.2 0.5 0.4 0.1 0.2 6.2 0.1 10.1 0.1 2.0 1.4 0.2 0.5 0.5 0.1 0.1 100.0

8720 8721 8730 8742 8744 8745 8761 8770 8772 8780

Malignant melanoma, NOS Nodular melanoma Amelanotic melanoma Lentigo maligna melanoma Acral lentiginous melanoma, malignant Desmoplastic melanoma, malignant Malignant melanoma in giant pigmented nevus Mixed epithelioid and spindle cell melanoma Spindle cell melanoma, NOS Blue nevus, malignant

294 6 1 7 3 2 1 3 2 1 320

91.9 1.9 0.3 2.2 0.9 0.6 0.3 0.9 0.6 0.3 100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C44

OTHER SKIN

C45

MESOTHELIOMA

C46

KAPOSI SARCOMA

C47, C49

CONNECTIVE, SOFT TISSUE

3 56 15 1 5 1 7 1 9 14 773 13 15 4 2 19 1 5 1,246 3 4 4 10 1 1 2 4 45 19 1 6 1 1 1 5 4 1 25 5 2 2 1 3 1 1 3 67 3 2 4 1 2,423

0.1 2.3 0.6 0.0 0.2 0.0 0.3 0.0 0.4 0.6 31.9 0.5 0.6 0.2 0.1 0.8 0.0 0.2 51.4 0.1 0.2 0.2 0.4 0.0 0.0 0.1 0.2 1.9 0.8 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 1.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 2.8 0.1 0.1 0.2 0.0 100.0

Mesothelioma, malignant Fibrous mesothelioma, malignant Mesothelioma, biphasic, malignant

35 3 3 41

85.4 7.3 7.3 100.0

9140

Kaposi sarcoma

18 18

100.0 100.0

8001 8002 8003 8800 8801 8802 8803 8804 8805 8806 8810

Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, giant cell type Sarcoma, NOS Spindle cell sarcoma Giant cell sarcoma Small cell sarcoma Epithelioid sarcoma Undifferentiated sarcoma Desmoplastic small round cell tumor Fibrosarcoma, NOS

3 1 1 203 12 7 1 8 2 3 46

0.4 0.1 0.1 26.0 1.5 0.9 0.1 1.0 0.3 0.4 5.9

8001 8010 8020 8021 8022 8031 8032 8033 8050 8051 8070 8071 8072 8073 8075 8081 8082 8083 8090 8091 8092 8093 8094 8095 8098 8102 8110 8140 8147 8200 8247 8260 8263 8310 8390 8402 8403 8410 8430 8480 8542 8550 8560 8562 8821 8830 8832 8833 8940 8980 9364

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Pleomorphic carcinoma Giant cell carcinoma Spindle cell carcinoma, NOS Pseudosarcomatous carcinoma Papillary carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Bowen disease Lymphoepithelial carcinoma Basaloid squamous cell carcinoma Basal cell carcinoma, NOS Multifocal superficial basal cell carcinoma Infiltrating basal cell carcinoma, NOS Basal cell carcinoma, fibroepithelial Basosquamous carcinoma Metatypical carcinoma Adenoid basal carcinoma Trichilemmocarcinoma Pilomatrix carcinoma Adenocarcinoma, NOS Basal cell adenocarcinoma Adenoid cystic carcinoma Merkel cell carcinoma Papillary adenocarcinoma, NOS Adenocarcinoma in tubulovillous adenoma Clear cell adenocarcinoma, NOS Skin appendage carcinoma Nodular hidradenoma, malignant Malignant eccrine spiradenoma Sebaceous adenocarcinoma Mucoepidermoid carcinoma Mucinous adenocarcinoma Paget disease, extramammary Acinar cell carcinoma Adenosquamous carcinoma Epithelial-myoepithelial carcinoma Aggressive fibromatosis Malignant fibrous histiocytoma Dermatofibrosarcoma, NOS Pigmented dermatofibrosarcoma protuberans Mixed tumor, malignant, NOS Carcinosarcoma, NOS Peripheral neuroectodermal tumor

9050 9051 9053

187

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C50

188

BREAST

8811 8814 8821 8830 8840 8850 8851 8852 8853 8854 8858 8890 8894 8895 8900 8901 8902 8910 8920 8963 8990 9040 9041 9043 9044 9064 9071 9080 9082 9085 9120 9150 9240 9251 9252 9364 9370 9500 9540 9560 9580 9581

Fibromyxosarcoma Infantile fibrosarcoma Aggressive fibromatosis Malignant fibrous histiocytoma Myxosarcoma Liposarcoma, NOS Liposarcoma, well differentiated Myxoid liposarcoma Round cell liposarcoma Pleomorphic liposarcoma Dedifferentiated liposarcoma Leiomyosarcoma, NOS Angiomyosarcoma Myosarcoma Rhabdomyosarcoma, NOS Pleomorphic rhabdomyosarcoma, adult type Mixed type rhabdomyosarcoma Embryonal rhabdomyosarcoma, NOS Alveolar rhabdomyosarcoma Malignant rhabdoid tumor Mesenchymoma, malignant Synovial sarcoma, NOS Synovial sarcoma, spindle cell Synovial sarcoma, biphasic Clear cell sarcoma, NOS Germinoma Yolk sac tumor Teratoma, malignant, NOS Malignant teratoma, undifferentiated Mixed germ cell tumor Hemangiosarcoma Hemangiopericytoma, malignant Mesenchymal chondrosarcoma Malignant giant cell tumor of soft parts Malignant tenosynovial giant cell tumor Peripheral neuroectodermal tumor Chordoma, NOS Neuroblastoma, NOS Malignant peripheral nerve sheath tumor Neurilemoma, malignant Granular cell tumor, malignant Alveolar soft part sarcoma

7 3 4 49 3 96 9 26 1 10 3 51 2 3 47 10 1 11 6 1 1 23 3 2 8 1 3 7 1 1 27 4 2 1 5 2 2 5 35 14 2 2 781

0.9 0.4 0.5 6.3 0.4 12.3 1.2 3.3 0.1 1.3 0.4 6.5 0.3 0.4 6.0 1.3 0.1 1.4 0.8 0.1 0.1 2.9 0.4 0.3 1.0 0.1 0.4 0.9 0.1 0.1 3.5 0.5 0.3 0.1 0.6 0.3 0.3 0.6 4.5 1.8 0.3 0.3 100.0

8001 8003 8004 8010 8013 8020 8021 8022 8032 8033 8034 8050 8052 8070 8071 8072 8074 8075 8076 8123 8140 8200 8201 8210 8211 8230 8246 8251 8260 8315 8430 8440

Tumor cells, malignant Malignant tumor, giant cell type Malignant tumor, spindle cell type Carcinoma, NOS Large cell neuroendocrine carcinoma Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Pleomorphic carcinoma Spindle cell carcinoma, NOS Pseudosarcomatous carcinoma Polygonal cell carcinoma Papillary carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, spindle cell Squamous cell carcinoma, adenoid Squamous cell carcinoma, microinvasive Basaloid carcinoma Adenocarcinoma, NOS Adenoid cystic carcinoma Cribriform carcinoma, NOS Adenocarcinoma in adenomatous polyp Tubular adenocarcinoma Solid carcinoma, NOS Neuroendocrine carcinoma, NOS Alveolar adenocarcinoma Papillary adenocarcinoma, NOS Glycogen-rich carcinoma Mucoepidermoid carcinoma Cystadenocarcinoma, NOS

11 1 1 542 1 71 3 3 2 1 1 1 67 1 72 1 1 1 2 1 328 8 6 1 14 2 1 1 6 1 1 2

0.1 0.0 0.0 3.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C51

VULVA

C52

VAGINA

151 1 14,882 11 3 64 2 102 1 2 267 1,267 116 26 2 8 8 2 1 3 1 5 4 1 3 1 1 2 3 7 1 2 57 94 2 18,258

0.8 0.0 81.5 0.1 0.0 0.4 0.0 0.6 0.0 0.0 1.5 6.9 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 100.0

Carcinoma, NOS Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Basaloid squamous cell carcinoma Basal cell carcinoma, NOS Adenocarcinoma, NOS Adenoid cystic carcinoma Mucoepidermoid carcinoma Mucin-producing adenocarcinoma Paget disease, extramammary Adenosquamous carcinoma Malignant melanoma, NOS Epithelioid sarcoma Malignant fibrous histiocytoma Leiomyosarcoma, NOS Granular cell tumor, malignant

9 2 72 2 2 1 5 8 1 1 1 3 1 10 2 1 1 1 123

7.3 1.6 58.5 1.6 1.6 0.8 4.1 6.5 0.8 0.8 0.8 2.4 0.8 8.1 1.6 0.8 0.8 0.8 100.0

Carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Squamous cell carcinoma, microinvasive Basaloid squamous cell carcinoma Adenocarcinoma, NOS Adenoid cystic carcinoma Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Cystadenocarcinoma, NOS Mucinous adenocarcinoma Adenosquamous carcinoma Sarcoma, NOS Leiomyosarcoma, NOS

11 58 3 8 2 1 1 1 21 1 2 1 1 1 1 1 1

8.9 47.2 2.4 6.5 1.6 0.8 0.8 0.8 17.1 0.8 1.6 0.8 0.8 0.8 0.8 0.8 0.8

8440 8480 8481 8500 8501 8502 8503 8504 8510 8512 8513 8520 8521 8522 8523 8530 8540 8541 8543 8550 8560 8573 8575 8800 8802 8810 8821 8850 8851 8852 8890 8894 8935 8980 9020 9120

Cystadenocarcinoma, NOS Mucinous adenocarcinoma Mucin-producing adenocarcinoma Infiltrating duct carcinoma, NOS Comedocarcinoma, NOS Secretory carcinoma of breast Intraductal papillary adenocarcinoma with invasion Intracystic carcinoma, NOS Medullary carcinoma, NOS Medullary carcinoma with lymphoid stroma Atypical medullary carcinoma Lobular carcinoma, NOS Infiltrating ductular carcinoma Infiltrating duct and lobular carcinoma Infiltrating duct mixed with other types of carcinoma Inflammatory carcinoma Paget disease, mammary Paget disease and infiltrating duct carcinoma Paget disease and intraductal carcinoma Acinar cell carcinoma Adenosquamous carcinoma Adenocarcinoma with apocrine metaplasia Metaplastic carcinoma, NOS Sarcoma, NOS Giant cell sarcoma Fibrosarcoma, NOS Aggressive fibromatosis Liposarcoma, NOS Liposarcoma, well differentiated Myxoid liposarcoma Leiomyosarcoma, NOS Angiomyosarcoma Stromal sarcoma, NOS Carcinosarcoma, NOS Phyllodes tumor, malignant Hemangiosarcoma

8010 8020 8070 8071 8072 8083 8090 8140 8200 8430 8481 8542 8560 8720 8804 8830 8890 9580

8010 8070 8071 8072 8073 8075 8076 8083 8140 8200 8260 8310 8440 8480 8560 8800 8890

189

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

190

C53

CERVIC UTERI

C54

CORPUS UTERI

8901 8980 8990 9071 9364

Pleomorphic rhabdomyosarcoma, adult type Carcinosarcoma, NOS Mesenchymoma, malignant Yolk sac tumor Peripheral neuroectodermal tumor

1 4 1 1 1 123

0.8 3.3 0.8 0.8 0.8 100.0

8001 8003 8010 8013 8015 8020 8021 8032 8033 8041 8050 8051 8052 8070 8071 8072 8073 8074 8075 8076 8083 8098 8123 8140 8200 8231 8246 8260 8262 8263 8310 8320 8380 8384 8440 8480 8481 8482 8560 8570 8800 8810 8890 8900 8933 8950 8980

Tumor cells, malignant Malignant tumor, giant cell type Carcinoma, NOS Large cell neuroendocrine carcinoma Glassy cell carcinoma Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Spindle cell carcinoma, NOS Pseudosarcomatous carcinoma Small cell carcinoma, NOS Papillary carcinoma, NOS Verrucous carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, spindle cell Squamous cell carcinoma, adenoid Squamous cell carcinoma, microinvasive Basaloid squamous cell carcinoma Adenoid basal carcinoma Basaloid carcinoma Adenocarcinoma, NOS Adenoid cystic carcinoma Carcinoma simplex Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Villous adenocarcinoma Adenocarcinoma in tubulovillous adenoma Clear cell adenocarcinoma, NOS Granular cell carcinoma Endometrioid adenocarcinoma, NOS Adenocarcinoma, endocervical type Cystadenocarcinoma, NOS Mucinous adenocarcinoma Mucin-producing adenocarcinoma Mucinous adenocarcinoma, endocervical type Adenosquamous carcinoma Adenocarcinoma with squamous metaplasia Sarcoma, NOS Fibrosarcoma, NOS Leiomyosarcoma, NOS Rhabdomyosarcoma, NOS Adenosarcoma Mullerian mixed tumor Carcinosarcoma, NOS

3 1 244 4 1 93 1 1 1 1 14 1 6 1,673 195 862 42 1 5 37 3 2 1 857 1 1 1 27 4 2 31 1 47 11 2 26 1 1 74 5 2 1 8 1 2 5 21 4,324

0.1 0.0 5.6 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 38.7 4.5 19.9 1.0 0.0 0.1 0.9 0.1 0.0 0.0 19.8 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.0 1.1 0.3 0.0 0.6 0.0 0.0 1.7 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 100.0

8010 8011 8020 8021 8022 8032 8050 8052 8070 8071 8072 8073 8140 8260 8310 8320 8380 8381

Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Pleomorphic carcinoma Spindle cell carcinoma, NOS Papillary carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Adenocarcinoma, NOS Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Granular cell carcinoma Endometrioid adenocarcinoma, NOS Endometrioid adenofibroma, malignant

121 1 35 1 1 1 19 1 38 1 8 2 780 17 23 2 955 8

5.6 0.0 1.6 0.0 0.0 0.0 0.9 0.0 1.8 0.0 0.4 0.1 35.9 0.8 1.1 0.1 44.0 0.4

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C55

UTERUS UNSPEC.

C56

OVARY

8440 8480 8560 8570 8800 8803 8804 8810 8814 8850 8890 8930 8931 8933 8935 8940 8950 8951 8963 8980

Cystadenocarcinoma, NOS Mucinous adenocarcinoma Adenosquamous carcinoma Adenocarcinoma with squamous metaplasia Sarcoma, NOS Small cell sarcoma Epithelioid sarcoma Fibrosarcoma, NOS Infantile fibrosarcoma Liposarcoma, NOS Leiomyosarcoma, NOS Endometrial stromal sarcoma, NOS Endometrial stromal sarcoma, low grade Adenosarcoma Stromal sarcoma, NOS Mixed tumor, malignant, NOS Mullerian mixed tumor Mesodermal mixed tumor Malignant rhabdoid tumor Carcinosarcoma, NOS

1 4 11 2 9 1 1 2 1 1 16 60 12 1 1 1 18 1 1 13 2,171

0.0 0.2 0.5 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.7 2.8 0.6 0.0 0.0 0.0 0.8 0.0 0.0 0.6 100.0

8001 8002 8010 8020 8050 8052 8070 8071 8072 8073 8140 8260 8262 8310 8323 8380 8381 8384 8440 8480 8560 8800 8805 8840 8852 8890 8891 8896 8900 8901 8933 8940 8950 8980

Tumor cells, malignant Malignant tumor, small cell type Carcinoma, NOS Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Adenocarcinoma, NOS Papillary adenocarcinoma, NOS Villous adenocarcinoma Clear cell adenocarcinoma, NOS Mixed cell adenocarcinoma Endometrioid adenocarcinoma, NOS Endometrioid adenofibroma, malignant Adenocarcinoma, endocervical type Cystadenocarcinoma, NOS Mucinous adenocarcinoma Adenosquamous carcinoma Sarcoma, NOS Undifferentiated sarcoma Myxosarcoma Myxoid liposarcoma Leiomyosarcoma, NOS Epithelioid leiomyosarcoma Myxoid leiomyosarcoma Rhabdomyosarcoma, NOS Pleomorphic rhabdomyosarcoma, adult type Adenosarcoma Mixed tumor, malignant, NOS Mullerian mixed tumor Carcinosarcoma, NOS

1 1 42 7 3 2 26 1 4 1 195 7 1 8 1 110 1 1 1 7 1 11 1 1 1 101 1 3 2 1 4 1 7 20 575

0.2 0.2 7.3 1.2 0.5 0.3 4.5 0.2 0.7 0.2 33.9 1.2 0.2 1.4 0.2 19.1 0.2 0.2 0.2 1.2 0.2 1.9 0.2 0.2 0.2 17.6 0.2 0.5 0.3 0.2 0.7 0.2 1.2 3.5 100.0

8001 8002 8003 8010 8011 8020 8050 8070 8071 8072 8075 8076 8140 8200 8210 8211

Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, giant cell type Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, adenoid Squamous cell carcinoma, microinvasive Adenocarcinoma, NOS Adenoid cystic carcinoma Adenocarcinoma in adenomatous polyp Tubular adenocarcinoma

21 1 1 311 2 89 12 56 7 4 1 1 766 3 1 1

0.6 0.0 0.0 9.1 0.1 2.6 0.4 1.6 0.2 0.1 0.0 0.0 22.5 0.1 0.0 0.0

191

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C57

192

OTHER FEMALE GENITAL

8240 8243 8246 8260 8310 8313 8320 8380 8381 8384 8440 8441 8450 8460 8461 8470 8471 8480 8481 8490 8560 8562 8570 8600 8620 8621 8631 8640 8670 8800 8810 8850 8890 8891 8935 8940 8950 8951 8980 8990 9000 9014 9015 9060 9064 9065 9070 9071 9080 9082 9083 9084 9085 9090 9100 9101 9110 9580

Carcinoid tumor, NOS Goblet cell carcinoid Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Clear cell adenocarcinofibroma Granular cell carcinoma Endometrioid adenocarcinoma, NOS Endometrioid adenofibroma, malignant Adenocarcinoma, endocervical type Cystadenocarcinoma, NOS Serous cystadenocarcinoma, NOS Papillary cystadenocarcinoma, NOS Papillary serous cystadenocarcinoma Serous surface papillary carcinoma Mucinous cystadenocarcinoma, NOS Papillary mucinous cystadenocarcinoma Mucinous adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell carcinoma Adenosquamous carcinoma Epithelial-myoepithelial carcinoma Adenocarcinoma with squamous metaplasia Thecoma, malignant Granulosa cell tumor, malignant Granulosa cell-theca cell tumor Sertoli-Leydig cell tumor, poorly differentiated Sertoli cell carcinoma Steroid cell tumor, malignant Sarcoma, NOS Fibrosarcoma, NOS Liposarcoma, NOS Leiomyosarcoma, NOS Epithelioid leiomyosarcoma Stromal sarcoma, NOS Mixed tumor, malignant, NOS Mullerian mixed tumor Mesodermal mixed tumor Carcinosarcoma, NOS Mesenchymoma, malignant Brenner tumor, malignant Serous adenocarcinofibroma Mucinous adenocarcinofibroma Dysgerminoma Germinoma Germ cell tumor, nonseminomatous Embryonal carcinoma, NOS Yolk sac tumor Teratoma, malignant, NOS Malignant teratoma, undifferentiated Malignant teratoma, intermediate Teratoma with malignant transformation Mixed germ cell tumor Struma ovarii, malignant Choriocarcinoma, NOS Choriocarcinoma combined with other germ cell elements Mesonephroma, malignant Granular cell tumor, malignant

8010 8020 8140 8260 8380 8440 8441 8460 8480 9100

Carcinoma, NOS Carcinoma, undifferentiated, NOS Adenocarcinoma, NOS Papillary adenocarcinoma, NOS Endometrioid adenocarcinoma, NOS Cystadenocarcinoma, NOS Serous cystadenocarcinoma, NOS Papillary serous cystadenocarcinoma Mucinous adenocarcinoma Choriocarcinoma, NOS

3 1 6 42 225 5 4 241 3 1 270 356 28 191 29 199 26 122 2 6 2 2 1 1 68 2 7 3 2 2 1 1 10 1 1 2 6 3 10 1 2 3 4 27 18 2 2 60 85 2 1 5 13 4 9 2 1 5 3,408

0.1 0.0 0.2 1.2 6.6 0.1 0.1 7.1 0.1 0.0 7.9 10.4 0.8 5.6 0.9 5.8 0.8 3.6 0.1 0.2 0.1 0.1 0.0 0.0 2.0 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.1 0.3 0.0 0.1 0.1 0.1 0.8 0.5 0.1 0.1 1.8 2.5 0.1 0.0 0.1 0.4 0.1 0.3 0.1 0.0 0.1 100.0

5 1 14 1 6 1 3 4 1 3 39

12.8 2.6 35.9 2.6 15.4 2.6 7.7 10.3 2.6 7.7 100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C58

PLACENTA

C60

PENIS

C61

PROSTATE

C62

TESTIS

8010 8890 9100 9101 9104

Carcinoma, NOS Leiomyosarcoma, NOS Choriocarcinoma, NOS Choriocarcinoma combined with other germ cell elements Placental site trophoblastic tumor

1 2 52 2 5 62

1.6 3.2 83.9 3.2 8.1 100.0

8001 8010 8020 8051 8070 8071 8081 8090 8140 8542 8720 8800 8832 8910

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Bowen disease Basal cell carcinoma, NOS Adenocarcinoma, NOS Paget disease, extramammary Malignant melanoma, NOS Sarcoma, NOS Dermatofibrosarcoma, NOS Embryonal rhabdomyosarcoma, NOS

1 8 2 3 84 3 1 2 4 2 1 1 1 1 114

0.9 7.0 1.8 2.6 73.7 2.6 0.9 1.8 3.5 1.8 0.9 0.9 0.9 0.9 100.0

8001 8010 8011 8020 8021 8041 8050 8070 8072 8120 8130 8140 8260 8310 8320 8480 8490 8500 8550 8802 8810 8900

Tumor cells, malignant Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Small cell carcinoma, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Transitional cell carcinoma, NOS Papillary transitional cell carcinoma Adenocarcinoma, NOS Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Granular cell carcinoma Mucinous adenocarcinoma Signet ring cell carcinoma Infiltrating duct carcinoma, NOS Acinar cell carcinoma Giant cell sarcoma Fibrosarcoma, NOS Rhabdomyosarcoma, NOS

8 235 2 60 1 1 1 29 1 20 2 2,645 1 1 1 2 2 9 64 1 1 2 3,089

0.3 7.6 0.1 1.9 0.0 0.0 0.0 0.9 0.0 0.6 0.1 85.6 0.0 0.0 0.0 0.1 0.1 0.3 2.1 0.0 0.0 0.1 100.0

8001 8010 8020 8070 8140 8480 8550 8631 8640 8650 8800 8830 8890 8900 8910 8940 9061 9062 9063 9064 9065 9070 9071 9080 9081 9082

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Adenocarcinoma, NOS Mucinous adenocarcinoma Acinar cell carcinoma Sertoli-Leydig cell tumor, poorly differentiated Sertoli cell carcinoma Leydig cell tumor, malignant Sarcoma, NOS Malignant fibrous histiocytoma Leiomyosarcoma, NOS Rhabdomyosarcoma, NOS Embryonal rhabdomyosarcoma, NOS Mixed tumor, malignant, NOS Seminoma, NOS Seminoma, anaplastic Spermatocytic seminoma Germinoma Germ cell tumor, nonseminomatous Embryonal carcinoma, NOS Yolk sac tumor Teratoma, malignant, NOS Teratocarcinoma Malignant teratoma, undifferentiated

3 25 6 22 29 1 1 2 10 1 2 1 2 5 1 2 144 2 1 69 5 19 41 49 5 1

0.6 5.1 1.2 4.5 5.9 0.2 0.2 0.4 2.0 0.2 0.4 0.2 0.4 1.0 0.2 0.4 29.5 0.4 0.2 14.1 1.0 3.9 8.4 10.0 1.0 0.2

193

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

194

C63

OTHER MALE GENITAL

C64

KIDNEY

C65

RENAL PELVIS

C66

URETER

9085 9100 9102 9120

Mixed germ cell tumor Choriocarcinoma, NOS Malignant teratoma, trophoblastic Hemangiosarcoma

34 3 1 1 488

7.0 0.6 0.2 0.2 100.0

8010 8020 8051 8070 8090 8140 8480 8542 8850 8858 8910 9061 9064 9071 9081

Carcinoma, NOS Carcinoma, undifferentiated, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Basal cell carcinoma, NOS Adenocarcinoma, NOS Mucinous adenocarcinoma Paget disease, extramammary Liposarcoma, NOS Dedifferentiated liposarcoma Embryonal rhabdomyosarcoma, NOS Seminoma, NOS Germinoma Yolk sac tumor Teratocarcinoma

3 1 1 6 2 7 1 2 2 1 1 1 1 1 1 31

9.7 3.2 3.2 19.4 6.5 22.6 3.2 6.5 6.5 3.2 3.2 3.2 3.2 3.2 3.2 100.0

8000 8001 8010 8020 8050 8070 8071 8072 8120 8130 8140 8260 8310 8312 8317 8318 8320 8510 8800 8801 8840 8850 8858 8860 8900 8901 8959 8960 8963 8964 8980 9110 9364

Neoplasm, malignant Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Transitional cell carcinoma, NOS Papillary transitional cell carcinoma Adenocarcinoma, NOS Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Renal cell carcinoma, NOS Renal cell carcinoma, chromophobe type Renal cell carcinoma, sarcomatoid Granular cell carcinoma Medullary carcinoma, NOS Sarcoma, NOS Spindle cell sarcoma Myxosarcoma Liposarcoma, NOS Dedifferentiated liposarcoma Angiomyolipoma Rhabdomyosarcoma, NOS Pleomorphic rhabdomyosarcoma, adult type Malignant cystic nephroma Nephroblastoma, NOS Malignant rhabdoid tumor Clear cell sarcoma of kidney Carcinosarcoma, NOS Mesonephroma, malignant Peripheral neuroectodermal tumor

1 5 79 18 8 19 1 2 74 4 39 15 122 818 4 10 4 1 4 1 1 2 1 1 1 1 2 50 1 7 2 1 3 1,302

0.1 0.4 6.1 1.4 0.6 1.5 0.1 0.2 5.7 0.3 3.0 1.2 9.4 62.8 0.3 0.8 0.3 0.1 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.2 3.8 0.1 0.5 0.2 0.1 0.2 100.0

8010 8020 8070 8120 8130 8310 8800 8810

Carcinoma, NOS Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Transitional cell carcinoma, NOS Papillary transitional cell carcinoma Clear cell adenocarcinoma, NOS Sarcoma, NOS Fibrosarcoma, NOS

1 1 3 9 2 2 1 1 20

5.0 5.0 15.0 45.0 10.0 10.0 5.0 5.0 100.0

8010 8070 8120 8130

Carcinoma, NOS Squamous cell carcinoma, NOS Transitional cell carcinoma, NOS Papillary transitional cell carcinoma

2 3 22 2 29

6.9 10.3 75.9 6.9 100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C67

BLADDER

C68

OTHER URINARY ORGAN

C69

EYE

8 138 3 51 1 2 55 1 53 3 3 1,205 1 1 146 135 1 7 3 2 1 3 1 2 1 1 1 1 1 1 2 1 3 1 1 1 1 1,842

0.4 7.5 0.2 2.8 0.1 0.1 3.0 0.1 2.9 0.2 0.2 65.4 0.1 0.1 7.9 7.3 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 100.0

Carcinoma, NOS Carcinoma, undifferentiated, NOS Papillary carcinoma, NOS Squamous cell carcinoma, NOS Transitional cell carcinoma, NOS Papillary transitional cell carcinoma Adenocarcinoma, NOS Carcinosarcoma, NOS

4 1 1 2 3 1 12 2 26

15.4 3.8 3.8 7.7 11.5 3.8 46.2 7.7 100.0

Tumor cells, malignant Malignant tumor, giant cell type Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Adenocarcinoma, NOS Basal cell adenocarcinoma Adenoid cystic carcinoma Mucoepidermoid carcinoma Mucinous adenocarcinoma Malignant melanoma, NOS Rhabdomyosarcoma, NOS Pleomorphic rhabdomyosarcoma, adult type Hemangiosarcoma Hemangiopericytoma, malignant Lymphangiosarcoma Neuroblastoma, NOS Retinoblastoma, NOS Retinoblastoma, differentiated Retinoblastoma, undifferentiated Retinoblastoma, diffuse

1 1 5 1 4 29 13 2 4 2 1 10 3 1 1 1 1 2 69 2 1 1 155

0.6 0.6 3.2 0.6 2.6 18.7 8.4 1.3 2.6 1.3 0.6 6.5 1.9 0.6 0.6 0.6 0.6 1.3 44.5 1.3 0.6 0.6 100.0

8001 8010 8011 8020 8032 8033 8050 8052 8070 8071 8072 8120 8122 8123 8130 8140 8210 8260 8310 8430 8440 8480 8481 8490 8550 8570 8800 8804 8851 8852 8890 8900 8910 8980 9130 9580 9581

Tumor cells, malignant Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Spindle cell carcinoma, NOS Pseudosarcomatous carcinoma Papillary carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Transitional cell carcinoma, NOS Transitional cell carcinoma, spindle cell Basaloid carcinoma Papillary transitional cell carcinoma Adenocarcinoma, NOS Adenocarcinoma in adenomatous polyp Papillary adenocarcinoma, NOS Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Cystadenocarcinoma, NOS Mucinous adenocarcinoma Mucin-producing adenocarcinoma Signet ring cell carcinoma Acinar cell carcinoma Adenocarcinoma with squamous metaplasia Sarcoma, NOS Epithelioid sarcoma Liposarcoma, well differentiated Myxoid liposarcoma Leiomyosarcoma, NOS Rhabdomyosarcoma, NOS Embryonal rhabdomyosarcoma, NOS Carcinosarcoma, NOS Hemangioendothelioma, malignant Granular cell tumor, malignant Alveolar soft part sarcoma

8010 8020 8050 8070 8120 8130 8140 8980

8001 8003 8010 8011 8020 8070 8140 8147 8200 8430 8480 8720 8900 8901 9120 9150 9170 9500 9510 9511 9512 9513

195

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C70-C72

C73

196

BRAIN, NERVOUS SYSTEM

THYROID

8001 8002 8003 8720 8800 8801 8802 8806 8963 9060 9064 9070 9071 9080 9081 9085 9120 9130 9150 9170 9364 9370 9380 9381 9382 9383 9390 9391 9392 9393 9394 9400 9401 9411 9420 9423 9430 9440 9441 9442 9450 9451 9460 9470 9471 9472 9473 9480 9490 9500 9501 9503 9505 9508 9530 9531 9537 9538 9539 9540 9560 9561 9580

Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, giant cell type Malignant melanoma, NOS Sarcoma, NOS Spindle cell sarcoma Giant cell sarcoma Desmoplastic small round cell tumor Malignant rhabdoid tumor Dysgerminoma Germinoma Embryonal carcinoma, NOS Yolk sac tumor Teratoma, malignant, NOS Teratocarcinoma Mixed germ cell tumor Hemangiosarcoma Hemangioendothelioma, malignant Hemangiopericytoma, malignant Lymphangiosarcoma Peripheral neuroectodermal tumor Chordoma, NOS Glioma, malignant Gliomatosis cerebri Mixed glioma Subependymoma Choroid plexus carcinoma Ependymoma, NOS Ependymoma, anaplastic Papillary ependymoma Myxopapillary ependymoma Astrocytoma, NOS Astrocytoma, anaplastic Gemistocytic astrocytoma Fibrillary astrocytoma Polar spongioblastoma Astroblastoma Glioblastoma, NOS Giant cell glioblastoma Gliosarcoma Oligodendroglioma, NOS Oligodendroglioma, anaplastic Oligodendroblastoma Medulloblastoma, NOS Desmoplastic nodular medulloblastoma Medullomyoblastoma Primitive neuroectodermal tumor, NOS Cerebellar sarcoma, NOS Ganglioneuroblastoma Neuroblastoma, NOS Medulloepithelioma, NOS Neuroepithelioma, NOS Ganglioglioma, anaplastic Atypical teratoid/rhabdoid tumor Meningioma, malignant Meningothelial meningioma Transitional meningioma Papillary meningioma Meningeal sarcomatosis Malignant peripheral nerve sheath tumor Neurilemoma, malignant Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation Granular cell tumor, malignant

8001 8010 8011 8020 8021 8030 8032 8033

Tumor cells, malignant Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Giant cell and spindle cell carcinoma Spindle cell carcinoma, NOS Pseudosarcomatous carcinoma

64 3 2 1 13 1 2 2 3 1 68 1 4 9 2 6 4 1 8 1 8 1 162 6 11 1 4 62 7 4 2 236 52 6 8 1 4 343 11 42 57 19 4 93 7 3 34 12 2 73 1 1 9 6 324 15 2 10 9 16 51 4

3.3 0.2 0.1 0.1 0.7 0.1 0.1 0.1 0.2 0.1 3.5 0.1 0.2 0.5 0.1 0.3 0.2 0.1 0.4 0.1 0.4 0.1 8.4 0.3 0.6 0.1 0.2 3.2 0.4 0.2 0.1 12.3 2.7 0.3 0.4 0.1 0.2 17.8 0.6 2.2 3.0 1.0 0.2 4.8 0.4 0.2 1.8 0.6 0.1 3.8 0.1 0.1 0.5 0.3 16.8 0.8 0.1 0.5 0.5 0.8 2.6 0.2

6 1,925

0.3 100.0

1 121 19 53 51 2 1 2

0.0 5.4 0.8 2.4 2.3 0.1 0.0 0.1

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

C74

ADRENAL GLAND

C75

OTHER ENDOCRINE

8050 8051 8052 8070 8071 8073 8076 8140 8190 8241 8246 8260 8263 8290 8330 8331 8332 8335 8340 8341 8346 8350 8440 8480 8510 8550 8850 8980

Papillary carcinoma, NOS Verrucous carcinoma, NOS Papillary squamous cell carcinoma Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, microinvasive Adenocarcinoma, NOS Trabecular adenocarcinoma Enterochromaffin cell carcinoid Neuroendocrine carcinoma, NOS Papillary adenocarcinoma, NOS Adenocarcinoma in tubulovillous adenoma Oxyphilic adenocarcinoma Follicular adenocarcinoma, NOS Follicular adenocarcinoma, well differentiated Follicular adenocarcinoma, trabecular Follicular carcinoma, minimally invasive Papillary carcinoma, follicular variant Papillary microcarcinoma Mixed medullary-follicular carcinoma Nonencapsulated sclerosing carcinoma Cystadenocarcinoma, NOS Mucinous adenocarcinoma Medullary carcinoma, NOS Acinar cell carcinoma Liposarcoma, NOS Carcinosarcoma, NOS

956 1 11 36 1 1 1 101 1 1 1 246 2 5 420 4 10 1 139 23 3 2 1 3 22 1 2 4 2,249

42.5 0.0 0.5 1.6 0.0 0.0 0.0 4.5 0.0 0.0 0.0 10.9 0.1 0.2 18.7 0.2 0.4 0.0 6.2 1.0 0.1 0.1 0.0 0.1 1.0 0.0 0.1 0.2 100.0

8000 8010 8011 8020 8070 8140 8260 8370 8510 8700 8850 9120 9500

Neoplasm, malignant Carcinoma, NOS Epithelioma, malignant Carcinoma, undifferentiated, NOS Squamous cell carcinoma, NOS Adenocarcinoma, NOS Papillary adenocarcinoma, NOS Adrenal cortical carcinoma Medullary carcinoma, NOS Pheochromocytoma, malignant Liposarcoma, NOS Hemangiosarcoma Neuroblastoma, NOS

1 9 1 3 1 9 1 17 1 13 1 1 29 87

1.1 10.3 1.1 3.4 1.1 10.3 1.1 19.5 1.1 14.9 1.1 1.1 33.3 100.0

8001 8010 8020 8022 8070 8140 8200 8210 8263 8270 8272 8280 8281 8430 8710 8711 9064 9070 9080 9085 9361 9362 9380 9400 9580

Tumor cells, malignant Carcinoma, NOS Carcinoma, undifferentiated, NOS Pleomorphic carcinoma Squamous cell carcinoma, NOS Adenocarcinoma, NOS Adenoid cystic carcinoma Adenocarcinoma in adenomatous polyp Adenocarcinoma in tubulovillous adenoma Chromophobe carcinoma Pituitary carcinoma, NOS Acidophil carcinoma Mixed acidophil-basophil carcinoma Mucoepidermoid carcinoma Glomangiosarcoma Glomus tumor, malignant Germinoma Embryonal carcinoma, NOS Teratoma, malignant, NOS Mixed germ cell tumor Pineocytoma Pineoblastoma Glioma, malignant Astrocytoma, NOS Granular cell tumor, malignant

3 9 1 2 2 55 1 3 1 1 32 1 1 2 1 1 10 1 1 1 2 19 1 1 1 153

2.0 5.9 0.7 1.3 1.3 35.9 0.7 2.0 0.7 0.7 20.9 0.7 0.7 1.3 0.7 0.7 6.5 0.7 0.7 0.7 1.3 12.4 0.7 0.7 0.7 100.0

197

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

198

C81-C85, C96

LYMPHOMA

C90

MULTIPLE MYELOMA

C91-C95

LEUKAEMIA

9530 9590 9591 9596 9650 9651 9652 9653 9659 9661 9662 9663 9664 9665 9670 9671 9673 9675 9679 9680 9684 9687 9689 9690 9691 9695 9698 9699 9700 9701 9702 9705 9708 9709 9714 9717 9718 9719 9727 9728 9729 9740 9741 9754 9755 9756 9758

Meningioma, malignant Malignant lymphoma, NOS Malignant lymphoma, non-Hodgkin, NOS Composite Hodgkin and non-Hodgkin lymphoma Hodgkin lymphoma, NOS Hodgkin lymphoma, lymphocyte-rich Hodgkin lymphoma, mixed cellularity, NOS Hodgkin lymphoma, lymphocyte depletion, NOS Hodgkin lymphoma, nodular lymphocyte predominance Hodgkin granuloma Hodgkin sarcoma Hodgkin lymphoma, nodular sclerosis, NOS Hodgkin lymphoma, nodular sclerosis, cellular phase Hodgkin lymphoma, nodular sclerosis, grade 1 Malignant lymphoma, small B lymphocytic, NOS Malignant lymphoma, lymphoplasmacytic Mantle cell lymphoma Malignant lymphoma, mixed small and large cell, diffuse Mediastinal large B-cell lymphoma Malignant lymphoma, large B-cell, diffuse, NOS Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS Burkitt lymphoma, NOS Splenic marginal zone B-cell lymphoma Follicular lymphoma, NOS Follicular lymphoma, grade 2 Follicular lymphoma, grade 1 Follicular lymphoma, grade 3 Marginal zone B-cell lymphoma, NOS Mycosis fungoides Sezary syndrome Mature T-cell lymphoma, NOS Angioimmunoblastic T-cell lymphoma Subcutaneous panniculitis-like T-cell lymphoma Cutaneous T-cell lymphoma, NOS Anaplastic large cell lymphoma, T cell and Null cell type Intestinal T-cell lymphoma Primary cutaneous CD30+ T-cell lymphoproliferative disorder NK/T-cell lymphoma, nasal and nasal-type Precursor cell lymphoblastic lymphoma, NOS Precursor B-cell lymphoblastic lymphoma Precursor T-cell lymphoblastic lymphoma Mast cell sarcoma Malignant mastocytosis Langerhans cell histiocytosis, disseminated Histiocytic sarcoma Langerhans cell sarcoma Follicular dendritic cell sarcoma

1 701 1,652 152 528 27 13 15 3 1 3 59 1 8 47 8 45 7 4 1,395 17 33 4 163 6 6 16 30 44 3 167 19 1 5 97 1 4 7 9 19 6 4 1 11 3 1 1 5,348

0.0 13.1 30.9 2.8 9.9 0.5 0.2 0.3 0.1 0.0 0.1 1.1 0.0 0.1 0.9 0.1 0.8 0.1 0.1 26.1 0.3 0.6 0.1 3.0 0.1 0.1 0.3 0.6 0.8 0.1 3.1 0.4 0.0 0.1 1.8 0.0 0.1 0.1 0.2 0.4 0.1 0.1 0.0 0.2 0.1 0.0 0.0 100.0

9731 9732 9733 9734

Plasmacytoma, NOS Multiple myeloma Plasma cell leukemia Plasmacytoma, extramedullary

40 679 4 2 725

5.5 93.7 0.6 0.3 100.0

9800 9801 9805 9820 9823 9826 9827 9832 9833 9834 9835 9836 9837 9840 9860 9861 9863 9866

Leukemia, NOS 126 Acute leukemia, NOS 659 Acute biphenotypic leukemia 4 Lymphoid leukemia, NOS 105 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma 124 Burkitt cell leukemia 85 Adult T-cell leukemia/lymphoma (HTLV-1 positive) 27 Prolymphocytic leukemia, NOS 4 Prolymphocytic leukemia, B-cell type 1 Prolymphocytic leukemia, T-cell type 1 Precursor cell lymphoblastic leukemia, NOS 789 Precursor B-cell lymphoblastic leukemia 125 Precursor T-cell lymphoblastic leukemia 32 Acute myeloid leukemia, M6 type 93 Myeloid leukemia, NOS 159 Acute myeloid leukemia, NOS 1,362 Chronic myeloid leukemia, NOS 559 Acute promyelocytic leukemia 130

2.8 14.4 0.1 2.3 2.7 1.9 0.6 0.1 0.0 0.0 17.3 2.7 0.7 2.0 3.5 29.8 12.2 2.8

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

OTHER & UNSPEC.

9867 9870 9871 9872 9873 9874 9875 9876 9891 9895 9896 9910 9930 9931 9940 9945 9946

Acute myelomonocytic leukemia Acute basophilic leukemia Acute myeloid leukemia, with abnormal marrow eosinophils Acute myeloid leukemia, minimal differentiation Acute myeloid leukemia without maturation Acute myeloid leukemia with maturation Chronic myelogenous leukemia, BCR/ABL positive Atypical chronic myeloid leukemia, BCR/ABL negative Acute monocytic leukemia Acute myeloid leukemia with multilineage dysplasia Acute myeloid leukemia, t(8;21)(q22;q22) Acute megakaryoblastic leukemia Myeloid sarcoma Acute panmyelosis with myelofibrosis Hairy cell leukemia Chronic myelomonocytic leukemia, NOS Juvenile myelomonocytic leukemia

36 2 6 12 1 1 5 9 26 7 6 8 21 18 11 11 5 4,570

0.8 0.0 0.1 0.3 0.0 0.0 0.1 0.2 0.6 0.2 0.1 0.2 0.5 0.4 0.2 0.2 0.1 100.0

8000 8001 8002 8003 8004 8010 8012 8013 8020 8021 8022 8031 8032 8041 8050 8051 8070 8071 8072 8073 8075 8082 8083 8120 8140 8141 8153 8200 8210 8211 8240 8246 8249 8260 8263 8290 8310 8430 8440 8461 8470 8480 8490 8500 8521 8550 8560 8680 8800 8801 8802 8803 8810 8821 8830 8850 8851

Neoplasm, malignant Tumor cells, malignant Malignant tumor, small cell type Malignant tumor, giant cell type Malignant tumor, spindle cell type Carcinoma, NOS Large cell carcinoma, NOS Large cell neuroendocrine carcinoma Carcinoma, undifferentiated, NOS Carcinoma, anaplastic, NOS Pleomorphic carcinoma Giant cell carcinoma Spindle cell carcinoma, NOS Small cell carcinoma, NOS Papillary carcinoma, NOS Verrucous carcinoma, NOS Squamous cell carcinoma, NOS Squamous cell carcinoma, keratinizing, NOS Squamous cell carcinoma, large cell, nonkeratinizing, NOS Squamous cell carcinoma, small cell, nonkeratinizing Squamous cell carcinoma, adenoid Lymphoepithelial carcinoma Basaloid squamous cell carcinoma Transitional cell carcinoma, NOS Adenocarcinoma, NOS Scirrhous adenocarcinoma Gastrinoma, malignant Adenoid cystic carcinoma Adenocarcinoma in adenomatous polyp Tubular adenocarcinoma Carcinoid tumor, NOS Neuroendocrine carcinoma, NOS Atypical carcinoid tumor Papillary adenocarcinoma, NOS Adenocarcinoma in tubulovillous adenoma Oxyphilic adenocarcinoma Clear cell adenocarcinoma, NOS Mucoepidermoid carcinoma Cystadenocarcinoma, NOS Serous surface papillary carcinoma Mucinous cystadenocarcinoma, NOS Mucinous adenocarcinoma Signet ring cell carcinoma Infiltrating duct carcinoma, NOS Infiltrating ductular carcinoma Acinar cell carcinoma Adenosquamous carcinoma Paraganglioma, malignant Sarcoma, NOS Spindle cell sarcoma Giant cell sarcoma Small cell sarcoma Fibrosarcoma, NOS Aggressive fibromatosis Malignant fibrous histiocytoma Liposarcoma, NOS Liposarcoma, well differentiated

2 39 3 2 3 217 7 1 65 4 1 1 3 13 3 1 185 3 11 1 1 1 2 3 285 1 1 4 1 1 3 10 1 5 2 2 5 2 1 17 1 13 4 1 1 1 5 1 9 1 1 1 1 1 3 13 3

0.2 3.6 0.3 0.2 0.3 20.1 0.6 0.1 6.0 0.4 0.1 0.1 0.3 1.2 0.3 0.1 17.1 0.3 1.0 0.1 0.1 0.1 0.2 0.3 26.3 0.1 0.1 0.4 0.1 0.1 0.3 0.9 0.1 0.5 0.2 0.2 0.5 0.2 0.1 1.6 0.1 1.2 0.4 0.1 0.1 0.1 0.5 0.1 0.8 0.1 0.1 0.1 0.1 0.1 0.3 1.2 0.3

199

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

8852 8854 8858 8890 8900 8936 8940 8963 8980 8981 9064 9071 9080 9085 9100 9170 9364 9370 9372 9500 9760 9761 9762

200

Myxoid liposarcoma Pleomorphic liposarcoma Dedifferentiated liposarcoma Leiomyosarcoma, NOS Rhabdomyosarcoma, NOS Gastrointestinal stromal sarcoma Mixed tumor, malignant, NOS Malignant rhabdoid tumor Carcinosarcoma, NOS Carcinosarcoma, embryonal Germinoma Yolk sac tumor Teratoma, malignant, NOS Mixed germ cell tumor Choriocarcinoma, NOS Lymphangiosarcoma Peripheral neuroectodermal tumor Chordoma, NOS Dedifferentiated chordoma Neuroblastoma, NOS Immunoproliferative disease, NOS Waldenstrom macroglobulinemia Heavy chain disease, NOS

1 1 2 8 6 43 1 2 2 1 8 1 11 3 1 5 3 2 1 7 3 6 2 1,093

0.1 0.1 0.2 0.7 0.6 4.0 0.1 0.2 0.2 0.1 0.7 0.1 1.0 0.3 0.1 0.5 0.3 0.2 0.1 0.6 0.3 0.5 0.2 100.0

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 100: CANCER NOTIFICATION FORM

201

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

APPENDIX 101: EXPLANATORY NOTES FOR COMPLETING CANCER NOTIFICATION FORM Please Notify a) All case of cancers (i.e. carcinomas, sarcomas, leukaemias and all other malignant tumours) diagnosed or treated in your hospital, clinic or practice. b) Confirmed cases of cancer as well as cases of ‘probable cancer’ in which the diagnosis is based only on clinical finding (i.e. without histological, radiological or other methods of confirmation). c) All cases diagnosed in Malaysia regardless of citizenships or place of domicile of the patient. d) Cancer cases referred to your hospital/clinic/practice which may have already been notified by the previous attending doctor. e) Follow up cases; please use the same form (Fill in name, I/C number, source of information and any other information that is different from the original previous notification form). You may choose to notify only once.

PROCEDURE 1. Patient Identification No. - For Malaysian patient with new I/C No. fill up all the 12 digits and the old I/C No. if available - For patient with only old I/C No. fill up his/her I/C No. in the Identification No. boxes.

- Children below 12 years without NRIC, insert patient’s I/C No. with additional M or F in the appropriate boxes indicating mother or father NRIC was used (e.g. A 1234567M) - Passport No. Police/ Arm Forces Identification Card Number to be used for foreigners/ police/ arms personnel. (please indicate) Name – Full name in block letters as in NRIC/ passport Usual Resident Address: Address where the patient usually resides at least for 6 months [Note: The address NRIC may not be the same] Date of birth: Insert date of birth of patient into boxes. [If not available insert year of birth] Sex, Ethnic Group, Citizenship : Tick appropriate box 2. Source of Information (refers to Hospital/ Clinic the notifying doctor is working in) 3. Diagnosis (If insufficient space, write the information on a piece of paper and attach as appendix) Diagnosis (Site for topography): This refers to the diagnosis at the time of notification Please write in words with as much detail as possible.

Pathological Diagnosis (Morphology): Please write in words with as much detail as possible 4. Date of Diagnosis: Insert date of diagnosis made (Date that can be verified from records) and follow IARC definition* 5.

6.

7.

8.

9.

202

Basis of diagnosis: Tick appropriate box(es) Stage of Disease at the time of diagnosis: Fill in and tick appropriate box(es) Type of treatment: Tick appropriate box(es) and fill in date of first treatment Present status: Tick the appropriate box and fill in relevant details.

Date of notification: Insert the date into the appropriate box

MALAYSIAN NATIONAL CANCER REGISTRY REPORT

2007-2011

*Definition of Incidence Date 1. Date of first histological or cytological confirmation

a) Date when the specimen was taken (biopsy or operation)

b) Date of receipt by the pathologist

c) Date of the pathology report.

2. Date of admission to the hospital because of this malignancy.

3. Date of first consultation at the outpatient clinic (only).

4. Date of diagnosis, other than 1, 2 or 3.

5. Date of death, if no information than that the patient has died because of a malignancy.

6. Date of death, if the malignancy is discovered at autopsy.

203

National Cancer Institute, Ministry of Health No. 4, Jalan P7, Presint 7, 62250 Putrajaya Tel : (603) 8892 5555 Fax : (603) 8892 5625